Sentence,class,file
2008;26(1): 41-44. http://www.medscape.com/viewarticle/572312.,Non-OADS,/arxiv_data1/oa_pdf/76/38/10.1177_2333392817701050.PMC5406120.pdf
2008;22(11):829-832. http://en.cnki.com.cn/Article_en/CJFDTotal- ZXWS200811012.htm.,OADS,/arxiv_data1/oa_pdf/76/38/10.1177_2333392817701050.PMC5406120.pdf
2002;40(4):271-282. http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/76/38/10.1177_2333392817701050.PMC5406120.pdf
The Cochrane Colla- boration; 2011. http://www.handbook.cochrane.org.,OADS,/arxiv_data1/oa_pdf/76/38/10.1177_2333392817701050.PMC5406120.pdf
"https://doi.org/10.1177/2050313X17703021 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17703021 journals.sagepub.com/home/sco Introduction Myotonic dystrophy type 2, also known as proximal myotonic  myopathy (PROMM), is an autosomal dominant, progressive multisystem disorder, affecting the muscle, peripheral nerves, central nervous system, eyes, ears, endocrine system, liver, blood (eosinophilia), and the myocardium.",Non-OADS,/arxiv_data1/oa_pdf/d6/94/10.1177_2050313X17703021.PMC5406121.pdf
"https://doi.org/10.1177/2054358117705372Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –9 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117705372 journals.sagepub.com/home/cjkOriginal Research Article705372 CJKXXX10.1177/2054358117705372Canadian Journal of Kidney Health and DiseaseWhitlock et al research-article 2017 Validation of the Kidney Failure Risk  Equation in Manitoba Reid H. Whitlock1,2, Mariette Chartier1,3, Paul Komenda1,2,4,   Jay Hingwala4,5, Claudio Rigatto1,2,4, Randy Walld3,   Allison Dart1, and Navdeep Tangri1,2,4 Abstract Background: Patients with chronic kidney disease (CKD) are at risk to progress to kidney failure.",Non-OADS,/arxiv_data1/oa_pdf/db/5d/10.1177_2054358117705372.PMC5406122.pdf
http://www12.statcan.ca/census-recensement/2006/dp-pd/prof/92-594/index.cfm?Lang=E.,OADS,/arxiv_data1/oa_pdf/db/5d/10.1177_2054358117705372.PMC5406122.pdf
"https://doi.org/10.1177/2333721417702350Gerontology & Geriatric Medicine Volume 3: 1–8 © The Author(s) 2017 Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417702350 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Health and Expectations Regarding  Aging Older adults are encouraged to use health-promoting  resources and to participate in a healthy lifestyle (Center  for Disease Control and Prevention, 2013), but there is wide variability in the adoption of active lifestyles.",Non-OADS,/arxiv_data1/oa_pdf/19/a4/10.1177_2333721417702350.PMC5406123.pdf
"Retrieved from http://www.afhayes.com/public/process2012.pdf Hays, R. D., & Morales, L. S. (2001).",Non-OADS,/arxiv_data1/oa_pdf/19/a4/10.1177_2333721417702350.PMC5406123.pdf
"https://doi.org/10.1177/2054358117699822Canadian Journal of Kidney Health  and Disease  Volume 4 : 1 –10 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117699822 journals.sagepub.com/home/cjkOriginal Research Article699822 CJKXXX10.1177/2054358117699822Canadian Journal of Kidney Health and DiseaseZimmerman et al research-article 2017 The Risk of Acute Rejection Following  Kidney Transplant by 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Status:  A Prospective Cohort Study Deborah Zimmerman1, Andrew A. House2, S. Joseph Kim3,  Ronald A. Booth4, Tinghua Zhang5, Tim Ramsay5,   and Greg Knoll1 Abstract Background: Prediction of acute kidney transplant rejection remains imperfect despite several known risk factors.",Non-OADS,/arxiv_data1/oa_pdf/f3/1d/10.1177_2054358117699822.PMC5406125.pdf
"https://doi.org/10.1177/2333721417700368Gerontology & Geriatric Medicine Volume 3: 1 –5 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417700368 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Case: AB Mrs. AB is an 84-year-old Caucasian female with a his- tory of hypertension, osteoporosis, type 2 diabetes, dys-lipidemia, osteoarthritis, and persistent depression who presents to the office as a new patient with worsening ambulation: “I’m just not getting around well.” The patient lives in a small house above the family  farm, on the side of a mountain.",Non-OADS,/arxiv_data1/oa_pdf/ed/89/10.1177_2333721417700368.PMC5406126.pdf
"Care Level Summary: Locked Dementia  Unit in AL (http://www.aplaceformom.com/ blog/2013-3-4-assisted-living-vs-memory- care/) AB knows many of the staff in the locked unit, as  they also work on the AL side; she does not become agi- tated after her move.",Non-OADS,/arxiv_data1/oa_pdf/ed/89/10.1177_2333721417700368.PMC5406126.pdf
Care Level Summary: Nursing Home  Intermediate Care (ICF) (https://www.caring.,Non-OADS,/arxiv_data1/oa_pdf/ed/89/10.1177_2333721417700368.PMC5406126.pdf
"Retrieved from http://www.cdc.gov/nchs/fastats/nursing-home-care.htm Doyle, T. (2015).",Non-OADS,/arxiv_data1/oa_pdf/ed/89/10.1177_2333721417700368.PMC5406126.pdf
"Retrieved from http://lcbseniorliving.com/2015/01/09/ assisted-living-vs-nursing-home-care Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007).",Non-OADS,/arxiv_data1/oa_pdf/ed/89/10.1177_2333721417700368.PMC5406126.pdf
"American Journal of Geriatric Pharmacotherapy, 5,   345-351. http://hospiceactionnetwork.org/linked_documents/get_ informed/issues/nursing_home/HAN_NH_QA.pdf https://www.caring.com/articles/assisted-living-versus- skilled-nursing-care https://www.nccdp.org/wanderingNeufeld, K. J., Yue, J., Robinson, T. N., Inouye, S. K., &  Needham, D. M. (2016).",Non-OADS,/arxiv_data1/oa_pdf/ed/89/10.1177_2333721417700368.PMC5406126.pdf
"SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1603119/DC1Supplementary TextSCIENCE ADVANCES |RESEARCH ARTICLE Wilts et al .,Sci.",Non-OADS,/arxiv_data1/oa_pdf/79/33/1603119.PMC5406134.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602411/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/29/d5/1602411.PMC5406135.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602750/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/aa/7e/1602750.PMC5406136.pdf
"D. Bates, M. Maechler, B. Bolker, S. Walker, “lme4: Linear mixed-effects models using ‘eigen ’and S4, ”R package version 1.1-7 (2014); https://cran.r-project.org/web/packages/ lme4/index.html.",Non-OADS,/arxiv_data1/oa_pdf/aa/7e/1602750.PMC5406136.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602614/DC1IntroductionPDE-FIND Examples Limitationsfig.,Non-OADS,/arxiv_data1/oa_pdf/f7/f8/1602614.PMC5406137.pdf
All data and codes used in this manuscript are publicly available on GitHub at https://github.com/snagcliffs/PDE-FIND.,Non-OADS,/arxiv_data1/oa_pdf/f7/f8/1602614.PMC5406137.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602847/DC1Synthetic proceduresfig.,Non-OADS,/arxiv_data1/oa_pdf/45/33/1602847.PMC5406138.pdf
"We used the monthly 25 × 25 –km 2Bootstrap sea ice concentra- tions from Nimbus-7 SMMR and DMSP SSM/I-SSMIS, Version 2 (35) downloaded from http://nsidc.org/data/docs/daac/nsidc0079_ bootstrap_seaice.gd.html.",OADS,/arxiv_data1/oa_pdf/97/c0/1601365.PMC5406139.pdf
Data on the weekly presence of snow cover are available on a 25 × 25–km 2grid from 1966 to 2014 ( 36) from the National Snow and Ice Data Center (ftp://sidads.colorado.edu/pub/DATASETS/nsidc0046_weekly_snow_seaice/).,OADS,/arxiv_data1/oa_pdf/97/c0/1601365.PMC5406139.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1601365/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/97/c0/1601365.PMC5406139.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602429/DC1Supplementary Materials and Methodsfig.,Non-OADS,/arxiv_data1/oa_pdf/06/5c/1602429.PMC5406140.pdf
"https://doi.org/10.1177/2333721417697843Gerontology & Geriatric Medicine Volume 3: 1 –6 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417697843 journals.sagepub.com/home/ggm Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use,  reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction Vitamin D insufficiency and deficiency have been  related to a range of adverse health outcomes (Pludowski et al., 2013).",Non-OADS,/arxiv_data1/oa_pdf/c7/cb/10.1177_2333721417697843.PMC5406141.pdf
Each vitamin D result was aligned with an associated  postcode and linked its LSOA using the GeoConvert tool (http://geoconvert.mimas.ac.uk).,OADS,/arxiv_data1/oa_pdf/c7/cb/10.1177_2333721417697843.PMC5406141.pdf
"https://doi.org/10.1177/2333794X17696681Global Pediatric Health Volume 4: 1 –6  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17696681 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Special Collection on Children’s Health and Environmental Risk Introduction Cerebral palsy (CP) is a group of disorders that affect a  person’s ability to move and maintain balance and pos-ture.",Non-OADS,/arxiv_data1/oa_pdf/54/8a/10.1177_2333794X17696681.PMC5406142.pdf
Available from: http://www.cdc.gov/ nceh/lead/ACCLPP/blood_lead_levels.htm.,OADS,/arxiv_data1/oa_pdf/54/8a/10.1177_2333794X17696681.PMC5406142.pdf
"https://doi.org/10.1177/2333393617703198Global Qualitative Nursing Research Volume 4: 1 –10 © The Author(s) 2017Reprints and permissions:  sagepub.com/journalsPermissions.nav DOI: 10.1177/2333393617703198 journals.sagepub.com/home/gqn Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0  License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the  work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/ en-us/nam/open-access-at-sage).Article Introduction In March 2014, El Salvador began implementing a national  combination prevention intervention for HIV , funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria.",Non-OADS,/arxiv_data1/oa_pdf/56/32/10.1177_2333393617703198.PMC5406143.pdf
"Retrieved from http://www.theglobalfund.org/en/portfolio/country/grant/?grant=SLV-H-PLAN Goffman, E. (1963).",Non-OADS,/arxiv_data1/oa_pdf/56/32/10.1177_2333393617703198.PMC5406143.pdf
"Retrieved from http://www.elfaro.net/es/201601/ el_salvador/17819/Las-muertes-invisibles-de-las-mujeres-y- los-hombres-trans.htmLatkin, C., Donnell, D., & Metzger, D. (2009).",Non-OADS,/arxiv_data1/oa_pdf/56/32/10.1177_2333393617703198.PMC5406143.pdf
"https://doi.org/10.1177/2333794X17698525Global Pediatric Health Volume 4: 1 –6  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17698525 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Childhood Obesity and Nutrition Introduction Although current cross-sectional data suggest that  most Americans, including children and adolescents, consume a significant portion of their daily energy as snacks, snacking remains a poorly understood behav-ior.",Non-OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
"15 Next, we obtained brand information for the 3 market  leaders in each snack category identified from the NET based on 2014-2015 sales data from Information Resources, Inc (IRI; http://www.iriworldwide.com/en-US).",Non-OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
"Snacks: distribution of snack occasions, by gen- der and age, what we eat in America, NHANES 2009-2010. http://www.ars.usda.gov/ba/bhnrc/fsrg.",Non-OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
http://health.gov/dietaryguide-lines/2015/guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
http://www.census.gov/ quickfacts/.,OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
https://www.census.gov/quickfacts/table/PST045215/00#headnote-js-a.,OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
"Dietary guidelines for Americans, 2010. https://health.gov/dietaryguidelines/dga2010/dietaryguidelines2010.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
"Appendix F: Calculate the percent daily value for the appropriate nutrients), 2013. https://www.fda.gov/Food/GuidanceRegulation/Guidance   DocumentsRegulatoryInformation/LabelingNutrition/ucm064928.htm.",Non-OADS,/arxiv_data1/oa_pdf/c1/1b/10.1177_2333794X17698525.PMC5406144.pdf
"https://doi.org/10.1177/2333721417704947Gerontology & Geriatric Medicine Volume 3: 1 –10 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417704947 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction Hearing loss is a highly prevalent chronic health condi- tion that affects nearly two thirds of adults aged 70 years and older in the United States (Lin, Thorpe, Gordon-Salant, & Ferrucci, 2011).",Non-OADS,/arxiv_data1/oa_pdf/db/0b/10.1177_2333721417704947.PMC5406145.pdf
A website providing our protocols and test forms has been designed to facilitate broader use of these outcome measures among researchers in otology and audiology (http://www.linresearch.org/for-researchers.html).,Non-OADS,/arxiv_data1/oa_pdf/db/0b/10.1177_2333721417704947.PMC5406145.pdf
"Refer to http://www.linresearch.org/for-researchers.html, for links to references, coding forms, and scoring instructions.",Non-OADS,/arxiv_data1/oa_pdf/db/0b/10.1177_2333721417704947.PMC5406145.pdf
"https://doi.org/10.1177/2333794X16687190Global Pediatric Health Volume 4: 1 –7  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X16687190 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Short-term orogastric (OG) or nasogastric (NG) tube  insertion is a routine procedure in a newborn care unit for short-term assisted feeding in cases of neonates with functional gastrointestinal system.",Non-OADS,/arxiv_data1/oa_pdf/77/80/10.1177_2333794X16687190.PMC5406146.pdf
http://www.gosh.nhs.uk/health-professionals/clinical-guidelines/nasogastric- and-orogastric-tube-management#References.,Non-OADS,/arxiv_data1/oa_pdf/77/80/10.1177_2333794X16687190.PMC5406146.pdf
http://www.iupui.edu/~ikux100/rosa/ngtube1.html.,Non-OADS,/arxiv_data1/oa_pdf/77/80/10.1177_2333794X16687190.PMC5406146.pdf
Available at: http://journals.lww.com/ajnonline/Fulltext/1978/09000/Infant_Gavage_Reconsidered_.37.aspx.,Non-OADS,/arxiv_data1/oa_pdf/77/80/10.1177_2333794X16687190.PMC5406146.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/3102880.,Non-OADS,/arxiv_data1/oa_pdf/77/80/10.1177_2333794X16687190.PMC5406146.pdf
"https://doi.org/10.1177/2333794X17702980Global Pediatric Health Volume 4: 1 –5  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17702980 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Thiamine deficiency is common in parts of Southeast  Asia.",Non-OADS,/arxiv_data1/oa_pdf/6f/2b/10.1177_2333794X17702980.PMC5406147.pdf
http://www.inchem.,Non-OADS,/arxiv_data1/oa_pdf/6f/2b/10.1177_2333794X17702980.PMC5406147.pdf
"Injury Prevention and Control: Opioid Overdose, https://www.cdc.gov/drugoverdose/data/prescribing.html (2017, accessed 19 March 2017).",Non-OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"Indiana legislature emergency rule LSA document #13–495(E) 2013, http://www.in.gov/legislative/iac/20131030-IR-844130495ERA.xml.pdf (2013, accessed 27 November 2016).",Non-OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"Washington state legislature WAC 246–919–850 to WAC 246–919–863, http://app.leg.wa.gov/WAC/default.",Non-OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"Stat News, https://www.statnews.com/2017/03/07/missouri-prescription-drug-database/ (2017, accessed 19 March 2017).",OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"Minnesota prescription monitoring program, http://pmp.phar-macy.state.mn.us/ (2016, accessed 27 November 2016).",Non-OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"Facilitating panel management (Practice facilitation  handbook), http://www.ahrq.gov/professionals/prevention-  chronic-care/improve/system/pfhandbook/mod20.html (2016, accessed 27 November 2016).",Non-OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"Evaluation of the CMS-HCC  risk adjustment model, https://www.cms.gov/Medicare/Health- Plans/MedicareAdvtgSpecRateStats/Downloads/Evaluation_Risk_Adj_Model_2011.pdf (2011, accessed 27 November 2016).",OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"National bureau of economic research CMS risk adjustment  2015, http://www.nber.org/data/cms-risk-adjustment.html  (2015, accessed 27 November 2016).",Non-OADS,/arxiv_data1/oa_pdf/1d/81/10.1177_2050312117701024.PMC5406148.pdf
"https://doi.org/10.1177/2333794X17696685Global Pediatric Health Volume 4: 1 –5  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17696685 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Diarrhea is one of the leading infectious causes of death  in children younger than 5 years.",Non-OADS,/arxiv_data1/oa_pdf/71/c1/10.1177_2333794X17696685.PMC5406149.pdf
"https://doi.org/10.1177/2333721417703736Gerontology & Geriatric Medicine Volume 3: 1 –8 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417703736 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article In 2010, there were 23.4 million adults 65 years and  older living with a disability in the United States (Brault, 2012).",Non-OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
Retrieved from http://www.census.gov/people/disability/Table 4.,OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
"Retrieved from  http://t2rerc.buffalo.edu/pubs/ip/MT/2009%20IP%20on%20Wheeled%20Mobility%20v2.0.pdf Frank, A., Neophytou, C., Frank, J., & de Souza, L. (2010).",OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
"Retrieved from http://www.wheelchairskillsprogram.ca/eng/manual.php Lisspers, J., Nygren, A., & Soderman, E. (1997).",OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
"Retrieved  from https://www.ncbi.nlm.nih.gov/pubmed/15208888 Sund, T., Iwarsson, S., Anttila, H., & Brandt, Å.",OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
"Retrieved from http://www.statcan.gc.ca/pub/75-006-x/2013001/article/11858-eng.pdf Wolff, J. L., Spillman, B. C., Freedman, V. A., & Kasper, J. D.  (2016).",OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
"Retrieved from http://www.who.int/classifications/icf/en/ Zigmond, A. S., & Snaith, R. P. (1983).",OADS,/arxiv_data1/oa_pdf/08/4b/10.1177_2333721417703736.PMC5406150.pdf
"https://doi.org/10.1177/2041731417704791Journal of Tissue Engineering Volume 8: 1 –14  © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2041731417704791 journals.sagepub.com/home/tej Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial  use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and  Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Bone tissue has a remarkable ability to regenerate without  forming fibrous scar tissue, due to complex biological pro-cesses that recapitulate bone development.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
Figure generated using the Servier medical art database (http://www.servier.,Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Sequestered growth factors interact with chondroprogenitors, activating cell-signalling pathways that promote  chondrogenesis, which in turn promotes the expression of matrix remodelling factors.42 Figure generated using the Servier medical  art database (http://www.servier.com/Powerpoint-image-bank).",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Am Acad Orthop Surg  2012; 20(5): 273–282, http://www.ncbi.nlm.nih.gov/pub- med/22553099  4.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Clin Cases Miner Bone Metab 2016; 13(2): 101–105, http://www.ncbi.nlm.nih.gov/pubmed/27920804  5.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"BMJ Open 2013; 3(2): e002276, http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Proc Natl Acad Sci U S A  2010; 107(16): 7251–7256, http://www.ncbi.nlm.nih.gov/pubmed/20406908",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials 2010; 31(2): 242–249, http://www.ncbi.nlm.nih.gov/pubmed/19796807  10.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Bone 2015; 70: 10–18, http://www.ncbi.nlm.nih.gov/pubmed/25193160  12.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Orthop Res 2010; 28(6): 778– 784, http://www.ncbi.nlm.nih.gov/pubmed/20041490  13.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Bone Miner  Res 2014; 29(6): 1478–1491, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Bone 2007;  41(6): 928–936, http://www.ncbi.nlm.nih.gov/pubmed/  17921078  15.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Bone Miner Res 2003; 18(9): 1584–1592, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Proc Natl Acad  Sci U S A 2011; 108(4): 1585–1590, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat Commun 2016; 7: 10928, http://www.ncbi.nlm.nih.gov/pubmed/26965320  20.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Cell  Death Differ 2014; 21(11): 1758–1768, http://www.ncbi.nlm.nih.gov/pubmed/25034782  21.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Arthritis  Rheum 2009; 60(6): 1694–1703, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat Rev Rheumatol 2012; 8(6): 358–366, http://www.ncbi.nlm.nih.gov/pubmed/22450551  25.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Dev Dyn 2009; 238(3): 766–774, http://www.ncbi.nlm.nih.gov/pubmed/19235733  27.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Bone 2010; 46(3): 841–851, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"8): S8–S19, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Cell Mol Med 2015; 19(4): 685–713, http://www.ncbi.nlm.nih.gov/pubmed/25726940  35.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng  Part B Rev 2009; 15(4): 381–394, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng Part B Rev 2009; 15(4): 395–422, http://www.ncbi.nlm.nih.gov/pubmed/19589040",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Adv Drug Deliv Rev 2016; 97: 4–27, http://www.ncbi.nlm.nih.gov/pubmed/26562801  40.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Glaucoma 23(8): S20–S23, http://www.ncbi.nlm.nih.gov/pubmed/25275899  42.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Endocrinol  2011; 209(2): 139–151, http://www.ncbi.nlm.nih.gov/pubmed/21307119  43.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J  Biomater Sci Polym Ed 1995; 6(9): 775–795, http://www.ncbi.nlm.nih.gov/pubmed/7772566  44.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials  2006; 27(20): 3782–3792, http://www.ncbi.nlm.nih.gov/pubmed/16556462  45.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"3): S311– S324, http://www.ncbi.nlm.nih.gov/pubmed/19324684  46.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"In: Ratner BD, Hoffman AS, Schoen FJ (eds) Biomaterials science: an introduction to materi-als in medicine, 1996, https://books.google.com/books?hl =en&lr=&id=pZFzd8GtUe8C&oi=fnd&pg=PA37&ots=J 8aYUxkqF1&sig=RfVi4itRhRqT33VuA70uaMFwJWQ  47.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Biomed Mater Res A 2007; 80(3): 565–580,  http://www.ncbi.nlm.nih.gov/pubmed/17031819  50.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Polym Sci B Polym Phys 2011; 49(12): 832–864, http://www.ncbi.nlm.nih.gov/pubmed/21769165  52.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Curr Pharm Des 2012; 18(18): 2536–2557,  http://www.ncbi.nlm.nih.gov/pubmed/22512444 53.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng 10(11–12): 1830–1840,  http://www.ncbi.nlm.nih.gov/pubmed/15684691  54.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Cell Mol Med 2012; 16(10): 2247–2270, http://www.ncbi.nlm.nih.gov/pubmed/22452848  56.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials 2009; 30(27): 4723–4731, http://www.ncbi.nlm.nih.gov/pubmed/19560200  58.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials 2009; 30(28): 5094–5103, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Biomed Mater Res A 2009; 91(1): 195–208,  http://www.ncbi.nlm.nih.gov/pubmed/18814275  60.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng Part A 2017; 23(1–2): 43–54, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials 2010; 31(24):  6190–6200, http://www.ncbi.nlm.nih.gov/pubmed/20494438  63.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials 2015; 44: 173–185, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biofabrication 2016; 8(2): 025012, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Int J  Nanomedicine 2014; 9: 1845–1853, http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat Mater 2008; 7(10): 816–823, http://www.ncbi.nlm.nih.gov/pub-med/18724374  68.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nature 2009; 462(7272): 433–441,  http://www.ncbi.nlm.nih.gov/pubmed/19940913  70.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Acta Biomater 2016; 34: 60–72,  http://www.ncbi.nlm.nih.gov/pubmed/26497624  71.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat Biotechnol 2004; 22(7): 863–866, http://www.ncbi.nlm.nih.gov/pubmed/15195101  72.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat Mater 2010; 9(9): 768–778, http://www.ncbi.nlm.nih.gov/pubmed/20729850  73.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Proc Natl Acad Sci U S A 2014; 111(51): 18126–18131, http://www.ncbi.nlm.nih.gov/pubmed/25422477  75.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Proc Natl Acad Sci U S A 2011; 108(40): 16565– 16570, http://www.ncbi.nlm.nih.gov/pubmed/21949368  79.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J R Soc Interface 2013; 10(78): 20120753, http://www.ncbi.nlm.nih.gov/pubmed/23152103  80.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng Part B Rev 2015; 21(1): 103– 114, http://www.ncbi.nlm.nih.gov/pubmed/25084122 81.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Biomed Mater  Res A 2008; 86(2): 459–466, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biofabrication 2014; 6(2): 24103, http://www.ncbi.nlm.nih.gov/pubmed/24464765  88.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Tissue Eng Regen Med 2015; 9(11): 1286–1297, http://www.ncbi.nlm.nih.gov/pubmed/23349081  89.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng Part C Methods 2012; 18(1): 33–44,  http://www.ncbi.nlm.nih.gov/pubmed/21854293  90.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng Part B Rev 2014; 20(2): 106–125,  http://www.ncbi.nlm.nih.gov/pubmed/23815376  91.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat Protoc 2014; 9(6): 1451–1468, http://www.nature.com/doifinder/10.1038/nprot.2014.097  96.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng Part A 2015; 21(3–4):  694–703, http://online.liebertpub.com/doi/abs/10.1089/ten.tea.2014.0117  100.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Arch Histol Cytol 2003; 66(3): 221–228, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14527163  103.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nature 1981;  292(5819): 154–156, http://www.ncbi.nlm.nih.gov/pub- med/7242681  107.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biochem Biophys Res Commun 2015; 461(2): 281–286, http://www.ncbi.nlm.nih.gov/pubmed/25871791  110.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Cell Physiol 2009; 219(2): 235–242, http://www.ncbi.nlm.nih.gov/pubmed/19115244 111.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Cell Cycle 2011; 10(14): 2281–2286,  http://www.ncbi.nlm.nih.gov/pubmed/21654195  112.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Cell Death Differ 2010; 17(8): 1222–1229, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng 2001; 7(1): 89–99, http://www.ncbi.nlm.nih.gov/pubmed/11224927  114.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Cloning Stem Cells 2003; 5(2): 149–155, http://www.ncbi.nlm.nih.gov/pub-med/12930627  115.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Proc Natl Acad Sci U S A 2008; 105(19): 6840–6845, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2374550&tool=pmcentrez&rendertype=abstract  116.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Tissue Eng 10(9–10): 1518–1525, http://www.ncbi.nlm.nih.gov/pub- med/15588411  117.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Nat  Biotechnol 2015; 33(6): 638–645, http://www.ncbi.nlm.nih.gov/pubmed/25961409  118.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Stem Cell Res Ther 2014; 5(4): 85, http://www.ncbi.nlm.nih.gov/pubmed/25157428  119.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Philos Trans R Soc Lond B Biol Sci 2002;  357(1420): 405–417, http://www.ncbi.nlm.nih.gov/pub-med/12028783  120.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Cell 2006; 126(4): 663–676,  http://www.ncbi.nlm.nih.gov/pubmed/16904174  121.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Stem Cells  2012; 30(6): 1174–1181, http://www.ncbi.nlm.nih.gov/ pubmed/22415987  123.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials 2014; 35(11): 3571– 3581, http://www.ncbi.nlm.nih.gov/pubmed/24462354  125.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Cell Reprogram 2014; 16(1): 29–39, http://www.ncbi.nlm.nih.gov/pubmed/24459991  127.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Crit Rev Biomed Eng 2012; 40(5): 363–408, http://www.ncbi.nlm.nih.gov/pubmed/23339648  128.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Bone Marrow Transplant 2012; 47(2): 164–171,  http://www.ncbi.nlm.nih.gov/pubmed/21478914  129.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Science  1999; 284(5411): 143–147, http://www.ncbi.nlm.nih.gov/pubmed/10102814  130.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Orthop Res  1991; 9(5): 641–650, http://www.ncbi.nlm.nih.gov/pub- med/1870029  132.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Science 1968; 161(3836): 54–56, http://www.ncbi.nlm.nih.gov/pubmed/4871792  133.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Cell Mol Med 2011; 15(4): 718–746, http://www.ncbi.nlm.nih.gov/pub-med/21129153  136.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Stem Cells  Int 2016; 2016: 6180487, http://www.ncbi.nlm.nih.gov/pubmed/26880976  137.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Orthop Res 2010; 28(7): 942–949, http://www.ncbi.nlm.nih.gov/pub-med/20058266  138.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Artif Organs 2006; 30(12): 960–962, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Int J Clin Exp Med 2015; 8(1): 1406–1410, http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Cell Physiol 2015;  230(6): 1258–1269, http://www.ncbi.nlm.nih.gov/pub-med/25413299  142.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Bone  2004; 35(5): 1003–1012, http://www.ncbi.nlm.nih.gov/ pubmed/15542024  143.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Bone 2008; 43(6): 1075–1083, http://www.ncbi.nlm.nih.gov/pubmed/18773980  146.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"J Bone Miner Res 2005; 20(12): 2124–2137, http://www.ncbi.nlm.nih.gov/pubmed/16294266  147.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Sci Rep 2016; 6: 36011, http://www.ncbi.nlm.nih.gov/pub-med/27808102  152.",OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"14 Journal of Tissue Engineering   2016; 22(5): 473–486, http://www.ncbi.nlm.nih.gov/pub- med/27018617  153.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"Biomaterials   2013; 34(19): 4612–4621, http://www.ncbi.nlm.nih.gov/pubmed/23537666  154.",Non-OADS,/arxiv_data1/oa_pdf/ac/2a/10.1177_2041731417704791.PMC5406151.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/eb/99/10.1177_2048004017701870.PMC5406152.pdf
"https://doi.org/10.1177/2333794X17696684Global Pediatric Health Volume 4: 1 –8  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17696684 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction Invasive fungal infections (IFIs) are an important cause  of nosocomial infection in the neonates, especially the extremely premature infants given the immaturity of the immune system.",Non-OADS,/arxiv_data1/oa_pdf/f7/00/10.1177_2333794X17696684.PMC5406153.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of the Royal Society of Medicine Cardiovascular Disease 6: 1–7 !The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2048004017705273 journals.sagepub.com/home/cvd",Non-OADS,/arxiv_data1/oa_pdf/c2/7b/10.1177_2048004017705273.PMC5406155.pdf
"We used an elec-tronic calculator for this process, on this webpage:‘‘http://publication.radioanatomie.com/002_manipula-teurs/calcul-de-la-clairance-de-la-creatinine.php.’’2 Journal of the Royal Society of Medicine Cardiovascular Disease 0(0)",Non-OADS,/arxiv_data1/oa_pdf/c2/7b/10.1177_2048004017705273.PMC5406155.pdf
"It was electronic-ally derived on this web page ‘‘https://www.cvdrisk- checksecure.com/FraminghamRiskScore.aspx,’’ based on the following parameters: age (years), sex (male/female), diabetes (yes/no), smoking (yes/no), BP low-ering medications (yes/no), SBP (mmHg), TC (mmol/l),and HDL-C (mmol/l).",Non-OADS,/arxiv_data1/oa_pdf/c2/7b/10.1177_2048004017705273.PMC5406155.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"2, 112 –120 http://dx.doi.org/10.1080/19336934.2016.1244591",Non-OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"ORCID F. Javier Bernardo-Garcia http://orcid.org/0000-0002-8945- 4919Tim-Henning Humberg http://orcid.org/0000-0002-2824- 2453 Simon G. Sprecher http://orcid.org/0000-0001-9060-3750 References [1] Tsachaki M, Sprecher SG.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
Dev Dyn 2012; 241:40-56;PMID:21932322; http://dx.doi.org/10.1002/dvdy.22738 [2] Treisman JE.,OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Wiley Interdiscip Rev Dev Biol 2013; 2:545-57;PMID:24014422; http://dx.doi.org/10.1002/wdev.100 [3] Potier D, Davie K, Hulselmans G, Naval Sanchez M, Haagen L, Huynh-Thu VA, Koldere D, Celik A, Geurts P, Christiaens V, et al.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Cell Rep 2014;9:2290-303; PMID:25533349; http://dx.doi.org/10.1016/j.celrep.2014.11.038 [4] Halder G, Callaerts P, Gehring WJ.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
Science 1995; 267:1788-92; PMID:7892602; http://dx.doi.org/10.1126/science.7892602118 F. J. BERNARDO-GARCIA ET AL.,OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
Cell 1997; 91:881-91; PMID:9428512;http://dx.doi.org/10.1016/S0092-8674(00)80480-8 [6] Hoge MA.,OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Am Nat 1915; 49:47-9; http://dx.doi.org/ 10.1086/279455 [7] Silver SJ, Rebay I.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Signaling circuitries in development: insights from the retinal determination gene network.Development 2005; 132:3-13; PMID:15590745; http://dx.doi.org/10.1242/dev.01539 [8] Cheyette BN, Green PJ, Martin K, Garren H, Hartenstein V, Zipursky SL.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Neuron 1994; 12:977-96; PMID:7910468; http://dx.doi.org/10.1016/0896-6273(94)90308-5 [9] Bernardo-Garcia FJ, Fritsch C, Sprecher SG.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Develop-ment 2016; 143:1413-23; PMID:26952983; http://dx.doi.org/10.1242/dev.128801 [10] Naval-Sanchez M, Potier D, Haagen L, Sanchez M, Munck S, Van de Sande B, Casares F, Christiaens V,Aerts S. Comparative motif discovery combined withcomparative transcriptomics yields accurate targetomeand enhancer predictions.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Genome Res 2013; 23:74-88; PMID:23070853; http://dx.doi.org/10.1101/gr.140426.112 [11] Moses K, Ellis MC, Rubin GM.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Nature 1989; 340:531-6; PMID:2770860; http://dx.doi.org/10.1038/340531a0 [12] Liang X, Mahato S, Hemmerich C, Zelhof AC.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Development2003; 130:4383-92; PMID:12900454; http://dx.doi.org/10.1242/dev.00651 [14] Moses K, Rubin GM.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Gen Dev 1991; 5:583-93; PMID:2010085; http://dx.doi.org/10.1101/gad.5.4.583 [15] Ellis MC, O ’Neill EM, Rubin GM.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Development 2010; 137:2895-904;PMID:20667913; http://dx.doi.org/10.1242/dev.051722 [17] Mishra AK, Bargmann BO, Tsachaki M, Fritsch C, Sprecher SG.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
Dev Biol 2016; 410:164-77; PMID:26769100; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"PLoS genetics 2013; 9:e1004027; PMID:24385925; http://dx.doi.org/10.1371/journal.pgen.1004027 [19] Stark WS, Sapp R, Carlson SD.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"J Neurogenet 1989; 5:127-53; PMID:2500507; http://dx.doi.org/10.3109/01677068909066203 [20] Schmucker D, Taubert H, Jackle H. Formation of the Drosophila larval photoreceptor organ and its neuronaldifferentiation require continuous Kruppel gene activity.Neuron 1992; 9:1025-39; PMID:1463605; http://dx.doi.org/10.1016/0896-6273(92)90063-J [21] Park S, Bustamante EL, Antonova J, McLean GW, Kim SK.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"PLoS Genet 2011; 7:e1002241;PMID:21901108; http://dx.doi.org/10.1371/journal.pgen.1002241 [22] Chou WH, Huber A, Bentrop J, Schulz S, Schwab K, Chadwell LV, Paulsen R, Britt SG.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Neuron 1989; 3:81-94; PMID:2482778;http://dx.doi.org/10.10 16/0896-6273(89)90117-7 [25] Dolph PJ, Ranganathan R, Colley NJ, Hardy RW, Socolich M, Zuker CS.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Science1993; 260:1910-6; PMID:8316831; http://dx.doi.org/ 10.1126/science.8316831 [26] Zhu L, McKay RR, Shortridge RD.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
Neuron 1994; 13:1143-57; PMID:7946351; http://dx.doi.org/10.1016/0896-6273(94) 90052-3FLY 119,OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Cell 1996;85:651-9; PMID:8646774; http://dx.doi.org/10.1016/S0092-8674(00)81232-5 [29] Shieh BH, Niemeyer B.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
Neuron 1995; 14:201-10; PMID:7826638; http://dx.doi.org/10.1016/0896-6273(95)90255-4 [30] Montell C. Drosophila visual transduction.,OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Trends Neu- rosci 2012; 35:356-63; PMID:22498302; http://dx.doi.org/10.1016/j.tins.2012.03.004 [31] Enuameh MS, Asriyan Y, Richards A, Christensen RG, Hall VL, Kazemian M, Zhu C, Pham H, Cheng Q, BlattiC, et al.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Genome Res 2013;23:928-40; PMID:23471540; http://dx.doi.org/10.1101/gr.151472.112 [32] Le Bourg E, Badia J.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"J Insect Behav 1995; 8:835-45; http://dx.doi.org/10.1007/BF02009510[33] Pak WL, Gross ﬁeld J, White NV.",Non-OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Nature 1969; 222:351-4;PMID:5782110; http://dx.doi.org/10.1038/222351a0 [34] Rister J, Razzaq A, Boodram P, Desai N, Tsanis C, Chen H, Jukam D, Desplan C. Single –base pair differences in a shared motif determine differential Rhodopsin expres-sion.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Nat Rev Genet 2007; 8:450-61;PMID:17510665; http://dx.doi.org/10.1038/nrg2102 [36] Campos-Ortega JA, Hartenstein V. The embryonic devel- opment of Drosophila melanogaster.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"Development2013; 140:2434-42; PMID:23637332; http://dx.doi.org/10.1242/dev.088757 [38] Rothwell WF, Sullivan W. Fluorescent analysis of Dro- sophila embryos.",OADS,/arxiv_data1/oa_pdf/c6/44/kfly-11-02-1244591.PMC5406162.pdf
"https://doi.org/10.1177/1178633717702869 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Integrative Medicine Insights Volume 12: 1–15 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178633717702869 Introduction Honey is produced by bees from the genus Apis, which collect  the nectar from plants or from secretions of aphids (plant-sucking insects belonging to the genus Rhynchota).",Non-OADS,/arxiv_data1/oa_pdf/bb/6b/10.1177_1178633717702869.PMC5406168.pdf
2014;13:23. http://www.jdmdonline.com/content/13/1/23.,Non-OADS,/arxiv_data1/oa_pdf/bb/6b/10.1177_1178633717702869.PMC5406168.pdf
"https://doi.org/10.1177/2333794X17696682Global Pediatric Health Volume 4: 1 –4  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17696682 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Reports Presentation A 3-year-old boy with no known significant past medical  history apart from mild speech delay presented with a 10-day history of an upper respiratory infection and inter - mittent low-grade fever followed by irritability, lethargy, and an unsteady gait.",Non-OADS,/arxiv_data1/oa_pdf/80/ff/10.1177_2333794X17696682.PMC5406187.pdf
"https://doi.org/10.1177/2333794X17703462Global Pediatric Health Volume 4: 1 –3  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17703462 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Report Introduction Congenital hyperinsulinism, characterized by excessive  and dysregulated insulin secretion, is the most common cause of persistent hypoglycemia in children.",Non-OADS,/arxiv_data1/oa_pdf/88/56/10.1177_2333794X17703462.PMC5406188.pdf
"2 SAGE Open Medicine From 2008 on, the NZ government through the Ministry  of Health focused on achieving Better, Sooner, More  Convenient (BSMC) health services, this policy emphasised integration of care and the need for greater efficiency and cost reduction (http://www.health.govt.nz/publication/bet-ter-sooner-more-convenient-health-care-community).",Non-OADS,/arxiv_data1/oa_pdf/e2/30/10.1177_2050312117701052.PMC5406189.pdf
"Aged care literature review: coordination  and integration of services, 2001, http://www.health.govt.nz/system/files/documents/pages/aged-care-literature-review.pdf  5.",Non-OADS,/arxiv_data1/oa_pdf/e2/30/10.1177_2050312117701052.PMC5406189.pdf
"Health Syst Transit 2014; 4(2), http://www.wpro.who.int/asia_pacific_observatory/hits/series/Nez_Health_Systems_ Review.pdf 13.",Non-OADS,/arxiv_data1/oa_pdf/e2/30/10.1177_2050312117701052.PMC5406189.pdf
"Designing case studies: identifying your case(s)  and establishing the logic of your case study, 2011, http://www.sagepub.com/sites/default/files/upm-binaries/24736_Chapter2.pdf  23.",Non-OADS,/arxiv_data1/oa_pdf/e2/30/10.1177_2050312117701052.PMC5406189.pdf
"https://doi.org/10.1177/2333721417702349Gerontology & Geriatric Medicine Volume 3: 1 –14 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417702349 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction The house we live in and where we live can have a major  impact on our physical and mental health; this is particu-larly true for groups of people who tend to spend more time in the home, including older adults (Centre for Ageing Research and Development in Ireland, 2013).",Non-OADS,/arxiv_data1/oa_pdf/23/da/10.1177_2333721417702349.PMC5406190.pdf
Retrieved from http://www.cso.ie/en/census/census- 2011reports/census2011profile4theroofoverourheads- housinginireland/ Centre for Ageing Research and Development in Ireland.,OADS,/arxiv_data1/oa_pdf/23/da/10.1177_2333721417702349.PMC5406190.pdf
Retrieved from https://www.beehive.govt.,Non-OADS,/arxiv_data1/oa_pdf/23/da/10.1177_2333721417702349.PMC5406190.pdf
"14 Gerontology & Geriatric Medicine Retrieved from http://www.housing.gov.ie/housing/social- housing/voluntary-and-cooperative-housing/register- housing-bodies-approved-status Fahey, T. (1999).",Non-OADS,/arxiv_data1/oa_pdf/23/da/10.1177_2333721417702349.PMC5406190.pdf
Retrieved from http://agefriendlyireland.ie/wp-content/uploads/2014/10/AFN_Loneliness_MR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/da/10.1177_2333721417702349.PMC5406190.pdf
Retrieved from http://www.cardi.ie/publications/ruralageinginnorthernirelandquali-tyoflifeamongstolderpeople National Disability Authority.,Non-OADS,/arxiv_data1/oa_pdf/23/da/10.1177_2333721417702349.PMC5406190.pdf
"https://doi.org/10.1177/2054358117703070Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –10 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117703070 journals.sagepub.com/home/cjkNarrative Review703070 CJKXXX10.1177/2054358117703070Canadian Journal of Kidney Health and DiseaseDemian et al research-article 2017 Opportunities for Engaging   Patients in Kidney Research Maryam N. Demian1, Ngan N. Lam2, Fabrice Mac-Way3,   Ruth Sapir-Pichhadze4, and Nicolas Fernandez5 Abstract Purpose: The purpose of this review is to provide a summary of the rationale for engaging patients in research as well  as to review the established and envisioned advantages and strategies for patient-researcher partnerships.",Non-OADS,/arxiv_data1/oa_pdf/5b/c4/10.1177_2054358117703070.PMC5406191.pdf
"https://doi.org/10.1177/2333721417700758Gerontology & Geriatric Medicine Volume 3: 1 –8 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417700758 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction Residential fires, which may not only cause property  damage but also lead to injury and death, are still a very real problem in modern communities.",Non-OADS,/arxiv_data1/oa_pdf/97/d9/10.1177_2333721417700758.PMC5406193.pdf
d The chi-square statistic is 116 for Nonsmoker/Smoker; p value is <.00001; result is significant at p < .01; http://www.socscistatistics.com/tests/chisquare2/ Default2.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4c/37/10.1177_2050312117699503.PMC5406194.pdf
"DOI:  10.1177/0890117116671390, http://journals.sagepub.com/doi/full/10.1177/0890117116671390 (accessed 4 January 2017).",Non-OADS,/arxiv_data1/oa_pdf/4c/37/10.1177_2050312117699503.PMC5406194.pdf
"https://doi.org/10.1177/2050313X17705050 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17705050 journals.sagepub.com/home/sco Introduction Methotrexate (MTX) is a dihydrofolate reductase inhibitor  that blocks de novo nucleotide synthesis.",Non-OADS,/arxiv_data1/oa_pdf/b5/19/10.1177_2050313X17705050.PMC5406195.pdf
"https://doi.org/10.1177/2054358117703986Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –11 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117703986 journals.sagepub.com/home/cjkOriginal Research Article703986 CJKXXX10.1177/2054358117703986Canadian Journal of Kidney Health and DiseaseManns et al research-article 2017 The Financial Impact of Advanced Kidney  Disease on Canada Pension Plan and Private Disability Insurance Costs Braden Manns1,2, Susan Q. McKenzie3,4, Flora Au1,   Pamela M. Gignac4, and Lawrence Ian Geller4,5; for the  Canadians Seeking Solutions and Innovations to Overcome  Chronic Kidney Disease (Can-SOLVE CKD) Network Abstract Background: Many working-age individuals with advanced chronic kidney disease (CKD) are unable to work, or are only  able to work at a reduced capacity and/or with a reduction in time at work, and receive disability payments, either from the Canadian government or from private insurers, but the magnitude of those payments is unknown.Objective: The objective of this study was to estimate Canada Pension Plan Disability Benefit and private disability insurance  benefits paid to Canadians with advanced kidney failure, and how feasible improvements in prevention, identification, and early treatment of CKD and increased use of kidney transplantation might mitigate those costs.Design: This study used an analytical model combining Canadian data from various sources.Setting and Patients: This study included all patients with advanced CKD in Canada, including those with estimated glomerular filtration rate (eGFR) <30 mL/min/m 2 and those on dialysis.",Non-OADS,/arxiv_data1/oa_pdf/32/97/10.1177_2054358117703986.PMC5406196.pdf
http://www.esdc.gc.ca/en/cpp/disability/eligibil-ity.page.,Non-OADS,/arxiv_data1/oa_pdf/32/97/10.1177_2054358117703986.PMC5406196.pdf
"https://doi.org/10.1177/2050313X17700347 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17700347 journals.sagepub.com/home/sco Introduction Creutzfeldt–Jakob disease (CJD) is a rare, rapidly pro-   gressive and eventually fatal spongiform encephalopathy.",Non-OADS,/arxiv_data1/oa_pdf/5d/fd/10.1177_2050313X17700347.PMC5406197.pdf
"https://doi.org/10.1177/2333794X17704764Global Pediatric Health Volume 4: 1 –5  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17704764 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Report Introduction Anticholinergic drug exposure is very common and  responsible for 15% to 20% of hospital admissions and up to 40% of intensive care admissions related to acute poisonings.",Non-OADS,/arxiv_data1/oa_pdf/06/f5/10.1177_2333794X17704764.PMC5406198.pdf
"https://doi.org/10.1177/2054358117703985Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –13 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117703985 journals.sagepub.com/home/cjkOriginal Research Article703985 CJKXXX10.1177/2054358117703985Canadian Journal of Kidney Health and DiseaseScheuermeyer et al research-article 2017 The Clinical Epidemiology and 30-Day  Outcomes of Emergency Department Patients With Acute Kidney Injury Frank Xavier Scheuermeyer1,2, Eric Grafstein2,3, Brian Rowe4,5,   Jay Cheyne1,2, Brian Grunau1,2, Aaron Bradford1,2,   and Adeera Levin2,6 Abstract Background: Acute kidney injury (AKI) is associated with increased mortality and dialysis in hospitalized patients but has  been little explored in the emergency department (ED) setting.Objective: The objective of this study was to describe the risk factors, prevalence, management, and outcomes in the ED  population, and to identify the proportion of AKI patients who were discharged home with no renal-specific follow-up.Design: This is a retrospective cohort study using administrative and laboratory databases.Setting: Two urban EDs in Vancouver, British Columbia, Canada.Patients: We included all unique ED patients over a 1-week period.Methods: All patients had their described demographics, comorbidities, medications, laboratory values, and ED treatments  collected.",Non-OADS,/arxiv_data1/oa_pdf/17/29/10.1177_2054358117703985.PMC5406199.pdf
http://www.kdigo.,Non-OADS,/arxiv_data1/oa_pdf/17/29/10.1177_2054358117703985.PMC5406199.pdf
http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2010_ed_web_tables.,OADS,/arxiv_data1/oa_pdf/17/29/10.1177_2054358117703985.PMC5406199.pdf
http://www.kdigo.,Non-OADS,/arxiv_data1/oa_pdf/17/29/10.1177_2054358117703985.PMC5406199.pdf
"https://doi.org/10.1177/2050313X17701373 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17701373 journals.sagepub.com/home/sco Introduction Dirofilariasis is a parasitic infection caused by filarial nem- atodes belonging to the genus Dirofilaria (Nematoda, Filarioidea, Onchocercidae).",Non-OADS,/arxiv_data1/oa_pdf/de/40/10.1177_2050313X17701373.PMC5406200.pdf
"Medscape 2005, http://emedicine.medscape.com/ article/236698-treatment (accessed 16 February 2017).",Non-OADS,/arxiv_data1/oa_pdf/de/40/10.1177_2050313X17701373.PMC5406200.pdf
"https://doi.org/10.1177/2333794X17705239Global Pediatric Health Volume 4: 1 –3  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17705239 journals.sagepub.com/home/gph Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Brief Report Introduction Hypereosinophilic syndrome (HES) is a heterogeneous  group of disorders characterized by sustained overpro-duction of eosinophils.",Non-OADS,/arxiv_data1/oa_pdf/1e/a7/10.1177_2333794X17705239.PMC5406201.pdf
"https://doi.org/10.1177/2050313X17701374 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17701374 journals.sagepub.com/home/sco Introduction Pituitary abscess is characterized by symptoms and signs  particular to central nervous system (CNS) infection, mass effect, and endocrine dysfunction 1 and accounts for <1% of  all pituitary conditions.1–3 Multiple infectious organisms  including bacteria,4 fungi,5,6 and mycobacterium1 have  been reported as etiologic agents.",Non-OADS,/arxiv_data1/oa_pdf/08/e5/10.1177_2050313X17701374.PMC5406206.pdf
"3, 206 –214 http://dx.doi.org/10.1080/15592294.2016.1276680",Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Ann Surg Oncol 2012; 19:4238-43; PMID:22766991; http://dx.doi.org/10.1245/s10434-012-2488-y 2.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
PLoS One 2011; 6:e16252; PMID:21311577; http://dx.doi.org/10.1371/journal.pone.0016252 3.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Environ Health Perspect 2009;117:217-22; PMID:19270791; http://dx.doi.org/10.1289/ehp.11898 5.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Environ Health Perspect 2008; 116:1547-52; PMID:19057709; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Nat Biotechnol 2016; 34:726-37; PMID:27347756; http://dx.doi.org/10.1038/nbt.3605 8.,OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
PLoS Genet 2011; 7:e1002384; PMID:22144907; http://dx.doi.org/10.1371/ journal.pgen.100238410.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Science 2003;300:455; PMID:12702868; http://dx.doi.org/10.1126/science.1083557 11.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Cell 2010; 141:1159-70; PMID:20602998; http://dx.doi.org/ 10.1016/j.cell.2010.05.021 14.,OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
PLoS One 2013; 8: e79044; PMID:24260150; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
J Biosci Bioeng 2003; 96:317-23; PMID:16233530; http://dx.doi.org/10.1016/S1389-1723(03)90130-7 16.,OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Epigenetics2012; 7:652-63; PMID:22531475; http://dx.doi.org/10.4161/epi.20221 18.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Clin Epigenetics 2016; 8:60; PMID:27222668;http://dx.doi.org/10.1186/s13148-016-0227-0 19.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
PLoS Genet 2015; 11:e1005442; PMID:26241857; http://dx.doi.org/10.1371/journal.pgen.1005442 20.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Am J Respir Crit Care Med 2009; 180:462-7; PMID:19498054; http://dx.doi.org/10.1164/rccm.200901-0135OC 21.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Cancer Res 2007; 67:876-80; PMID:17283117; http://dx.doi.org/10.1158/0008-5472.CAN-06-2995 22.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
BMC Gen 2013; 14:774; PMID:24206606; http://dx.doi.org/10.1186/1471-2164-14-774 24.,OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Mol Autism 2016; 7:51; PMID:28018572;http://dx.doi.org/10.1186/s13229-016-0114-8 25.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Environmental Epigenetics in press; http://dx.doi.org/10.1093/eep/dvw024 26.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
Genome Res 2004; 14:1188-90; PMID:15173120;http://dx.doi.org/10.1101/gr.849004 27.,OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
http://homes.cs.washington.edu/ »dcjones/fastq-tools/214 F. K. CRARY-DOOLEY ET AL.,Non-OADS,/arxiv_data1/oa_pdf/45/cc/kepi-12-03-1276680.PMC5406214.pdf
"https://doi.org/10.1177/2054358117703071Canadian Journal of Kidney Health  and Disease  Volume 4: 1 –16 © The Author(s) 2017Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/2054358117703071 journals.sagepub.com/home/cjkOriginal Research Article703071 CJKXXX10.1177/2054358117703071Canadian Journal of Kidney Health and DiseaseHayward et al research-article 2017 Kidney Disease Among Registered Métis  Citizens of Ontario: A Population-Based Cohort Study Jade S. Hayward1, Eric McArthur1, Danielle M. Nash1,   Jessica M. Sontrop2, Storm J. Russell3, Saba Khan1,   Jennifer D. Walker1,4, Gihad E. Nesrallah5,   Manish M. Sood1,6, and Amit X. Garg1,7 Abstract Background: Indigenous peoples in Canada have higher rates of kidney disease than non-Indigenous Canadians.",Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
https://secure.cihi.,Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
https://secure.cihi.ca/free_products/IHC2004rev_e.pdf.,OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
http://www12.statcan.gc.ca/ nhs-enm/2011/dp-pd/dt-td/Ap-eng.cfm?LANG=E&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=0&PID=107647&PRID=0&PTYPE=105277&S= 0&SHOWALL=0&SUB=0&Temporal=2013&THEME=95& VID=0&VNAMEE=undefined&VNAMEF=undefined  10.,OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
http://www.metisnation.org/media/146769/faq_guide_interactive_revised.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
http://www.pre.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/chapter9-chapitre9/.,Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
http://www.metisnation.org/media/229165/119finaldiabetestechnicalen.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
http://www.nccah-ccnsa.ca/ docs/factsheets/socialdeterminates/AccesstoHealthServices_ Eng2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
https://www.aadnc-aandc.gc.ca/eng/1100100028564/1100100028566.,Non-OADS,/arxiv_data1/oa_pdf/4e/7b/10.1177_2054358117703071.PMC5406217.pdf
"In many cases, this implies a rapid or immediate relationship  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/84/b8/nihms856657.PMC5406225.pdf
2015. http://dx.doi.org/10.1111/dote.12339 11.,Non-OADS,/arxiv_data1/oa_pdf/84/b8/nihms856657.PMC5406225.pdf
"@ERSpublications Members of the @ERStalk Clinical Assembly give their highlights from #ERSLDN16http://ow.ly/MkKb30a58J7 Cite this article as: Kahn N, Fregonese L, Barrecheguren M, et al.",Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.Received: Dec 02 2016 | Accepted after revision: March 05 2017 Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00147-2016 ERJ Open Res 2017; 3: 00147-2016 LONDON CALLING CLINICAL HIGHLIGHTS,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
"Patients with ACOS were older, more frequently men and had more https://doi.org/10.1183/23120541.00147-2016 2CLINICAL HIGHLIGHTS | N. KAHN ET AL.",Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
https://doi.org/10.1183/23120541.00147-2016 3CLINICAL HIGHLIGHTS | N. KAHN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
After identification of https://doi.org/10.1183/23120541.00147-2016 4CLINICAL HIGHLIGHTS | N. KAHN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
"However, a similar mortality to https://doi.org/10.1183/23120541.00147-2016 5CLINICAL HIGHLIGHTS | N. KAHN ET AL.",Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
[79] identified that the commonest misconception was not https://doi.org/10.1183/23120541.00147-2016 6CLINICAL HIGHLIGHTS | N. KAHN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
https://doi.org/10.1183/23120541.00147-2016 7CLINICAL HIGHLIGHTS | N. KAHN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
QJM 2016 [in press https://doi.org/10.1093/qjmed/hcw142].,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
https://doi.org/10.1183/23120541.00147-2016 8CLINICAL HIGHLIGHTS | N. KAHN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
https://doi.org/10.1183/23120541.00147-2016 9CLINICAL HIGHLIGHTS | N. KAHN ET AL.,Non-OADS,/arxiv_data1/oa_pdf/70/83/00147-2016.PMC5406227.pdf
"To facilitate the early treatment of IOPD, we performed newborn http://dx.doi.org/10.1016/j.ymgmr.2017.04.004 Received 9 April 2017; Accepted 9 April 2017☆Clinicaltrials.gov : NCT02405598.",Non-OADS,/arxiv_data1/oa_pdf/1b/17/main.PMC5406275.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/17/main.PMC5406275.pdf
"(2016), http://dx.doi.org/ 10.1016/j.ejpn.2016.12.004 .",OADS,/arxiv_data1/oa_pdf/1b/17/main.PMC5406275.pdf
"The conspicuous expression ofthe CRF 1receptor in the NI of the rat and its high co- expression with relaxin-3 (Potter et al., 1994; Chalmers et al., 1995; Bittencourt and Sawchenko, 2000; Tanaka et al., 2005; Ma et al., 2013), not only de ﬁned the topography of the NI but also inspired early studies to evaluate its role instress responses (Figure 1) (Rivest et al., 1995; Tanaka et al., 2005).Tables of Links TARGETS GPCRsaPAC 1receptor 5-HT 1Areceptor RXFP3 receptor CRF 1receptor V 1Areceptor CRF 2receptor Y 5receptor Dopamine D 2receptor Nuclear hormone receptorsb Dopamine D 3receptor Glucocorticoid receptor, NR3C1 Neuropeptide S receptorLIGANDS 5-HT Lidocaine Agouti-related protein Neuropeptide YAntalarmin Orexin-A cAMP Orexin-B Corticotrophin-releasing hormone OxytocinDopamine Quinpiroleβ-Endorphin Relaxin-3 Fenclonine Relaxin-3 (B chain) GABA Substance PGhrelin Vasopressin Insulin These Tables list key protein targets and ligands in this article that are hy perlinked to corresponding entries in http://www.guidetopharmacology .org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016), and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (a,bAlexander et al., 2015a,b).",OADS,/arxiv_data1/oa_pdf/cc/e5/BPH-174-1061.PMC5406295.pdf
"1586 Biophysical Journal 112, 1586–1596, April 25, 2017http://dx.doi.org/10.1016/j.bpj.2017.03.005 /C2112017 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/28/5b/main.PMC5406370.pdf
"Biophysical Journal 112, 1539–1550, April 25, 2017 1539http://dx.doi.org/10.1016/j.bpj.2017.02.044 This is an open access article under the CC BY-NC-ND license ( http:// creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c1/10/main.PMC5406374.pdf
"Numerical methods Our model consists of a system of ordinary differential equations which we integrate numerically using a dense linear solver with the backward dif- ferentiation formula, and Newton iteration methodology from CVODE from the SUNDIALS solver suite ( http://computation.llnl.gov/projects/ sundials/cvode )(18).",Non-OADS,/arxiv_data1/oa_pdf/c1/10/main.PMC5406374.pdf
"The network was rendered using GeneNetWeaver (http://gnw.sourceforge.net/ )—a bioinformatics tool originally designed to assess the accuracy of network inference algorithms, which annotatestranscriptional-regulatory interactions between protein-coding genes for theE.",OADS,/arxiv_data1/oa_pdf/c1/10/main.PMC5406374.pdf
"Biophysical Journal 112, 1609–1620, April 25, 2017 1609http://dx.doi.org/10.1016/j.bpj.2017.03.013 /C2112017 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/79/b0/main.PMC5406375.pdf
"We searched COSMIC (http://cancer.sanger.ac.uk/cosmic/)and the Human Gene Mutation Database (HGMD (http://www.hgmd.cf.ac.uk/ac/index.php)) Professional v.2016.3 (BIOBASE, Beverly, MA, USA) todetermine whether detected mutations had been previously reported asbeing associated with diseases.",OADS,/arxiv_data1/oa_pdf/39/ef/hgv201713.PMC5406389.pdf
"With regard to somatic mutations in the two pancreatic tumors, we did not detect genetic changes in 609 cancer-associated genesbelonging to the COSMIC cancer gene census (http://cancer.sanger.ac.uk/census).",Non-OADS,/arxiv_data1/oa_pdf/39/ef/hgv201713.PMC5406389.pdf
"Our WES analysisof the two pancreatic tumor tissues revealed that, except for a germline MEN1 mutation, none of these tumors possessed tumor- speci ﬁc somatic mutations in the 609 cancer-associated genes designated by the COSMIC cancer gene census (http://cancer.sanger.ac.uk/census).",OADS,/arxiv_data1/oa_pdf/39/ef/hgv201713.PMC5406389.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information for this article can be found on the Human Genome Variation website (http://www.nature.com/hgv)Germline and somatic genetic changes A Naruoka et al 6 Human Genome Variation (2017) 17013 Of ﬁcial journal of the Japan Society of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/39/ef/hgv201713.PMC5406389.pdf
Both treatments similarly reducedEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8097F06066FC0C29 .,Non-OADS,/arxiv_data1/oa_pdf/0f/2c/12325_2017_Article_497.PMC5406448.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0f/2c/12325_2017_Article_497.PMC5406448.pdf
"4,13 Resistance in P falciparum to the antimalarials Lancet Infect Dis 2017;  17: 491–97 Published Online  February 1, 2017 http://dx.doi.org/10.1016/S1473-3099(17)30048-8 This online publication has  been corrected.",Non-OADS,/arxiv_data1/oa_pdf/8c/3e/main.PMC5406483.pdf
"2011. http://www.who.int/malaria/publications/atoz/9789241500838/en/ (accessed July 12, 2016).",Non-OADS,/arxiv_data1/oa_pdf/8c/3e/main.PMC5406483.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.011 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/a2/main.PMC5406515.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  68–69 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/8b/a2/main.PMC5406515.pdf
"Secondly, a 73-year old woman with a history of bilateral breast cancer was seen at with severe pain and swelling of the left breast ten days after her ablation which was complicated by a large hamatoma http://dx.doi.org/10.1016/j.idcr.2017.03.014 Received 14 March 2017; Received in revised form 29 March 2017; Accepted 29 March 2017⁎Corresponding author at: Henri Dunantstraat 1, 5223 GZ, Den Bosch, The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/cb/63/main.PMC5406516.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cb/63/main.PMC5406516.pdf
Infection 2011;39:97. http://dx.doi.org/10.1007/s15010-011-0088-6 .,Non-OADS,/arxiv_data1/oa_pdf/cb/63/main.PMC5406516.pdf
J Gynecol Obstet Biol Reprod (Paris) 2010;39(February (1)):64 –7.http://dx.doi.org/ 10.1016/j.jgyn.2009.09.005 .,OADS,/arxiv_data1/oa_pdf/cb/63/main.PMC5406516.pdf
Diagn Cytopathol 2009;37(April (4)):311 –2.http://dx.doi.org/10.1002/dc.21044 .,Non-OADS,/arxiv_data1/oa_pdf/cb/63/main.PMC5406516.pdf
Infect Drug Resist 2014;5(July (7)):183 –97.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/63/main.PMC5406516.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.03.002,Non-OADS,/arxiv_data1/oa_pdf/95/ab/main.PMC5406518.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3–5 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/95/ab/main.PMC5406518.pdf
MALDI-TOF MS spectra The MALDI-TOF-MS spectra of ‘Prevotella ihumii ’and ‘Varibac- ulum timonense ’are available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/95/ab/main.PMC5406518.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,3–5 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/95/ab/main.PMC5406518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.04.013 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
Law Rep. 1 (1984) 1018 e1036 http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Ethics 42 (2016)85e88,http://dx.doi.org/10.1136/medethics-2015-102861 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Ethics 42 (2016) 89 e94,http://dx.doi.org/10.1136/ medethics-2015-102862 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"89 (2014) 1245 e1251, http://dx.doi.org/10.1097/ ACM.0000000000000388 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"108 (2015) 451 e456, http://dx.doi.org/10.1177/0141076815604494 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"46 (2016) 1443 e1446, http://dx.doi.org/10.1111/ imj.13276 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Irvine, et al., Completion of hand-written surgical consent forms is frequently suboptimal and could be improved by usingelectronically generated, procedure-speci ﬁc forms, Surgeon (2015) 2 e7, http://dx.doi.org/10.1016/j.surge.2015.11.004 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"47 (2008) 287 e295, http://dx.doi.org/10.1016/ j.jvs.2007.10.050 .",OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Wee, Informed consent for epidural analgesia in labour: a survey of UK practice, Anaesthesia 64 (2009) 161 e164, http://dx.doi.org/ 10.1111/j.1365-2044.2008.05679.x .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"41 (2006) 368 e371, http://dx.doi.org/10.1016/j.jpedsurg.2005.11.015 .",OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"91 (2004) 1377 e1380, http://dx.doi.org/10.1002/bjs.4590 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"(2016) 10 e11,http://dx.doi.org/10.1016/j.bjps.2016.11.015 .",OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Bmj 355 (2016) 1 e2,http://dx.doi.org/ 10.1136/bmj.i5447 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
http://www.ncbi.nlm.nih.gov/pubmed/27872045 .,Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Macfarlane, S. McKinlay, Consent for anaes- thesiadsleepwalking into trouble, Bmj 6189 (2016) i6189, http://dx.doi.org/ 10.1136/bmj.i6189 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"Lancet 388 (2016) 2210, http://dx.doi.org/10.1016/S0140-6736(16)32114-6 .",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
"99 (2017) 36 e38, http://dx.doi.org/10.1308/rcsbull.2017.36 .J.W.",Non-OADS,/arxiv_data1/oa_pdf/42/a9/main.PMC5406519.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.03.005,Non-OADS,/arxiv_data1/oa_pdf/36/81/main.PMC5406520.pdf
nov. MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of ‘Corynebacterium fournierii ’is available online ( http://www.mediterranee-infection.com/ article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/36/81/main.PMC5406520.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,6–7 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/36/81/main.PMC5406520.pdf
This  is  an  open  access  article under the CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC5406521.pdf
4)  was  excised  by  means  of  aspira- http://dx.doi.org/10.1016/j.ijscr.2017.04.008 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC5406521.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/73/main.PMC5406522.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.03.023 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/73/main.PMC5406522.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/65/main.PMC5406523.pdf
Chest  Ct-scan  with  IV  and  oral  contrast  was  requested  to http://dx.doi.org/10.1016/j.ijscr.2017.04.010 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/04/65/main.PMC5406523.pdf
"(online)  1  (404)  (2008)  1–3,  Retrieved  from  http://www.casesjournal.com/ content/1/1/404 .",Non-OADS,/arxiv_data1/oa_pdf/04/65/main.PMC5406523.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.03.006,Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,8–14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/17/main.PMC5406524.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/f7/main.PMC5406525.pdf
Surgery  and  hospital  stay  were  uneventful  and  was http://dx.doi.org/10.1016/j.ijscr.2017.04.014 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5b/f7/main.PMC5406525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/c8/main.PMC5406526.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2017.03.001,OADS,/arxiv_data1/oa_pdf/11/c8/main.PMC5406526.pdf
"Physicochemical char- acterization of the matrix and the immobilized invertase functionality, http://dx.doi.org/10.1016/j.btre.2017.03.001 Received 11 January 2017; Received in revised form 25 March 2017; Accepted 29 March 2017⁎Corresponding author at: Laboratório de Imunopatologia Keizo Asami (LIKA), Universidade Federal de, Pernambuco, Cidade Universitária, Recife –PE, CEP 50670-901, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/ab/86/main.PMC5406527.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/86/main.PMC5406527.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.btre.2017.03.001 .",OADS,/arxiv_data1/oa_pdf/ab/86/main.PMC5406527.pdf
The validation study was carried out using Gene Expression-based Outcome for Breast Cancer Online (GOBO; http://co.bmc.lu.se/gobo).,Non-OADS,/arxiv_data1/oa_pdf/fa/c0/CAS-108-604.PMC5406535.pdf
3.3.2 (http://cran.r-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/f1/d4/CAS-108-795.PMC5406537.pdf
The English used in this article was revisedby KN International (http://www.kninter.com/).,Non-OADS,/arxiv_data1/oa_pdf/27/b2/CAS-108-547.PMC5406539.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
OAGB/MGB  as  a  gastric  bypass  surgery  offers a  safe  and  effective  revisional  surgery  for  failed  gastric  restrictive http://dx.doi.org/10.1016/j.ijscr.2017.04.020 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"24 (June  (6))  (2014)  841–846,  http://dx.doi.org/10.1007/s11695- 014-1180-7 .",Non-OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"12  (September −October  (8))  (2016) 1611–1615,  http://dx.doi.org/10.1016/j.soard.2016.05.025 .",OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"8 (November-December  (6))  (2012)  679–684,  http://dx.doi.org/10.1016/j.soard.",OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"10  (January-February  (1))  (2014)  177–183,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"11  (January-February  (1))  (2015)  79–85,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"150  (December  (6))  (2013)  373–378,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/4d/39/main.PMC5406540.pdf
"In addition, microarray data of LS174T cells treated witha dominant negative form of TCF7L2 were obtained from Gene Expression Omnibus (GSE46465, https://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/d2/72/CAS-108-612.PMC5406541.pdf
"To elucidate the roleof FRMD5 as a downstream target of canonical Wnt signalingin colon cancer, we selected genes whose expression levels were commonly altered more than two-fold by the FRMD5 siRNA and the b-catenin siRNA in HCT116 cells.Additionally, gene set enrichment analysis was performed using MSigDB (Molecular signatures database, http://www.broadinstitute.org/gsea/msigdb/index.jsp) with gene sets derived from Canonical pathways, BioCarta, KEGG, and Reactome.",OADS,/arxiv_data1/oa_pdf/d2/72/CAS-108-612.PMC5406541.pdf
Statistical analysis was carried out by R (https://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/d2/72/CAS-108-612.PMC5406541.pdf
"We therefore searched further for TCF7L2-binding elements (TBEs) in this region using a motif search for transcriptionfactor-binding motifs, JASPAR (http://jaspar.genereg.net/).",OADS,/arxiv_data1/oa_pdf/d2/72/CAS-108-612.PMC5406541.pdf
"(1)To examine DIMT1 expression in MM progression, we compared its expression among MGUS, SMM, symptomatic MM, and plasma cell leu-kemia cases using gene expression datasets previouslyuploaded to the NCBI GEO database (http://www.ncbi.nim.nih.",OADS,/arxiv_data1/oa_pdf/b4/4d/CAS-108-641.PMC5406542.pdf
"However, in some situations, mutations within the cells' DNA make http://dx.doi.org/10.1016/j.redox.2017.04.018 Received 21 February 2017; Received in revised form 7 April 2017; Accepted 10 April 2017E-mail address: balarama@mcw.edu .Abbreviations: ATP, adenosine triphosphate; BrP, bromopyruvate; CO 2, carbon dioxide; CoA, acetyl-coenzyme A; 2-DG, 2-deoxyglucose; ETC, electron transport chain; FAO, fatty acid oxidation; FAD, ﬂavin adenine dinucleotide; FDG, ﬂuorinated deoxyglucose; FFA, free fatty acid; GAPDH, glyceraldehyde-3-phosphate; GIAN, Global Initiative of Academic Networks; G- 6P, glucose-6-phosphate; GLUT, glucose transporters; H 2O, water; HK, hexokinase; HIF-1, hypoxia-inducible factor 1; IDH-2, isocitrate dehydrogenase-2; KRAS, V-Ki-ras2 Kirsten rat sarcoma; LDH, lactate dehydrogenase; LN, lonidamine; MAGL, monoacylglycerol lipase; MCT, monocarboxylate transporter; MDR, multidrug resistance; NAD+, nicotinamide adenine dinucleotide; NADPH, nicotinamide adenine dinucleotide phosphate; OXPHOS, oxidative phosphorylation; PHGDH, 3-phosphoglycerate dehydrogenase; PDH, pyruvate dehydrogenase;PDK, pyruvate dehydrogenase kinase; PET, positron emission tomography; PK, pyruvate kinase; TCA, tricarboxylic acid; TPP +, triphenylphosphonium; VDAC, voltage-dependent anion channelRedox Biology 12 (2 017) 833–842 Available online 13 April 2017 2213-2317/ © 2017 The Author.",Non-OADS,/arxiv_data1/oa_pdf/5d/da/main.PMC5406543.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/da/main.PMC5406543.pdf
"[53] H. Feldwisch-Drentrup, Candidate cancer drug suspected after death of three patients at an alternative medicine clinic, Science (2016) (August 12, 2016),http://www.sciencemag.org/news/2016/08/candidate-cancer-drug-suspected- after-death-three-patients-alternative-medicine-clinic .",Non-OADS,/arxiv_data1/oa_pdf/5d/da/main.PMC5406543.pdf
"To test whether APOE allele types relate to COX activity, we compared the total protein and http://dx.doi.org/10.1016/j.redox.2017.04.010 Received 1 April 2017; Received in revised form 6 April 2017; Accepted 8 April 2017⁎Corresponding author at: MD University of Kansas School of Medicine MS 2012, Landon Center on Aging 3901, Rainbow Blvd, Kansas City, KS 66160, USA.",OADS,/arxiv_data1/oa_pdf/74/7b/main.PMC5406545.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7b/main.PMC5406545.pdf
The level of 25(OH)D in humans and other animals is well known to rise in summer and decline in winter in response to seasonal variation in the http://dx.doi.org/10.1016/j.redox.2017.04.009 Received 25 January 2017; Received in revised form 5 April 2017; Accepted 5 April 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/6f/23/main.PMC5406546.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6f/23/main.PMC5406546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.1016/j.tranon.2017.02.005,OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1002/cncr.24121 [Epub 2009/02/07, PubMed PMID: 19197972 ;P u b M e dC e n t r a lP M C I D : PMC2813207 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1016/j.ctrv.2013.11.006 [Epub 2013/12/19, PubMed PMID: 24345772 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1245/s10434-007-9483-8 [Epub 2007/07/27, PubMed PMID: 17653803 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1002/pbc.22673 [Epub 2010/08/25, PubMed PMID: 20734401 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.1016/j.fob.,OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1200/JCO.2008.14.0095 [Epub 2008/02/01, PubMed PMID: 18235123 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1084/jem.20050915 [Epub 2005/12/21, PubMed PMID: 16365148 ; PubMed Central PMCID: PMC2212968 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1146/ annurev.med.45.1.491 [Epub 1994/01/01, PubMed PMID: 8198398 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1182/- blood-2003-04-1039 [Epub 2003/08/23, PubMed PMID: 12933583 ].",Non-OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1038/bjc.2013.421 [Epub 2013/07/28, PubMed PMID: 23887603 ; PubMed Central PMCID: PMC3778281 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1038/81183 [Epub 2000/11/04, PubMed PMID: 11062439 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1016/j.jcon- rel.2015.05.282 [Epub 2015/05/25, PubMed PMID: 26003042 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"J Exp Clin Cancer Res 35(1), 113. http://dx.doi.org/10.1186/s13046-016-0392-1 [Epub 2016/07/17, PubMed PMID: 27421768 ].",Non-OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1007/s10585-011-9377-9 [Epub 2011/03/05, PubMed PMID: 21374084 ; PubMed Central PMCID: PMC4284437 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1002/jbmr.535 [Epub 2011/10/07, PubMed PMID: 21976359 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1177/0023677215570989 [Epub 2015/02/05, PubMed PMID: 25650386 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1002/jor.21304 [Epub 2011/02/02, PubMed PMID: 21284029 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1006/bbrc.2000.3379 [Epub 2000/09/07, PubMed PMID: 10973797 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1016/j.bone.2004.08.008 [Epub 2004/12/14, PubMed PMID: 15589214 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1016/j.ctrv.2014.12.001 [Epub 2014/12/17, PubMed PMID: 25499997 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-13-1885 [Epub 2014/03/07, PubMed PMID: 24599131 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.18632/oncotarget.4282 [Epub 2015/06/21, PubMed PMID: 26093091 ; PubMed Central PMCID: PMC4695143 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1158/1541-7786.MCR-07-0007 [Epub 2007/10/24, PubMed PMID: 17951400 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-13-2574 [Epub 2014/05/08, PubMed PMID: 24803583 ;P u b M e dC e n t r a lP M C I D : PMC4134738 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.18632/oncotarget.,OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.1016/j.canlet.,OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.05.010 [Epub 2010/07/08, PubMed PMID: 20605485 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1038/nature14282 [Epub 2015/03/31, PubMed PMID: 25822788 ; PubMed Central PMCID: PMC4475637 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1111/j.1600-065X.2008.00608.x [Epub 2008/03/28, PubMed PMID: 18364002 ; PubMed Central PMCID: PMC3546504 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1159/000368414 [Epub 2014/11/18, PubMed PMID: 25402182 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1007/s00262-013-1476-9 [Epub 2013/10/05, PubMed PMID: 24092389 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1038/nri3399 [Epub 2013/02/26, PubMed PMID: 23435331 ].",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"Nat Commun 7, 10828. http://dx.doi.org/10.1038/ncomms10828 [Epub 2016/03/05, PubMed PMID: 26940548; PubMed Central PMCID: PMC4785224].430 F8-TNF- αTargeting Metastatic Osteosarcoma Robl et al.",OADS,/arxiv_data1/oa_pdf/2a/54/main.PMC5406547.pdf
"http://dx.doi.org/10.1016/j.redox.2017.04.021 Received 11 February 2017; Received in revised form 23 March 2017; Accepted 13 April 2017⁎Corresponding author at: Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain.",Non-OADS,/arxiv_data1/oa_pdf/ed/c8/main.PMC5406579.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ed/c8/main.PMC5406579.pdf
"http://dx.doi.org/10.1016/j.redox.2017.04.019 Received 1 March 2017; Received in revised form 8 April 2017; Accepted 11 April 2017⁎Corresponding authors at: Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto, de Investigación Sanitaria, Santiago de Compostela 15782, Spain E-mail addresses: cristina.contreras@usc.es (C. Contreras), m.lopez@usc.es (M. López).Redox Biology 12 (2 017) 854–863 Available online 15 April 2017 2213-2317/ © 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bb/69/main.PMC5406580.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/69/main.PMC5406580.pdf
http://dx.doi.org/10.1016/j.tranon.2017.02.007,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"World J Surg Oncol 12, 397. http://dx.doi.org/10.1186/1477-7819-12-397 .",Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1007/ s10120-013-0259-5 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"Int J Cancer 136,2 1 –33.http://dx.doi.org/10.1002/ijc.28954 .",Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1038/nrc1098 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1016/j.cell.2006.11.001 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1056/NEJMoa1113205 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1126/science.1228522 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1016/j.ctrv.2012.12.007 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1097/JTO.0b013e31823c5c16 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1038/jid.2010.141 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1038/bjc.2011.294 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1002/ijc.25819 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1002/hep.20091 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1016/j.cell.2014.07.013 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1007/ s10552-014-0457-4 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1016/j.jtcvs.2015.09.126 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1200/jco.2010.33.3716 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1016/S0002-9440(10)64706-2 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1158/1078-0432.CCR-10-0445 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1309/AJCP9X8OZBEIQVVI .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1007/s10616-015-9866-9 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1097/MD.,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1016/- j.ajpath.2010.12.003 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1126/science.1203543 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-12-4140 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"Exp Mol Med 33,8–14.http://dx.doi.org/10.1038/emm.2001.2 .",OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1155/2006/281315 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"Cancer Lett 336,3 4 –45.http://dx.doi.org/10.1016/j.canlet.2013.04.021 .",OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1016/j.humpath.2006.01.026 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1200/JCO.2007.15.8923 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1056/NEJMoa040766 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-08-0872 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1200/JCO.2010.28.7045 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.2147/OTT.S82437 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
Oncotarget .http://dx.doi.org/10.18632/ oncotarget.8770 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/10.1186/ 1476-4598-5-50 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1074/jbc.M312372200 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1002/jso.22024 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1016/j.humpath.2012.01.005 .,OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1038/nrm2720 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"Breast Cancer Res 13, 202. http://dx.doi.org/ 10.1186/bcr2789 .",Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1186/1471-2407-12-178 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
http://dx.doi.org/ 10.1371/journal.pone.0123976 .,Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"J R Soc Interface , 13. http://dx.doi.org/10.1098/rsif.2015.1106 .",OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"Front Oncol 5, 155. http://dx.doi.org/10.3389/ fonc.2015.00155 .",Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
"Nature 527, 472 –476.http://dx.doi.org/ 10.1038/nature15748 .Translational Oncology Vol.",Non-OADS,/arxiv_data1/oa_pdf/70/a2/main.PMC5406582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/86/main.PMC5406583.pdf
http://dx.doi.org/10.1016/j.tranon.2017.02.009,OADS,/arxiv_data1/oa_pdf/60/86/main.PMC5406583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC5406584.pdf
http://dx.doi.org/10.1016/j.tranon.2017.03.003,OADS,/arxiv_data1/oa_pdf/8a/10/main.PMC5406584.pdf
(23)was analyzed to generate Kaplan –Meier plots of OS according to PSMA6 expression levels using the R2 genomics analysis and visualization platform (http://hgserver1.amc.nl/cgi-bin/r2/main.cgi).,OADS,/arxiv_data1/oa_pdf/a1/68/CAS-108-732.PMC5406588.pdf
"2006, from U.S. Food & Drug Admin - istration website: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm074965.pdf.",OADS,/arxiv_data1/oa_pdf/fe/c6/tox-30-111.PMC5406590.pdf
"2013, from The  American Veterinary Medical Association website: https://www.avma.org/KB/Policies/Documents/euthanasia.pdf.",Non-OADS,/arxiv_data1/oa_pdf/66/e0/tox-30-145.PMC5406593.pdf
"2015, from American Cancer Society website:  https://www.cancer.org/content/dam/cancer-org/research/ cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-3rd-edition.pdf.",Non-OADS,/arxiv_data1/oa_pdf/66/e0/tox-30-145.PMC5406593.pdf
Clinical information of breast cancer patients with HER2 somatic mutations ( n=27) Patient ID Protein change ImpactTumor typeGrade ER PR HER2Lymph nodes status 469 p.S310F Activating(26)IDC 1 /C0/C0 + /C0 3044 p.S310F Activating(26)IDC 2 + /C0/C0 /C0 3456 p.S310F Activating(26)IDC 2 ++ /C0/C0 5547 p.S310F Activating(26)ILC – ++ /C0/C0 9603 p.D769H Activating(22)IDC 2 /C0/C0 + /C0 4393 p.A775-G776insYVMA Activating(27)IDC 2 ++ /C0/C0 2619 p.A775-G776insYVMA Activating(27)IDC 2 ++ /C0 + 2373 p.V777L Activating(22)ILC – /C0/C0 /C0 + 3624 p.V777L Activating(22)IDC 2 + /C0/C0 /C0 4223 p.V777L Activating(22)IDC 1 ++ /C0/C0 5669 p.V777L Activating(22)IDC 2 /C0/C0 ++ 6795 p.V777L Activating(22)IDC 2 + /C0 + /C0 3943 p.V777L Activating(22)IDC 2 /C0/C0 /C0 /C0 3943 p.T862A Unknown † IDC 2 /C0/C0 /C0 /C0 1510 p.L12R Novel IDC 2 /C0/C0 /C0 + 327 p.E139D Novel IDC 3 + /C0/C0 /C0 930 p.E139G Novel IDC 2 ++ /C0/C0 3860 p.A466V Novel IDC 3 + /C0/C0 + 146 p.C515R Novel IDC 2 /C0/C0 /C0 /C0 407 p.T526A Novel ACC – /C0/C0 /C0 /C0 10001 p.G776R Novel IDC 2 ++ /C0 + 1028 p.L869R Unknown † IDC 2 ++ + /C0 3733 p.L869R Unknown † IDC 2 /C0/C0 /C0 + 3733 p.R897G Novel IDC 2 /C0/C0 /C0 + 4137 p.P885S Novel IDC 2 /C0/C0 /C0 /C0 4892 p.F1030C Novel IDC 3 ++ /C0/C0 4663 p.P1074S Novel IDC 2 ++ /C0/C0 2476 p.L755S Unknown(22)IDC 2 + /C0/C0 + 3896 p.L755S Unknown(22)IDC 3 ++ /C0 + †Reported in COSMIC (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).,Non-OADS,/arxiv_data1/oa_pdf/9b/04/CAS-108-671.PMC5406600.pdf
TargetScan (http://www.targetsca n.org/) and miRBase (http://www.mirbase.org/) were used to identify putative miRNAs regulating expression of E-cadherin.,OADS,/arxiv_data1/oa_pdf/1c/90/CAS-108-685.PMC5406602.pdf
"For quantitative analysis, ﬂuorescent areas were measured using theImageJ 1.44 software (available at http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/a9/73/CAS-108-704.PMC5406603.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/b9/rjx080.PMC5406612.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/2d/rjx076.PMC5406613.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/d9/rjw218.PMC5406614.pdf
"@ERSpublications A third of surgically treated NSCLC cases were detected incidentally; those detected by CT may have better survival http://ow.ly/S24I309M1VK Cite this article as: Orrason AW, Sigurdsson MI, Baldvinsson K, et al .",Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
ERJ Open Res 2017; 3: 00106-2016 [https://doi.org/10.1183/ 23120541.00106-2016].,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
https://doi.org/10.1183/23120541.00106-2016 ERJ Open Res 2017; 3: 00106-2016 ORIGINAL ARTICLE LUNG CANCER,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
https://doi.org/10.1183/23120541.00106-2016 2LUNG CANCER | A.W.,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
"TNM: tumour, node andmetastasis.80100Ratio of TNM stage I+II Incidental detection CT 60 40 20 0% 5-year periods1991–1995 1996–2000 2001–2005 2006–2010 https://doi.org/10.1183/23120541.00106-2016 3LUNG CANCER | A.W.",Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
COPD: chronic obstructive pulmonary disease; FEV 1: forced expiratory volume in 1 s. https://doi.org/10.1183/23120541.00106-2016 4LUNG CANCER | A.W.,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
"Approximately one-third of theFIGURE 2 Comparison of cancer-specific survival in patientswith nonsmall cell lung cancer detected incidentally by computed tomography (CT) (n=41) or chestradiography (CR) (n=130) and inpatients with symptomatic presentation (SYM) (n=334).00.20.40.60.81.0 YearsCancer-speciﬁc survival SYMCRCT 334 274 215 177 147 127130 112 98 85 76 6641 35 31 28 25 24Patients at risk nCT CR SYMp=0.003  p=0.01 5 4 3 2 1 0 FIGURE 3 Comparison of overall survival in patients with nonsmall cell lung cancer detectedincidentally by computedtomography (CT) (n=41) or chest radiography (CR) (n=130), and in patients with symptomaticpresentation (SYM) (n=334).5 4 3 2 1 000.20.40.60.81.0 YearsOverall survival SYMCRCT 334 274 215 177 147 127130 112 98 85 76 6641 35 31 28 25 24Patients at risk nCT CR SYMp=0.01  p=0.3 https://doi.org/10.1183/23120541.00106-2016 5LUNG CANCER | A.W.",Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
https://doi.org/10.1183/23120541.00106-2016 6LUNG CANCER | A.W.,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
https://doi.org/10.1183/23120541.00106-2016 7LUNG CANCER | A.W.,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
"http://globocan.iarc.fr Date last accessed: August 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
https://doi.org/10.1183/23120541.00106-2016 8LUNG CANCER | A.W.,Non-OADS,/arxiv_data1/oa_pdf/60/79/00106-2016.PMC5406653.pdf
"Kathryn E Hitchcock, R Charles Nichols, Christopher G Morris, Debashish Bose, Steven J Hughes,  John A Stauffer, Scott A Celinski, Elizabeth A Johnson, Robert A Zaiden, Nancy P Mendenhall,  Michael S RutenbergORIGINAL ARTICLE 103 April 27, 2017 |Volume 9 |Issue 4| WJGS|www.wjgnet.comFeasibility of pancreatectomy following high-dose proton  therapy for unresectable pancreatic cancerSubmit a Manuscript: http://www.f6publishing.com DOI: 10.4240/wjgs.v9.i4.103World J Gastrointest Surg   2017  April 27; 9(4): 103-108 ISSN 1948-9366 (online) Kathryn E Hitchcock, R Charles Nichols, Christopher G Morris,  Nancy P Mendenhall, Michael S Rutenberg, Department of  Radiation Oncology, University of Florida, Jacksonville, FL 32206,  United States Debashish Bose, Department of Surgical Oncology, UF Health  Cancer Center - Orlando Health, Orlando, FL 32806, United  States Steven J Hughes, Department of Surgery, University of Florida,  Gainesville, FL 32610, United States John A Stauffer, Department of Surgery, Mayo Clinic, Jack - sonville, FL 32224, United States Scott A Celinski, Department of Surgery, Baylor University  Medical Center at Dallas, Dallas, TX 75246, United States Elizabeth A Johnson, Department of Hematology/Oncology,  Mayo Clinic, Jacksonville, FL 32610, United States Robert A Zaiden,  Department of Hematology/Oncology, Baptist  Health, Jacksonville, FL 32610, United States Author contributions: Hitchcock KE, Nichols RC and Rutenberg  MS wrote the manuscript; Bose D, Hughes SJ, Stauffer JA, Celinski  SA, Johnson EA, Zaiden RA and Mendenhall NP reviewed the  manuscript; Morris CG performed statistical analysis; Bose D,  Hughes SJ, Stauffer JA, Celinski SA, Johnson EA and Zaiden RA  provided patient care.",Non-OADS,/arxiv_data1/oa_pdf/ce/1d/WJGS-9-103.PMC5406731.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: R Charles Nichols, MD, Department of  Radiation Oncology, University of Florida, 2015 North Jefferson St.  Jacksonville, FL 32206, United States.",Non-OADS,/arxiv_data1/oa_pdf/ce/1d/WJGS-9-103.PMC5406731.pdf
"World J  Gastrointest Surg  2017; 9(4): 103-108  Available from: URL:   http://www.wjgnet.com/ 1948-9366 /full/v9/i4/103.htm  DOI:  http://dx.doi.org/10.4240/wjgs.v9.i4.103 INTRODUCTION Patients undergoing pancreatectomy for tumors which  are believed to be resectable by preoperative imaging  experience high rates of lymph node positivity, margin  positivity and local/regional recurrence[1-6].",Non-OADS,/arxiv_data1/oa_pdf/ce/1d/WJGS-9-103.PMC5406731.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ce/1d/WJGS-9-103.PMC5406731.pdf
"Carlos HoyuelaORIGINAL ARTICLE 109 April 27, 2017 |Volume 9 |Issue 4| WJGS|www.wjgnet.comFive-year outcomes of laparoscopic sleeve gastrectomy as a  primary procedure for morbid obesity: A prospective studySubmit a Manuscript: http://www.f6publishing.com DOI: 10.4240/wjgs.v9.i4.109World J Gastrointest Surg   2017  April 27; 9(4): 109-117 ISSN 1948-9366 (online) Carlos Hoyuela, Department of General and Digestive Surgery,  Hospital Plató, Universitat Autònoma de Barcelona, 08006  Barcelona, Spain Author contributions:  Hoyuela C designed the study, collected  and analyzed the data, wrote the paper and revised the manuscript  for final submission.",Non-OADS,/arxiv_data1/oa_pdf/29/3d/WJGS-9-109.PMC5406732.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Carlos Hoyuela, MD, Associate Professor   of Surgery, Chief, Department of General and Digestive Surgery,  Hospital Plató, Universitat Autònoma de Barcelona, Plató 21, 08006  Barcelona, Spain.",Non-OADS,/arxiv_data1/oa_pdf/29/3d/WJGS-9-109.PMC5406732.pdf
World J Gastrointest Surg  2017; 9(4): 109-117  Available from:  URL:  http://www.wjgnet.com/ 1948-9366 /full/v9/i4/109.htm   DOI: http://dx.doi.org/10.4240/wjgs.v9.i4.109 INTRODUCTION The laparoscopic bariatric procedure commonly referred  to as “sleeve gastrectomy” (LSG) is a left partial gas­ trectomy of the fundus and body to create a long tubular  gastric conduit constructed along the lesser curve of the  stomach[1].,Non-OADS,/arxiv_data1/oa_pdf/29/3d/WJGS-9-109.PMC5406732.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/29/3d/WJGS-9-109.PMC5406732.pdf
"Sanjay S Reddy, Beth Handorf, Jeffrey M Farma, Elin R SigurdsonORIGINAL ARTICLE 97 April 27, 2017 |Volume 9 |Issue 4| WJGS|www.wjgnet.comTrends with neoadjuvant radiotherapy and clinical staging  for those with rectal malignanciesSubmit a Manuscript: http://www.f6publishing.com DOI: 10.4240/wjgs.v9.i4.97World J Gastrointest Surg   2017  April 27; 9(4): 97-102 ISSN 1948-9366 (online) Sanjay S Reddy, Jeffrey M Farma, Elin R Sigurdson, Department  of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA  19111, United States Beth Handorf,  Department of Biostatistics, Fox Chase Cancer  Center, Philadelphia, PA 19111, United States Author contributions: Reddy SS designed, performed the research,  and wrote the paper; Handorf B performed the statistical analysis;  Farma JM and Sigurdson ER edited and supervised the project.",Non-OADS,/arxiv_data1/oa_pdf/5b/ff/WJGS-9-97.PMC5406733.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscriptCorrespondence to: Sanjay S Reddy, Assistant Professor,  Department of Surgical Oncology, Fox Chase Cancer Center, 333  Cottman Ave, Philadelphia, PA 19111,  United States.",Non-OADS,/arxiv_data1/oa_pdf/5b/ff/WJGS-9-97.PMC5406733.pdf
"World J Gastrointest Surg  2017; 9(4): 97-102   Available from: URL:  http://www.wjgnet.com/ 1948-9366 /full/ v9/i4/97.htm  DOI: http://dx.doi.org/10.4240/wjgs.v9.i4.97 INTRODUCTION The implementation of radiotherapy for rectal cancer  has seen many adaptations over time, particularly when  comparing adoption in community vs academic centers  in the United States.",Non-OADS,/arxiv_data1/oa_pdf/5b/ff/WJGS-9-97.PMC5406733.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5b/ff/WJGS-9-97.PMC5406733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/d0/mdx044.PMC5406754.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"Thisendeavor of simplicity and clarity is required throughout the en- tire document, text must be legible and easy-to-read that corres- ponds to an ‘eighth grade’ reading level according US standardsor Flesch Reading Ease grade level of 60–70 provided by mostword processing programs, a font of minimum 12 pc, be ad- equately paginated, bear a version number and the date of issue (http://www.nlm.nih.gov/medlineplus/etr.html).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"https://www.loc.gov/rr/frd/Military_Law/pdf/NT_war-crim inals_Vol-II.pdf (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice (E6) 1997; http://ichgcp.net/48-informed-consent-of-trialsub jects (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"http://www.fondationarcad.org/la-fondation/arcad-group (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
https://www.google.,Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/ ucm114928.htm (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"850, 1995, Annex 3; http://apps.who.int/medicinedocs/pdf/ whozip13e/whozip13e.pdf (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"Food and Drug Administration Ofﬁce of Good Clinical Practice Center for Drug Evaluation and ResearchCenter for Biologics Evaluation and ResearchCenter for Devices and Radiological Health July 2014; http://www.fda.gov/ RegulatoryInformation/Guidances/ucm404975.htm (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"4 April 2001; http://ec.europa.eu/health/documents/eudralex/vol-10/inde x_en.htm (3 April 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3b/fa/mdx050.PMC5406755.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/53/mdx027.PMC5406756.pdf
"613 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/aa/czw162.PMC5406757.pdf
Available from URL: http://www.equinetafrica.,Non-OADS,/arxiv_data1/oa_pdf/02/aa/czw162.PMC5406757.pdf
Available: http://www.un.org/millennium/declaration/ares552e.htm [Accessed February 2013].,Non-OADS,/arxiv_data1/oa_pdf/02/aa/czw162.PMC5406757.pdf
"Available at https://sustainabledevelopment.un.org/post2015/transformingourworld/publication (accessed 8 March, 2016).",Non-OADS,/arxiv_data1/oa_pdf/02/aa/czw162.PMC5406757.pdf
Available at: http://www.who.int/workforcealliance/knowledge/resources/GHWA-a_uni versal_truth_report.pdf?ua ¼1 (accessed September 2016).,OADS,/arxiv_data1/oa_pdf/02/aa/czw162.PMC5406757.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/2e/mdx029.PMC5406758.pdf
http://dx.doi.org/ 10.2499/9780896298835.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
"https://www.adb.org/sites/default/666 Health Policy and Planning , 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
"http://www.copenhagenconsensus.com/sites/de fault/ﬁles/food_security_and_nutrition_perspective_-_horton_hoddinott_0.pdf, accessed 1 December 2015.",Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
Water and Sanitation Program Technical Paper 103171. http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2016/02/08/090224b08415bdca/1_0/Rendered/PDF/The0costs0of0m0itation00and0hygiene.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
"Global Nutrition Report 2015 .Washington, DC: Actions and Accountability to Advance Nutrition and Sustainable Development, http://dx.doi.org/10.2499/9780896298835.Johns B, Munthali S, Walker D, Masanjala W, Bishai D. 2013.",Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
http://livessavedtool.org/.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
http://www.powerofnutrition.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
Mandaluyong City:Philippines: Asian Development Bank https://www.adb.org/sites/default/ ﬁles/publication/30345/impact-oop-expenditures-mnch-services-asia-paciﬁc.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
http://scalingupnutrition.org/wp-content/uploads/2014/05/Final-Synthesis-Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
http://www.who.int/ nutgrowthdb/estimates2014/en/.,OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
"World Population Prospects: The 2015 Revision, custom data acquired via website: http://esa.un.org/unpd/wpp/ DataQuery/.",Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
http://www.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/czw184.PMC5406759.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/cd/mdx052.PMC5406760.pdf
"http://seer.cancer.gov/ (26 August 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/16/cd/mdx052.PMC5406760.pdf
"http://www.mayoclinic.org/med ical professionals/cancer-prediction-tools/colon-cancer (26 August 2016,date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/16/cd/mdx052.PMC5406760.pdf
R: A Language and Environment for Statistical Computing (http://www.R-project.org).,Non-OADS,/arxiv_data1/oa_pdf/16/cd/mdx052.PMC5406760.pdf
"699 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/da/czx014.PMC5406762.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/f2/mdx049.PMC5406764.pdf
"[article on internet] 2016. https://www.cancer.org/cancer/ovarian- cancer/about/key-statistics.html (22 September 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/35/f2/mdx049.PMC5406764.pdf
"SEER Stat Fact Sheets: Ovarian Cancer [database on internet] 2016. https://seer.cancer.gov/statfacts/html/ovar-y.html (9 November 2016, date last accessed).",OADS,/arxiv_data1/oa_pdf/35/f2/mdx049.PMC5406764.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/72/mdx105.PMC5406765.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/cc/mdx047.PMC5406766.pdf
"710 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
Available from: http://unpan1.un.org/intradoc/groups/pub lic/documents/UNPAN/UNPAN011842.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
"http://www.health systemassessment.com/health-system-assessment-approach-a-how-to- manual/Health Policy and Planning , 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
"http://www.who.int/alliance-hpsr/ AllianceHPSR_ResearchIssue_Governance.pdf Lucas P, Roberts H, Law C, Arai L, Baird J.",OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
Retrieved from: http://www.institutions-africa.org/ﬁlestream/20090109-discussion-paper-5-researching-the-practical-norms-of-real-governance-in-africa-jean- pierre-olivier-de-sardan-jan-2009.,Non-OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
"https://www.utwente.nl/ bms/pa/staff/warntjen/warntjen_wonka_governance_in_e.pdf Shukla M, Johnson Lassner K. 2012.",Non-OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
"http://www.who.int/healthsystems/strategy/everybodys_business.pdf722 Health Policy and Planning , 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ea/2c/czx007.PMC5406767.pdf
Available from: http://www.emedicine.,Non-OADS,/arxiv_data1/oa_pdf/a2/20/JOMFP-21-132.PMC5406794.pdf
Available from: http://www.dentistryiq.com/articles/2014/01/ new‑oral‑features‑can‑be‑considered‑unique‑as‑a‑fingerprint.html.,Non-OADS,/arxiv_data1/oa_pdf/38/b5/JOMFP-21-176.PMC5406805.pdf
Available from:  https://www.prezi.com/0o1lr5lssutc/tongue‑scanner.,Non-OADS,/arxiv_data1/oa_pdf/38/b5/JOMFP-21-176.PMC5406805.pdf
Updated  information about prenatal testing and preimplantation  testing is available at GeneTests  (http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/02/aa/JOMFP-21-181a.PMC5406808.pdf
Available from: http://www.hd.cnrds.net/hd/.,Non-OADS,/arxiv_data1/oa_pdf/a4/89/CMJ-130-885.PMC5407033.pdf
Available from: https://secure.cihi.,OADS,/arxiv_data1/oa_pdf/a4/89/CMJ-130-885.PMC5407033.pdf
doi: https://doi.org/10.1210/ jcem.86.6.7593.,Non-OADS,/arxiv_data1/oa_pdf/65/95/CMJ-130-936.PMC5407040.pdf
Available from: https://www.who‑umc.org/media/2768/ standardised‑case‑causality‑assessment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e5/38/CMJ-130-943.PMC5407041.pdf
Available from: http://www.ohri.ca/programs/clinical_ epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/6e/ad/CMJ-130-979.PMC5407046.pdf
doi: https://doi.org/10.4049/ jimmunol.177.3.1967.,OADS,/arxiv_data1/oa_pdf/21/b7/CMJ-130-986.PMC5407047.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/d1/jix041.PMC5407050.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/05/jix046.PMC5407053.pdf
Geneva: World Health Organisation [updated 2015 Jan;  cited 2015 Nov 24] Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/PM-13-1.PMC5407099.pdf
"Blood glucose concentration was estimated using an Accu-Check active (Roche Diagnostics GmbH, Sandhoferstrasse 116,  DE-68305 Mannheim, GERMANY , http://www.roche.de/diagnostics/ index.htm), based on the glucose oxidase method.",OADS,/arxiv_data1/oa_pdf/90/2b/PM-13-115.PMC5407102.pdf
"Joint FAO/WHO Codex Alimentarius Commission Proposed draft standard for ginseng  products (conversion of the regional standard for ginseng products to a worldwide standard),  (Agenda Item 5), ftp://ftp.fao.org/codex/reports/reports_2015/REP15_PFVe.pdf.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/PM-13-142.PMC5407106.pdf
Available at https://www.niaaa.nih.gov/news- events/news-releases/largest-ever-comorbidity-study-reports-prevalence-and-co-occurrence.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/PM-13-148.PMC5407107.pdf
Drug free world available at http://www.medicalnewstoday.com/ info/addiction/.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/PM-13-148.PMC5407107.pdf
Physiochemical properties calculation and  bioactivity prediction Both physiochemical properties and the predicted bioactivity parameters  for embelin were determined using chemi-informatics software known as  Molinspiration (http://www.molinspiration.com).,OADS,/arxiv_data1/oa_pdf/38/92/PM-13-48.PMC5407116.pdf
Mal Res Treat 2014;2014:http://dx.doi.org/10.1155/2014/950424.,Non-OADS,/arxiv_data1/oa_pdf/38/92/PM-13-48.PMC5407116.pdf
Available at: http://www.ecdc.europa.eu/en/publications/Publications/ annual-epidemiological-report-2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/ea/piv003.PMC5407124.pdf
Available at: http://www.hpa-bioinformatics.org.uk/euibis/ documents/2006_meningo.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at:https://www.gov.uk/government/uploads/system/uploads/ attachment_data/ ﬁle/401058/Table_1_Invasive_meningococcal_ infections_lab_reports__E_W_by_capsular_group___epi_year.,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at: http://www.ecdc.europa.eu/en/publications/Publications/1107_SUR_IBD_2008-09.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at: http://www.cdc.gov/abcs/ reports- ﬁndings/surv-reports.html .,OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at: http://www.medicines.org.uk/emc/medicine/17377/ PIL/repevax/ .,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at: http://www.medicines.org.uk/ emc/medicine/15256 .,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at: https://extranet.who.int/iris/restricted/ handle/10665/66298 .,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
Available at: http://www.fda.gov/downloads/advisorycommittees/ committeesmeetingmaterials/blo odvaccinesandotherbiologics/ vaccinesandrelatedbiologicalproductsadvisorycommittee/ ucm248585.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3d/04/piv064.PMC5407129.pdf
"303 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/23/dyw093.PMC5407149.pdf
https://unstats.un.,Non-OADS,/arxiv_data1/oa_pdf/76/8c/dyw061.PMC5407171.pdf
"http://www.census.gov/popest/data/national/ asrh/pre-1980/PE-11.html (9 January 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/76/8c/dyw061.PMC5407171.pdf
"International Data Bas e. 2010. http://www.census.gov/population/international/data/idb/ informationGateway.php (25 June, 2015, date last accessed).26.",OADS,/arxiv_data1/oa_pdf/76/8c/dyw061.PMC5407171.pdf
"2010. https://www.census.gov/population/www/ cen2010/glance/(9 January 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/76/8c/dyw061.PMC5407171.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commer- cial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/92/dyw369.PMC5407173.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 356 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/89/dyw095.PMC5407174.pdf
"2015. http://andrewgelman.com/ 2015/11/10/death-rates-have-been-increasing-for-middle-aged- white-women-decreasing-for-men/ (30 December 2015, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/11/89/dyw095.PMC5407174.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 219 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/1d/dyw048.PMC5407175.pdf
"Stockholm 2011. http://www.scb.se/statistik/_publikationer/BE9999_2011A01_BR_BE96BR1102.pdf(15 November 2015, date last accessed).",OADS,/arxiv_data1/oa_pdf/26/1d/dyw048.PMC5407175.pdf
"IZAdiscussion paper no 5425 January 2011. http://www.iza.org/en/webcontent/publications/papers/viewAbstract?dp_id ¼5425 (15 November 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/26/1d/dyw048.PMC5407175.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 44 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/dyw043.PMC5407176.pdf
"2003. http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/ nhanes_analytic_guidelines_dec_2005.pdf (19 February 2010,date last accessed).",OADS,/arxiv_data1/oa_pdf/18/cc/dyw043.PMC5407176.pdf
"2012. http://www.atsdr.cdc.gov/toxproﬁles/ tp.asp?id ¼48&tid ¼15 (21 February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/18/cc/dyw043.PMC5407176.pdf
"http://www.epa.gov/epa waste/hazard/tsd/pcbs/pubs/about.htm (5 February 2009, datelast accessed; website out of action for improvement).",OADS,/arxiv_data1/oa_pdf/18/cc/dyw043.PMC5407176.pdf
"MeSH Keywords:  Cognition Disorders • Neurosciences • Smoking  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901870Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Psychiatry, First Faculty of Medicine Charles University in Prague  and General University Hospital in Prague, Prague, Czech Republice-ISSN 1643-3750 © Med Sci Monit, 2017; 23: 1907-1915  DOI: 10.12659/MSM.901870 1907 Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]   [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]   [Chemical Abstracts/CAS] [Index Copernicus]REVIEW ARTICLES This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/2b/72/medscimonit-23-1907.PMC5407177.pdf
"MeSH Keywords:  Cyclic AMP-Dependent Protein Kinase RIalpha Subunit • Parathyroid Hormone •   Phosphoinositide Phospholipase C • Protein Kinase C  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/903699Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Spinal Surgery, Nanfang Hospital, Southern Medical University,  Guangzhou, Guangdong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/9a/48/medscimonit-23-1896.PMC5407178.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/nihms855594.PMC5407188.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/a0/ofx048.PMC5407207.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/3c/ofx044.PMC5407208.pdf
Available at: http://urn.fi/ URN:ISBN:978-952-245-658-8.,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/ofx044.PMC5407208.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/f1/ofx032.PMC5407210.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/99/ofx042.PMC5407211.pdf
MATERIAL AND METHODS Donor feces infusion was performed using the support of the National Donor Feces Bank (http://www.ndfb.nl/) according to the FECAL trial protocol with minor modifications [2].,Non-OADS,/arxiv_data1/oa_pdf/5a/5a/ofx047.PMC5407212.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/5a/ofx047.PMC5407212.pdf
"Raw sequences were processed and analyzed using the open-source bioinformatics pipeline QIIME 1.9.1 (http://qiime.org/), and the Operational Taxonomic Unit was picked using the open-reference protocol.",OADS,/arxiv_data1/oa_pdf/5a/5a/ofx047.PMC5407212.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/0b/ofx030.PMC5407213.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/65/ofx039.PMC5407215.pdf
Available at: https://www.cdc.gov/drugresistance/threat-re- port-2013/.,OADS,/arxiv_data1/oa_pdf/b9/65/ofx039.PMC5407215.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/71/ofx045.PMC5407217.pdf
Available at: http://apps.who.int/iris/bitstream/ 10665/250441/1/9789241565394-eng.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/16/71/ofx045.PMC5407217.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/ofx012.PMC5407218.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March 2017, Volume: 9 , Issue: 3, Pages: 3883-3895,DOI:http://dx.doi.org/10.19082/3883 Corresponding author: Masoud Behzadifar, Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
http://www.ephysician.,Non-OADS,/arxiv_data1/oa_pdf/b4/f9/epj-09-3883.PMC5407219.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3896-3904,DOI:http://dx.doi.org/10.19082/ 3896 Corresponding author: Associate Profes sor Dr. Hamid Reza Riasi, Department of Neurology, Birjand University of Medical Sciences, Birjand, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ef/a4/epj-09-3896.PMC5407220.pdf
http://www.ephysician.ir Page38982.4.,Non-OADS,/arxiv_data1/oa_pdf/ef/a4/epj-09-3896.PMC5407220.pdf
http://www.ephysician.ir Page3900Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/a4/epj-09-3896.PMC5407220.pdf
"http://www.ephysician.ir Page3902show the significant differences, while, in the Q10 group, except the two parameters of IVCT and MPI, an in crease in the other parameters after six months’ treatment was observed which is due to intensity of the systolic dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/ef/a4/epj-09-3896.PMC5407220.pdf
http://www.ephysician.ir Page390416)Langsjoen PH.,OADS,/arxiv_data1/oa_pdf/ef/a4/epj-09-3896.PMC5407220.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT00654784.,Non-OADS,/arxiv_data1/oa_pdf/ef/a4/epj-09-3896.PMC5407220.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3905-3911,DOI:http://dx.doi.org/10.19082/ 3905 Corresponding author: Assistant Professor Dr. Amin Torabipour, Department of Health Service s Management, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/fa/e3/epj-09-3905.PMC5407221.pdf
http://www.ephysician.ir Page3906for patients in health organizations (6).,Non-OADS,/arxiv_data1/oa_pdf/fa/e3/epj-09-3905.PMC5407221.pdf
http://www.ephysician.ir Page3908remaining items were rejected by CVR less than zero (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/fa/e3/epj-09-3905.PMC5407221.pdf
http://www.ephysician.ir Page3910ofthe study can be used for health policy makers and hospital managers to determine the strengths and weaknesses of medical centers and medical tourism industry.,Non-OADS,/arxiv_data1/oa_pdf/fa/e3/epj-09-3905.PMC5407221.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3912-3917,DOI:http://dx.doi.org/10.19082/ 3912 Corresponding author: Assistant Professor Dr. Zahra Fotokian, Ramsar Nursing Care Research Center, Scho ol of Nursing and Midwifery, Babol University of Medical Sciences, Babol, Mazandaran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/95/54/epj-09-3912.PMC5407222.pdf
Clinical trial registration: The trial was registered at the Thai Clinical Trials Registry (TCTR) (http://www.clinicaltrials.in.th/) with the ID: TCTR20160927003.,Non-OADS,/arxiv_data1/oa_pdf/95/54/epj-09-3912.PMC5407222.pdf
http://www.ephysician.ir Page39142.3.,Non-OADS,/arxiv_data1/oa_pdf/95/54/epj-09-3912.PMC5407222.pdf
"http://www.ephysician.ir Page3916improved photophobia by 30% an d phonophobia by 49% (p<0.001), suggesting significantly better results compared to the results produced with the administration of 200 mg Ibuprofen.",Non-OADS,/arxiv_data1/oa_pdf/95/54/epj-09-3912.PMC5407222.pdf
"Trial Registration: The trial was registered at the Thai Clinical Trials Registry (T CTR) (http://www.clinicaltrials.in.th) with the ID: TCTR20160927003 Funding: The authors received no financial support for the research, authorship, and/or publication of this article.",Non-OADS,/arxiv_data1/oa_pdf/95/54/epj-09-3912.PMC5407222.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3918-3924,DOI:http://dx.doi.org/10.19082/ 3918 Corresponding author: Fariba Shoushi, MSc student of Nursing and Midwifery faculty & Student's Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.",Non-OADS,/arxiv_data1/oa_pdf/17/00/epj-09-3918.PMC5407223.pdf
http://www.ephysician.ir Page39202.6.,Non-OADS,/arxiv_data1/oa_pdf/17/00/epj-09-3918.PMC5407223.pdf
"http://www.ephysician.ir Page3922In a study by Chien et al., need -based training reduced the anxiety score of families with ICU patients from 58.23 to 48.81 during and after the intervention (18).",Non-OADS,/arxiv_data1/oa_pdf/17/00/epj-09-3918.PMC5407223.pdf
"http://www.ephysician.ir Page392420)Tel H, Tel H. The effect of ind ividualized education on the transfer anxiety of patients with myocardial infarction and their families.",Non-OADS,/arxiv_data1/oa_pdf/17/00/epj-09-3918.PMC5407223.pdf
"Electronic Ph ysician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3925-3933,DOI:http://dx.doi.org/10.19082/ 3925 Corresponding author: Professor Dr. Nahid Dehghan Nayeri, Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/eb/fa/epj-09-3925.PMC5407224.pdf
"http://www.ephysician.ir Page3926tobacco and alcoholic beverages (11), hiking, mental health, and the use of leisure facilities, in order to prevent development of hypertension.",Non-OADS,/arxiv_data1/oa_pdf/eb/fa/epj-09-3925.PMC5407224.pdf
http://www.ephysician.ir Page3928Table 2.Main categories and primary categories extracted from participants ’experience Main Category Primary Categories Individual experiences Negligence and ignorance Life stress The lack of healthy life styles and abuse awareness Leaving Spirituality Family life Family conflicts Inheritance Dysfunctional eating style Social life Job stress Financial problems Urbanization Chemical agents during the war 3.1.,Non-OADS,/arxiv_data1/oa_pdf/eb/fa/epj-09-3925.PMC5407224.pdf
http://www.ephysician.ir Page3930risk factors of hypertension.,Non-OADS,/arxiv_data1/oa_pdf/eb/fa/epj-09-3925.PMC5407224.pdf
"http://www.ephysician.ir Page3932Referenc es: 1)Savadpour MT, Sharifirad Gh, Mohebi M, Kamran A, Dargahi A.",Non-OADS,/arxiv_data1/oa_pdf/eb/fa/epj-09-3925.PMC5407224.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephy sician.ir March2017, Volume: 9, Issue:3, Pages:3934-3942,DOI:http://dx.doi.org/10.19082/ 3934 Corresponding author: Assistant Professor Dr. Nilgoon Pasdar, Babol University of Medical sciences, Babol, Iran.",Non-OADS,/arxiv_data1/oa_pdf/80/1e/epj-09-3934.PMC5407225.pdf
http://www.ephysician.ir Page3936adhesion of bacte ria to tooth surfaces and formation of cariogenic biofilms.,Non-OADS,/arxiv_data1/oa_pdf/80/1e/epj-09-3934.PMC5407225.pdf
http://www.ephysician.ir Page3938Table 2.,Non-OADS,/arxiv_data1/oa_pdf/80/1e/epj-09-3934.PMC5407225.pdf
"http://www.ephysician.ir Page3940microorganisms, including Streptococcus mutans .",Non-OADS,/arxiv_data1/oa_pdf/80/1e/epj-09-3934.PMC5407225.pdf
"http://www.ephysician.ir Page394221)VysalT, Amasyali M, koyuturk AE, Ozcen S. Effect of difference topical agent on enamel demineralizations around onthodentics brackets an in vivo and in vitro study.",Non-OADS,/arxiv_data1/oa_pdf/80/1e/epj-09-3934.PMC5407225.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume:9, Issue:3, Pages:3943-3949,DOI:http://dx.doi.org/10.19082/ 3943 Corresponding author: Assistant Professor Dr. Fereshte Sheybani, Department of Infectious Diseases, Imam Reza Teaching Hospital, Mashhad University of Medical Sciences, Mashhad,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/f6/69/epj-09-3943.PMC5407226.pdf
Available from: http://www.who.int/tb/country/data/profiles/en/.,OADS,/arxiv_data1/oa_pdf/f6/69/epj-09-3943.PMC5407226.pdf
Available from: http://tb-lep.behdasht.gov.ir/TB_Situation_in_Iran.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f6/69/epj-09-3943.PMC5407226.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3950-3957,DOI:http://dx.doi.org/ 10.19082/ 3950 Corresponding author: Homayoun Sadeghi -Bazargani, Department of Statistics & Epidemiology, Tabriz University of Medical Sciences, Tabriz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/96/24/epj-09-3950.PMC5407227.pdf
http://www.ephysician.ir Page3952regular smokers (P<0.001).,Non-OADS,/arxiv_data1/oa_pdf/96/24/epj-09-3950.PMC5407227.pdf
"http://www.ephysician.ir Page3954Regarding the m ultivariate regression analysis , two models were run to determine the predictors of smoking including personality disorders.",Non-OADS,/arxiv_data1/oa_pdf/96/24/epj-09-3950.PMC5407227.pdf
"http://www.ephysician.ir Page39565)Safiri S, Sadeghi -Bazargani H, Amiri Sh, Khanjani N, Safarpour H, Karamzad N, et al.",Non-OADS,/arxiv_data1/oa_pdf/96/24/epj-09-3950.PMC5407227.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3958-3965,DOI:http://dx.doi.org/10.19082/3958 Corresponding autho r: Dr.Tarek Elnaggar, Research Institute of Ophthalmology, Giza, Egypt .",Non-OADS,/arxiv_data1/oa_pdf/24/d8/epj-09-3958.PMC5407228.pdf
"http://www.ephysician.ir Page3960(85%) reached 20/20 of UDVA, which reflected excellent efficacy of the procedure.",Non-OADS,/arxiv_data1/oa_pdf/24/d8/epj-09-3958.PMC5407228.pdf
"http://www.ephysician.ir Page3962Figure 5 shows a comparison between the preoperative refractive astigmatism and 12 months’ postoperative refractive astigmatism, 85% of the eyes (17 eyes) had less than or equal to 1D of astigmatism 12 months postoperatively, and 30% (six eyes) ha d less than or equal to 0.5 D astigmatism 12 months postoperatively.",Non-OADS,/arxiv_data1/oa_pdf/24/d8/epj-09-3958.PMC5407228.pdf
"http://www.ephysician.ir Page396410)Zaldivar R, Oscherow S, Bains HS.",Non-OADS,/arxiv_data1/oa_pdf/24/d8/epj-09-3958.PMC5407228.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3966-3973,DOI:http://dx.doi.org/10.19082/ 3966 Corresponding author: Associate Professor Dr. Nooshin Peyman, Department of Health Education and Health Promotion, School of Health, Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/08/c2/epj-09-3966.PMC5407229.pdf
"http://www.ephysician.ir Page3968of E-Health, it is hypothesized that the E -Health literacy of the Medicine and Health Sciences university students is low.",Non-OADS,/arxiv_data1/oa_pdf/08/c2/epj-09-3966.PMC5407229.pdf
http://www.ephysician.ir Page3970Table 3.,Non-OADS,/arxiv_data1/oa_pdf/08/c2/epj-09-3966.PMC5407229.pdf
http://www.ephysician.ir Page39724)Ratzan SC.,Non-OADS,/arxiv_data1/oa_pdf/08/c2/epj-09-3966.PMC5407229.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3974-3979,DOI:http://dx.doi.org/10.19082/ 3974 Corresponding author: Nasser Novinmehr, Department of Mental Health Nursing, School of Nursing and Midwifery, Tehran University of Medical Sciences (TUMS), Nosrat St., Tohid Sq., 141 9733171, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ee/68/epj-09-3974.PMC5407230.pdf
http://www.ephysician.ir Page3976time for EMS arrival was 7.4 ± 4.2 minutes.,OADS,/arxiv_data1/oa_pdf/ee/68/epj-09-3974.PMC5407230.pdf
"http://www.ephysician.ir Page39782)Khoddam H, Joybari L, sanagoo A.",Non-OADS,/arxiv_data1/oa_pdf/ee/68/epj-09-3974.PMC5407230.pdf
Available from: http://www.iom.edu/CMS/8089.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/epj-09-3974.PMC5407230.pdf
Available from: http://www.irc.dhs.gov/.,OADS,/arxiv_data1/oa_pdf/ee/68/epj-09-3974.PMC5407230.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3980-3985,DOI:http://dx.doi.org/10.19082/ 3980 Corresponding author: Tayebe Mehrabi, Nursing and Midwifery Care Res earch Center, Faculty of Nursing and Midwifery, Isfahan University of Medical Science, Isfahan, Iran .Tel: +98.3137927595, Email: mehrabi@nm.mui.ac.ir Received: December 03, 2016 , Accepted: January 22, 2017 , Published: March2017 iThenticate screening: January 21, 2017 , English editing: February 09, 2017 , Quality control: March 06, 2017 © 2017The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e0/7c/epj-09-3980.PMC5407231.pdf
http://www.ephysician.ir Page39822.3.,Non-OADS,/arxiv_data1/oa_pdf/e0/7c/epj-09-3980.PMC5407231.pdf
"http://www.ephysician.ir Page3984References : 1)Missler M, Stroebe M, Geurtsen L, Mastenbroek M, Chmoun S, Van Der Houwen K. Exploring death anxiety among elderly people: A literature review and empirical investigation.",Non-OADS,/arxiv_data1/oa_pdf/e0/7c/epj-09-3980.PMC5407231.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3986-3990,DOI:http://dx.doi.org/10.19082/ 3986 Corresponding author: Associate Professor Dr. Omid Mehrpour, M edical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Moallem Avenue, Birjand, 9713643138 Iran.",Non-OADS,/arxiv_data1/oa_pdf/6b/bb/epj-09-3986.PMC5407232.pdf
http://www.ephysician.ir Page3988Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/bb/epj-09-3986.PMC5407232.pdf
"http://www.ephysician.ir Page399017)Rao CP1, Shivappa P, Mothi VR.",Non-OADS,/arxiv_data1/oa_pdf/6b/bb/epj-09-3986.PMC5407232.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3,Pages:3991-3996,DOI:http://dx.doi.org/10.19082/ 3991 Corresponding author: Shima Sadat Aghahosseini, Department of Medical Surgical Nursing, Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/68/e2/epj-09-3991.PMC5407233.pdf
http://www.ephysician.ir Page3992after marriage (6).,Non-OADS,/arxiv_data1/oa_pdf/68/e2/epj-09-3991.PMC5407233.pdf
http://www.ephysician.ir Page3994delivery method and urinary and fecal incontinency.,Non-OADS,/arxiv_data1/oa_pdf/68/e2/epj-09-3991.PMC5407233.pdf
"http://www.ephysician.ir Page399624)Cichowski SB, Komesu YM, Dunivan GC, Rogers RG.",Non-OADS,/arxiv_data1/oa_pdf/68/e2/epj-09-3991.PMC5407233.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:3997-4002,DOI:http://dx.doi.org/10.19082/ 3997 Corresponding author: Dr. Habib Dadvand, Infectious and TropicalDiseasesResearchCenter,Hormozgan Health Institute, Hormozgan University of Medical Sci ences, Bandar Abbas, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b1/49/epj-09-3997.PMC5407234.pdf
http://www.ephysician.ir Page39981.,Non-OADS,/arxiv_data1/oa_pdf/b1/49/epj-09-3997.PMC5407234.pdf
http://www.ephysician.ir Page40004.Discussion During 2006 -2015 four outbreaks of measles occurred in Hormozgan province.,Non-OADS,/arxiv_data1/oa_pdf/b1/49/epj-09-3997.PMC5407234.pdf
"http://www.ephysician.ir Page400216)Munoz-Alia MA, Fernandez -Munoz R, Casasnovas JM, Porras -Mansilla R, Serrano -Pardo A, Pagan I, et al.",OADS,/arxiv_data1/oa_pdf/b1/49/epj-09-3997.PMC5407234.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4003-4008,DOI:http://dx.doi.org/10.19082/ 4003 Corresponding author: Iffat Mirza Ahmed, Al -Farabi College, Jeddah, Saudi Arabia .Tel:+966126735693 , E-mail:iffatfarabi@gmail.com Received: November 21, 2016 , Accepted: February 10, 2017 , Published: March2017 iThenticate screening: January 15, 2017 , English editing: March 01, 2017 , Quality control: March 06, 2017 © 2017The Authors.",Non-OADS,/arxiv_data1/oa_pdf/85/29/epj-09-4003.PMC5407235.pdf
http://www.ephysician.ir Page4004in the development of thalassemia in the patient.,Non-OADS,/arxiv_data1/oa_pdf/85/29/epj-09-4003.PMC5407235.pdf
"http://www.ephysician.ir Page4006Table 1.Facial feature s and oral manifestations of thalassemia Features Cause Facial features Class II malocclusion Maxillary protrusion, mandibular atrophy Maxillary protrusion (32, 33) Early fusion of occipital sutures, hyperplasia of anterior maxillofacial structures Lateral displacement of orbits (34) Marrow overgrowth in maxillary bone Chipmunk facies (35, 36) Malar prominence, saddle nose, frontal bossing Brodie syndrome (37) Mandibular arch is telescoped within the maxillary arch Pneumatisation of paranasal si nuses Hyperplasia of marrow in frontal, temporal and facial bones (33, 34) Oral manifestationsMalocclusion Maxillary protrusion, increased overjet, anterior open bite High caries index (33) Poor oral hygiene, less phosphorous and IgA in saliva Mucosal pallor, atrophic glossitis Decreased haemoglobin levels Severe gingivitis If splenectomy done (35) Inflammation of salivary glands Iron deposits Dark coloured gingiva High ferritin levels in blood Thin mandibular cortex (33) Marrow proliferation, expansion of medulla Multiple diastemas Roots-short and spike shaped, taurodontism (33) 2.2.2.Management of thalassaemic patients Before beginning the treatment, the following should be ascertained: 1) type of thalassemia: major, minor or intermedia, 2) present haemoglobin level of the patient, and 3) ddegree of iron overload in the body.",Non-OADS,/arxiv_data1/oa_pdf/85/29/epj-09-4003.PMC5407235.pdf
http://www.ephysician.ir Page400823)Gabuzda TG.,Non-OADS,/arxiv_data1/oa_pdf/85/29/epj-09-4003.PMC5407235.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4009-4013,DOI:http://dx.doi.org/10.19082/ 4009 Corresponding author: Assistant Professor Dr. Almraghy Yousry, Faculty of Medicine, Assuit Al -Azhar University, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/83/2b/epj-09-4009.PMC5407236.pdf
"http://www.ephysician.ir Page4010presented to the Woman's Health Hospital (WHH) of Assuit University, 2) Clinical audit on strategies for management of ectopic pregnancy in the WHH.",Non-OADS,/arxiv_data1/oa_pdf/83/2b/epj-09-4009.PMC5407236.pdf
"http://www.ephysician.ir Page4012other tube and IP blood collection were reported in 86.0 % and 68.0%, respectively.",OADS,/arxiv_data1/oa_pdf/83/2b/epj-09-4009.PMC5407236.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4014-4019,DOI:http://dx.doi.org/10.19082/ 4014 Correspo nding author: Dr. Iman Ghasemzadeh, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/epj-09-4014.PMC5407237.pdf
"http://www.ephysician.ir Page4016based on Table 4, we can observe a mean score and SD of patients with each of HCV, HBV, and HIV regarding age, in which, according to Mann -Whitney and p -value, there was no significant difference bet ween two groups of positive and negative in age (p=0.556).",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/epj-09-4014.PMC5407237.pdf
"http://www.ephysician.ir Page40183)Jamal R, Fadzillah G, Zulkifli SZ, Yasmin M. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/epj-09-4014.PMC5407237.pdf
"Electronic Physician (I SSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4020-4026,DOI:http://dx.doi.org/10.19082/ 4020 Corresponding author: Assistant Professor Dr. Sakineh Var mazyar, Department Of Occupational He alth Engineering, Social Determinants Health Research Center, Faculty of Health, Qazvin University of Medical Sciences, Qazvin, Iran.",Non-OADS,/arxiv_data1/oa_pdf/a7/18/epj-09-4020.PMC5407238.pdf
http://www.ephysician.ir Page4022health of the participants.,Non-OADS,/arxiv_data1/oa_pdf/a7/18/epj-09-4020.PMC5407238.pdf
http://www.ephysician.ir Page4024Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a7/18/epj-09-4020.PMC5407238.pdf
"http://www.ephysician.ir Page40269)Morris M, Lamb KL, Hayton J, Cotterrell D, Bu ckley J.",OADS,/arxiv_data1/oa_pdf/a7/18/epj-09-4020.PMC5407238.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4027-4034,DOI:http://dx.doi.org/10.19082/ 4027 Corresponding author: Assistant Profe ssor Dr. Abd El -Hamid Mohamed Elwy, Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Tanta University, Tanta city -Gharbia Governorate -Egypt.",Non-OADS,/arxiv_data1/oa_pdf/65/b8/epj-09-4027.PMC5407239.pdf
"http://www.ephysician.ir Page4028for opioid receptors and lacks selectivity towards the different receptor subtypes, and its analgesic potency is less than 10% that of morphine (2) and binds to m -opioid receptors with approximately 10 0 times less affinity than morphine (3).",Non-OADS,/arxiv_data1/oa_pdf/65/b8/epj-09-4027.PMC5407239.pdf
"http://www.ephysician.ir Page4030Table3.Effect of morphine repeated doses (therapeutic), 4 mg/kg on acetyl cholinesterase (AChE) activity (nmol /min/g) in cerebral cortex of male a lbino rat for 7, 14 and 21 day intervals and withdrawal effect.",Non-OADS,/arxiv_data1/oa_pdf/65/b8/epj-09-4027.PMC5407239.pdf
"http://www.ephysician.ir Page4032come in accordance with Dang and Williams (21) who reported that tolerance and dependence result from long -term exposure to opioids, and there is growing evidence linking acute receptor desensitization to this more long -term process.",Non-OADS,/arxiv_data1/oa_pdf/65/b8/epj-09-4027.PMC5407239.pdf
"http://www.ephysician.ir Page403424)Brines ML, Dare AO, de Lanerolle NC.",Non-OADS,/arxiv_data1/oa_pdf/65/b8/epj-09-4027.PMC5407239.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4035-4041,DOI:http://dx.doi.org/10.19082/ 4035 Corresponding author: Dr. Sadaf Mahmoudi, Dental Faculty, Babol University of Medical Sciences, Babol, Iran.",Non-OADS,/arxiv_data1/oa_pdf/2a/97/epj-09-4035.PMC5407240.pdf
http://www.ephysician.ir Page40361.,Non-OADS,/arxiv_data1/oa_pdf/2a/97/epj-09-4035.PMC5407240.pdf
"http://www.ephysician.ir Page4038values, i.e.",Non-OADS,/arxiv_data1/oa_pdf/2a/97/epj-09-4035.PMC5407240.pdf
http://www.ephysician.ir Page40405.,Non-OADS,/arxiv_data1/oa_pdf/2a/97/epj-09-4035.PMC5407240.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2017, Volume: 9, Issue:3, Pages:4042-4047,DOI:http://dx.doi.org/10.19082/ 4042 Corresponding author: Dr. Zahra Abdol i, Department of Pediatric Dentistry, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/f3/86/epj-09-4042.PMC5407241.pdf
http://www.ephysician.ir Page4044of broth medium was collected from those wells t hat had not shown any signs of growth (at different concentrations) and was inoculated on to a blood agar medium.,Non-OADS,/arxiv_data1/oa_pdf/f3/86/epj-09-4042.PMC5407241.pdf
http://www.ephysician.ir Page4046Conflict of Interest: There is no conflict of interest to be declared.,Non-OADS,/arxiv_data1/oa_pdf/f3/86/epj-09-4042.PMC5407241.pdf
"Mass fragments were identiﬁed by manual comparison of mass-to-charge ratio peaks to the theoretical peaks and isotopic mass distributions from MS-Digest (http://prospector.ucsf.edu, in the public domain).",OADS,/arxiv_data1/oa_pdf/d6/23/i1552-5783-58-4-2397.PMC5407245.pdf
"For statistical analysis, the number of microglia in the widefield BAF images was counted using ImageJ (version 1.48v; provided in the public domain at http://imagej.nih.gov by the National Institutes of Health, Bethesda, MD).",OADS,/arxiv_data1/oa_pdf/42/3b/i2164-2591-6-2-10.PMC5407246.pdf
All DNA sequences were designed to minimize undesired cross hybridization using NUPACK (http://www.nupack.org/).The sequences are given in Table S1 of the ESI.,OADS,/arxiv_data1/oa_pdf/34/0e/SC-008-C6SC03892A.PMC5407271.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/80/c7/CG-CGCR170026.PMC5407358.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/39/bd/CG-CGCR170032.PMC5407359.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/24/16/CG-CGCR170031.PMC5407360.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/97/2d/CG-CGCR170029.PMC5407361.pdf
"@ERSpublications Conversations about palliative care in COPD http://ow.ly/NlKt307jgRs Cite this article as: Tavares N, Jarrett N, Hunt K, et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
ERJ Open Res 2017; 3: 00068-2016 [https://doi.org/10.1183/ 23120541.00068-2016].,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.This article has supplementary material available from openres.ersjournals.com Received: June 09 2016 | Accepted after revision: Dec 10 2016 Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00068-2016 ERJ Open Res 2017; 3: 00068-2016 REVIEW COPD,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"The last search was conducted on the February 2, https://doi.org/10.1183/23120541.00068-2016 2COPD | N. TAVARES ET AL.",OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
https://doi.org/10.1183/23120541.00068-2016 3COPD | N. TAVARES ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
https://doi.org/10.1183/23120541.00068-2016 4COPD | N. TAVARES ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"In contrast, all respiratory physicians agreed that this should ideally be initiated when a patient was in a stable condition; https://doi.org/10.1183/23120541.00068-2016 5COPD | N. TAVARES ET AL.",Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
https://doi.org/10.1183/23120541.00068-2016 6COPD | N. TAVARES ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"The interventions tested in these studiesincluded: the use of computer-based reminders by physicians to improve frequency of conversations and TABLE 3 Topics discussed during palliative care conversations Rarely discussed topics Frequent topics The process of dying and the discussion of prognosis Spiritual or religious beliefs What dying might be like How long the patient has to liveGetting sicker Future treatment decisions Preferences for life sustaining treatments, such as intubation, tracheostomy, oxygen, tube feeding, intravascular fluids and hospital careThe possibility of an intensive care unit admission The intubation procedure The patient ’s inability to speak or to eat while being ventilated The likelihood of death if mechanical ventilation was not performed The death rate associated with mechanical ventilation https://doi.org/10.1183/23120541.00068-2016 7COPD | N. TAVARES ET AL.",Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
https://doi.org/10.1183/23120541.00068-2016 8COPD | N. TAVARES ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"Most of these data were generated from quantitative research, yetmuch could be gained from in-depth qualitative research specifically collecting information from patients https://doi.org/10.1183/23120541.00068-2016 9COPD | N. TAVARES ET AL.",OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"Available from www.nice.org.uk/guidance/qs10/resources/chronic-obstructive-pulmonary-disease-in-adults-2098478 592709 Date last accessed: October, 2016. https://doi.org/10.1183/23120541.00068-2016 10COPD | N. TAVARES ET AL.",Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"Available from https://pathways.nice.org.uk/pathways/opioids-for-pain-relief-in-palliative-careDate last accessed: October, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
https://doi.org/10.1183/23120541.00068-2016 11COPD | N. TAVARES ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
https://doi.org/10.1183/23120541.00068-2016 12COPD | N. TAVARES ET AL.,Non-OADS,/arxiv_data1/oa_pdf/b0/aa/00068-2016.PMC5407435.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ndt-13-1163.PMC5407443.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1163–1173Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1163OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13236 3 The effectiveness and safety of amisulpride in  chinese patients with schizophrenia who switch  from risperidone or olanzapine: a subgroup  analysis of the escaPe study Ying liang Xin Yu On behalf of the esca Pe  study group Peking University sixth hospital,   Peking University institute of Mental  health, Key laboratory of Mental  health, Ministry of health (Peking  University), National clinical research  center for Mental Disorders (Peking  University sixth hospital), Beijing,   People’s republic of chinaIntroduction:  Second-generation antipsychotics show significant interpatient variability in   treatment response and side-effect profiles, and the majority of patients with schizophrenia  require multiple treatment changes.",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ndt-13-1163.PMC5407443.pdf
"A large epidemiological study conducted in 2013 found that the overall  point prevalence of schizophrenia in China was 4.62 per 1,000 (95% confidence interval  [95% CI]: 4.18–5.06) with an overall lifetime prevalence of 5.44 per 1,000 (95%  CI: 5.01–5.88).1 The current prevalence of schizophrenia-related functional disability  among noninstitutionalized Chinese adult patients is estimated to be 0.41%.2 In addi - tion, the suicide attempt rate among Chinese patients with schizophrenia is estimated correspondence: Xin Yu Peking University sixth hospital, Peking  University institute of Mental health,  Key laboratory of Mental health,  Ministry of health (Peking University),  National clinical research center for  Mental Disorders (Peking University  sixth hospital), 51 huayuanbei road,  haidian District, Beijing 100191, People’s  republic of china Tel +86 10 8280 1999 Fax +86 10 6202 6310 email yuxin078@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Liang and Yu Running head recto: Switching from risperidone or olanzapine to amisulpride DOI: http://dx.doi.org/10.2147/NDT.S132363",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ndt-13-1163.PMC5407443.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ndt-13-1163.PMC5407443.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/6f/ndt-13-1163.PMC5407443.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/40/dddt-11-1283.PMC5407444.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1283–1290Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1283Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S13381 4 Functional characterization of wild-type and 24  CYP2D6 allelic variants on gefitinib metabolism  in vitro Ping Fang1 Xiang Zheng1 Jiayang he1 honglei ge1 Pengfei Tang1 Jianping cai2 guoxin hu1 1Department of Pharmacology,   school of Pharmacy, Wenzhou  Medical University, Wenzhou,   Zhejiang, 2The Ministry of health  (MOH) Key Laboratory of Geriatrics,   Beijing hospital, national center  of gerontology, Beijing, People’s  Republic of ChinaBackground:  Cytochrome P450 2D6 (CYP2D6), a member of the CYP450 enzyme super  family, is a polymorphic enzyme that metabolizes ~25% of therapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/c1/40/dddt-11-1283.PMC5407444.pdf
"EGFR is a known transmembrane receptor, which upon ligand binding, induces  receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation.4–6  Mutation in this gene is significantly associated with lung cancer.7 In previous studies,  the EGFR is detected by immunohistochemistry on 40%–80% of NSCLC.8,9 Accord - ingly, promising molecular inhibitors targeting the activating mutants of the EGFR have  been intensely pursued in the treatment of EGFR-mutant positive NSCLC.correspondence: guoxin hu Department of Pharmacology, school of  Pharmacy, Wenzhou Medical University,  University-Town, Wenzhou 325000,  Zhejiang, People’s Republic of China email hgx@wmu.edu.c n  Jianping cai The Key Laboratory of Geriatrics, Beijing  hospital, Beijing institute of geriatrics,  Ministry of health, Beijing 100730,  People’s Republic of China email caijp61@vip.sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Fang et al Running head recto: Functional characterization of CYP2D6 variants on gefitinib metabolism DOI: http://dx.doi.org/10.2147/DDDT.S133814",Non-OADS,/arxiv_data1/oa_pdf/c1/40/dddt-11-1283.PMC5407444.pdf
"To date, over 100 CYP2D6 alleles have been  identified and named by the Human CYP Allele Nomencla - ture committee ( http://www.cypalleles.ki.se/cy p2d6.ht m).",Non-OADS,/arxiv_data1/oa_pdf/c1/40/dddt-11-1283.PMC5407444.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c1/40/dddt-11-1283.PMC5407444.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/40/dddt-11-1283.PMC5407444.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a5/e0/jaa-10-131.PMC5407445.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a5/e0/jaa-10-131.PMC5407445.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 131–140Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 131 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S130459Sensitization to Aspergillus species is associated  with frequent exacerbations in severe asthma Ken Junyang Goh1 Anthony Chau Ang Yii1,2 Therese Sophie Lapperre1,2 Adrian KW Chan1–3 Fook Tim Chew4 Sanjay H Chotirmall5,* Mariko Siyue Koh1–3,* 1Department of Respiratory and  Critical Care Medicine, Singapore  General Hospital, 2Duke-National  University of Singapore Medical School,  3Allergy Centre, Singapore  General Hospital, 4Department of  Biological Sciences, Faculty of Science,  National University of Singapore,   5Lee Kong Chian School of Medicine,   Nanyang T echnological University,  Singapore *These authors contributed equally to  this workBackground: Severe asthma is a largely heterogeneous disease with varying phenotypic pro- files.",Non-OADS,/arxiv_data1/oa_pdf/a5/e0/jaa-10-131.PMC5407445.pdf
"3 Among the various allergens, fungal sensiti- zation is associated with increased asthma severity,4–6 evidenced by increased hospital  admissions for exacerbations and poorer lung function.7,8 The entity of severe asthma  with fungal sensitization (SAFS) has, therefore, been coined, which is characterized by the presence of severe asthma, fungal sensitization and the exclusion of allergic Correspondence: Sanjay H Chotirmall Lee Kong Chian School of Medicine, Level 12 Clinical Sciences Building (CSB), 11 Mandalay Road, 308232 SingaporeEmail schotirmall@ntu.edu.sgJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Goh et alRunning head recto: Aspergillus sensitization and asthmaDOI: http://dx.doi.org/10.2147/JAA.S130459",Non-OADS,/arxiv_data1/oa_pdf/a5/e0/jaa-10-131.PMC5407445.pdf
Available from: http://ginaasthma.org/archived-reports/.,OADS,/arxiv_data1/oa_pdf/a5/e0/jaa-10-131.PMC5407445.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/a5/e0/jaa-10-131.PMC5407445.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/36/ijn-12-3303.PMC5407446.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3303–3314International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3303OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12140 0 combining nano-physical and computational  investigations to understand the nature of “aging”  in dermal collagen Tarek ahmed1 anthony Nash2 Kristina eN clark3 Marion ghibaudo4 Nora h de leeuw2 anne Potter4 richard stratton3 helen l Birch5 ramona enea casse4 laurent Bozec1 1Division of Biomaterials and  Tissue engineering, eastman Dental  Institute, University college  london, 2Department of chemistry,   University college london, 3centre  for rheumatology and connective  Tissue Diseases, Division of Medicine,   University college london, london,   UK; 4l’Oréal research and Innovation,   aulnay-sous-Bois, France; 5Division of  surgery and Interventional science,   Ucl Institute of Orthopaedics and  Musculoskeletal science, University  college london, london, UKAbstract:  The extracellular matrix of the dermis is a complex, dynamic system with the various  dermal components undergoing individual physiologic changes as we age.",Non-OADS,/arxiv_data1/oa_pdf/b1/36/ijn-12-3303.PMC5407446.pdf
"These undergo differ - ent age-related changes.4 Other major components of the dermal extracellular matrix  (ECM) include elastic fibers (elastin), which provide mechanical elasticity allowing  responsiveness to physical loading;3,5 proteoglycans, decorin and versican, with a pro - tein core and sulfated glycosaminoglycan (GAG) chains which are highly hydrophilic  and provide water retention properties to the ECM;6 and hyaluronic acid (HLA), a  nonsulfated GAG chain which, due to its hydrophilicity, also has a great capacity to  bind with water, providing hydration and water transport to the dermis.7,8correspondence: Tarek ahmed Division of Biomaterials and Tissue  engineering, Ucl eastman Dental  Institute, University college london,  256 gray’s Inn road, london  Wc1X 8lD, UK Tel +44 020 3456 1096 email tarek.ahmed.10@ucl.ac.u k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ahmed et al Running head recto: Nano-physical and computational investigations on aging  DOI: http://dx.doi.org/10.2147/IJN.S121400",Non-OADS,/arxiv_data1/oa_pdf/b1/36/ijn-12-3303.PMC5407446.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/36/ijn-12-3303.PMC5407446.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/36/ijn-12-3303.PMC5407446.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/51/copd-12-1233.PMC5407447.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1233–1241International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1233OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13037 7 COPD is a clear risk factor for increased use  of resources and adverse outcomes in patients  undergoing intervention for colorectal cancer:  a nationwide study in spain Marisa Baré,1,2 Concepción  Montón,2,3 laura Mora,2,4  Maximino redondo,2,5  Marina Pont,1,2 antonio  escobar,2,6 Cristina  sarasqueta,2,7,8 nerea  Fernández de larrea,9,10  eduardo Briones,10,11 Jose  Maria Quintana2,12 1Clinical epidemiology and Cancer  screening, Parc Taulí University  hospital, Universitat autònoma  de Barcelona, sabadell, 2research  network on health services in  Chronic Diseases – reDIsseC,  3service of respiratory Medicine,  4service of general surgery, Parc  Taulí University hospital, Universitat  autònoma de Barcelona, sabadell,  5laboratory service, hospital  Costa del sol, Málaga, 6Unidad de  Investigación, hospital Universitario  Basurto, Bilbao, 7Unidad de  Investigación, hospital Universitario  Donostia, 8Instituto de Investigación  sanitaria Biodonostia, Donostia,  9Centro nacional de epidemiología,  Instituto de salud Carlos III, 10CIBer   epidemiología y salud Pública –  CIBeresP , Madrid, 11Unidad de  epidemiología, Distrito sevilla, servicio  andaluz de salud, seville, 12Unidad  de Investigación, hospital galdakao- Usansolo, galdakao-Bizkaia, spainBackground:  We hypothesized that patients undergoing surgery for colorectal cancer (CRC)  with COPD as a comorbidity would consume more resources and have worse in-hospital  outcomes than similar patients without COPD.",Non-OADS,/arxiv_data1/oa_pdf/98/51/copd-12-1233.PMC5407447.pdf
"However, few studies of postopera - tive outcomes in patients with COPD focus on patients with CRC or on postoperative  outcomes other than mortality, such as reintervention, complications, or length of stay  (LOS).8 Recently, Platon et al9 found COPD was a strong predictor of intensive care  unit (ICU) admission and 30-day mortality after CRC surgery.9Correspondence: Marisa Baré Clinical epidemiology and Cancer  screening, Parc Taulí University  hospital, autonomous University of  Barcelona, Parc Taulí 1, 08208 sabadell,  Catalonia, spain Tel +34 93 745 8245 email mbare@tauli.ca t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Baré et al Running head recto: COPD: an important risk factor for adverse outcomes in CRC patients DOI: http://dx.doi.org/10.2147/COPD.S130377",Non-OADS,/arxiv_data1/oa_pdf/98/51/copd-12-1233.PMC5407447.pdf
"Available from: http://globocan.iarc.f r. Accessed July 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/98/51/copd-12-1233.PMC5407447.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/98/51/copd-12-1233.PMC5407447.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/51/copd-12-1233.PMC5407447.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/b9/ppa-11-811.PMC5407448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 811–820Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  811OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12764 5 Motivational interviewing for adherence: post- training attitudes and perceptions of physicians  who treat asthma patients Miguel román-rodríguez1 lara ibarrola-ruiz2 Fernando Mora3 Vicente Plaza4 Joaquín sastre5 Alfonso T orrego4 José María Vega6  guadalupe sánchez- herrero2 1centro de salud son Pisà, iB-salut,   Balearic health service, Unidad  de investigación en enfermedades  crónicas respiratorias en atención  primaria, instituto de investigación  sanitaria de Baleares ( idisBa), Palma  de Mallorca, 2gsK, 3Department  of Psychiatry, hospital infanta  leonor, Madrid, 4Department of  respiratory Medicine, hospital de  la santa creu i sant Pau, institut  d’investigació Biomédica sant Pau ( iiB  sant Pau), Universitat Autònoma de  Barcelona, Barcelona, 5Department  of Allergology, Fundación Jimenez  Díaz y Universidad Autónoma de  Madrid, ciBer de enfermedades  respiratorias, Ministerio de economía  y competitividad, Madrid, 6Unidad  de gestión clínica de Alergología,   hospital regional Universitario de  Málaga, Málaga, spainObjective:  The aim of this study was to evaluate the attitudes and perceptions of health care  professionals (HCPs) who have been trained in motivational interviewing (MI) to improve  adherence.",Non-OADS,/arxiv_data1/oa_pdf/7e/b9/ppa-11-811.PMC5407448.pdf
"Keywords:  asthma, adherence, control, training, motivational interviewing, education Introduction Medication adherence is considered to be a key factor in asthma control,1,2 and non - adherence is associated with increased asthma symptoms,3 uncontrolled asthma,4,5  frequent emergency department visits,4 hospitalizations6 and higher health care uti - lization and costs.7,8 Recent guidelines9–11 specifically recommend the evaluation and follow-up of patient  medication adherence, although it continues to be a difficult goal, and adherence rates correspondence: Miguel román-rodríguez centro de salud son Pisà, c/De Vicenç  Joan rossello ribas, no 65,   07011 Palma de Mallorca, spain Tel +34 97 163 4115 email miguelroman@ibsalut.caib.e s Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Román-Rodríguez et al Running head recto: Impact of training initiatives on asthma adherence DOI: http://dx.doi.org/10.2147/PPA.S127645",Non-OADS,/arxiv_data1/oa_pdf/7e/b9/ppa-11-811.PMC5407448.pdf
Available  from: http://ginasthma.org/gina-reports/.,Non-OADS,/arxiv_data1/oa_pdf/7e/b9/ppa-11-811.PMC5407448.pdf
"Available from: https://www.gov.uk/government/uploads/sys - tem/uploads/ attachment_data /file/216139/dh_128428.pd f. Accessed  February 26, 2016.",OADS,/arxiv_data1/oa_pdf/7e/b9/ppa-11-811.PMC5407448.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7e/b9/ppa-11-811.PMC5407448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/0e/ijwh-9-245.PMC5407449.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 245–254International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  245RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10632 1 Cervical elastography during pregnancy: clinical  perspectives Malgorzata Swiatkowska- Freund Krzysztof Preis Department of Obstetrics, Medical  University of Gdańsk, Gdańsk, PolandAbstract:  Uterine cervix is a part of the uterus responsible for maintaining pregnancy till term.",Non-OADS,/arxiv_data1/oa_pdf/49/0e/ijwh-9-245.PMC5407449.pdf
"Kliniczna 1A,  80-402 Gdańsk, Poland Tel +48 58 349 3445 Fax +48 58 349 3416 email malswi@gumed.edu.p l Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2017 Volume: 9 Running head verso: Swiatkowska-Freund and Preis Running head recto: Cervical elastography DOI: http://dx.doi.org/10.2147/IJWH.S106321",Non-OADS,/arxiv_data1/oa_pdf/49/0e/ijwh-9-245.PMC5407449.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/49/0e/ijwh-9-245.PMC5407449.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/0e/ijwh-9-245.PMC5407449.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 709–720Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  709RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11357 6 Depression and chronic pain in the elderly: links  and management challenges Panagiotis Zis1 Argyro Daskalaki2 Ilia Bountouni3 Panagiota Sykioti3 Giustino varrassi4 Antonella Paladini5 1Academic Department of  Neurosciences, Sheffield T eaching  Hospitals NHS Foundation Trust,   Sheffield, UK; 2Department of  Neurology, evangelismos General  Hospital, Athens, Greece; 3Belgrave  Liaison Team, Child and Adolescent  Mental Health Services, South London  and Maudsley NHS Foundation Trust,   London, UK; 4Fondazione Paolo  Procacci and european League against  Pain, Rome, 5Department of M eSvA,   University of L’Aquila, L’Aquila, ItalyAbstract:  Aging is an inevitable process and represents the accumulation of bodily alterations  over time.",Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
"This comprehensive review of the current literature aims to explore the clinical links  between chronic pain and depression and also to discuss the management challenges Correspondence: Giustino varrassi c/o Fondazione Paolo Procacci,  via Tacito 7, 00193 Roma, Italy email giuvarr@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Zis et al Running head recto: Depression and chronic pain in the elderly DOI: http://dx.doi.org/10.2147/CIA.S113576",Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs369/en /.,Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
Available from: https://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/28/96/cia-12-709.PMC5407450.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/69/90/ndt-13-1141.PMC5407453.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1141–1151Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1141OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S12979 3 agomelatine in the treatment of mild-to-moderate  depression in patients with cardiovascular disease:  results of the national multicenter observational  study PUlse Vladimir e Medvedev Department of Psychiatry,   Psychotherapy and Psychosomatic  Pathology, rUDN University,   Moscow, russiaBackground:  PULSE was a large, observational, multicenter study designed to evaluate  the efficacy and safety of agomelatine in the treatment of major depression in patients with  cardiovascular disease (CVD).",Non-OADS,/arxiv_data1/oa_pdf/69/90/ndt-13-1141.PMC5407453.pdf
"Keywords:  depression, cardiovascular disease, agomelatine, anxiety, hypochondria, tolerability Introduction Patients with cardiovascular disease (CVD) are three times more likely to experience  depression than other members of the community.1 Depression is more frequently  observed in ambulatory cardiac patients (9.3%) than in the general population (4.8%),  and in patients undergoing treatment in hospital.2,3 Large, international, epidemiologic  studies have shown that many patients treated by physicians, including cardiologists  and neurologists, have some form of clinical depression that requires antidepressant  therapy.4 Depression affects around one-fifth of heart failure patients (21%) and between  15% and 20% of patients admitted to hospital for myocardial infarction.5,6 Patients  with CVD diagnosed with depression have an increased risk of poor cardiovascular correspondence: Vladimir e Medvedev Department of Psychiatry, Psychotherapy  and Psychosomatic Pathology, rUDN  University, slavyansky bulvar, 1-95,  Moscow, 121352 russia Tel/fax +7 495 350 2875 email medvedev_ve@pfur.r u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Medvedev Running head recto: Agomelatine for mild-to-moderate depression in patients with CVD DOI: http://dx.doi.org/10.2147/NDT.S129793",Non-OADS,/arxiv_data1/oa_pdf/69/90/ndt-13-1141.PMC5407453.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/69/90/ndt-13-1141.PMC5407453.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/90/ndt-13-1141.PMC5407453.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/d8/ndt-13-1153.PMC5407455.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1153–1162Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1153OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12859 2 Trichotillomania: the impact of treatment history  on the outcome of an internet-based intervention steffi Weidt1 annette Beatrix Bruehl2,3 aba Delsignore1 gwyneth Zai2,4–6 alexa Kuenburg1 richard Klaghofer1 Michael rufer1 1Department of Psychiatry and  Psychotherapy, University hospital  Zurich, University of Zurich,   Zurich, switzerland; 2Department  of Psychiatry, Behavioural and  clinical Neuroscience institute,   University of cambridge, cambridge,   UK; 3Department of Psychiatry,   Psychotherapy and Psychosomatics,   University hospital of Psychiatry,   Zurich, switzerland; 4Department  of Psychiatry, institute of Medical  science, University of T oronto,   5Neurogenetics section, centre  for addiction and Mental health,   6Department of Psychiatry, Frederick  W. Thompson anxiety Disorders  centre, sunnybrook health sciences  centre, T oronto, ON, canadaBackground:  Many patients suffering from trichotillomania (TTM) have never undergone  treatment.",Non-OADS,/arxiv_data1/oa_pdf/41/d8/ndt-13-1153.PMC5407455.pdf
"Most  frequent locations of hairpulling are the scalp, eyebrows, and eyelashes.3 Affected  individuals tend to avoid group activities because they are worried about their appear - ance and that others may uncover their problem.4,5 Approximately 86% of TTM  individuals report a reduced quality of close friendships.6 Additionally, TTM often  interferes with work performance and health-related quality of life (HRQoL),3,7 and it  is frequently comorbid with other psychiatric disorders such as anxiety, mood, eating,8,9  and personality disorders.10Correspondence: Steffi Weidt Department of Psychiatry and  Psychotherapy, University hospital  Zurich, University of Zurich,  culmannstrasse 8, ch-8091  Zurich, switzerland Tel +41 44 255 5280 Fax +41 44 255 4408 email steffi.weidt@usz.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Weidt et al Running head recto: Trichotillomania: treatment history and Internet-based self-help DOI: http://dx.doi.org/10.2147/NDT.S128592",Non-OADS,/arxiv_data1/oa_pdf/41/d8/ndt-13-1153.PMC5407455.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/41/d8/ndt-13-1153.PMC5407455.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/d8/ndt-13-1153.PMC5407455.pdf
Bmp signaling plays an indirect role mediated by  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/40/nihms813879.PMC5407493.pdf
"2013 Original Article https://doi.org/European Journal of Cardiovascular Nursing 2014, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e5/5c/10.1177_1474515113502748.PMC5407505.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.navMULTIPLE SCLEROSIS MSJJOURNAL 604 journals.sagepub.com/home/msjIntroduction Patient satisfaction with medication, resulting from factors such as the effectiveness, convenience (e.g.",Non-OADS,/arxiv_data1/oa_pdf/96/6c/10.1177_1352458516657441.PMC5407510.pdf
Available at https://www.rand.org/ content/dam/rand/pubs/reports/2006/R1987.5.pdf  20.,Non-OADS,/arxiv_data1/oa_pdf/96/6c/10.1177_1352458516657441.PMC5407510.pdf
"Presented at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 2015, P562, http://www.empireneuro.org/sitebuildercontent/ sitebuilderfiles/ECTRIMS2015TeriPro.pdf  32.",Non-OADS,/arxiv_data1/oa_pdf/96/6c/10.1177_1352458516657441.PMC5407510.pdf
Visit SAGE journals online  http://journals.sagepub.com/home/msj  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/96/6c/10.1177_1352458516657441.PMC5407510.pdf
"MULTIPLE SCLEROSIS MSJJOURNAL https://doi.org/10.1177/1352458517690822 https://doi.org/10.1177/1352458517690822Multiple Sclerosis Journal 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f2/8e/10.1177_1352458517690822.PMC5407511.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav 734 journals.sagepub.com/home/msjHistorical perspective In the 1990s, the multiple sclerosis (MS) Clinical Outcome Assessments Task Force recommended a multidimensional composite outcome measure con-sisting of simple tests of walking, manual dexterity, and cognition, which is termed as the Multiple Sclerosis Functional Composite (MSFC).",Non-OADS,/arxiv_data1/oa_pdf/f2/8e/10.1177_1352458517690822.PMC5407511.pdf
"CLINICAL REHABILITATION https://doi.org/10.1177/0269215516673884Clinical Rehabilitation 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/53/a5/10.1177_0269215516673884.PMC5407512.pdf
National Joint Registry 11th Annual Report  2014. http://www.njrcentre.org.uk/njrcentre/Portals/0/ Documents/England/Reports/11th_annual_report/ NJR%2011th%20Annual%20Report%202014.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/10.1177_0269215516673884.PMC5407512.pdf
2013. http://media.wix.,Non-OADS,/arxiv_data1/oa_pdf/53/a5/10.1177_0269215516673884.PMC5407512.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.acgme.org/ acgmeweb/Portals/0/PDFs/Mile stones/BrainInjuryMedicine Milestones.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.acgme.org/acgmeweb/Portals/0/ PDFs/Milestones/NeurologyMilestones.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
"October 27, 2012. http://www.forbes.com/sites/ dandiamond/2012/10/27/arizona-just-broke-the-ncaas-concussion- policy-will-it-matter/.",Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://web1.ncaa.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.kyats.com/Re sources/Documents/Education% 20Documents/NCAA%20Concussi on%20Management%20Plan .pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.ncaa.org/sit es/default/files/Concussion% 20Safety%20Protocol%20Checklist%20final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.ncaa.org/health-and-safety/concussion- safety-protocol-committee-roster.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://web1.ncaa.org/GSRSearch/exec/homePage.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.ncaa.org/ health-and-safety/independent- medical-care-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
http://www.ncsl.org/research/health/traumatic-brain-injury- legislation.aspx.,Non-OADS,/arxiv_data1/oa_pdf/cb/23/10.1177_2325967117702606.PMC5407527.pdf
"2010. http://www.arb.ca.gov/research/health/pm-mort/HEI_Correspondence.pdf cMcDonnell WF, Nishino-Ishikawa N, Petersen FF, Chen LH, Abbey DE.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"2005;17(14):803-816. http://www.arb.ca.gov/ planning/gmerp/dec1plan/gmerp_comments/enstrom.pdf, and http://www.scientificintegrityinstitute.org/IT121505.pdf fEnstrom JE.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"2008;116:1614-1619. http://ehp03.niehs.nih.gov/article/info: doi/10.1289/ehp.11449 hJerrett M. February 26, 2010 CARB Symposium Presentation by Principal Investigator, Michael Jerrett, UC Berkeley/CARB Proposal No.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"2011;184(7);828-835. http://ajrccm.atsjournals.org/content/184/7/828.full.pdf kOstro B, Lipsett M, Reynolds P, et al.",OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"2010;118(3):363-369. http://ehp03.niehs.nih.gov/article/info: doi/10.1289/ehp.0901181 lJerrett M, Burnett RT, Beckerman BS, et al.",OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"2015;123(6):549-556. http://ehp.niehs.nih.gov/1408565/, or http://dx.doi.org/10.1289/ehp.1408565 nThurston GD, Ahn J, Cromar KR, et al.",OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
2016;124(4):484-490. http://ehp.niehs.nih.gov/1509676/ US EPA.,OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
2012. http://www.epa.gov/ttn/ecas/regdata/RIAs/PMRIACombinedFile_Bookmarked.pdfEnstrom 9,OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"Appendix C Acknowledgments The author thanks the American Cancer Society for helping initiate my epidemiologic career (http://www.sc ientificintegrityinstitute.org/ Detels082773.pdf), for providing me with essential research support for many years (http://www.scientificintegrityinstitute.org/Mormon- LAT120689.pdf), for granting me unique access to California CPS I cohort data (http://www.scientific integrityinstitute.org/CACP- SI090391.pdf), for selecting me as a Researcher who enrolled CPS II participants and worked with C PS II epidemiologists (http:// www.scientificintegrityinstitute.org/Enstrom090213.pdf), and for mak- ing it possible for me to obtain unique access to the CPS II cohort data and detailed documentation.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"August 17, 2015. https://www.nas.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"Sensitivity Analyses, particularly Figure 5 on page 161, Figure 13 on page 89, and Figure 21 on page 197 and Appendix D and Appendix F. https://www.healtheffects.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"Pro- ceedings of the American Statistical Association 2012 Joint Sta- tistical Meeting, Section on Risk Analysis, San Diego, CA: 2012: pages 2324-2336. https://www.am stat.org/meetings/jsm/2012/ proceedings.cfm, and http://www.scientificintegrityinstitute.org/ ASAS092812.pdf 11.",OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"https ://science.house.gov/news/ press-releases/committee-threatens-subpoena-epa-secret-science, and https://science.house.gov/s ites/republicans.science.house .gov/files/documents/07-22-2013 %20Smith %20and%20Stewart %20to%20McCarthy.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"https://science.house.gov/news/ press-releases/smith-subpoenas-epa-s-secret-science, and https:// science.house.gov/sites/republi cans.science.house.gov/files/ documents/Subpoena %20link.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
http://nepis.epa.gov/Exe/ZyPDF.cgi/ 20015OU3.PDF?Dockey ¼20015OU3.PDF.,OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
http://nepis.epa.gov/Exe/ZyPDF.cgi/9101R4L8.PDF?,Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"Cary, NC: SAS Institute Inc. http://support.sas.com/ documentation/94/index.html.",OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"1980 CDC WONDER On-line Database, compiled from Com- pressed Mortality File CMF 1968-1988. http://wonder.cdc.gov/ cmf-icd9.html.",OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"HEI Research Report 140, Health Effects Institute, Boston, MA: 2009, particularly Table 34. https://www.healtheffects.org/publication/extended-follow-and- spatial-analysis-american-cancer-society-study-linking-particulate.",Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
http://www.arb.ca.gov/ research/health/pm- mort/HEI_Corresponde nce.pdf.,OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
http://www.osti.,Non-OADS,/arxiv_data1/oa_pdf/ba/59/10.1177_1559325817693345.PMC5407529.pdf
"https://doi.org/10.1369/0022155416689675Journal of Histochemistry & Cytochemistry 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e8/07/10.1369_0022155416689675.PMC5407564.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/4a/main.PMC5407570.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.007Urology Case Reports 13 (2017) 51 e52,Non-OADS,/arxiv_data1/oa_pdf/69/4a/main.PMC5407570.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.03.003,Non-OADS,/arxiv_data1/oa_pdf/83/58/main.PMC5407572.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,1 5 –17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/83/58/main.PMC5407572.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,18,1 5 –17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/83/58/main.PMC5407572.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/ca/main.PMC5407574.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.016 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/ca/main.PMC5407574.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 132 e134,Non-OADS,/arxiv_data1/oa_pdf/33/ca/main.PMC5407574.pdf
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.rmcr.2017.04.016 .,Non-OADS,/arxiv_data1/oa_pdf/33/ca/main.PMC5407574.pdf
"A large body of studies over the years suggests that MnPs can also undergo diverse interactions with other reactive species, such as reducing peroxynitrite, http://dx.doi.org/10.1016/j.redox.2017.04.027 Received 28 January 2017; Received in revised form 12 April 2017; Accepted 13 April 2017⁎Correspondence to: Department of Radiation Oncology, Duke University Medical Center, 281b MSRB I, Research Drive, Durham, NC 27710, USA.",Non-OADS,/arxiv_data1/oa_pdf/61/00/main.PMC5407575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/61/00/main.PMC5407575.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.04.027 .,OADS,/arxiv_data1/oa_pdf/61/00/main.PMC5407575.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/eb/f2/10.1177_2325967117703399.PMC5407580.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2017:13 143–151Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  143 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S131259The changing trend of cardiovascular disease  and its clinical characteristics in Ethiopia:  hospital‑based observational study   Y onas Getaye T efera1 Tadesse Melaku Abegaz1 Tamrat Befekadu Abebe1 Abebe Basazn Mekuria2  1Department of Clinical Pharmacy,   2Department of Pharmacology, School  of Pharmacy, College of Medicine and  Health Sciences, University of Gondar,  Gondar, EthiopiaObjective: The aim of this study was to assess the pattern of cardiovascular diseases (CVDs),  their clinical characteristics, and associated factors in the outpatient department of the chronic  illness clinic of Gondar University Referral Hospital.",Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
"4 Correspondence: Yonas Getaye Tefera Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, PO Box 196, Gondar, EthiopiaTel +251 92 015 9494Email yonas1get@gmail.comJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 13Running head verso: Tefera et alRunning head recto: The changing trend of cardiovascular disease in EthiopiaDOI: http://dx.doi.org/10.2147/VHRM.S131259 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
Or use: http://youtu.be/yNeCjQuK6ms,Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
"Vascular Health and Risk Management  2017:13submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular ‑health‑and‑risk‑management‑journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 151 The changing trend of cardiovascular disease in Ethiopia 25.,Non-OADS,/arxiv_data1/oa_pdf/55/c9/vhrm-13-143.PMC5407597.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e54452 | Page 1 of 9Video Article Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing Ian G. Mackey1, Eric A. Dixon1, Kevin Johnson1, Jiang-Ti Kong1 1Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine Correspondence to: Jiang-Ti Kong at jtkong@stanford.edu URL: https://www.jove.com/video/54452 DOI: doi:10.3791/54452 Keywords: Neuroscience, Issue 120, thermal, temporal summation, second pain, contact-heat evoked potential stimulator (CHEPS), conditioned pain modulation, cold pressor test, endogenous analgesia Date Published: 2/16/2017 Citation: Mackey, I.G., Dixon, E.A., Johnson, K., Kong, J.T.",Non-OADS,/arxiv_data1/oa_pdf/67/f0/jove-120-54452.PMC5407598.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54452/ Introduction The International Association for the Study of Pain (IASP) defines pain as ""an unpleasant sensory and emotional experience.""",Non-OADS,/arxiv_data1/oa_pdf/67/f0/jove-120-54452.PMC5407598.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.017 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 124 e128,Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"Care 59 (9) (2014) e137 ee139, http://dx.doi.org/10.4187/respcare.02579 .",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"16 (7) (2010) 870 e877, http://dx.doi.org/10.1111/j.1469-0691.2009.03015.x [published Online First: 2009/11/13].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"81 (1) (2014) 15 e21,http://dx.doi.org/10.1016/j.jbspin.2013.05.002 [published Online First: 2013/07/03].",OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"48 (6) (2010) 817 e823, http://dx.doi.org/10.3109/13693780903514872 [published Online First: 2010/01/30].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"JCDR 10 (4) (2016) Te01 eTe05, http://dx.doi.org/10.7860/jcdr/2016/17141.7684 [published Online First: 2016/05/18].",OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"18 (4) (2014) 458, http://dx.doi.org/10.1186/s13054-014-0458-4 [published Online First: 2014/08/30].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"170 (6) (2004) 621 e625, http://dx.doi.org/10.1164/rccm.200401-093OC [published Online First: 2004/07/02].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"33 (10) (2007) 1694 e1703, http://dx.doi.org/10.1007/s00134-007- 0791-z [published Online First: 2007/07/25].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"65 (5) (2012) 447 e452, http://dx.doi.org/10.1016/ j.jinf.2012.07.006 [published Online First: 2012/08/07].",OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"(2016), http://dx.doi.org/10.1111/crj.12551 [published Online First: 2016/ 09/11].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"5 (1) (2008) 19 e27,http://dx.doi.org/10.1177/1479972307085637 [published Online First: 2008/02/28].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"187 (2) (2006) 404 e413, http://dx.doi.org/10.2214/ ajr.05.0513 [published Online First: 2006/07/25].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"44 (3) (2007) 373 e379, http://dx.doi.org/10.1086/509917 [pub- lished Online First: 2007/01/06].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"34 (1) (2002) 7 e14, http://dx.doi.org/10.1086/323335 .",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"9 (3) (2005) R191eR199, http://dx.doi.org/10.1186/cc3488 [published Online First: 2005/ 07/01].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"Allergy 5 (2015) 31, http://dx.doi.org/10.1186/s13601-015- 0073-8 [published Online First: 2015/09/05].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"55 (1) (2006) 1 e8, http://dx.doi.org/10.2332/allergolint.55.1 [published Online First: 2006/11/ 01].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"72 (2) (2015) 246 e252, http://dx.doi.org/10.1016/j.jaad.2014.10.032 [published Online First: 2015/01/17].",OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"25 (5) (2012)493e502, http://dx.doi.org/10.1111/j.1432-2277.2012.01443.x [published Online First: 2012/02/24].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"Marr, R.A. Carter, M. Boeckh, et al., Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors, Blood 100 (13) (2002) 4358 e4366, http://dx.doi.org/10.1182/blood-2002-05- 1496 [published Online First: 2002/10/24].",OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"43 (5) (2006) 577e584, http://dx.doi.org/10.1086/505870 [published Online First: 2006/08/ 04].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"41 (8) (2005) 1143 e1149, http://dx.doi.org/10.1086/444462 [published Online First: 2005/09/16].",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
"46 (3) (2008) 327 e360, http://dx.doi.org/10.1086/525258 .T.",Non-OADS,/arxiv_data1/oa_pdf/40/db/main.PMC5407638.pdf
Impairments in visual object perception can be investigated using http://dx.doi.org/10.1016/j.nicl.2017.04.012 Received 21 August 2016; Received in revised form 14 April 2017; Accepted 15 April 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.cub.2009.04.028 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/schbul/sbw078 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1001/archpsyc.56.9.781 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"32, 55–65.http://dx.doi.org/10.1111/j.2044-8260.1993.tb01027.x .",Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1162/ 089892903321662976 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1097/WCO.0b013e32832d93dd .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.02.048 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/S0720-048X(99)00048-0 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.cub.2005.10.,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2003.09.062 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1162/089892900562372 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1176/appi.ajp.158.11.1818 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1001/archpsyc.59.11.1011 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.10.042 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.mri.2008.01.045 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/schbul/13.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1073/ pnas.0504136102 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/S0165- 0173(99)00052-1 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1006/nimg.2001.1037 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1002/hbm.20249 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5434-09.2010 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"117, 13 –20.http://dx.doi.org/10.1016/j.schres.2009.09.",OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/schbul/sbp110 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/schbul/sbp100 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"118, 81 –87.http://dx.doi.org/10.1016/j.schres.2010.01.003 .",OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1002/mrm.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1097/01.wnr.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1523/jneurosci.1852-08.2008 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.schres.2010.11.009 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1038/nn957 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"167, 1 –11.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.schres.2014.10.036 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.euroneuro.2015.08.007 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.3522-07.2007 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"NeuroImage 104, 69 –78.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.2466/PMS.8.7.271- 276.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"117, 21 –30.http://dx.doi.org/10.1016/ j.schres.2010.01.001 .",OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/schbul/sbi011 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.07.049 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.schres.2012.11.037 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1002/hbm.20580 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/schbul/sbr052 .V.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1037/0096-3445.119.3.276 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.05.078 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1007/s11682-014-9351-7 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.2002-06.2006 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.03.050 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"http://dx.doi.org/10.1007/978-1-4614-4121-2 .van de Ven, V.G., Formisano, E., Prvulovic, D., Roeder, C.H., Linden, D.E.J., 2004.",Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/ 10.1002/hbm.20022 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1002/hbm.20479 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2011.07.044 .,OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1026//0084-5345.28.1.68 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"130, 86 –93.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1093/ schbul/sbp064 .,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
http://dx.doi.org/10.1371/journal.pone.0085489 .V.,Non-OADS,/arxiv_data1/oa_pdf/65/25/main.PMC5407639.pdf
"It also  regulates some pro-angiogenic and anti-angiogenic gene Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> Received 15 November 2016 | Accepted 24 April 2017 | Published 26 April 2017© 2017 Molecular Vision 286Inhibitory effects of S100A4  gene silencing on alkali burn-induced  corneal neovascularization: an in vivo study Yu-Lin Wang,1 Gui-Ping Gao,1 Yu-Qin Wang,2 Ying Wu,1 Zhi-You Peng,1 Quan Zhou1 1The Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang, China; 2Zhejiang Eye  Hospital, Eye Hospital of Wenzhou Medical University, Wenzhou, China Objective:  The purpose of this study is to explore the inhibitory effects of S100A4  gene silencing on alkali burn-induced  corneal neovascularization (CNV) in rabbit models.",Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  287expressions [ 17].,Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
"Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  288fixed in 4% poly formaldehyde, dehydrated, and embedded in  paraffin, while corneal tissue from the right eyes was frozen  at −80 °C for total RNA extraction.",Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
"Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  289Statistical analysis:  SPSS 13.0 statistical software (SPSS Inc.,  Chicago, IL) was used for data analysis and measurement.",OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  290cell infiltration in part of the CNV cavity (within the corneal  stroma).,Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  291expression of VEGF protein in the corneal epithelium 1 day  after alkali burning in the empty vector group.,Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  292gene silencing can inhibit the formation of CNV in rabbit  corneal alkali burns and reduce the inflammatory reaction.,Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
"Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  293The study also found that at each time point, S100A4  gene  silencing could suppress VEGF, TNF-α mRNA, and protein  expression.",Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  294This proves the results of our study [ 31].,Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
Molecular Vision  2017; 23:286-295 <http://www.molvis.org/molvis/v 23/286> © 2017 Molecular Vision  29519.,Non-OADS,/arxiv_data1/oa_pdf/da/71/mv-v23-286.PMC5407652.pdf
"https://doi.org/10.1177/2333721417704946Gerontology & Geriatric Medicine Volume 3: 1 –9 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417704946 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction Dementia is a progressive cognitive impairment that  affects primarily individuals 65 years of age and older.",Non-OADS,/arxiv_data1/oa_pdf/5b/7e/10.1177_2333721417704946.PMC5407657.pdf
Retrieved  from https://www.ccwdata.org/web/guest/medicare-charts/ medicare-chronic-condition-charts Centers for Medicare & Medicaid Services Chronic Conditions  Data Warehouse.,OADS,/arxiv_data1/oa_pdf/5b/7e/10.1177_2333721417704946.PMC5407657.pdf
Retrieved from https://www.ccwdata.org/web/guest/con- dition-categories Food and Drug Administration.,Non-OADS,/arxiv_data1/oa_pdf/5b/7e/10.1177_2333721417704946.PMC5407657.pdf
Retrieved from http://www.fda.gov/   Drugs/DrugSafety/PostmarketDrugSafetyInformation   forPatientsandProviders/ucm124830.htm,Non-OADS,/arxiv_data1/oa_pdf/5b/7e/10.1177_2333721417704946.PMC5407657.pdf
Retrieved from https://www.accessdata.,OADS,/arxiv_data1/oa_pdf/5b/7e/10.1177_2333721417704946.PMC5407657.pdf
"Retrieved from http://data.bls.gov/timeseries/PCU325412325412 Zhao, Y., Kuo, T.-C., Weir, S., Kramer, M., & Ash, A.",OADS,/arxiv_data1/oa_pdf/5b/7e/10.1177_2333721417704946.PMC5407657.pdf
"https://doi.org/10.1177/2333721417703734Gerontology & Geriatric Medicine Volume 3: 1 –7 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417703734 journals.sagepub.com/home/ggm Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction Sarcopenia is defined as a decrease in muscle mass and  strength associated with aging, it is considered a multi-factorial entity reflecting the interaction among genetic and behavioral mechanisms, comorbidities, and the aging process itself (Cruz-Jentoft, Landi, Topinková, & Michel, 2010; Evans, 2015).",Non-OADS,/arxiv_data1/oa_pdf/27/66/10.1177_2333721417703734.PMC5407660.pdf
Supplemental Material The supplemental materials are available at http://journals.sagepub.com/doi/suppl/10.1177/2333721417703734.,Non-OADS,/arxiv_data1/oa_pdf/27/66/10.1177_2333721417703734.PMC5407660.pdf
"Retrieved from http://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596 Arango-Lopera, V. E., Arroyo, P., Gutiérrez-Robledo, L. M.,  & Pérez-Zepeda, M. U.",Non-OADS,/arxiv_data1/oa_pdf/27/66/10.1177_2333721417703734.PMC5407660.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e54782 | Page 1 of 14Video Article Structural Information from Single-molecule FRET Experiments Using the Fast Nano-positioning System Thilo Dörfler*1, Tobias Eilert*1, Carlheinz Röcker1, Julia Nagy1, Jens Michaelis1 1Institute of Biophysics, Ulm University *These authors contributed equally Correspondence to: Jens Michaelis at jens.michaelis@uni-ulm.de URL: https://www.jove.com/video/54782 DOI: doi:10.3791/54782 Keywords: Biochemistry, Issue 120, Nano-Positioning System, Fast-NPS, single-molecule fluorescence, single-molecule Förster Resonance Energy Transfer, structural biology Date Published: 2/9/2017 Citation: Dörfler, T., Eilert, T., Röcker, C., Nagy, J., Michaelis, J.",Non-OADS,/arxiv_data1/oa_pdf/b1/e4/jove-120-54782.PMC5407667.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54782/ Introduction Determining the structure of a biomolecule is a key prerequisite for understanding its function.,Non-OADS,/arxiv_data1/oa_pdf/b1/e4/jove-120-54782.PMC5407667.pdf
Installation of Fast-NPS Software 1.Download UCSF Chimera from http://www.cgl.ucsf.edu/chimera and follow the installation guide.,Non-OADS,/arxiv_data1/oa_pdf/b1/e4/jove-120-54782.PMC5407667.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e54784 | Page 1 of 14Video Article Creating Virtual-hand and Virtual-face Illusions to Investigate Self- representation Ke Ma1, Dominique P. Lippelt1, Bernhard Hommel1 1Cognitive Psychology Unit, Leiden University Correspondence to: Bernhard Hommel at hommel@fsw.leidenuniv.nl URL: https://www.jove.com/video/54784 DOI: doi:10.3791/54784 Keywords: Behavior, Issue 121, Virtual-hand illusion, Virtual-face illusion, Self-representation, Illusory perception, Multisensory integration, Sense of agency, Self-other boundary Date Published: 3/1/2017 Citation: Ma, K., Lippelt, D.P., Hommel, B.",Non-OADS,/arxiv_data1/oa_pdf/af/d4/jove-121-54784.PMC5407672.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54784/ Introduction According to Western philosophy, the human self consists of two aspects1: For one, we perceive our own body and our activities in the here and now, which creates a phenomenal self-representation (often called the minimal self ).",Non-OADS,/arxiv_data1/oa_pdf/af/d4/jove-121-54784.PMC5407672.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54900 | Page 1 of 10Video Article Rapid Neuronal Differentiation of Induced Pluripotent Stem Cells for Measuring Network Activity on Micro-electrode Arrays Monica Frega*1,2, Sebastianus H. C. van Gestel*3, Katrin Linda2,3, Jori van der Raadt3, Jason Keller1,2, Jon-Ruben Van Rhijn1,2, Dirk Schubert1,2, Cornelis A. Albers2,3,4, Nael Nadif Kasri1,2,3 1Department of Cognitive Neurosciences, Radboudumc 2Donders Institute for Brain, Cognition and Behaviour, Radboud University 3Department of Human Genetics, Radboudumc 4Department of Molecular Developmental Biology, Radboud University *These authors contributed equally Correspondence to: Cornelis A. Albers at kees.albers@radboudumc.nl , Nael Nadif Kasri at n.nadif@donders.ru.nl URL: https://www.jove.com/video/54900 DOI: doi:10.3791/54900 Keywords: Developmental Biology, Issue 119, induced pluripotent stem cells, neuronal differentiation, micro-electrode arrays, lentiviral transduction, astrocyte isolation, neuronal network Date Published: 1/8/2017 Citation: Frega, M., van Gestel, S.H., Linda, K., van der Raadt, J., Keller, J., Van Rhijn, J.R., Schubert, D., Albers, C.A., Nadif Kasri, N. Rapid Neuronal Differentiation of Induced Pluripotent Stem Cells for Measuring Network Activity on Micro-electrode Arrays.",Non-OADS,/arxiv_data1/oa_pdf/d1/e6/jove-119-54900.PMC5407693.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54900/ Introduction The development of human induced Pluripotent Stem Cells (hiPSCs) differentiation protocols to generate human neurons in vitro  has provided a powerful new tool for studying neurological disorders.,Non-OADS,/arxiv_data1/oa_pdf/d1/e6/jove-119-54900.PMC5407693.pdf
"d’Annunzio” University 2Department of Veterinary Medicine, Pathology and Veterinary Clinic Section, University of Sassari 3Research and Development Department, Forza10 USA Corp. *These authors contributed equally Correspondence to: Alessandro Di Cerbo at alessandro811@hotmail.it URL: https://www.jove.com/video/54878 DOI: doi:10.3791/54878 Keywords: Behavior, Issue 119, behavioral disturbances, specific diet, intense and restless activity, specific sensor, clinical symptoms, behavioral symptoms Date Published: 1/3/2017 Citation: Di Cerbo, A., Sechi, S., Canello, S., Guidetti, G., Fiore, F., Cocco, R. Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet.",Non-OADS,/arxiv_data1/oa_pdf/bf/a0/jove-119-54878.PMC5407696.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54878/ Introduction Dogs are generally recognized as the most devoted domesticated animals that live with humans.,Non-OADS,/arxiv_data1/oa_pdf/bf/a0/jove-119-54878.PMC5407696.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e54912 | Page 1 of 10Video Article Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion Alexander H. Turaihi1, Erik M. van Poelgeest1, Victor W. M. van Hinsbergh1, Erik H. Serné2, Yvo M. Smulders2, Etto C. Eringa1 1Laboratory for Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center 2Department of Internal Medicine, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center Correspondence to: Alexander H. Turaihi at a.turaihi@vumc.nl URL: https://www.jove.com/video/54912 DOI: doi:10.3791/54912 Keywords: Medicine, Issue 121, Intravital microscopy, contrast-enhanced ultrasonography, insulin sensitivity, vascular responsiveness, endothelium, microsurgery Date Published: 3/20/2017 Citation: Turaihi, A.H., van Poelgeest, E.M., van Hinsbergh, V.W., Serné, E.H., Smulders, Y.M., Eringa, E.C.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/jove-121-54912.PMC5407697.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54912/ Introduction In response to a rise in blood glucose level, the pancreas secretes insulin into the bloodstream where it is quickly distributed to its target tissues such as skeletal muscle, via resistance arteries and capillaries.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/jove-121-54912.PMC5407697.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e54871 | Page 1 of 8Video Article Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts Mitchel C. Schiewe1, Shane Zozula1, Nancy Nugent1, Kelley Waggoner1, Jessica Borba1, Lisa Gamboa1, John B. Whitney1 1Ovation Fertility Correspondence to: Mitchel C. Schiewe at mcschiewe@verizon.net URL: https://www.jove.com/video/54871 DOI: doi:10.3791/54871 Keywords: Developmental Biology, Issue 121, blastocysts, cryopreservation, vitrification, infertility, quality control, aseptic storage Date Published: 3/2/2017 Citation: Schiewe, M.C., Zozula, S., Nugent, N., Waggoner, K., Borba, J., Gamboa, L., Whitney, J.B.",Non-OADS,/arxiv_data1/oa_pdf/d9/20/jove-121-54871.PMC5407698.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54871/ Introduction Vitrification is the single most impactful assisted reproductive technology in the in vitro  fertilization (IVF) industry since the development of intracytoplasmic sperm injection.,Non-OADS,/arxiv_data1/oa_pdf/d9/20/jove-121-54871.PMC5407698.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e54951 | Page 1 of 11Video Article A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection Silvia Murillo-Cuesta*1,2,3, Néstor Vallecillo*1, Rafael Cediel1,2,4, Adelaida M. Celaya1,2, Luis Lassaletta3,5, Isabel Varela-Nieto1,2,3, Julio Contreras1,2,4 1Instituto de Investigaciones Biomédicas (IIBm) Alberto Sols CSIC-UAM 2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII) 3Instituto de Investigación Sanitaria La Paz (IdiPAZ) 4Facultad de Veterinaria, Universidad Complutense de Madrid 5Departmento de Otorrino laringología, Hospital Universitario La Paz *These authors contributed equally Correspondence to: Silvia Murillo-Cuesta at smurillo@iib.uam.es URL: https://www.jove.com/video/54951 DOI: doi:10.3791/54951 Keywords: Medicine, Issue 121, Auditory brainstem response, cochlea, hearing loss, hydrogel, intratympanic, local drug delivery, microsurgery, rodents, vehicle Date Published: 3/8/2017 Citation: Murillo-Cuesta, S., Vallecillo, N., Cediel, R., Celaya, A.M., Lassaletta, L., Varela-Nieto, I., Contreras, J.",Non-OADS,/arxiv_data1/oa_pdf/00/5f/jove-121-54951.PMC5407703.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54951/ Introduction Hearing impairment is the most frequent human sensory deficit and affects 5.3% of the worldwide population, and 30% of individuals over the age of 65 ( http://www.who.int/topics/deafness/en, updated 2016).",Non-OADS,/arxiv_data1/oa_pdf/00/5f/jove-121-54951.PMC5407703.pdf
"MacDonald Centre for Lung Health Correspondence to: Michael K. Stickland at mks2@ualberta.ca URL: https://www.jove.com/video/54949 DOI: doi:10.3791/54949 Keywords: Medicine, Issue 120, Diffusing capacity, intrapulmonary arteriovenous anastomoses (IPAVA), exercise, agitated saline contrast echocardiography, pulmonary capillary blood volume, membrane diffusing capacity.",Non-OADS,/arxiv_data1/oa_pdf/12/80/jove-120-54949.PMC5407706.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54949/ Introduction During exercise, cardiac output can increase up to six-fold above resting values1.",Non-OADS,/arxiv_data1/oa_pdf/12/80/jove-120-54949.PMC5407706.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e54943 | Page 1 of 11Video Article Studying Dynamic Processes of Nano-sized Objects in Liquid using Scanning Transmission Electron Microscopy Justus Hermannsdörfer1, Niels de Jonge1,2 1INM-Leibniz Institute for New Materials 2Department of Physics, University of Saarland Correspondence to: Niels de Jonge at Niels.deJonge@leibniz-inm.de URL: https://www.jove.com/video/54943 DOI: doi:10.3791/54943 Keywords: Engineering, Issue 120, Scanning transmission electron microscopy, STEM, liquid-phase STEM, dynamic processes, gold nanoparticle, microchip, silicon nitride membrane Date Published: 2/5/2017 Citation: Hermannsdörfer, J., de Jonge, N. Studying Dynamic Processes of Nano-sized Objects in Liquid using Scanning Transmission Electron Microscopy.",Non-OADS,/arxiv_data1/oa_pdf/55/ac/jove-120-54943.PMC5407709.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54943/ Introduction Conventional Scanning Transmission Electron Microscopy (STEM) is limited by the range of specimens appropriate for analysis, specifically the dry and solid samples suitable for placement in a high vacuum.",Non-OADS,/arxiv_data1/oa_pdf/55/ac/jove-120-54943.PMC5407709.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on The Journal of Antibiotics website (http://www.nature.com/ja)Enhanced dereplication of fungal cultures using MDF ND Paguigan et al 561 The Journal of Antibiotics",Non-OADS,/arxiv_data1/oa_pdf/a2/8f/ja2016145a.PMC5407915.pdf
"Retrieved from http://www.nutritionaction.com/get-download/download/?dtd=16511&n=1 Chen, B.H.",Non-OADS,/arxiv_data1/oa_pdf/9a/70/67_16118.PMC5407916.pdf
"FAO (2015) FAOSTAT, http://faostat.fao.org/.",Non-OADS,/arxiv_data1/oa_pdf/9a/f5/67_16125.PMC5407917.pdf
"FAOSTAT (2013) URL: http://faostat3.fao.org/home/EFujise, K. (1964) Studies on flowering, seeds setting and self- and  cross-incompatibility in the varieties of sweet potato.",Non-OADS,/arxiv_data1/oa_pdf/e8/96/67_16129.PMC5407919.pdf
"Its global production volume is around 104,000,000 t (FAO 2014; http://www.fao.org/home/en/),  with close to 75% of the amount produced in Asia, and China itself produces around 71,000,000 t, which accounts  for 70% of the global production.",Non-OADS,/arxiv_data1/oa_pdf/cd/1c/67_16142.PMC5407921.pdf
All the generated data are available on the Sweetpotato GARDEN (http://sweetpotato-garden.kazusa.or.jp/) database.,OADS,/arxiv_data1/oa_pdf/e8/92/67_16186.PMC5407923.pdf
"The  transcripts were annotated by similarity searches against the NCBI NR database (http://www.ncbi.nlm.nih.gov), the gene ontology (GO) terms (http://www.geneontology.org), Kyoto encyclopedia of genes and genomes (KEGG) pathways (http://www.genome.jp/kegg/), known transcription factors and protein kinases.",OADS,/arxiv_data1/oa_pdf/e8/92/67_16186.PMC5407923.pdf
"A total of 24,657 putatively unique genes were annotated by BLASTX search with the UniRef100 database (http://www.uniprot.org), and 1,661 gene-based microsatellite sequences were identified in the unique genes.",OADS,/arxiv_data1/oa_pdf/e8/92/67_16186.PMC5407923.pdf
"A total of 128,052 transcripts (≥100 bp) were subjected to annota - tion by Blast2GO (https://www.blast2go.com), BLASTX (https://blast.ncbi.nlm.nih.gov/Blast.cgi), GO and KEGG analysis.",OADS,/arxiv_data1/oa_pdf/e8/92/67_16186.PMC5407923.pdf
This project was founded by the Bill & Melinda Gates Foundation with a funding amount of more than 12M USD (http://www.sweetpotatoknowledge.org/project/genomic-tools-for-sweetpotato-improvement-gt4sp/).,Non-OADS,/arxiv_data1/oa_pdf/e8/92/67_16186.PMC5407923.pdf
"Literature Cited International Potato Center (CIP) (2017) http://www.cgiar.org/about- us/research-centers/international-potato-center-cip/?posts-1003_ page=2&posts-1004_page=2&posts-1009_page=2&posts-1006_ page=3 (Accessed 2017 February 22) Makoto Tahara Graduate School of Environmental and Life Science,  Okayama UniversityBreeding Science 67: 1 (2017)   doi:10.1270/jsbbs.67.1 Editorial Current developments in breeding, genetics, genomics, and molecular biology  applied to sweetpotato improvement",Non-OADS,/arxiv_data1/oa_pdf/90/cc/67_67.1.PMC5407924.pdf
"http://immunenetwork.org 103pISSN 1598-2629 · eISSN 2092-6685 Detection of Autoantibodies against Aquaporin-1 in the  Sera of Patients with Primary Sjögren’s Syndrome Jehan Alam1, Yun Sik Choi1, Jung Hee Koh2, Seung-Ki Kwok2, Sung-Hwan Park2, Yeong Wook Song3,  Kyungpyo Park1 and Youngnim Choi1* 1School of Dentistry and Dental Research Institute, Seoul National University , Seoul 03080, 2Seoul St. Mary’s Hospital, The Catholic  University of Korea, Seoul 06591, 3College of Medicine, Seoul National University, Seoul 03080, Koreahttps://doi.org/10.4110/in.2017.17.2.103ORIGINAL ARTICLE INTRODUCTION Sjögren’s syndrome (SS) is a chronic autoimmune disease  that primarily targets the lacrimal and salivary glands.",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/in-17-103.PMC5407981.pdf
"Anti-AQP1 Antibodies in Sjögren’s Syndrome http://immunenetwork.org 105Zeiss, Jena, Germany).",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/in-17-103.PMC5407981.pdf
"Anti-AQP1 Antibodies in Sjögren’s Syndrome http://immunenetwork.org 107loop D, and loop E, as well as the C-terminal cytoplasmic  tail, which may provide cross-reactive epitopes.",Non-OADS,/arxiv_data1/oa_pdf/cf/fc/in-17-103.PMC5407981.pdf
Anti-AQP1 Antibodies in Sjögren’s Syndrome http://immunenetwork.org 1098.,Non-OADS,/arxiv_data1/oa_pdf/cf/fc/in-17-103.PMC5407981.pdf
"110pISSN 1598-2629 · eISSN 2092-6685 Characterization of the Indirubin Derivative LDD970 as  a Small Molecule Aurora Kinase A Inhibitor in Human  Colorectal Cancer Cells Karyn Muzinga Ndolo1, Kyeong Ryang Park1, Hyo Jeong Lee1, Kyoung Bin Yoon1, Yong-Chul Kim2  and Sun-Young Han1* 1College of Pharmacy and Research Institute of Pharmaceutical Science s, Gyeongsang National University, Jinju 52828, 2School of life  Sciences, Gwangju Institute of Science &Technology, Gwangju 61186, Koreahttps://doi.org/10.4110/in.2017.17.2.110ORIGINAL ARTICLE INTRODUCTION Aurora kinase A belongs to a family of serine/threonine  protein kinases that are implicated in important processes  during mitosis including centrosome and microtubule  activities.",Non-OADS,/arxiv_data1/oa_pdf/00/01/in-17-110.PMC5407982.pdf
LDD970 as an Aurora Kinase A Inhibitor http://immunenetwork.org 111with colorectal cancers (6).,Non-OADS,/arxiv_data1/oa_pdf/00/01/in-17-110.PMC5407982.pdf
LDD970 as an Aurora Kinase A Inhibitor http://immunenetwork.org 113Effects of LDD970 on HT29 cell growth and apoptosis Cytotoxicity of LDD970 was measured to evaluate HT29  colorectal cancer cells growth.,OADS,/arxiv_data1/oa_pdf/00/01/in-17-110.PMC5407982.pdf
LDD970 as an Aurora Kinase A Inhibitor http://immunenetwork.org 1158.,Non-OADS,/arxiv_data1/oa_pdf/00/01/in-17-110.PMC5407982.pdf
"116pISSN 1598-2629 · eISSN 2092-6685 IL-32-induced Inflammatory Cytokines Are Selectively  Suppressed by a1-antitrypsin in Mouse Bone Marrow Cells Siyoung Lee1,2#, Dong-Ki Choi3#, Areum Kwak1,4#, Sinae Kim1,4, Tam Thanh Nguyen1,4, Gaae Gil1,4,  Eunhye Kim1,4, Kwang Ha Yoo5, In Ae Kim5, Youngmin Lee6, Hyunjhung Jhun1,7, Edward D. Chan8,  Xiyuan Bai8, Hyunwoo Kim9, Yong-Sung Kim3 and Soohyun Kim1,4,10* 1Laboratory of Cytokine Immunology, Department of Biomedical Science and Technology, Konkuk University, Seoul 05029,  2YbdYbiotech Research Center, Seoul 08589, 3Department of Molecular Science and Technology, Ajou University, Suwon 16499,  4College of Veterinary Medicine, 5Division of Pulmonology, Department of Internal Medicine, School of Medicine, Konkuk University,  Seoul 05029, 6Department of Medicine, Pusan Paik Hospital, College of Medicine, Inje University, Busan 47392, 7Korea Food Research  Institute, Seongnam 13539, Korea, 8Departments of Medicine and Academic Affairs, National Jewish Health, Denver, CO 80206, USA,  9Division of Nephrology, Department of Internal Medicine, Jeju National University School of Medicine, Jeju 63243, 10College of  Veterinary Medicine and Veterinary Science Research Institute, Konkuk University, Seoul 05029, Koreahttps://doi.org/10.4110/in.2017.17.2.116BRIEF COMMUNICATION INTRODUCTION a1-antitrypsin (AAT) exhibits anti-inflammatory activity  and its deficiency causes respiratory and inflammatory  disorders (1-8).",Non-OADS,/arxiv_data1/oa_pdf/4b/50/in-17-116.PMC5407983.pdf
Recombinant AAT-Fc Inhibits IL-32 Activity http://immunenetwork.org 117isolation of neutrophil proteinase 3 (PR3) from human  urine (9).,Non-OADS,/arxiv_data1/oa_pdf/4b/50/in-17-116.PMC5407983.pdf
Recombinant AAT-Fc Inhibits IL-32 Activity http://immunenetwork.org 119reading frame of PR3 fused to human Fc as described  previously (21).,Non-OADS,/arxiv_data1/oa_pdf/4b/50/in-17-116.PMC5407983.pdf
"http://immunenetwork.org 121pISSN 1598-2629 · eISSN 2092-6685 Augmented Serum Amyloid A1/2 Mediated by   TNF-induced NF- kB in Human Serous Ovarian Epithelial  Tumors Hyeongjwa Choi1#, Rosa Mistica C. Ignacio1#, Eun-Sook Lee2, Andrew J. Wilson3, Dineo Khabele3 and  Deok-Soo Son1* 1Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, 2Department of Pharmaceutical  Sciences, College of Pharmacy, Florida A&M University, Tallahassee, FL 32301, 3Department of Obstetrics and Gynecology, Vanderbilt- Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USAhttps://doi.org/10.4110/in.2017.17.2.121BRIEF COMMUNICATION INTRODUCTION Ovarian cancer is the most common cause of cancer death  from gynecologic malignancies and a heterogeneous disease (1).",Non-OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
Serum Amyloid A in Ovarian Cancer http://immunenetwork.org 123CAG-3 ʹ (sense) and 5 ʹ-TTC CTC AGC TTT CTC GTT  GG-3 ʹ (antisense) for human SAA4.,Non-OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
Data  analysis was performed using PCR Array Data Analysis  Software (http://www.sabiosciences.com/RTPCR.php)  provided by SABiosciences/Qiagen.,OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
"Data analysis from GEO dataset  Data analysis was performed using microarray data sets deposited in the NCBI Gene Expression Omnibus  (GEO, http://www.ncbi.nlm.nih.gov/geo/) database under  accession number GSE51088.",OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
"We employed  Gitools 2.2.3 (http://www.gitools.org) based on Oracle  Java 7, an open-source tool to perform Genomic Data  Analysis and Visualization as interactive heat-maps (19).",OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
"Identities  of mRNAs (M23698 vs. M23700) and protein (AAI05797  vs. NP_110381) for SAA1 and SAA2 are 97% and  93%, respectively, by Align Sequences Nucleotide  and Protein BLAST (https://blast.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
Serum Amyloid A in Ovarian Cancer http://immunenetwork.org 125normal vs. tumor tissues and the correlation between  TNF and SAA isoforms.,Non-OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
Serum Amyloid A in Ovarian Cancer http://immunenetwork.org 127UL1TR000445 (A.W.,Non-OADS,/arxiv_data1/oa_pdf/1b/d6/in-17-121.PMC5407984.pdf
"128pISSN 1598-2629 · eISSN 2092-6685 Sterile Pyometra in Two Dogs Hun-Young Yoon1, Jae-Young Byun1, Kang-Hyo Park1, Byong-Su Min1 and Jung-Hyun Kim2* Departments of 1Veterinary Surgery and 2Veterinary Internal Medicine, Konkuk University Veterinary Medical Teaching Hospital,  Konkuk University, Seoul 05029, Koreahttps://doi.org/10.4110/in.2017.17.2.128CASE REPORT INTRODUCTION Pyometra is one of the most common diseases affecting  intact bitches and is usually seen in middle or older age  dogs (1).",Non-OADS,/arxiv_data1/oa_pdf/4c/3d/in-17-128.PMC5407985.pdf
"Sterile Pyometra http://immunenetwork.org 129to the Veterinary Medical Teaching Hospital of Konkuk  University for evaluation of vaginal discharge of two days’ duration and after being hit by a car, respectively.",Non-OADS,/arxiv_data1/oa_pdf/4c/3d/in-17-128.PMC5407985.pdf
"Sterile Pyometra http://immunenetwork.org 131patterns for the predominant pathogen, Escherichia coli   (2).",Non-OADS,/arxiv_data1/oa_pdf/4c/3d/in-17-128.PMC5407985.pdf
"http://immunenetwork.org 77pISSN 1598-2629 · eISSN 2092-6685 Mitochondrial Control of Innate Immunity and  Inflammation Hyo Sun Jin1,2,3, Hyun-Woo Suh1,2, Seong-Jun Kim4 and Eun-Kyeong Jo1,2* 1Department of Microbiology, 2Infection Signaling Network Research Center, Chungnam National University School of Medicine,  3Biomedical Research Institute, Chungnam National University Hospital, Daejeon 35015, 4Center for Convergent Research of Emerging  Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea  https://doi.org/10.4110/in.2017.17.2.77REVIEW ARTICLE INTRODUCTION Mitochondria are the major cellular organelle responsible  for energy provision when energy needs are to be met.",Non-OADS,/arxiv_data1/oa_pdf/ca/85/in-17-77.PMC5407986.pdf
"Mitochondria and Inflammation http://immunenetwork.org 79gers oligomerization of inflammasome components and  caspase-1 auto-activation, followed by assembly of the NLRP3 inflammasome (32).",Non-OADS,/arxiv_data1/oa_pdf/ca/85/in-17-77.PMC5407986.pdf
"Mitochondria and Inflammation http://immunenetwork.org 81  More recently, the cytochrome c oxidase (CcO) complex  subunit, COX5B, a component of the mitochondrial elec-tron transport system, was shown to be physically associ- ated with the MA VS protein and to inhibit MA VS protein-mediated antiviral immunity via autophagy- and ROS- dependent pathways (66).",Non-OADS,/arxiv_data1/oa_pdf/ca/85/in-17-77.PMC5407986.pdf
"Mitochondria and Inflammation http://immunenetwork.org 83A virus titers, and induction of antiviral innate immune  responses, via regulation of IFN- l secretion by normal  human nasal epithelial cells (86).",Non-OADS,/arxiv_data1/oa_pdf/ca/85/in-17-77.PMC5407986.pdf
Mitochondria and Inflammation http://immunenetwork.org 85Opin.,Non-OADS,/arxiv_data1/oa_pdf/ca/85/in-17-77.PMC5407986.pdf
Mitochondria and Inflammation http://immunenetwork.org 87Activates the RIG-I-like Receptor-Mediated Antiviral  Immune Response by Targeting the MA VS signalosome.,Non-OADS,/arxiv_data1/oa_pdf/ca/85/in-17-77.PMC5407986.pdf
"http://immunenetwork.org 89pISSN 1598-2629 · eISSN 2092-6685 Mesenchymal Stromal Cells and Toll-Like Receptor  Priming: A Critical Review Mehdi Najar1#, Mohammad Krayem2#*, Nathalie Meuleman1, Dominique Bron1 and   Laurence Lagneaux1 1Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Campus Erasme, 2Laboratory of  Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels 1000, Belgiumhttps://doi.org/10.4110/in.2017.17.2.89REVIEW ARTICLE MESENCHYMAL STROMAL CELLS Mesenchymal stromal cells (MSCs) represent nowadays  an important immunotherapeutic cell population with  several possible application for the treatment of immu - nological-based diseases (1).",Non-OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
TLR-priming of MSCs http://immunenetwork.org 91initiated when host recognizes conserved molecular  structures that are essential for the life-cycle of the pathogen and which are known as a pathogen-associated  molecular patterns (PAMPs) (23).,Non-OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
"TLR-priming of MSCs http://immunenetwork.org 93the immunogenic properties of MSCs from BM and AT  (47,49,62-65).",Non-OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
"TLR-priming of MSCs http://immunenetwork.org 95highly secreting IL-4, IL-6, and IL-8 (56).",Non-OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
TLR-priming of MSCs http://immunenetwork.org 97(96).,Non-OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
TLR-priming of MSCs http://immunenetwork.org 99G.,Non-OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
"TLR-priming of MSCs http://immunenetwork.org 101Bron, M. Toungouz, and L. Lagneaux.",OADS,/arxiv_data1/oa_pdf/8a/47/in-17-89.PMC5407987.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bc/b3/40266_2017_Article_447.PMC5408060.pdf
http://www.medicijnkosten.nl/ .,Non-OADS,/arxiv_data1/oa_pdf/bc/b3/40266_2017_Article_447.PMC5408060.pdf
2013. http://statline.cbs.nl/ .,Non-OADS,/arxiv_data1/oa_pdf/bc/b3/40266_2017_Article_447.PMC5408060.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/cc/evx068.PMC5408089.pdf
doi: https://doi.org/10.1101/080804.,Non-OADS,/arxiv_data1/oa_pdf/94/cc/evx068.PMC5408089.pdf
"This is an Open Access article distrib uted under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/6f/evx071.PMC5408090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/08/main.PMC5408129.pdf
http://dx.doi.org/10.1016/j.eucr.2016.04.004Urology Case Reports 13 (2017) 72 e73,Non-OADS,/arxiv_data1/oa_pdf/a7/08/main.PMC5408129.pdf
This is an openaccess article underthe CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
"Further- more, for bone tissue engineering applications, design of scaffold permeability is essential to successful bone repair (Hollister, 2005; http://dx.doi.org/10.1016/j.bonr.2016.12.002 2352-1872/©2016 TheAuthors.",Non-OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
This is an open access articleunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
http://dx.doi.org/10.1016/j.ultras.2012.01.001 .,OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
ISSN 0021-9290. http://dx.doi.org/ 10.1016/S0021-9290(97)00016-X .,OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
"27 (4), 517–524.ISSN 0090-6964. http://dx.doi.org/10.1114/1.195 .",Non-OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
"http://dx.doi.org/10.1007/s11004-008-9182-4 .Odsæter, L., 2013.",OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
ISSN 1617-7959. http://dx.doi.org/10.1007/ s10237-015-0704-y .,Non-OADS,/arxiv_data1/oa_pdf/37/8a/main.PMC5408131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/e0/main.PMC5408132.pdf
http://dx.doi.org/10.1016/j.eucr.2016.08.007Urology Case Reports 13 (2017) 77 e78,Non-OADS,/arxiv_data1/oa_pdf/74/e0/main.PMC5408132.pdf
2016 Jul 5. http://dx.doi.org/10.1016/j.urology.2016.06.041 [pii: S0090-4295(16)30370-3].,Non-OADS,/arxiv_data1/oa_pdf/74/e0/main.PMC5408132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/5d/main.PMC5408139.pdf
http://dx.doi.org/10.1016/j.eucr.2016.10.010Urology Case Reports 13 (2017) 61 e62,Non-OADS,/arxiv_data1/oa_pdf/ac/5d/main.PMC5408139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/1b/main.PMC5408140.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.017Urology Case Reports 13 (2017) 107 e109,Non-OADS,/arxiv_data1/oa_pdf/3a/1b/main.PMC5408140.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/main.PMC5408141.pdf
http://dx.doi.org/10.1016/j.eucr.2016.09.007Urology Case Reports 13 (2017) 87 e88,Non-OADS,/arxiv_data1/oa_pdf/2f/e5/main.PMC5408141.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/7b/main.PMC5408142.pdf
http://dx.doi.org/10.1016/j.eucr.2016.12.006Urology Case Reports 13 (2017) 92 e93,Non-OADS,/arxiv_data1/oa_pdf/6d/7b/main.PMC5408142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/4d/main.PMC5408143.pdf
http://dx.doi.org/10.1016/j.eucr.2017.01.004Urology Case Reports 13 (2017) 94 e96,Non-OADS,/arxiv_data1/oa_pdf/c9/4d/main.PMC5408143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/3a/main.PMC5408144.pdf
http://dx.doi.org/10.1016/j.eucr.2017.03.019Urology Case Reports 13 (2017) 110 e112,Non-OADS,/arxiv_data1/oa_pdf/be/3a/main.PMC5408144.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/0b/main.PMC5408145.pdf
http://dx.doi.org/10.1016/j.eucr.2016.10.009Urology Case Reports 13 (2017) 53 e54,Non-OADS,/arxiv_data1/oa_pdf/ea/0b/main.PMC5408145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/a9/main.PMC5408146.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.029Urology Case Reports 13 (2017) 89 e91,Non-OADS,/arxiv_data1/oa_pdf/b9/a9/main.PMC5408146.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/e5/main.PMC5408147.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.04.014 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/e5/main.PMC5408147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 21 (2017) 129 e131,Non-OADS,/arxiv_data1/oa_pdf/c3/e5/main.PMC5408147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/1e/main.PMC5408148.pdf
http://dx.doi.org/10.1016/j.eucr.2016.11.019Urology Case Reports 13 (2017) 63 e65,Non-OADS,/arxiv_data1/oa_pdf/94/1e/main.PMC5408148.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/49/main.PMC5408150.pdf
http://dx.doi.org/10.1016/j.eucr.2016.12.012Urology Case Reports 13 (2017) 104 e106,Non-OADS,/arxiv_data1/oa_pdf/14/49/main.PMC5408150.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/4f/main.PMC5408151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/4f/main.PMC5408151.pdf
http://dx.doi.org/10.1016/j.eucr.2016.08.015Urology Case Reports 13 (2017) 66 e68,Non-OADS,/arxiv_data1/oa_pdf/9b/4f/main.PMC5408151.pdf
Conﬂict of interest There is no con ﬂict of interest.Supplementary data Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.eucr.2016.08.015 .,OADS,/arxiv_data1/oa_pdf/9b/4f/main.PMC5408151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/7a/main.PMC5408152.pdf
http://dx.doi.org/10.1016/j.eucr.2016.09.004Urology Case Reports 13 (2017) 69 e71,Non-OADS,/arxiv_data1/oa_pdf/ee/7a/main.PMC5408152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/2f/main.PMC5408153.pdf
http://dx.doi.org/10.1016/j.tranon.2017.01.015,OADS,/arxiv_data1/oa_pdf/20/2f/main.PMC5408153.pdf
"Given the strong association between the generation of MPO oxidants in vivo and the development ofinﬂammatory disease, there is signi ﬁcant interest in developing novel scavengers and / or inhibitors, which may be of therapeutic bene ﬁt http://dx.doi.org/10.1016/j.redox.2017.04.023 Received 23 March 2017; Received in revised form 15 April 2017; Accepted 17 April 2017⁎Corresponding author at: Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Blegdamsvej 3, Copenhagen N 2200, Denmark.",Non-OADS,/arxiv_data1/oa_pdf/e8/f6/main.PMC5408155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/f6/main.PMC5408155.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.04.023 .,OADS,/arxiv_data1/oa_pdf/e8/f6/main.PMC5408155.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2017.04.001 2352-2895/ ©2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/f2/ce/main.PMC5408156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 7 (2017) 57 e67,Non-OADS,/arxiv_data1/oa_pdf/f2/ce/main.PMC5408156.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/0e/main.PMC5408158.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.015Urology Case Reports 13 (2017) 101 e103,Non-OADS,/arxiv_data1/oa_pdf/ec/0e/main.PMC5408158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/b7/main.PMC5408467.pdf
E-mail address: daniela.moga@uky.edu http://dx.doi.org/10.1016/j.trci.2017.01.003 2352-8737/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/b7/main.PMC5408467.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/b7/main.PMC5408467.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.trci.2017.01.003 .,OADS,/arxiv_data1/oa_pdf/19/b7/main.PMC5408467.pdf
"[http://dx.doi.org/10.1001/2012.jama.11153 ] [PMID: 23011713 ] [2] Della Valle C, Parvizi J, Bauer TW, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.5435/00124635-201012000-00006 ] [PMID: 21119142 ] [3] Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.E.01149 ] [PMID: 16595481 ] [4] Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1080/17453670710015229 ] [PMID: 18622836 ] [5] Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2012.02.022 ] [PMID: 22554729 ] [6] Helwig P, Morlock J, Oberst M, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1007/s00264-013-2265-y ] [PMID: 24390010 ] [7] Darouiche RO.,Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1056/NEJMra035415 ] [PMID: 15070792 ] [8] Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2010.04.011 ] [PMID: 20570103 ] [9] Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/520731 ] [PMID: 17932825 ] [10] Parvizi J, Adeli B, Zmistowski B, Restrepo C, Greenwald AS.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.K.01417 ] [PMID: 22810411 ] [11] Parvizi J, Erkocak OF, Della Valle CJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.L.01793 ] [PMID: 24599206 ] [12] Bjerke-Kroll BT, Christ AB, McLawhorn AS, Sculco PK, Jules-Elysée KM, Sculco TP.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2013.09.053 ] [PMID: 24199997 ] [13] Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.H.00155 ] [PMID: 19122087 ] [14] Bozic KJ, Kurtz SM, Lau E, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-009-0945-0 ] [PMID: 19554385 ] [15] Parvizi J, Ghanem E, Azzam K, Davis E, Jaberi F, Hozack W. Periprosthetic infection: are current treatment strategies adequate?",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1055/s-0033-1364102 ] [PMID: 24414388 ] [17] Bozic KJ, Lau E, Kurtz S, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.K.00072 ] [PMID: 22552668 ] [18] Bozic KJ, Lau E, Kurtz S, Ong K, Berry DJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-011-2043-3 ] [PMID: 21874391 ] [19] Zhu Y, Zhang F, Chen W, Liu S, Zhang Q, Zhang Y.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.jhin.2014.10.008 ] [PMID: 25575769 ] [20] Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-008-0209-4 ] [PMID: 18421542 ] [22] Lieberman JR, Fuchs MD, Haas SB, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/S0883-5403(05)80126-3 ] [PMID: 7798100 ] [23] Ritter MA, Fechtman RW.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-010-1411-8 ] [PMID: 20544319 ] [25] Aggarwal VK, Tischler EH, Lautenbach C, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1002/jor.22547 ] [PMID: 24464892 ] [26] Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, Parvizi J.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.J.01046 ] [PMID: 21123590 ] [27] Marculescu CE, Berbari EF, Cockerill FR III, Osmon DR. Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/01.blo.0000229337.21653.f2 ] [PMID: 16906078 ] [28] DeLeo  FR,  Otto  M,  Kreiswirth  BN,  Chambers  HF.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/S0140-6736(09)61999-1 ] [PMID: 20206987 ] [29] Goyal N, Miller A, Tripathi M, Parvizi J. Methicillin-resistant Staphylococcus aureus  (MRSA): colonisation and pre-operative screening.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1302/0301-620X.95B1.27973 ] [PMID: 23307666 ] [30] Chambers HF.,Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.3201/eid0908.030089 ] [PMID: 12967497 ] [33] Kocsis E, Kristof K, Hermann P, Rozgonyi F. A comparative review on the pathogenicity and virulence factors of methicillin resistant and methicillin susceptible Staphylococcus aureus .",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/MRM.0b013e3283393cd4 ] [34] Diekema DJ, Richter SS, Heilmann KP, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/675283 ] [PMID: 24521595 ] [35] Cui L, Isii T, Fukuda M, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1128/AAC.00437-10 ] [PMID: 20837752 ] [36] Morales G, Picazo JJ, Baos E, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/650574 ] [PMID: 20144045 ] [37] Tornero E, Senneville E, Euba G, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1111/1469-0691.12721 ] [PMID: 24943469 ] [38] Rasouli MR, Tripathi MS, Kenyon R, Wetters N, Della Valle CJ, Parvizi J.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-012-2374-8 ] [PMID: 22552769 ] [39] Reynolds PE, Courvalin P. Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1128/AAC.49.1.21-25.2005 ] [PMID: 15616270 ] [40] Billot-Klein D, Blanot D, Gutmann L, van Heijenoort J.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1042/bj3041021 ] [PMID: 7818465 ] [41] Krzyściak W, Pluskwa KK, Jurczak A, Kościelniak D. The pathogenicity of the Streptococcus genus.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s10096-013-1914-9 ] [PMID: 24141975 ] [42] Apsingi S, Kulkarni A, Gould KF, McCaskie AW.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s00167-006-0208-5 ] [PMID: 17072656 ] [43] Zmistowski B, Fedorka CJ, Sheehan E, Deirmengian G, Austin MS, Parvizi J. Prosthetic joint infection caused by gram-negative organisms.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2011.03.044 ] [PMID: 21641762 ] [44] Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Osmon DR. Prosthetic joint infection due to Mycobacterium tuberculosis : a case series and review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.3109/00365548.2013.830192 ] [PMID: 24047227 ] [46] Shanbhag V, Kotwal R, Gaitonde A, Singhal K. Total hip replacement infected with Mycobacterium tuberculosis .",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.I.00574 ] [PMID: 19884422 ] [48] OShaughnessy EM, Shea YM, Witebsky FG.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1016/S0891-5520(02)00069-7 ] [PMID: 12751264 ],OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1128/IAI.70.2.878-888.2002 ] [PMID: 11796623 ] [50] Gebauer M, Frommelt L, Achan P, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2013.09.049 ] [PMID: 24360494 ] [51] Kuiper JW, van den Bekerom MP, van der Stappen J, Nolte PA, Colen S. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.3109/17453674.2013.859422 ] [PMID: 24171675 ] [52] Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.M.01316 ] [PMID: 25187582 ] [53] Berbari EF, Marculescu C, Sia I, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/522184 ] [PMID: 17918072 ] [54] Trampuz A, Piper KE, Jacobson MJ, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1056/NEJMoa061588 ] [PMID: 17699815 ] [55] Burnett RS, Kelly MA, Hanssen AD, Barrack RL.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.9314ebo ] [PMID: 21792503 ] [57] Barrack RL, Jennings RW, Wolfe MW, Bertot AJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-010-1245-4 ] [PMID: 20131022 ] [59] Font-Vizcarra L, García S, Martínez-Pastor JC, Sierra JM, Soriano A.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-010-1254-3 ] [PMID: 20162386 ] [60] Shanbhag V, Kotwal R, Gaitonde A, Singhal K. Total hip replacement infected with Mycobacterium tuberculosis .",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s00402-007-0454-0 ] [PMID: 17874243 ] [62] Parvizi J, Ghanem E, Sharkey P, Aggarwal A, Burnett RS, Barrack RL.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-008-0471-5 ] [PMID: 18781372 ] [63] Zmistowski B, Della Valle C, Bauer TW, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1016/j.arth.2013.09.040 ] [PMID: 24342275 ] [64] New definition for periprosthetic joint infection.,Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2011.09.026 ] [PMID: 22075161 ] [65] Tigges S, Stiles RG, Roberson JR.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2214/ajr.163.2.8037035 ] [PMID: 8037035 ] [66] Love C, Marwin SE, Palestro CJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1053/j.semnuclmed.2008.08.007 ] [PMID: 19038601 ] [67] Hayter CL, Koff MF, Potter HG.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1002/jmri.23523 ] [PMID: 22499278 ] [68] Zywiel MG, Stroh DA, Johnson AJ, Marker DR, Mont MA.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.ijid.2011.05.015 ] [PMID: 21764346 ] [69] Toossi N, Adeli B, Rasouli MR, Huang R, Parvizi J. Serum white blood cell count and differential do not have a role in the diagnosis of periprosthetic joint infection.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1016/j.arth.2012.03.021 ] [PMID: 22608690 ],OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.ijid.2009.02.017 ] [PMID: 19473865 ] [71] Ghanem E, Parvizi J, Burnett RS, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.G.00470 ] [PMID: 18676892 ] [72] Bedair H, Ting N, Jacovides C, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-010-1433-2 ] [PMID: 20585914 ] [73] Yi PH, Cross MB, Moric M, Sporer SM, Berger RA, Della Valle CJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-013-3089-1 ] [PMID: 23884798 ] [74] Ostrosky-Zeichner L, Alexander BD, Kett DH, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/432470 ] [PMID: 16080087 ] [75] Tsaras G, Maduka-Ezeh A, Inwards CY, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.J.00756 ] [PMID: 22992880 ] [76] Atkins BL, Athanasou N, Deeks JJ, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/S0891-5520(03)00049-7 ] [PMID: 11917810 ] [78] Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/592973 ] [PMID: 18937579 ] [79] Tokarski AT, ONeil J, Deirmengian CA, Ferguson J, Deirmengian GK.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-013-2917-7 ] [PMID: 23504537 ] [80] Gollwitzer H, Dombrowski Y, Prodinger PM, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.L.00205 ] [PMID: 23553300 ] [81] Wetters NG, Berend KR, Lombardi AV, Morris MJ, Tucker TL, Della Valle CJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2012.03.037 ] [PMID: 22608686 ] [82] Deirmengian C, Kardos K, Kilmartin P, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-014-3722-7 ] [PMID: 24942960 ] [83] Chalifour A, Jeannin P, Gauchat JF, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1182/blood-2003-08-2820 ] [PMID: 15166032 ] [84] Deirmengian C, Kardos K, Kilmartin P, Gulati S, Citrano P, Booth RE Jr.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-015-4152-x ] [PMID: 25631170 ] [85] Moojen DJ, Spijkers SN, Schot CS, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.F.00822 ] [PMID: 17545434 ] [86] Bergin PF, Doppelt JD, Hamilton WG, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.I.00400 ] [PMID: 20194324 ] [87] Tarkin IS, Henry TJ, Fey PI, Iwen PC, Hinrichs SH, Garvin KL.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/01.blo.0000087323.60612.5d ] [PMID: 12966281 ] [88] Jacovides CL, Kreft R, Adeli B, Hozack B, Ehrlich GD, Parvizi J.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.2106/JBJS.L.00210 ] [PMID: 23318615 ],OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.M.01133 ] [PMID: 25187588 ] [91] Goyal N, Miller A, Tripathi M, Parvizi J. Methicillin-resistant Staphylococcus aureus  (MRSA): colonisation and pre-operative screening.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1302/0301-620X.95B1.27973 ] [PMID: 23307666 ] [92] Gallo J, Holinka M, Moucha CS.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.3390/ijms150813849 ] [PMID: 25116685 ] [93] Senthi S, Munro JT, Pitto RP.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s00264-010-1144-z ] [PMID: 21085957 ] [94] Parvizi J, Zmistowski B, Adeli B. Periprosthetic joint infection: treatment options.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1302/0301-620X.93B1.25120 ] [PMID: 21196538 ] [96] Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-009-0857-z ] [PMID: 19408061 ] [97] Salgado CD, Dash S, Cantey JR, Marculescu CE.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/00003086-200211000-00021 ] [PMID: 12439249 ] [99] Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-010-1725-6 ] [PMID: 21161741 ] [100] Lim  SJ,  Park  JC,  Moon  YW,  Park  YS.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2009.05.012 ] [PMID: 19523784 ] [101] Volin SJ, Hinrichs SH, Garvin KL.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/01.blo.0000143559.34143.3d ] [PMID: 15552143 ] [102] Murray TG, Cochran J, Klika AK, Krebs VE, Barsoum WK.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/BCO.0b013e31820f7730 ] [103] Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.E.01192 ] [PMID: 17545425 ] [104] Shaikh AA, Ha CW, Park YG, Park YB.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-014-3545-6 ] [PMID: 24599649 ] [105] Voleti PB, Baldwin KD, Lee GC.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.2106/JBJS.L.01461 ] [PMID: 24005200 ] [106] Westrich GH, Walcott-Sapp S, Bornstein LJ, Bostrom MP, Windsor RE, Brause BD.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"J Arthroplasty 2010; 25(7): 1015-21,1021.e1-2.2010; [http://dx.doi.org/10.2106/JBJS.L.01461 ] [PMID: 24005200 ] [107] Gehrke T, Kendoff D. Peri-prosthetic hip infections: in favour of one-stage.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.5301/HIP.2012.9569 ] [PMID: 22956386 ] [108] Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1302/0301-620X.90B12.20742 ] [PMID: 19043128 ] [109] Koyonos L, Zmistowski B, Della Valle CJ, Parvizi J.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1007/s11999-011-1910-2 ] [PMID: 21553171 ],Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2011.03.031 ] [PMID: 21621955 ] [111] Marculescu CE, Berbari EF, Hanssen AD, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/499234 ] [PMID: 16421790 ] [112] Azzam KA, Seeley M, Ghanem E, Austin MS, Purtill JJ, Parvizi J. Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2010.01.104 ] [PMID: 20378306 ] [113] Vilchez F, Martínez-Pastor JC, García-Ramiro S, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.5301/ijao.5000029 ] [PMID: 22094567 ] [114] Hansen E, Tetreault M, Zmistowski B, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-013-3079-3 ] [PMID: 23775569 ] [115] Bori G, Muñoz-Mahamud E, Cuñé J, Gallart X, Fuster D, Soriano A. One-stage revision arthroplasty using cementless stem for infected hip arthroplasties.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2013.11.005 ] [PMID: 24332970 ] [116] Choi HR, Kwon YM, Freiberg AA, Malchau H. Comparison of one-stage revision with antibiotic cement versus  two-stage revision results for infected total hip arthroplasty.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2013.02.037 ] [PMID: 23972299 ] [117] Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s00264-008-0640-x ] [PMID: 18704412 ] [118] Walls RJ, Roche SJ, ORourke A, McCabe JP.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1302/0301-620X.90B3.20155 ] [PMID: 18310748 ] [119] Bradbury T, Fehring TK, Taunton M, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2009.04.028 ] [PMID: 19553077 ] [120] Parvizi J, Gehrke T, Chen AF.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1302/0301-620X.95B11.33135 ] [PMID: 24151261 ] [121] Burnett RS, Aggarwal A, Givens SA, McClure JT, Morgan PM, Barrack RL.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-009-1014-4 ] [PMID: 19669849 ] [122] Restrepo C, Schmitt S, Backstein D, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1016/j.arth.2013.09.047 ] [PMID: 24360490 ] [123] Windsor RE, Insall JN, Urs WK, Miller DV, Brause BD.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s00264-014-2510-z ] [PMID: 25183296 ] [125] El Helou OC, Berbari EF, Marculescu CE, et al.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1086/591536 ] [PMID: 18754743 ] [126] Ries MD.,OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1054/arth.2001.24951 ] [PMID: 11547381 ] [127] Hsieh  PH,  Lee  MS,  Hsu  KY,  Chang  YH,  Shih  HN,  Ueng  SW.  Gram-negative  prosthetic  joint  infections:  risk  factors  and  outcome  of treatment.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1086/605593 ] [PMID: 19691430 ] [128] Blumberg HM, Burman WJ, Chaisson RE, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1164/rccm.167.4.603 ] [PMID: 12588714 ] [129] Silverberg D, Kodali P, Dipersio J, Acus R, Askew M. In vitro  analysis of antifungal impregnated polymethylmethacrylate bone cement.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1097/00003086-200210000-00033 ] [PMID: 12360031 ] [130] Cunningham B, McLaren AC, Pauken C, McLemore R. Liposomal formulation increases local delivery of amphotericin from bone cement: a pilot study.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-012-2317-4 ] [PMID: 22467417 ] [131] Miller RB, McLaren AC, Pauken C, Clarke HD, McLemore R. Voriconazole is delivered from antifungal-loaded bone cement.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"[http://dx.doi.org/10.1007/s11999-012-2463-8 ] [PMID: 22782573 ] [132] Pappas PG, Kauffman CA, Andes D, et al.",OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
[http://dx.doi.org/10.1086/596757 ] [PMID: 19191635 ] © McLawhorn et al.,Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/76/TOORTHJ-10-615.PMC5408484.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/main.PMC5408500.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.03.025 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/2e/c4/main.PMC5408500.pdf
"However, within this http://dx.doi.org/10.1016/j.ymgmr.2017.04.005 Received 5 March 2017; Received in revised form 13 April 2017; Accepted 13 April 2017⁎Correspondence to: Serviço de Genética Médica, HCPA, Rua Ramiro Barcelos, 2350, 90.035-003 Porto Alegre, RS, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/bd/08/main.PMC5408501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/08/main.PMC5408501.pdf
"[51] The Human Gene Mutation Database, http://www.hgmd.cf.ac.uk/ac/gene.",Non-OADS,/arxiv_data1/oa_pdf/bd/08/main.PMC5408501.pdf
"DBS samples from the DNSB have previously been used in genetic studies aiming at elucidating genetic factors of various clinical http://dx.doi.org/10.1016/j.ymgmr.2017.04.002 Received 9 December 2016; Received in revised form 2 April 2017; Accepted 2 April 2017⁎Corresponding author at: Danish Center for Neonatal Screening, Department of Congenital Diseases, Statens Serum Institut, Artillerivej 5, DK-2300, Copenhagen S, Denmark.",OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"107 (2012) 281 –293, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"29 (2014) 541 –549, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"45 (2013) 76 –82, http://dx.doi.org/10.1038/ng.2477 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"46 (2014) 51 –55,http://dx.doi.org/10.1038/ng.2830 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"Psychiatry 19 (2014) 325 –333, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"Psychiatry 19 (2014) 108 –114, http://dx.doi.org/ 10.1038/mp.2012.157 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"42 (2005) e60, , http://dx.doi.org/10.1136/jmg.2005.032987 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"Acta 402 (2009) 107 –113, http://dx.doi.org/10.1016/j.cca.2008.12.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"59 (2013)1045 –1051, http://dx.doi.org/10.1373/clinchem.2012.198945 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"12 (2011) 58, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"37 (2009) 450 –453, http://dx.doi.org/10.1042/BST0370450 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"36 (2008) e80, , http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"[15] T. Han, C.-W. Chang, J.C. Kwekel, Y. Chen, Y. Ge, F. Martinez-Murillo, D. Roscoe, Z. Te žak, R. Philip, K. Bijwaard, J.C. Fuscoe, Characterization of whole genome ampliﬁ ed (WGA) DNA for use in genotyping assay development, BMC Genomics 13 (2012) 217, http://dx.doi.org/10.1186/1471-2164-13-217 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"Rep. 5 (2015) 11415, http://dx.doi.org/10.1038/srep11415 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"81 (2007) 559 –575, http://dx.doi.org/10.1086/519795 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"16 (2006) 1136 –1148, http://dx.doi.org/ 10.1101/gr.5402306 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"89 (2011) 807 –815, http://dx.doi.org/10.1007/ s00253-010-2926-3 .",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"Hougaard, Genome-wide scans using archived neonatal dried blood spotsamples, BMC Genomics 10 (2009) 297, http://dx.doi.org/10.1186/1471-2164-10- 297.",OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"17 (2008) 1781 –1789, http://dx.doi.org/ 10.1158/1055-9965.EPI-07-2849 .M.",Non-OADS,/arxiv_data1/oa_pdf/67/cd/main.PMC5408502.pdf
"creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/2b/cd/10.1177_2055217317704450.PMC5408503.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: C ChavesClaudia Chaves, Neurology Department, Lahey Clinic, 16 Hayden Avenue, Lexington, MA, USA.",Non-OADS,/arxiv_data1/oa_pdf/41/c8/10.1177_2055217317702933.PMC5408504.pdf
"creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/41/c8/10.1177_2055217317702933.PMC5408504.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Jacopo Perugini Neuroimmunology and Neuromuscular DiseasesUnit, IRCCS Fondazione Istituto Neurologico Carlo Besta, via Celoria 11, 20133 Milan, Italy.",Non-OADS,/arxiv_data1/oa_pdf/86/26/10.1177_2055217317701317.PMC5408506.pdf
"creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/86/26/10.1177_2055217317701317.PMC5408506.pdf
The top  websites in cardiac anaesthesia includes SCA ‑  Society  of Cardiovascular Anesthesiologists (https://www.scahq.,Non-OADS,/arxiv_data1/oa_pdf/a1/0f/ACA-20-125.PMC5408512.pdf
"Kapoor: Online virtual world and cardiac anaesthesiologist126 Annals of Cardiac Anaesthesia  |  Volume 20  |  Issue 2  |  April-June 2017anesthesiology – Wikipedia (https://en.wikipedia.org/ wiki/ Cardiothoracic anesthesiology), pie.med.utoronto.ca/CA.",Non-OADS,/arxiv_data1/oa_pdf/a1/0f/ACA-20-125.PMC5408512.pdf
jcvaonline.com) Cardiac Anaesthesia at Amazon (www.amazon.in/books‎) Cardiothoracic anesthesiology – Wikipedia (https://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/a1/0f/ACA-20-125.PMC5408512.pdf
Available from: http://www.homepages.cwi.,Non-OADS,/arxiv_data1/oa_pdf/c5/83/ACA-20-135.PMC5408515.pdf
Available from: https://www.advisory.com/research/cardiovascular ‑ roundtable/cardiovascular‑rounds/2014/07/what ‑ can ‑ you ‑ learn ‑ from‑fy‑2013‑tavr‑data.,Non-OADS,/arxiv_data1/oa_pdf/5a/6f/ACA-20-145.PMC5408517.pdf
Available from:  http://www.hcup‑us.ahrq.gov/ nisoverview.jsp.,OADS,/arxiv_data1/oa_pdf/5a/6f/ACA-20-145.PMC5408517.pdf
Available from: http://www.emedicine.medscape.com/ article/1839677.,Non-OADS,/arxiv_data1/oa_pdf/7d/a3/ACA-20-163.PMC5408520.pdf
J Vasc Bras 2010;9:196 ‑ 9. https://dx.doi.org/10.1590/ S1677 ‑ 54492010000300019.,Non-OADS,/arxiv_data1/oa_pdf/33/91/ACA-20-268.PMC5408542.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.04.005 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1111/j.1469-8749.,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1080/1750984X.2015.1068829 .,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1038/sj.ijo.,OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1542/peds.2011-2898 .,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1177/0363546515614585 .,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1097/00042752-199207000-00007 .,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1249/JSR.,OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
http://dx.doi.org/10.1001/jama.2009.2012 .,Non-OADS,/arxiv_data1/oa_pdf/17/99/main.PMC5408554.pdf
"Available at http://www.cambridgecognition.com/tests/choice-reaction-time-crt [22] Atkinson G., Nevill A.M.: ‘Statistical methods for assessing measure- ment error (reliability) in variables relevant to sports medicine ’, Sports Med.",Non-OADS,/arxiv_data1/oa_pdf/d4/92/HTL.2016.0106.PMC5408555.pdf
"MeSH Keywords:  Anemia, Hemolytic • Ceftriaxone • Jehovah’s Witnesses  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903507Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GGraduate Medical Education, Arnot Ogden Medical Center, Elmira, NY, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 431-435 DOI: 10.12659/AJCR.903507 431 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/32/fd/amjcaserep-18-431.PMC5408558.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Kevin K McCully University of Georgia, Department of Kinesiology,Ramsey Center, 330 River Rd., Athens, GA 30602- 6554, USA mccully@uga.edu Mary Ann Harp, Kevin K McCully Department of Kinesiology, University of Georgia, USA Marina Moldavskiy, Deborah Backus Shepherd Center, USA Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www .creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/f9/dc/10.1177_2055217316678020.PMC5408569.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Andrew Lee Biogen, 225 Binney Street, Cambridge, MA 02142,USA.",Non-OADS,/arxiv_data1/oa_pdf/fe/4a/10.1177_2055217316634111.PMC5408570.pdf
"Available at: http://main.nationalmssociety.org/docs/HOM/MSFC_Manual_ and_Forms.pdf (10 January 2001, accessed 6 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/fe/4a/10.1177_2055217316634111.PMC5408570.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55019 | Page 1 of 7Video Article SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry Jakob V. Larsen1, Claus M. Petersen1 1Department of Biomedicine, Aarhus University Correspondence to: Jakob V. Larsen at jvl@biomed.au.dk , Claus M. Petersen at cmp@biomed.au.dk URL: https://www.jove.com/video/55019 DOI: doi:10.3791/55019 Keywords: Biochemistry, Issue 119, CLC:CLF-1, NNT-1, BSF-3, CRLF1, CNTFRα, sorLA, Vps10p, STAT3 Date Published: 1/6/2017 Citation: Larsen, J.V., Petersen, C.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/c5/jove-119-55019.PMC5408589.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55019/ Introduction The CLC and CLF-1 constitute the two subunits of the heterodimeric cytokine CLC:CLF-11-3.,Non-OADS,/arxiv_data1/oa_pdf/a7/c5/jove-119-55019.PMC5408589.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55010 | Page 1 of 6Video Article Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation Ruiye Bi1,2, Yi Fan2,3, En Luo2,4, Quan Yuan2,4, Michael Mannstadt1 1Endocrine Unit, Massachusetts General Hospital, Harvard Medical School 2West China School of Stomatology, Sichuan University 3Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine 4State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University Correspondence to: Michael Mannstadt at mannstadt@mgh.harvard.edu URL: https://www.jove.com/video/55010 DOI: doi:10.3791/55010 Keywords: Medicine, Issue 121, hypoparathyroidism, parathyroidectomy, parathyroid glands, GFP, diphtheria toxin, animal model Date Published: 3/14/2017 Citation: Bi, R., Fan, Y., Luo, E., Yuan, Q., Mannstadt, M. Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation.",Non-OADS,/arxiv_data1/oa_pdf/cf/38/jove-121-55010.PMC5408591.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55010/ Introduction Since the first systematic description of the parathyroid glands in human and in several other species by Sandström in 1880 1, understanding the significance of this small endocrine organ for human physiology and disease has continuously improved.",OADS,/arxiv_data1/oa_pdf/cf/38/jove-121-55010.PMC5408591.pdf
<http://www.criver.com/products-services/basic-research/rodent-surgery/soft-tissue-procedures> (1996).,Non-OADS,/arxiv_data1/oa_pdf/cf/38/jove-121-55010.PMC5408591.pdf
"MeSH Keywords:  Abortion, Spontaneous • Factor XIII Deficiency • Pregnancy Complications, Hematologic  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/901502Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Internal Medicine, The Moncton Hospital, Moncton, NB,  CanadaISSN 1941-5923 © Am J Case Rep, 2017; 18: 436-439 DOI: 10.12659/AJCR.901502 436 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/73/26/amjcaserep-18-436.PMC5408647.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55039 | Page 1 of 7Video Article Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis Tik Nga Tong1, Donald R. Branch1,2 1Department of Laboratory Medicine and Pathobiology, University of Toronto 2Centre for Innovation, Canadian Blood Services Correspondence to: Donald R. Branch at don.branch@utoronto.ca URL: https://www.jove.com/video/55039 DOI: doi:10.3791/55039 Keywords: Immunology, Issue 119, phagocytosis, monocyte, macrophage, Fc receptors, antibodies, opsonization, in vitro Date Published: 1/2/2017 Citation: Tong, T.N., Branch, D.R.",Non-OADS,/arxiv_data1/oa_pdf/25/1e/jove-119-55039.PMC5408648.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55039/ Introduction The monocyte monolayer assay (MMA) is an in vitro assay originally developed to better predict blood transfusion outcomes in patients with auto- or alloantibodies to red blood cells (RBCs)1-5.,Non-OADS,/arxiv_data1/oa_pdf/25/1e/jove-119-55039.PMC5408648.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55054 | Page 1 of 11Video Article Dissection of the Auditory Bulla in Postnatal Mice: Isolation of the Middle Ear Bones and Histological Analysis Ayako Sakamoto1, Yukiko Kuroda1, Sho Kanzaki2, Koichi Matsuo1 1Laboratory of Cell and Tissue Biology, Keio University School of Medicine 2Department of Otolaryngology Head and Neck Surgery, Keio University School of Medicine Correspondence to: Koichi Matsuo at kmatsuo@keio.jp URL: https://www.jove.com/video/55054 DOI: doi:10.3791/55054 Keywords: Anatomy, Issue 119, auditory ossicles, middle ear, inner ear, malleus, incus, stapes, tympanic bulla, tympanic membrane, tensor tympani, otic capsule, cochlea, stapedial artery Date Published: 1/4/2017 Citation: Sakamoto, A., Kuroda, Y., Kanzaki, S., Matsuo, K. Dissection of the Auditory Bulla in Postnatal Mice: Isolation of the Middle Ear Bones and Histological Analysis.",Non-OADS,/arxiv_data1/oa_pdf/59/39/jove-119-55054.PMC5408703.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55054/ Introduction The three auditory ossicles of the middle ear, namely the malleus, incus, and stapes, form a mammalian-specific auditory chain that transmits sound from the tympanic membrane to the inner ear, or cochlea 1,2.",Non-OADS,/arxiv_data1/oa_pdf/59/39/jove-119-55054.PMC5408703.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55057 | Page 1 of 7Video Article Isolation and Characterization of Microvesicles from Peripheral Blood Kerstin Menck1, Annalen Bleckmann1, Matthias Schulz1, Lena Ries1, Claudia Binder1 1Department of Hematology/Medical Oncology, University Medical Center Göttingen Correspondence to: Kerstin Menck at kerstin.menck@inserm.fr URL: https://www.jove.com/video/55057 DOI: doi:10.3791/55057 Keywords: Cellular Biology, Issue 119, extracellular vesicles, microvesicles, blood, flow cytometry, biomarkers, liquid biopsy, cancer Date Published: 1/6/2017 Citation: Menck, K., Bleckmann, A., Schulz, M., Ries, L., Binder, C. Isolation and Characterization of Microvesicles from Peripheral Blood.",Non-OADS,/arxiv_data1/oa_pdf/9c/68/jove-119-55057.PMC5408706.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55057/ Introduction In the last years many in vitro  studies have demonstrated that extracellular vesicles (EVs) play an important role in intercellular communication.,Non-OADS,/arxiv_data1/oa_pdf/9c/68/jove-119-55057.PMC5408706.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e55084 | Page 1 of 8Video Article Influence of Hybrid Perovskite Fabrication Methods on Film Formation, Electronic Structure, and Solar Cell Performance Tobias Schnier1, Jennifer Emara1, Selina Olthof1, Klaus Meerholz1 1Department of Chemistry, University of Cologne Correspondence to: Klaus Meerholz at klaus.meerholz@uni-koeln.de URL: https://www.jove.com/video/55084 DOI: doi:10.3791/55084 Keywords: Chemistry, Issue 120, perovskite, fabrication method, photoelectron spectroscopy, X-ray diffraction, solar cell Date Published: 2/27/2017 Citation: Schnier, T., Emara, J., Olthof, S., Meerholz, K. Influence of Hybrid Perovskite Fabrication Methods on Film Formation, Electronic Structure, and Solar Cell Performance.",Non-OADS,/arxiv_data1/oa_pdf/e4/e1/jove-120-55084.PMC5408710.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55084/ Introduction Thin film photovoltaic technologies have attracted a significant attention in the research of solar cell applications due to their low material consumption and applicability on flexible substrates.,Non-OADS,/arxiv_data1/oa_pdf/e4/e1/jove-120-55084.PMC5408710.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55068 | Page 1 of 14Video Article A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae , H. influenzae , K. pneumoniae , P. aeruginosa  or A. baumannii Jennifer L. Hoover1, Thomas F. Lewandowski1, Cindy L. Mininger1, Christine M. Singley1, Scott Sucoloski1, Stephen Rittenhouse1 1Antibacterial Discovery Performance Unit, GlaxoSmithKline Correspondence to: Jennifer L. Hoover at Jennifer.L.Hoover@gsk.com URL: https://www.jove.com/video/55068 DOI: doi:10.3791/55068 Keywords: Infection, Issue 119, in vivo , pneumonia, lung, infection, model, mouse, rat, bacteria, microbiology, efficacy, drug, discovery Date Published: 1/2/2017 Citation: Hoover, J.L., Lewandowski, T.F., Mininger, C.L., Singley, C.M., Sucoloski, S., Rittenhouse, S. A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae , H. influenzae , K. pneumoniae , P. aeruginosa or A. baumannii .",Non-OADS,/arxiv_data1/oa_pdf/3d/30/jove-119-55068.PMC5408714.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55068/ Introduction Evaluating the efficacy of potential drug candidates in animal models of infection is a critical component of the antibacterial drug discovery process.,Non-OADS,/arxiv_data1/oa_pdf/3d/30/jove-119-55068.PMC5408714.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Mickael Bonnan Service de Neurologie, Centre Hospitalier de Pau, 4Bd Hauterive, 64000 Pau, France mickael_bonnan@yahoo.fr Philippe Cabre Service de neuologie, Hoˆpital Zobda Quitman, Fort-de-France, French West Indies Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www .creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/95/fe/10.1177_2055217315622794.PMC5408720.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Francois H Jacques Clinique Neuro-Outaouais, 147 boul.",Non-OADS,/arxiv_data1/oa_pdf/c4/4f/10.1177_2055217316657116.PMC5408753.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: K van der Hiele Leiden University, Institute of Psychology, Health,Medical and Neuropsychology Unit, PO Box 9555, Leiden 2300 RB, the Netherlands hiele@fsw.leidenuniv.nl K van der Hiele, National Multiple Sclerosis Foundation, the NetherlandsLeiden University, Institute of Psychology, Health, Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www .creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/f3/7b/10.1177_2055217316680638.PMC5408754.pdf
"Oxford: Oxford University Press, 2011.29. http://overhetnieuwewerken.nl (accessed 28 June 2016).",Non-OADS,/arxiv_data1/oa_pdf/f3/7b/10.1177_2055217316680638.PMC5408754.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Juan Ignacio Rojas MS Section, Italian Hospital of Buenos Aires, Gasco ´n 450 C1181ACH, Buenos Aires, Argentina.",Non-OADS,/arxiv_data1/oa_pdf/46/f6/10.1177_2055217315600193.PMC5408755.pdf
A program is availablefor download from http://www-gene.cimr.cam.ac.uk/ MSgenetics/GAMES/MSSS that calculates Global and Local MSSS values.,Non-OADS,/arxiv_data1/oa_pdf/46/f6/10.1177_2055217315600193.PMC5408755.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/main.PMC5408758.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/ed/main.PMC5408758.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.011Urology Case Reports 12 (2017) 34 e36,Non-OADS,/arxiv_data1/oa_pdf/34/ed/main.PMC5408758.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55141 | Page 1 of 6Video Article In Vitro Differentiation of Mature Myofibers for Live Imaging Mafalda R. Pimentel1, Sestina Falcone2, Bruno Cadot2, Edgar R. Gomes1,2 1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa 2Myology Research Center, UM76-INSERM U974-CNRS FRE 361, Sorbonne University, UPMC University of Paris 6 Correspondence to: Edgar R. Gomes at edgargomes@medicina.ulisboa.pt URL: https://www.jove.com/video/55141 DOI: doi:10.3791/55141 Keywords: Developmental Biology, Issue 119, muscle, myofiber, differentiation, in vitro , microscopy, development Date Published: 1/7/2017 Citation: Pimentel, M.R., Falcone, S., Cadot, B., Gomes, E.R.",Non-OADS,/arxiv_data1/oa_pdf/c9/5b/jove-119-55141.PMC5408763.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55141/ Introduction Skeletal muscle composes up to 40% of the human body weight1.,Non-OADS,/arxiv_data1/oa_pdf/c9/5b/jove-119-55141.PMC5408763.pdf
"72 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/87/btw550.PMC5408770.pdf
Source code and installation instructions are available at http://opensource.nibr.com.,OADS,/arxiv_data1/oa_pdf/88/d2/btw579.PMC5408772.pdf
"Other tools such as Karma ( Szekely et al., 2014 ) are designed specifically for mapping/alignment and address the initialintegration problem (see here for a review of useful tools: http://www.mkbergman.com/1769/50-ontology-mapping-and-alignment-tools/).However, none of the tools are designed to be part of an ecosystemfacilitating continuous data integration.",Non-OADS,/arxiv_data1/oa_pdf/88/d2/btw579.PMC5408772.pdf
"148 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/d2/btw579.PMC5408772.pdf
Availability and Implementation: Verdant is available at: http://verdant.iplantcollaborative.org/ plastidDB/.,OADS,/arxiv_data1/oa_pdf/67/46/btw583.PMC5408774.pdf
"130 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/46/btw583.PMC5408774.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55168 | Page 1 of 10Video Article Isolation of Mouse Endometrial Epithelial and Stromal Cells for In Vitro Decidualization Katrien De Clercq*1, Aurélie Hennes*1, Joris Vriens1 1Department of Development and Regeneration, Katholieke Universiteit Leuven (KU Leuven) *These authors contributed equally Correspondence to: Joris Vriens at joris.vriens@kuleuven.be URL: https://www.jove.com/video/55168 DOI: doi:10.3791/55168 Keywords: Developmental Biology, Issue 121, primary endometrial mouse cultures, mouse endometrial stromal cells, mouse endometrial epithelial cells, in vitro decidualization, estrogen treatment, coculture Date Published: 3/2/2017 Citation: De Clercq, K., Hennes, A., Vriens, J.",Non-OADS,/arxiv_data1/oa_pdf/66/b0/jove-121-55168.PMC5408775.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55168/ Introduction The human endometrium is the inner lining of the uterus and undergoes monthly cycles of breakdown and repair as a preparation for possible pregnancies.,Non-OADS,/arxiv_data1/oa_pdf/66/b0/jove-121-55168.PMC5408775.pdf
We would like to thank the Cell Imaging Core facility of the KU Leuven (http://gbiomed.kuleuven.be/english/corefacilities/microscopy/cic/cic.htm) for the use of the confocal microscope.,Non-OADS,/arxiv_data1/oa_pdf/66/b0/jove-121-55168.PMC5408775.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55163 | Page 1 of 6Video Article Determining the Chemical Composition of Corrosion Inhibitor/Metal Interfaces with XPS: Minimizing Post Immersion Oxidation Monika S. Walczak1, Perla Morales-Gil1,2, Turia Belashehr1, Kiran Kousar1, Paulina Arellanes Lozada1,3, Robert Lindsay1 1Corrosion and Protection Centre, School of Materials, The University of Manchester 2Laboratorio de Caracterización de Materiales Sintéticos y Naturales, Instituto Mexicano del Petróleo 3Departamento de Metalurgia y Materiales, Instituto Politécnico Nacional Correspondence to: Robert Lindsay at robert.lindsay@manchester.ac.uk URL: https://www.jove.com/video/55163 DOI: doi:10.3791/55163 Keywords: Chemistry, Issue 121, X-ray photoelectron spectroscopy, corrosion inhibition, acidic solution, metallic substrate, oxidation, inert atmosphere Date Published: 3/15/2017 Citation: Walczak, M.S., Morales-Gil, P., Belashehr, T., Kousar, K., Arellanes Lozada, P., Lindsay, R. Determining the Chemical Composition of Corrosion Inhibitor/Metal Interfaces with XPS: Minimizing Post Immersion Oxidation.",Non-OADS,/arxiv_data1/oa_pdf/58/63/jove-121-55163.PMC5408785.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55163/ Introduction Corrosion inhibitors (CIs) are substances that, when introduced into an aggressive environment, reduce the corrosion rate of a metallic material by inducing a change at the solid/liquid interface1,2,3,4,5.",Non-OADS,/arxiv_data1/oa_pdf/58/63/jove-121-55163.PMC5408785.pdf
Availability and Implementation : The code is available at https://github.com/dekoning-lab/wfes Contact: jason.dekoning@ucalgary.ca Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/13/07/btw802.PMC5408789.pdf
"1416 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/07/btw802.PMC5408789.pdf
"1421 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/cc/btw838.PMC5408791.pdf
"334 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/0d/btw629.PMC5408793.pdf
"2.2.4 Building and testing the models To obtain the model parameters in order to accomplish the best separation of promoter from non-promoter sequences, we appliedNeural Network techniques using the VISAN tool (http://www.soft berry.com/berry.phtml?topic ¼fdp.htm&no_menu ¼on).",Non-OADS,/arxiv_data1/oa_pdf/df/0d/btw629.PMC5408793.pdf
Availability and Implementation: http://www.rings.t.soka.ac.jp Contact: kkiyoko@soka.ac.jp Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/6e/89/btw827.PMC5408794.pdf
"1317 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/89/btw827.PMC5408794.pdf
The MCAW tool is available from http://www.rings.t.soka.ac.jp.,OADS,/arxiv_data1/oa_pdf/6e/89/btw827.PMC5408794.pdf
"453 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/btw636.PMC5408796.pdf
is particularly relevant given that popular tools often rely on old knowledgebases (http://dx.doi.org/10.1101/049288).,Non-OADS,/arxiv_data1/oa_pdf/f9/0a/btw636.PMC5408796.pdf
"PI is a scalable and parallelized web application, developed in Python exploiting the Django web framework and the d3 Javascriptlibraries, whereas CytoscapeJS is used for interactive result visualiza-tion (http://js.cytoscape.org).",OADS,/arxiv_data1/oa_pdf/f9/0a/btw636.PMC5408796.pdf
"The backend is based on Celery, a taskqueue/job system distributing the computation on different servers(http://www.celeryproject.org/).",OADS,/arxiv_data1/oa_pdf/f9/0a/btw636.PMC5408796.pdf
KEGG KGMLfiles are downloaded and parsed automatically through the bioservi-ces python libraries (https://pypi.python.org/pypi/bioservices/).,OADS,/arxiv_data1/oa_pdf/f9/0a/btw636.PMC5408796.pdf
Availability and Implementation: EGSEA is available as an R package at http://www.bioconductor.,OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
The gene sets collections are available in the R package EGSEAdata from http://www.bioconductor.org/packages/EGSEAdata/.,OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
"414 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
", 2005 ) v5.0 was downloaded from http://www.broadinstitute.org/ gsea/msigdb (05 July 2015, date last accessed) and the human genesets were extracted for each collection (h, c1, c2, c3, c4, c5, c6, c7).",OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
"Mouse orthologous gene sets of these MSigDB collections were adopted from http://bioinf.wehi.edu.au/software/MSigDB/index.html ( Wu and Smyth, 2012 ).",OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
", 2012 ) http://genesetdb.auckland.ac.nz/sourcedb.html project.",Non-OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
R package version 1.1.10. http://bioconductor.org/packages/ EGSEA.,Non-OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
"R package version 1.1.4. http://bioconductor.org/pack ages/EGSEAdata Anders,S.",Non-OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
R package version 0.7. https://cran.r-project.org/package=metap.,Non-OADS,/arxiv_data1/oa_pdf/ad/b8/btw623.PMC5408797.pdf
"577 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/8a/btw670.PMC5408798.pdf
It is freely available at https://github.com/bcgsc/ntCard.,Non-OADS,/arxiv_data1/oa_pdf/55/ed/btw832.PMC5408799.pdf
"1324 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/ed/btw832.PMC5408799.pdf
Documentation and source code are freely available at https://github.com/bcgsc/ntCard.,Non-OADS,/arxiv_data1/oa_pdf/55/ed/btw832.PMC5408799.pdf
"The k-mer coverage histograms computed by ntCard can be also used as input to utilities like GenomeScope (http://qb.cshl.edu/ genomescope/) for estimating genome sizes, sequencing error rates,repeat contents, and heterozygosity of genomes ( Chikhi and Medvedev, 2014 ;Marc¸ais and Kingsford, 2011 ;Melsted and Halld /C19orsson, 2014 ;Simpson, 2014 ).",OADS,/arxiv_data1/oa_pdf/55/ed/btw832.PMC5408799.pdf
Full source code and installation instructions are freely available from https://github.com/ChrisMaherLab/ INTEGRATE-Neo.,OADS,/arxiv_data1/oa_pdf/cd/d5/btw674.PMC5408800.pdf
"555 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/d5/btw674.PMC5408800.pdf
Availability and Implementation: The method is available as web server at http://schloro.biocomp.,OADS,/arxiv_data1/oa_pdf/30/a1/btw656.PMC5408801.pdf
"347 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/a1/btw656.PMC5408801.pdf
The method is available as web server at http://schloro.biocomp.unibo.it.,OADS,/arxiv_data1/oa_pdf/30/a1/btw656.PMC5408801.pdf
The complete prediction system is available as web-server at http://schloro.biocomp.unibo.it.,OADS,/arxiv_data1/oa_pdf/30/a1/btw656.PMC5408801.pdf
Availability and Implementation: BDSS is available under version 2 of the GNU General Public License at https://github.com/feltus/BDSS.,OADS,/arxiv_data1/oa_pdf/6c/da/btw679.PMC5408802.pdf
"627 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/da/btw679.PMC5408802.pdf
Availability and Implementation: Recycler is available at http://github.com/Shamir-Lab/Recycler Contact: imizrahi@bgu.ac.il Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/6c/2c/btw651.PMC5408804.pdf
"475 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/2c/btw651.PMC5408804.pdf
"To avoid introducing coverage drops atsequence ends typical of linear sequences, we modified BEAR (https://github.com/rozovr/BEAR) to allow sampling of reads bridg- ing reference sequence ends, as is observed for circular sequences.",Non-OADS,/arxiv_data1/oa_pdf/6c/2c/btw651.PMC5408804.pdf
"3.2.2 E. coli isolate data We ran Recycler on two E. Coli strains: JJ1886, downloaded from http://www.ebi.ac.uk/ena/data/view/SRX321704, and E2022, sequenced locally.",OADS,/arxiv_data1/oa_pdf/6c/2c/btw651.PMC5408804.pdf
"580 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/14/btw689.PMC5408807.pdf
A Cons traint-Based Reconstruction and Analysis (COBRA) Toolbox extension to interact wi th ReconMap is available via https://github.com/ opencobra/cobratoolbox.,OADS,/arxiv_data1/oa_pdf/a3/25/btw667.PMC5408809.pdf
"2 Features ReconMap content was derived from Recon 2.04, obtained from theVirtual Metabolic Human database (VMH, http://vmh.uni.lu).Reactions (hyperedges) were manually laid out using the biochem-ical network editor CellDesigner ( Funahashi et al.",OADS,/arxiv_data1/oa_pdf/a3/25/btw667.PMC5408809.pdf
"605 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/25/btw667.PMC5408809.pdf
"3 Implementation ReconMap was drawn using CellDesigner, is displayed using theMINERVA platform, built on the Google Map API, using human re-construction content from the VMH database http://vmh.uni.lu.Matlab scripts for analysis of COBRA Toolbox simulation resultsusing ReconMap are freely available from https://opencobra.github.io/cobratoolbox.",OADS,/arxiv_data1/oa_pdf/a3/25/btw667.PMC5408809.pdf
"1278 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/c9/btw804.PMC5408811.pdf
"Availability and Implementation: The code of SINE_Scan is freely available at http://github.com/ maohlzj/SINE_Scan, implemented in PERL and supported on Linux.",OADS,/arxiv_data1/oa_pdf/ee/94/btw718.PMC5408816.pdf
"743 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/94/btw718.PMC5408816.pdf
RepeatModeler (http://www.repeatmasker.org/RepeatModeler.html)) and run the second and thirdmodules to verify and annotate these candidates.,OADS,/arxiv_data1/oa_pdf/ee/94/btw718.PMC5408816.pdf
Availability and Implementation: GENIUS currently supports eight model organisms and is freely available for public use at http://networks.bio.puc.cl/genius.Contact: genius.psbl@gmail.com Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/be/b1/btw702.PMC5408817.pdf
"760 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/b1/btw702.PMC5408817.pdf
ALTRE makes such analysis accessible to a wide range of users—from novice to practiced computational biologists.Availability and Implementation: https://github.com/Mathelab/ALTRE Contact: ewy.mathe@osumc.edu Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/13/09/btw688.PMC5408819.pdf
"740 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/09/btw688.PMC5408819.pdf
Full installation in-structions are found at https://github.com/Mathelab/ALTRE.,OADS,/arxiv_data1/oa_pdf/13/09/btw688.PMC5408819.pdf
A detailed vignette (https://mathelab.github.io/ALTRE/vignette.html) walks users through an example workflow analysis step-by-step.,Non-OADS,/arxiv_data1/oa_pdf/13/09/btw688.PMC5408819.pdf
A sample dataset is provided on GitHub and can be accessed at https://mathelab.github.io/ALTREsampledata/.,OADS,/arxiv_data1/oa_pdf/13/09/btw688.PMC5408819.pdf
"1394 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/db/btw753.PMC5408825.pdf
Availability and Implementation: https://bitbucket.org/XavMeyer/hogan Contact: nicolas.salamin@unil.ch Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/f2/47/btw712.PMC5408833.pdf
"669 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/47/btw712.PMC5408833.pdf
(2008) and available in TreeBASE (http://www.treebase.org).,OADS,/arxiv_data1/oa_pdf/f2/47/btw712.PMC5408833.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Att ribution- NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
"Moreover, despite recent requirements for Good Clinical Practice (GCP) train ing of investigators and clinical research staff, a decrease in these de ﬁciencies and violations have persisted (see http://bit.ly/1maLi8W [3]).",Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
"Materials and Methods Criteria for Selecting a Competency Framework The ECRPTQ leadership team considered a variety of competency frameworks for this phase: ∙The CTSA Education and Career Development Key Function Committee developed the CTSA master-level competencies, approvedin 2011 ( http://bit.ly/21cX5n8 ), to de ﬁne the training standards for individuals functioning at the master ’s level in clinical and translational research [ 15].",Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
"∙The NIH Clinical Research Nursing Domains of Practice for the Specialty of Clinical Research Nursing ( http://cc.nih.gov/nursing/crn/ DOP_document.pdf ) was another framework that was reviewed and considered, but also did not necessarily address the quali ﬁca- tions and skills for all team members.",Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
(See http://bit.ly/1Qfm5qr for more details about the assessments by competency domain.),Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
"In general, included were training and education offered by CTSAinstitutions; by professional organizations devoted to education and resources; by industry; and by government units (see http://bit.ly/ 1IV821x , entitled training gaps by competency domains).",Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
The education and training offerings that are listed in this report (see http://bit.ly/1U3PYbS ) are not endorsed by the ECRPTQ leadership team.,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
See http://bit.ly/1IV821x for more details about training gaps by competency domain.,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
Additional comments made by thegroup regarding trainings and assessments for select domains were made (reference to http://bit.ly/1RaeSIk ).,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
( https://www.ons.org/sites/default/ ﬁles/ctncompetencies.pdf ) 8.,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
(http://cambridge.crf.nihr.ac.uk/wp-content/uploads/2015/04/Research_ Nurse_Competency_Framework_-_Version_2_-_Full_-_Oct_20111.pdf ) 9.,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
( http://www.cc.nih.gov/nursing/crn/DOP_document.pdf ) 10.,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
(https://ctsacentral.org/consortium/best-practices/335-2 ) 16.,Non-OADS,/arxiv_data1/oa_pdf/85/87/S2059866116000029a.PMC5408836.pdf
"Data from the Department of Health and Human Services appro- priations justi ﬁcation ( https://ncats.nih.gov/ ﬁles/FY15-justi ﬁcation.pdf ) indicate that NIH allocated $471,719,000 in the 2015 –2016 ﬁscal year to support CTSA institutions that have the broad mission to encourage the translation of biomedical research from discovery to use and impact inthe population.",Non-OADS,/arxiv_data1/oa_pdf/55/a1/S205986611600008Xa.PMC5408837.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Att ribution- NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is unaltered and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/a1/S205986611600008Xa.PMC5408837.pdf
"Recently, the OPA at NIH has developed its own tool to estimate research in ﬂuence, iCite ( https://icite.od.nih.gov/ ), which calculates a comparative in ﬂuence measure, the Relative Citation Ratio (RCR), with NIH-supported publications as the benchmark [ 23].",OADS,/arxiv_data1/oa_pdf/55/a1/S205986611600008Xa.PMC5408837.pdf
( http://grants.nih.gov/ grants/guide/rfa- ﬁles/RFA-RM-08-002.html ) 2.,Non-OADS,/arxiv_data1/oa_pdf/55/a1/S205986611600008Xa.PMC5408837.pdf
( https://www.elsevier.com/research-intelligence/resource- library/scival-metrics-guidebook ).,Non-OADS,/arxiv_data1/oa_pdf/55/a1/S205986611600008Xa.PMC5408837.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Att ribution- NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distributio n, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/33/S2059866116000042a.PMC5408838.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Att ribution- NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distributio n, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/47/S2059866116000108a.PMC5408839.pdf
Availability and Implementation: dAPE can be accessed from http://cbdm-01.zdv.uni-mainz.de/ /C24munoz/polyx.,OADS,/arxiv_data1/oa_pdf/db/02/btw790.PMC5408840.pdf
", 2012 ) and four in five (UniProt, http://www.uniprot.org/help/comp bias).",Non-OADS,/arxiv_data1/oa_pdf/db/02/btw790.PMC5408840.pdf
"1221 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/02/btw790.PMC5408840.pdf
Source code and installationinstructions can be found at https://framagit.org/BBRIC/myGenomeBrowser.,OADS,/arxiv_data1/oa_pdf/50/23/btw800.PMC5408841.pdf
"1255 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/23/btw800.PMC5408841.pdf
Availability and Implementation: R scripts used in the processing of the data are available online at https://www.github.com/scottdbrown/RNAseq-TcellClonality Contacts: rholt@bcgsc.ca or ksavage@bccancer.bc.ca Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/79/69/btw810.PMC5408843.pdf
"1111 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/69/btw810.PMC5408843.pdf
"1261 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/46/btw811.PMC5408847.pdf
"Summary of overlap tools output formats, associated pipelines and availability Software Algorithm features Associated assembly toolsOutput Availability BLASR FM-Index, anchor clusters PBcR SAM alignment, other proprietary formats (overlap regions)https://github.com/PaciﬁcBiosciences/ blasr DALIGNER Cache efﬁcient k-mer sort (radix) and mergeDAZZLER, MARVEL, FALCONLocal Alignments, LAS format (alignment tracepoints)https://github.com/thegenemyers/ DALIGNER MHAP MinHash PBcR, Canu MHAP output format (overlap regions) https://github.com/marbl/MHAP GraphMap Gapped q-gram (spaced seeds), colinear clusteringRa SAM alignment, MHAP output format (overlap regions)https://github.com/isovic/GraphMap Minimap Minimizer colinear clustering Miniasm PAF (overlap regions) https://github.com/lh3/Minimap1264 J.Chu et al.",OADS,/arxiv_data1/oa_pdf/27/46/btw811.PMC5408847.pdf
"Examples ofemergent output standards include the Graphical Fragment Assembly (GFA) (https://github.com/pmelsted/GFA-spec) format, PAF ( Li, 2016 ), and the MHAP output format.",OADS,/arxiv_data1/oa_pdf/27/46/btw811.PMC5408847.pdf
com/HajkD/biomartr and https://cran.r-project.org/web/packages/biomartr/index.html.,OADS,/arxiv_data1/oa_pdf/4a/fb/btw821.PMC5408848.pdf
"1216 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/fb/btw821.PMC5408848.pdf
The package canbe downloaded from https://cran.r-project.org/web/packages/biomartr/index.html.,OADS,/arxiv_data1/oa_pdf/4a/fb/btw821.PMC5408848.pdf
The source code is publically available at https://github.com/HajkD/biomartr.,OADS,/arxiv_data1/oa_pdf/4a/fb/btw821.PMC5408848.pdf
"human gene GUCA2A by running the command: getGO(organism ¼‘Homo sapiens’ , genes¼‘GUCA2A’ , filters¼‘hgnc_symbol’) Tutorials are available at https://github.com/HajkD/biomartr#tutor ials and also in the Supplementary Tutorial .",Non-OADS,/arxiv_data1/oa_pdf/4a/fb/btw821.PMC5408848.pdf
"1147 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/13/btw786.PMC5408850.pdf
Availability and Implementation : Code is available on Github at: https://github.com/suyashss/var iant_validation Contacts : suyashs@stanford.edu or mtaub@jhsph.edu Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/33/13/btw786.PMC5408850.pdf
Availability and Implementation: SPADEVizR is distributed under the GPL-3 license and is available at https://github.com/tchitchek-lab/SPADEVizR.Contact: nicolas.tchitchek@gmail.com Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/d7/92/btw708.PMC5408860.pdf
"779 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/92/btw708.PMC5408860.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Jeffrey A Cohen Mellen Center U-10, Neurological Institute,Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA cohenj@ccf.org Jeffrey A Cohen Cleveland Clinic, USA Ho Jin Kim Research Institute and Hospital of National Cancer Center, South Korea Mar Tintore Hospital Universitari Valld’Hebron, Spain Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www .creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/14/bb/10.1177_2055217315626042.PMC5408885.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Alan Thompson Faculty of Brain Sciences, University College Londonalan.thompson@ucl.ac.uk",Non-OADS,/arxiv_data1/oa_pdf/70/01/10.1177_2055217315575457.PMC5408888.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: M Zappia Neurologic Clinic, University of Catania, ViaSanta Sofia, 78 Catania, 95123, Italy.",Non-OADS,/arxiv_data1/oa_pdf/7a/19/10.1177_2055217316631565.PMC5408896.pdf
"MeSH Keywords:  Acid Sensing Ion Channels • Acidosis, Renal Tubular • Purpura, Schoenlein-Henoch  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904132Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Pediatrics, First Affiliated Hospital of Anhui Medical University,  Hefei, Anhui, P.R.",Non-OADS,/arxiv_data1/oa_pdf/78/3f/medscimonit-23-1916.PMC5408900.pdf
"MeSH Keywords:  Anti-Inflammatory Agents • Molecular Docking Simulation • Plant Development  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/903357Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Orthopedic Surgery, Hongqi Hospital affiliated to Mudanjiang  Medical University, Mudanjiang, Heilongjiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/9f/b7/medscimonit-23-1923.PMC5408901.pdf
"MeSH Keywords:  Apoptosis • Cell Hypoxia • Free Radical Scavengers • Oxidative Stress  Full-text PDF:  http://www.basic.medscimonit.com/abstract/index/idArt/903764Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Pharmacy, Lanzhou General Hospital, Lanzhou, Gansu, P.R.",Non-OADS,/arxiv_data1/oa_pdf/d6/73/medscimonitbasicres-23-159.PMC5408902.pdf
"988 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/12/btw728.PMC5408919.pdf
"Availability and Implementation: The gene inference model described in this paper is available as a R package (affyImpute), which can be downloaded at http://simtk.org/home/affyimpute.",OADS,/arxiv_data1/oa_pdf/14/8f/btw664.PMC5408923.pdf
"522 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/8f/btw664.PMC5408923.pdf
Both coefficient matrices can be obtained at http://simtk.org/home/affyimpute.,Non-OADS,/arxiv_data1/oa_pdf/14/8f/btw664.PMC5408923.pdf
These associations were  This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ *Corresponding author: V .W.V .,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/emss-72479.PMC5408932.pdf
"Lifestyle and pregnancy related characteristics explained up to 33% and 40% of these associations,  This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Correspondence to: Vincent W.V .",Non-OADS,/arxiv_data1/oa_pdf/bd/f4/emss-66131.PMC5408938.pdf
Available from: http://www.cbs.nl/NR/rdonlyres/240E5858- D04D-47EA-9C22-AB8E9297E2D2/0/2010k4b15p22art.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/bd/f4/emss-66131.PMC5408938.pdf
Available from: http://www.cbs.nl/NR/rdonlyres/BD11B2EE-83DE-47FB-9ABC- F8FFFE1F3C07/0/2004b52pub.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/bd/f4/emss-66131.PMC5408938.pdf
[website]; Available from: http://www.rotterdam.nl/ onderzoek 22.,Non-OADS,/arxiv_data1/oa_pdf/bd/f4/emss-66131.PMC5408938.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55267 | Page 1 of 14Video Article Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development Zhong-Dong Shi*1, Chew-Li Soh*1, Zengrong Zhu*1, Danwei Huangfu1 1Developmental Biology Program, Sloan Kettering Institute *These authors contributed equally Correspondence to: Zengrong Zhu at zhuzengrong@gmail.com , Danwei Huangfu at huangfud@mskcc.org URL: https://www.jove.com/video/55267 DOI: doi:10.3791/55267 Keywords: Genetics, Issue 121, CRISPR/Cas9, iCas9, genome editing, AAVS1, human pluripotent stem cells, pancreatic differentiation, glucose- responsive β-like cells, diabetes Date Published: 3/5/2017 Citation: Shi, Z.D., Soh, C.L., Zhu, Z., Huangfu, D. Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development.",Non-OADS,/arxiv_data1/oa_pdf/fd/98/jove-121-55267.PMC5408939.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55267/ Introduction Human pluripotent stem cells (hPSCs) have the ability to both self-renew and give rise to all derivatives of the three embryonic germ lineages.,Non-OADS,/arxiv_data1/oa_pdf/fd/98/jove-121-55267.PMC5408939.pdf
2.Design gRNAs using the online CRISPR design tool (http://crispr.mit.edu).,Non-OADS,/arxiv_data1/oa_pdf/fd/98/jove-121-55267.PMC5408939.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e55292 | Page 1 of 8Video Article Polydimethylsiloxane-polycarbonate Microfluidic Devices for Cell Migration Studies Under Perpendicular Chemical and Oxygen Gradients Hung-Ju Chiang1, Sih-Ling Yeh1, Chien-Chung Peng1, Wei-Hao Liao1, Yi-Chung Tung1 1Research Center for Applied Sciences, Academia Sinica Correspondence to: Yi-Chung Tung at tungy@gate.sinica.edu.tw URL: https://www.jove.com/video/55292 DOI: doi:10.3791/55292 Keywords: Bioengineering, Issue 120, Polydimethylsiloxane, Polycarbonate, Microfluidics, Chemical Gradient, Oxygen Gradient, Cell Culture, Cell Migration Date Published: 2/23/2017 Citation: Chiang, H.J., Yeh, S.L., Peng, C.C., Liao, W.H., Tung, Y.C.",Non-OADS,/arxiv_data1/oa_pdf/f5/b4/jove-120-55292.PMC5408940.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55292/ Introduction The spatial distribution of soluble factors and oxygen tension can regulate a number of important cellular functions in vivo1,2,3,4.",Non-OADS,/arxiv_data1/oa_pdf/f5/b4/jove-120-55292.PMC5408940.pdf
"Analyze the images using an open source image analysis software, ImageJ, with an open source plugin for Manual Tracking (https://imagej.nih.gov/ij/plugins/track/track.html) and a free Chemotaxis Tool software (http:// ibidi.com/xtproducts/en/Software-and-Image-Analysis/Manual-Image-Analysis/Chemotaxis-and-Migration-Tool)15,16.",OADS,/arxiv_data1/oa_pdf/f5/b4/jove-120-55292.PMC5408940.pdf
"Institute Curie, Orsay, France, https://imagej.nih.gov/ij/plugins/track/Manual%20Tracking%20plugin.pdf, (2005).",Non-OADS,/arxiv_data1/oa_pdf/f5/b4/jove-120-55292.PMC5408940.pdf
"16.Asano, Y., Horn, E. Instructions Chemotaxis and Migration Tool 2.0. ibidi GmbH, Martinsried, Germany, Germany, http://ibidi.com/fileadmin/ products/software/chemotaxis_tool/IN_XXXXX_CT_Tool_2_0.pdf?x14743=a3676cb19a79449e2b05d5ecb4a8aae6, (2013).",OADS,/arxiv_data1/oa_pdf/f5/b4/jove-120-55292.PMC5408940.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55307 | Page 1 of 9Video Article Monovalent Cation Doping of CH 3NH3PbI 3 for Efficient Perovskite Solar Cells Mojtaba Abdi-Jalebi1, M. Ibrahim Dar2, Aditya Sadhanala1, Satyaprasad P. Senanayak1, Michael Grätzel2, Richard H. Friend1 1Cavendish Laboratory, University of Cambridge 2Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne Correspondence to: Mojtaba Abdi-Jalebi at ma571@cam.ac.uk URL: https://www.jove.com/video/55307 DOI: doi:10.3791/55307 Keywords: Engineering, Issue 121, Monovalent cation halide, additives, CH 3NH3PbI 3 perovskite, doping, surface passivation Date Published: 3/19/2017 Citation: Abdi-Jalebi, M., Dar, M.I., Sadhanala, A., Senanayak, S.P., Grätzel, M., Friend, R.H. Monovalent Cation Doping of CH3NH3PbI 3 for Efficient Perovskite Solar Cells.",Non-OADS,/arxiv_data1/oa_pdf/bd/89/jove-121-55307.PMC5408941.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55307/ Introduction Currently, the dominant portion of the world's energy requirement (i.e., 85%) is being supplied by the combustion of oil, coal, and natural gas, which facilitates global warming and has deleterious effects on our environment1.",Non-OADS,/arxiv_data1/oa_pdf/bd/89/jove-121-55307.PMC5408941.pdf
The data underlying this paper are available at: https://www.repository.cam.ac.uk/handle/1810/260187.,Non-OADS,/arxiv_data1/oa_pdf/bd/89/jove-121-55307.PMC5408941.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/88/opth-11-759.PMC5408942.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 759–765Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  759Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13239 2 The effect of vitreomacular and cataract surgery  on oxygen saturation in retinal vessels Yuki nakano Koichiro Manabe rie Osaka Yukari Takasago aoi Ono Mamoru Kobayashi T omoyoshi Fujita Chieko shiragami Kazuyuki hirooka akitaka Tsujikawa Department of Ophthalmology,   Kagawa University Faculty of  Medicine, Miki, JapanPurpose:  To evaluate the effects of vitreomacular and cataract surgery on retinal oximetry in  vitreomacular disease.",Non-OADS,/arxiv_data1/oa_pdf/4b/88/opth-11-759.PMC5408942.pdf
"However, cataract surgery might influence  the measurements and needs to be taken into consideration when using this tool.Correspondence: Yuki nakano Department of Ophthalmology,  Kagawa University Faculty of Medicine,  1750-1 ikenobe Miki-cho, Kagawa  761-0793, Japan Tel +81 87 891 2211 Fax +81 87 981 2212 email nakano.tee@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Nakano et al Running head recto: Retinal oximetry after vitrectomy DOI: http://dx.doi.org/10.2147/OPTH.S132392",Non-OADS,/arxiv_data1/oa_pdf/4b/88/opth-11-759.PMC5408942.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4b/88/opth-11-759.PMC5408942.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/88/opth-11-759.PMC5408942.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/68/opth-11-767.PMC5408943.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 767–771Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  767Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12903 7 Efficacy of transepithelial corneal collagen  crosslinking for keratoconus: 12-month follow-up Mohamed a heikal Tarek Tawfik soliman ayser Fayed abdelmonem M hamed Department of Ophthalmology,   Benha University, Benha, egyptPurpose:  To evaluate the efficacy of transepithelial corneal collagen crosslinking (TE-CXL)  in patients with progressive keratoconus.",Non-OADS,/arxiv_data1/oa_pdf/d6/68/opth-11-767.PMC5408943.pdf
"Debriding the corneal epithelium increases the risk of infec - tion, sub-epithelial haze, sterile corneal infiltrates, corneal scarring, and endothelial  damage.1,7–10Correspondence: Mohamed a heikal Department of Ophthalmology,  Benha University, 17 Fareed nada street,  Benha 13511, egypt Tel +20 0100 713 1431 email m ohammedheikel@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Heikal et al Running head recto: Efficacy of TE-CXL in patients with progressive keratoconus DOI: http://dx.doi.org/10.2147/OPTH.S129037",Non-OADS,/arxiv_data1/oa_pdf/d6/68/opth-11-767.PMC5408943.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d6/68/opth-11-767.PMC5408943.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/68/opth-11-767.PMC5408943.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/52/7a/ott-10-2257.PMC5408944.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2257–2266OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2257Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13187 3 results of adjuvant radiation therapy for  locoregional perihilar cholangiocarcinoma  after curative intent resection Kai-Ming leng1,* Yue-Ping liu1,* Zhi-Dong Wang1 Xiang-Yu Zhong1 guan-Qun liao2 Peng-cheng Kang1 Yun-Fu cui1 Xing-Ming Jiang1 1Department of hepatopan- creatobiliary surgery, second affiliated  hospital of harbin Medical University,   harbin, 2Department of general  surgery, Foshan hospital affiliated to  southern Medical University, Foshan,   People’s republic of china *These authors contributed equally  to this workPurpose:  This study sought to define the role of adjuvant radiation therapy (RT) for patients  with curative intent resection of perihilar cholangiocarcinoma (pCCA).",Non-OADS,/arxiv_data1/oa_pdf/52/7a/ott-10-2257.PMC5408944.pdf
"Moreover, locoregional recurrence is  found in ~60% of patients undergoing curative resection for pCCA, whereas distant correspondence: Yun-Fu cui;   Xing-Ming Jiang Department of hepatopancreatobiliary  Surgery, Second Affiliated Hospital of  harbin Medical University, no 246,  Xuefu street, nangang District, harbin  150086, People’s republic of china Tel +86 451 8660 5113 Fax +86 451 8660 5113 email yfcui777@163.co m;  xmjiang@hrbmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Leng et al Running head recto: Role of adjuvant RT in resected perihilar cholangiocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S131873",Non-OADS,/arxiv_data1/oa_pdf/52/7a/ott-10-2257.PMC5408944.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/52/7a/ott-10-2257.PMC5408944.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/7a/ott-10-2257.PMC5408944.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/32/opth-11-753.PMC5408945.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 753–758Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  753Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S13320 7 Comparison of the biometric measurements  calculated with Zeiss iOl-Master and Wavelight  OB-820 georgios labiris1,2 Panagiota ntonti2 Konstantinos ntitsos2 andreas Katsanos2 haris sideroudi2 Vasilios Kozobolis1,2 1Department of Ophthalmology,   University hospital of  alexandroupolis, 2eye institute of  Thrace, alexandroupolis, greeceBackground:  The primary objective of this study was to investigate the level of agreement  between IOL-Master and OB-820 ocular biometers.",Non-OADS,/arxiv_data1/oa_pdf/f6/32/opth-11-753.PMC5408945.pdf
"In B-scan biometry, the reflected echoes are represented as a multitude of dots in a  gray scale depending on the density of the tissue and are being imaged as a “slice” of Correspondence: georgios labiris Department of Ophthalmology,  University hospital of alexandroupolis,  68100 Dragana, alexandroupolis, greece Tel +30 255 103 0990 email labiris@usa.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Labiris et al Running head recto: Comparison of ocular biometers DOI: http://dx.doi.org/10.2147/OPTH.S133207",Non-OADS,/arxiv_data1/oa_pdf/f6/32/opth-11-753.PMC5408945.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f6/32/opth-11-753.PMC5408945.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/32/opth-11-753.PMC5408945.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/19/ott-10-2249.PMC5408946.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2249–2256OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2249Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11496 0 relationship between computed tomography  morphology and prognosis of patients with stage i  non-small cell lung cancer Jun Ma1,2 Yun-long Yang3 Ye Wang2 Xue-Wei Zhang2 Xue-song gu2 Zhen-chang Wang1 1Department of radiology, Beijing  Friendship hospital, capital Medical  University, Beijing, 2Department of  radiology, 3Department of Thoracic  surgery, The affiliated hospital of  Beihua University, Jilin, People’s  republic of chinaAbstract:  This study aimed to explore the relationship between computed tomography   morphology and prognosis of patients with stage I non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/ab/19/ott-10-2249.PMC5408946.pdf
"Keywords:  follow-up, survival rate, tumor node metastasis staging, tumor margin, tumor  periphery, pleural thickening, pleural indentation Introduction Lung cancer, as a malignant disease of heterogeneous nature, is the largest contributor  to new cancer diagnosis and the leading cause of cancer-related mortality in China,  followed by gastric, liver, and breast cancer.1 It is believed that the development of  lung cancer is influenced by factors such as cigarette smoking, secondhand or passive  smoking, excessive alcohol consumption, air pollution, occupational carcinogens, and  ionizing radiation.2 Clinically, lung cancer can be categorized as small cell lung cancer  and non-small cell lung cancer (NSCLC), and the latter accounts for ~75%–80% of  lung cancer.3 Interestingly, the incidence and mortality rates of NSCLC are highest  in developed countries, and the number of patients dying from NSCLC continues  to increase globally.4 Currently, most NSCLC is diagnosed clinically when patients  present with symptoms such as persistent hemoptysis, chest pain, low fever, weight  loss, anorexia, dyspnea, and emptysis.5 NSCLC patients in the early stages have correspondence: Zhen-chang Wang Department of radiology, Beijing  Friendship hospital, capital Medical  University, no 95, Yong’an road,  Xicheng, Beijing 100050, People’s  republic of china Tel/fax +86 10 6313 8625 email zcw010beijing@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Ma et al Running head recto: CT morphology and prognosis of stage I NSCLC DOI: http://dx.doi.org/10.2147/OTT.S114960",Non-OADS,/arxiv_data1/oa_pdf/ab/19/ott-10-2249.PMC5408946.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ab/19/ott-10-2249.PMC5408946.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/19/ott-10-2249.PMC5408946.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55380 | Page 1 of 10Video Article Physiological Preparation of Hair Cells from the Sacculus of the American Bullfrog ( Rana catesbeiana ) Julien B. Azimzadeh1, Joshua D. Salvi1 1Laboratory of Sensory Neuroscience, The Rockefeller University Correspondence to: Joshua D. Salvi at jsalvi@rockefeller.edu URL: https://www.jove.com/video/55380 DOI: doi:10.3791/55380 Keywords: Neuroscience, Issue 121, bullfrog, sacculus, hair cell, hair bundle, physiology, mechanotransduction, spontaneous oscillation, biophysics, hearing, auditory, vestibular, Rana catesbeiana Date Published: 3/17/2017 Citation: Azimzadeh, J.B., Salvi, J.D.",Non-OADS,/arxiv_data1/oa_pdf/8e/32/jove-121-55380.PMC5408964.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55380/ Introduction The acousticolateralis organs of mammals possess a complex architecture and lie within an anatomical niche that can be difficult to access.,Non-OADS,/arxiv_data1/oa_pdf/8e/32/jove-121-55380.PMC5408964.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55362 | Page 1 of 11Video Article A High-throughput Cell Microarray Platform for Correlative Analysis of Cell Differentiation and Traction Forces Kerim B. Kaylan1, Andreas P. Kourouklis1, Gregory H. Underhill1 1Department of Bioengineering, University of Illinois at Urbana–Champaign Correspondence to: Gregory H. Underhill at gunderhi@illinois.edu URL: https://www.jove.com/video/55362 DOI: doi:10.3791/55362 Keywords: Bioengineering, Issue 121, tissue engineering, biomaterials, biomechanics, microenvironment, cell microarrays, stem and progenitor cell biology Date Published: 3/1/2017 Citation: Kaylan, K.B., Kourouklis, A.P., Underhill, G.H.",Non-OADS,/arxiv_data1/oa_pdf/cc/12/jove-121-55362.PMC5408965.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55362/ Introduction Interactions between cells and surrounding microenvironmental factors mediate a large variety of biological processes throughout development, homeostasis, and disease pathogenesis1,2,3,4.",Non-OADS,/arxiv_data1/oa_pdf/cc/12/jove-121-55362.PMC5408965.pdf
"279 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction  in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/0d/pyw084.PMC5408966.pdf
http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c8/0d/pyw084.PMC5408966.pdf
http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/0d/pyw084.PMC5408966.pdf
"This clinical study has been registered at ClinicalTrials.gov (trial registration: NCT02392169, https://regis-ter.clinicaltrials.gov/).",Non-OADS,/arxiv_data1/oa_pdf/22/b9/pyw101.PMC5408967.pdf
These sites include http://clinicaltrials.gov  and http://www.,Non-OADS,/arxiv_data1/oa_pdf/4a/da/pyw091.PMC5408969.pdf
OCEBM Levels of Evidence Working Group The Oxford 2011 Lev - els of Evidence http://www.cebm.net/index.aspx?o=5653 .,Non-OADS,/arxiv_data1/oa_pdf/4a/da/pyw091.PMC5408969.pdf
Available at http://www.who.int/mediacen-tre/factsheets/fs369/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/6e/ff/pyw089.PMC5408970.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55427 | Page 1 of 8Video Article 3D Printing of Biomolecular Models for Research and Pedagogy Eduardo Da Veiga Beltrame1, James Tyrwhitt-Drake2, Ian Roy3, Raed Shalaby4, Jakob Suckale4, Daniel Pomeranz Krummel5 1Department of Physics, Brandeis University 2Bioinformatics and Computational Biosciences Branch (BCBB), NIH/NIAID/OD/OSMO/OCICB 3Library/LTS/MakerLab, Brandeis University 4Interfaculty Institute of Biochemistry (IFIB), University of Tübingen 5Winship Cancer Institute, Emory University School of Medicine Correspondence to: Jakob Suckale at jakob.suckale@uni-tuebingen.de , Daniel Pomeranz Krummel at dapk@brandeis.edu URL: https://www.jove.com/video/55427 DOI: doi:10.3791/55427 Keywords: Engineering, Issue 121, 3D printing, molecular biology, education, structure, biomolecules, models, extrusion printers Date Published: 3/13/2017 Citation: Da Veiga Beltrame, E., Tyrwhitt-Drake, J., Roy, I., Shalaby, R., Suckale, J., Pomeranz Krummel, D. 3D Printing of Biomolecular Models for Research and Pedagogy.",Non-OADS,/arxiv_data1/oa_pdf/9c/b1/jove-121-55427.PMC5408980.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55427/ Introduction A thorough understanding of the function and activity of a biomolecule requires the determination of its three-dimensional (3D) structure.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/jove-121-55427.PMC5408980.pdf
1.Download and install UCSF Chimera (https://www.cgl.ucsf.edu/chimera/download.html).,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/jove-121-55427.PMC5408980.pdf
"281 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/7a/pyw092.PMC5408981.pdf
"For Permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/c2/djw306.PMC5408989.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55486 | Page 1 of 10Video Article Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells Emrah Eroglu1, Rene Rost1, Helmut Bischof1, Sandra Blass1, Anna Schreilechner1, Benjamin Gottschalk1, Maria R. Depaoli1, Christiane Klec1, Suphachai Charoensin1, Corina T. Madreiter-Sokolowski1, Jeta Ramadani1, Markus Waldeck-Weiermair1, Wolfgang F. Graier1, Roland Malli1 1Institute of Molecular Biology and Biochemistry, Medical University of Graz Correspondence to: Roland Malli at roland.malli@medunigraz.at URL: https://www.jove.com/video/55486 DOI: doi:10.3791/55486 Keywords: Molecular Biology, Issue 121, Ca2+, eNOS, Fluorescence Microscopy, Fura-2, Genetically Encoded Probes, Live-Cell Imaging, Multichannel Imaging, Nitric Oxide, NO•-Donors, NOC-7, Single Cell Analysis, SNP Date Published: 3/16/2017 Citation: Eroglu, E., Rost, R., Bischof, H., Blass, S., Schreilechner, A., Gottschalk, B., Depaoli, M.R., Klec, C., Charoensin, S., Madreiter- Sokolowski, C.T., Ramadani, J., Waldeck-Weiermair, M., Graier, W.F., Malli, R. Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/jove-121-55486.PMC5408997.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55486/ Introduction We have recently developed a novel class of genetically encoded fluorescent NO• probes, called the geNOps1.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/jove-121-55486.PMC5408997.pdf
"Licenses related to this patent are provided to Next Generation Fluorescence Imaging (NGFI) GmbH ( http://www.ngfi.eu/), a spin-off company of the Medical University of Graz.",Non-OADS,/arxiv_data1/oa_pdf/e2/d0/jove-121-55486.PMC5408997.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/11/euw032.PMC5408998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/c1/djx015.PMC5408999.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/ac/djx014.PMC5409000.pdf
"The primer and probe sets for the genes analyzed were de- signed using Primer Express 3.0 Software (Applied Biosystems)according to their Ref Seq (http://www.ncbi.nlm.nih.gov/ locuslink) (Supplementary Table 1, available online).",OADS,/arxiv_data1/oa_pdf/23/ac/djx014.PMC5409000.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgRole of NO/V ASP Signaling Pathway against Obesity- Related Inflammation and Insulin Resistance Yu Mi Kang1, Francis Kim2, Woo Je Lee1 1Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, 2Department of Medicine, Diabetes and Obesity Center of Excellence, University of Washington, Seattle, W A, USA  Obesity has quickly become a worldwide pandemic, causing major adverse health outcomes such as dyslipidemia, type 2 diabetes  mellitus, cardiovascular disease and cancers.",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Keywords: Adipose tissue; Chronic inflammation; Endothelium, vascular; Insulin resistance; Liver; Macrophages; Nitric oxide;  Obesity; Vasodilator-stimulated phosphoprotein Corresponding author: Woo Je Lee    http://orcid.org/0000-0002-9605-9693  Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea E-mail: lwjatlas@amc.seoul.kr  Received: Sep. 8, 2016; Accepted: Oct. 26, 2016INTRODUCTION Obesity has become a huge burden worldwide.",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Besides these pleio-tropic effects, NO has recently emerged as an important regu-Review Pathophysiology https://doi.org/10.4093/dmj.2017.41.2.89 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:89-95",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Kang YM, et al.90 Diabetes Metab J 2017;41:89-95 http://e-dmj.orglator of energy metabolism.",OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
Role of NO/V ASP signaling against obesity91 Diabetes Metab J 2017;41:89-95 http://e-dmj.orgHF diet [10].,Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Kang YM, et al.92 Diabetes Metab J 2017;41:89-95 http://e-dmj.orgvolved in scavenging, host immunity and immune tolerance in  the liver [39].",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Role of NO/V ASP signaling against obesity93 Diabetes Metab J 2017;41:89-95 http://e-dmj.orgCONCLUSIONS Peripheral insulin resistance in obese state is crucial to the eti- ology of metabolic disorders such as type 2 diabetes mellitus [45], and thus, understanding the molecular mechanisms of insulin resistance in the organs involved in glucose homeosta-sis can provide further insights to the development of potential targeted therapy.",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Kang YM, et al.94 Diabetes Metab J 2017;41:89-95 http://e-dmj.org2.",OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"Role of NO/V ASP signaling against obesity95 Diabetes Metab J 2017;41:89-95 http://e-dmj.orgphosphorylation and maintains higher c-IAP1, livin, survivin,  and Mcl-1 expression and the inhibition of PKG-Ialpha kinase activity synergizes with cisplatin in non-small cell lung cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/49/23/dmj-41-89.PMC5409001.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgA Clinical Practice Guideline to Guide a System  Approach to Diabetes Care in Hong Kong Ip Tim Lau1,2 1Department of Medicine, Tseung Kwan O Hospital, Hong Kong, 2Central Committee on Diabetic Services, Hong Kong Hospital Authority, Hong Kong The Hospital Authority of Hong Kong is a statutory body that manages all the public medical care institutions in Hong Kong.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"Keywords: Delivery of health care, integrated; Diabetes mellitus; Disease management; Practice guideline; Risk assessment; Self  care Corresponding author: Ip Tim Lau    http://orcid.org/0000-0001-7136-407X  Department of Medicine, Tseung Kwan O Hospital.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
It manages Review Clinical Care/Education https://doi.org/10.4093/dmj.2017.41.2.81 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:81-88,Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"Lau IT82 Diabetes Metab J 2017;41:81-88 http://e-dmj.org41 hospitals and institutions, 47 Specialist Outpatient Clinics,  which together provide inpatient and specialist care; and 73 GOPCs where primary care for the early stages of chronic dis-eases for most patients is delivered.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"CPG to guide diabetes care in Hong Kong83 Diabetes Metab J 2017;41:81-88 http://e-dmj.orgpatients from the private to the public sector; an increase in the  prevalence of diabetes due to an increase in the incidence among younger people, etc.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"Lau IT84 Diabetes Metab J 2017;41:81-88 http://e-dmj.orgTHE HOSPITAL AUTHORITY CLINICAL  PRACTICE GUIDELINE ON THE  MANAGEMENT OF TYPE 2 DIABETES (2013) The intent of the guideline was to describe the minimal level of  care to be provided across the different care levels in the HA, with due consideration of available evidence and local systems factors.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
CPG to guide diabetes care in Hong Kong85 Diabetes Metab J 2017;41:81-88 http://e-dmj.orgitems are purchased by their patients out-of-pocket if the clini- cal indications are not met or present.,Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"Lau IT86 Diabetes Metab J 2017;41:81-88 http://e-dmj.org(5.77%, P<0.01) and a lower cardiovascular events incidence  (1.21% vs. 2.89%, P =0.003) [7].",Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
CPG to guide diabetes care in Hong Kong87 Diabetes Metab J 2017;41:81-88 http://e-dmj.orgfrom the laboratory information system of the corporate elec- tronic Clinical Management System.,Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
Available from: http://www.bloomberg.com/news/articles/2016-09-29/u-s-health-care-system-ranks-as-one-of-the-least-efficient (updated 2016 Sep 29).Fig.,Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
Lau IT88 Diabetes Metab J 2017;41:81-88 http://e-dmj.org4.,Non-OADS,/arxiv_data1/oa_pdf/ca/93/dmj-41-81.PMC5409002.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dmj-41-152.PMC5409003.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgEfficacy of Moderate Intensity Statins in the Treatment  of Dyslipidemia in Korean Patients with Type 2  Diabetes Mellitus (Diabetes Metab J  2017;41:23-30) Sung Hye Kong1, Bo Kyung Koo1,2, Min Kyong Moon1,2 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, 2 Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of  Medicine, Seoul, Korea  Corresponding author: Min Kyong Moon     http://orcid.org/0000-0002-5460-2846 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, KoreaE-mail: mkmoon@snu.ac.krWe appreciate Dr. Jeon’s interest and comments on our article  entitled “Efficacy of moderate intensity statins in the treatment of dyslipidemia in Korean patients with type 2 diabetes melli-tus” which was published in Diabetes and Metabolism Journal   [1].",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dmj-41-152.PMC5409003.pdf
"If the percent reduction is a priority, Response https://doi.org/10.4093/dmj.2017.41.2.152 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:152-153",Non-OADS,/arxiv_data1/oa_pdf/ea/89/dmj-41-152.PMC5409003.pdf
Statin efficacy in Korean patients with diabetes 153 Diabetes Metab J 2017;41:152-153 http://e-dmj.orgwe can recommend low-intensity statins to 40- to 75-year-old  Korean patients with T2DM for primary prevention.,Non-OADS,/arxiv_data1/oa_pdf/ea/89/dmj-41-152.PMC5409003.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
Copyright © 2017 Korean Diabetes Association http://e-dmj.orgRegulating Hypothalamus Gene Expression in Food  Intake: Dietary Composition or Calorie Density?,Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
"Keywords: Dietary fats; Eating; Gene expression; Hypothalamus Corresponding author: Jong-Y eon Kim    http://orcid.org/0000-0002-1481-7615  Obesity-Diabetes Advanced Research Center, Y eungnam University College of Medicine,  170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea E-mail: jykim@ynu.ac.kr Received: Jul.",Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
Intake of fish and long-chain n-3 PU-Original Article Obesity and Metabolic Syndrome https://doi.org/10.4093/dmj.2017.41.2.121 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:121-127,Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
"Jang M, et al.122 Diabetes Metab J 2017;41:121-127 http://e-dmj.orgFAs in young adulthood is inversely associated with metabolic  syndrome later in life [12].",Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
Hypothalamus gene expression by dietary fat composition 123 Diabetes Metab J 2017;41:121-127 http://e-dmj.orgtime PCR was performed using the real-time PCR 7500 system  and Power SYBR Green PCR Master Mix (Applied Biosystems) according to the manufacturer’s instructions.,Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
"Jang M, et al.124 Diabetes Metab J 2017;41:121-127 http://e-dmj.orgthe CHO group was higher (P <0.01) than in high-fat diet  groups, but the calories ingested were lower.",Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
Hypothalamus gene expression by dietary fat composition 125 Diabetes Metab J 2017;41:121-127 http://e-dmj.orgThe AgRP mRNA expression of the CHO group did not differ  from other groups (99% in SFA and 94% in n-3 PUFA com - pared with CHO) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
"Jang M, et al.126 Diabetes Metab J 2017;41:121-127 http://e-dmj.org0.001) between the ratio of NPY/POMC gene expressions and  food intake in calorie amount, but not with food intake in weight amount.",Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
Hypothalamus gene expression by dietary fat composition 127 Diabetes Metab J 2017;41:121-127 http://e-dmj.orgmethylation of their promoters.,Non-OADS,/arxiv_data1/oa_pdf/59/31/dmj-41-121.PMC5409004.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgAddition of Ipragliflozin to Metformin Treatment in  Korean Patients with Type 2 Diabetes Mellitus:  Subgroup Analysis of a Phase 3 Trial  Kyung-Wan Min1, Bon Jeong Ku2, Ji-Hyun Lee3, Min-Seon Kim4, Kyu-Jeung Ahn5, Moon-Kyu Lee6, Satoshi Kokubo7,   Satoshi Y oshida7, Hyun-Ji Cho8, Bong-Soo Cha9 1Department of Internal Medicine, Eulji General Hospital, Eulji University School of Medicine, Seoul,  2Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon,  3Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu,  4Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul,  5Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University Medical Center, Seoul,  6Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, 7Astellas Pharma Inc., Tokyo, Japan, 8Astellas Korea Inc., Seoul,   9Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Background: This is a subgroup analysis of Korean patients from a phase 3 clinical trial investigating the efficacy and safety of ip- ragliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin.",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Keywords: Asia; Diabetes mellitus, type 2; Ipragliflozin; Korea; Metformin; Randomized controlled trial; Sodium-glucose co- transporter 2 inhibitor  Corresponding author: Bong-Soo Cha    http://orcid.org/0000-0003-0542-2854  Department of Internal Medicine, Y onsei University College of Medicine, 50 Y onsei-ro, Seodaemun-gu, Seoul 03722, Korea  E-mail: bscha@yuhs.ac Received: Aug. 1, 2016; Accepted: Oct. 25, 2016INTRODUCTION The incidence of diabetes has increased by more than 6-fold over the past 40 years in Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
Recent estimates by the Ko- rean Diabetes Association indicate that type 2 diabetes mellitus affects approximately 2.7 million adults (aged 30 years or old-Original Article Others https://doi.org/10.4093/dmj.2017.41.2.135 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:135-145,Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Min KW , et al.136 Diabetes Metab J 2017;41:135-145 http://e-dmj.orger), placing the current prevalence of type 2 diabetes mellitus  at 8.0% [2].",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Ipragliflozin in Korean patients with type 2 diabetes mellitus137 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgsingle-blind 2-week placebo pretreatment period (visit 1), fol- lowed by a 24-week double-blind treatment period (visits 2 to 9), and a 4-week follow-up period (visit 10).",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Min KW , et al.138 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgoutcomes were summarized by treatment group.",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Ipragliflozin in Korean patients with type 2 diabetes mellitus139 Diabetes Metab J 2017;41:135-145 http://e-dmj.org147.3±47.81 days in the ipragliflozin and placebo groups, re- spectively.",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Min KW , et al.140 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgin both groups (Table 2).",OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
Ipragliflozin in Korean patients with type 2 diabetes mellitus141 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgline to the end of treatment in the SAF population are present- ed in Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Min KW , et al.142 Diabetes Metab J 2017;41:135-145 http://e-dmj.orglakiuria in the ipragliflozin group.",OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
Ipragliflozin in Korean patients with type 2 diabetes mellitus143 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgimprovements in insulin sensitivity (measured by HOMA-IR)  and β-cell function (measured by HOMA- β) with ipragliflozin  treatment compared to placebo.,Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"Min KW , et al.144 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgwere reported [10].",Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
Ipragliflozin in Korean patients with type 2 diabetes mellitus145 Diabetes Metab J 2017;41:135-145 http://e-dmj.orgAmerican Diabetes Association and the European Association  for the Study of Diabetes.,Non-OADS,/arxiv_data1/oa_pdf/c1/16/dmj-41-135.PMC5409005.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/82/dmj-41-150.PMC5409006.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgEfficacy of Moderate Intensity Statins in the Treatment  of Dyslipidemia in Korean Patients with Type 2  Diabetes Mellitus (Diabetes Metab J  2017;41:23-30) Jae-Han Jeon Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea Corresponding author: Jae-Han Jeon    http://orcid.org/0000-0002-9217-968X Department of Internal Medicine, Kyungpook National University School of  Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, KoreaE-mail: ggoloo@hanmail.netAccording to the recently released Diabetes Fact Sheet in Ko- rea 2016, the control rate of dyslipidemia in people with diabe-tes is still under 50%.",Non-OADS,/arxiv_data1/oa_pdf/d0/82/dmj-41-150.PMC5409006.pdf
"Nevertheless, it is still of great clinical signifi-cance because it provides a rationale that early, modest statin treatment can normalize LDL-C in over 90% of patients with Letter https://doi.org/10.4093/dmj.2017.41.2.150 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:150-151",Non-OADS,/arxiv_data1/oa_pdf/d0/82/dmj-41-150.PMC5409006.pdf
Statin efficacy in Korean patients with diabetes 151 Diabetes Metab J 2017;41:150-151 http://e-dmj.orgdiabetes.,Non-OADS,/arxiv_data1/oa_pdf/d0/82/dmj-41-150.PMC5409006.pdf
"DIABETES  & METABOLISM JOURNAL Copyright © 2017 Korean Diabetes Association http://e-dmj.orgThis is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Diabetes Camp as Continuing Education for Diabetes  Self-Management in Middle-Aged and Elderly People  with Type 2 Diabetes Mellitus So Y oung Park1, Sun Y oung Kim2, Hye Mi Lee2, Kyu Y eon Hur1, Jae Hyeon Kim1, Moon-Kyu Lee1, Kang-Hee Sim2, Sang-Man Jin1 1Division of Endocrinology and Metabolism, Department of Medicine, 2Diabetes Education Unit, Diabetes Center, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea Background: Despite the established benefits of diabetes camps for the continuing education of children with type 1 diabetes  mellitus, little is known about the long-term metabolic benefits of diabetes camps for middle-aged and elderly people with type 2 diabetes mellitus (T2DM), especially in terms of glycosylated hemoglobin (HbA1c) variability.Methods: The 1-year mean and variability of HbA1c before and after the diabetes camp was compared between the participants of the diabetes camp (n =57; median age 65 years [range, 50 to 86 years]; median diabetes duration 14 years [range, 1 to 48 years]).",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Keywords: Adult; Diabetes camp; Hemoglobin A, glycosylated, variability; Metabolic outcome; Psychosocial outcome Corresponding authors: Sang-Man Jin    http://orcid.org/0000-0001-5929-3627  Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of  Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea E-mail: sangman.jin@samsung.com Kang-Hee Sim    http://orcid.org/0000-0002-0400-5154  Diabetes Education Unit, Diabetes Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea E-mail: jsmercy@naver.com Received: Apr.",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"According to the recent recommendation by the American Di-abetes Association, annual visits for diabetes education are rec-ommended to assess all areas of self-management, even for Original Article Clinical Care/Education https://doi.org/10.4093/dmj.2017.41.2.99 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:99-112",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.100 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgthose who meet the goals [6].",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Diabetes camp as continuing education101 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgThe measurements of HbA1c were performed every 3 months  for 15 months (maximum five times) before the camp and af-ter the camp, respectively.",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.102 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgbefore the diabetes camp (P =0.022 and P =0.011).",OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Diabetes camp as continuing education103 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgIn the matched control group, BMI and the levels of FPG  and HbA1c were significantly lower after the conventional ed- ucation than before the education (P =0.021, P=0.002, and  P=0.005, respectively) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.104 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgmean HbA1c of ≥6.5% and a diabetes duration of <15 years.",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
Diabetes camp as continuing education105 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgcamp as a continuing diabetes education in patients with a  long duration of diabetes has not been extensively investigated.,Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.106 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgcomplications of diabetes [20-22].",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
Diabetes camp as continuing education107 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgcamp experience on glycemic control among children and ad- olescents living with type 1 diabetes in sub-Saharan Africa.,Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.108 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgSupplementary  Table 1.",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
Diabetes camp as continuing education109 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgSupplementary  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.110 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgSupplementary  Table 3.",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
Diabetes camp as continuing education111 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgSupplementary  Fig.,Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"Park SY , et al.112 Diabetes Metab J 2017;41:99-112 http://e-dmj.orgSupplementary  Fig.",Non-OADS,/arxiv_data1/oa_pdf/f5/12/dmj-41-99.PMC5409007.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgA Cutoff for Age at Menarche Predicting Metabolic  Syndrome in Egyptian Overweight/Obese  Premenopausal Women Ibrahim Elsehely1, Hala Abdel Hafez1, Mohammed Ghonem1, Ali Fathi2, Rasha Elzehery3 1Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura,  2Department of Internal Medicine, Demira Hospital, Ministry of Health, Dakhlia,  3Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt Previous studies showed that early age at menarche is associated with increased risk of metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
"Keywords: Menarche; Metabolic syndrome; Overweight Corresponding author: Ibrahim Elsehely    http://orcid.org/0000-0002-9152-0938  Department of Internal Medicine, Faculty of Medicine, Mansoura University, Gomheria  St, Mansoura, Egypt E-mail: dr_hima_dm@yahoo.com Received: Jun.",Non-OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
Women taking hypolipidemic Brief Report Obesity and Metabolic Syndrome https://doi.org/10.4093/dmj.2017.41.2.146 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:146-149,Non-OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
Age at menarche and metabolic syndrome147 Diabetes Metab J 2017;41:146-149 http://e-dmj.orgor corticosteroid medications were also excluded.,Non-OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
"Elsehely I, et al.148 Diabetes Metab J 2017;41:146-149 http://e-dmj.orgtion are summarized in Table 1.",OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
"Age at menarche and metabolic syndrome149 Diabetes Metab J 2017;41:146-149 http://e-dmj.orgtion Task Force on Epidemiology and Prevention; National  Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.",Non-OADS,/arxiv_data1/oa_pdf/5a/bb/dmj-41-146.PMC5409008.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/1b/dmj-41-96.PMC5409009.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgAssociation between Blood Mercury Level and Visceral  Adiposity in Adults Seong-Su Moon Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju, Korea Corresponding author: Seong-Su Moon    http://orcid.org/0000-0001-8881-3927 Department of Internal Medicine, Dongguk University College of Medicine,  123 Dongdae-ro, Gyeongju 38066, KoreaE-mail: drmoonss@hanmail.netRecently, there has been increasing concern with regard to  health problems due to exposure to environmental pollutants, such as substances found in our food and consumer or indus-trial products that interfere with our body’s hormone synthe-sis, secretion, activity, and metabolism [1,2].",Non-OADS,/arxiv_data1/oa_pdf/d6/1b/dmj-41-96.PMC5409009.pdf
Besides Editorial Obesity and Metabolic Syndrome https://doi.org/10.4093/dmj.2017.41.2.96 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:96-98,Non-OADS,/arxiv_data1/oa_pdf/d6/1b/dmj-41-96.PMC5409009.pdf
"Blood mercury and visceral adiposity 97 Diabetes Metab J 2017;41:96-98 http://e-dmj.orgthe major finding, Park et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/1b/dmj-41-96.PMC5409009.pdf
98Moon SS Diabetes Metab J 2017;41:96-98 http://e-dmj.orgylmercury.,Non-OADS,/arxiv_data1/oa_pdf/d6/1b/dmj-41-96.PMC5409009.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgAssociation between Blood Mercury Level and Visceral  Adiposity in Adults Jong Suk Park1, Kyoung Hwa Ha2,3, Ka He4, Dae Jung Kim2,3 1Department of Endocrinology and Metabolism, Y onsei University College of Medicine, Seoul,  2 Cardiovascular and Metabolic Disease Etiology Research Center, 3Department of Endocrinology and Metabolism, Ajou University School of Medicine,  Suwon, Korea, 4Department of Epidemiology and Biostatistics, Indiana University Bloomington School of Public Health, Bloomington, IN, USA Background:  Few studies have examined the association between mercury exposure and obesity.",Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Keywords: Body mass index; Intra-abdominal fat; Mercury; Obesity; Waist circumference Corresponding author: Dae Jung Kim    http://orcid.org/0000-0003-1025-2044  Department of Endocrinology and Metabolism, Ajou University School of Medicine,   164 World cup-ro, Y eongtong-gu, Suwon 16499, Korea  E-mail: djkim@ajou.ac.kr Received: May 25, 2016; Accepted: Aug. 16, 2016INTRODUCTION There has been a growing concern regarding the environmen- tal and health effects of heavy metals.",Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Although a few human studies have investigated the associ-ation between blood mercury level and adiposity, which is measured using body mass index (BMI) and waist circumfer -Original Article Obesity and Metabolic Syndrome https://doi.org/10.4093/dmj.2017.41.2.113 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:113-120",Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Park JS, et al.114 Diabetes Metab J 2017;41:113-120 http://e-dmj.orgence (WC), the findings have been inconsistent [4,5,9,13].",OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
Mercury and visceral adiposity115 Diabetes Metab J 2017;41:113-120 http://e-dmj.orgwere estimated from FSG and insulin using the updated ho- meostatic model assessment (HOMA2) calculator [20].,Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Park JS, et al.116 Diabetes Metab J 2017;41:113-120 http://e-dmj.orging and data acquisition were conducted in accordance with  the operator’s manual [14].",OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
Mercury and visceral adiposity117 Diabetes Metab J 2017;41:113-120 http://e-dmj.orgThe blood mercury concentration was lowest in those with  normal BMI and higher in the obese group.,Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Park JS, et al.118 Diabetes Metab J 2017;41:113-120 http://e-dmj.orgmercury concentration tended to increase with increasing fish  consumption frequency, and this finding is consistent with that of previous studies [31,32].",OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Mercury and visceral adiposity119 Diabetes Metab J 2017;41:113-120 http://e-dmj.orgACKNOWLEDGMENTS  This study was supported by a grant from the Korean Health  Technology R&D Project, Ministry of Health and Welfare, Ko-rea (HI13C0715).",Non-OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"Park JS, et al.120 Diabetes Metab J 2017;41:113-120 http://e-dmj.orggram.",OADS,/arxiv_data1/oa_pdf/91/eb/dmj-41-113.PMC5409010.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgLipid Abnormalities in Type 2 Diabetes Mellitus  Patients with Overt Nephropathy Sabitha Palazhy, Vijay Viswanathan M.V .",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Keywords: Cardiovascular risk; Diabetic nephropathy; Dyslipidemia; Small, dense low density lipoprotein Corresponding author: Sabitha Palazhy    http://orcid.org/0000-0002-8159-9347  M.V .",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Lipoprotein abnormalities are known to occur among patients with diabetic nephropathy, and majority of Original Article Complications https://doi.org/10.4093/dmj.2017.41.2.128 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:128-134",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Lipid abnormalities in diabetic nephropathy129 Diabetes Metab J 2017;41:128-134 http://e-dmj.orgsuch patients die of cardiovascular events before their renal  dysfunction progresses to end stage renal disease [4,5].",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Palazhy S, et al.130 Diabetes Metab J 2017;41:128-134 http://e-dmj.orgRESULTS The mean age was 54.28±9.26 and 55.72±10.33 years and mean  duration of diabetes was 10.76±7.61 and 12.27±7.04 for con-trols and nephropathy subjects, respectively.",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
Lipid abnormalities in diabetic nephropathy131 Diabetes Metab J 2017;41:128-134 http://e-dmj.orgjects ( P=0.067).,Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Palazhy S, et al.132 Diabetes Metab J 2017;41:128-134 http://e-dmj.orgnephropathy group).",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Lipid abnormalities in diabetic nephropathy133 Diabetes Metab J 2017;41:128-134 http://e-dmj.orgstatins can improve renal outcomes, though this is not proven  conclusively [11].",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
"Palazhy S, et al.134 Diabetes Metab J 2017;41:128-134 http://e-dmj.org1997;12:1908-15.",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/dmj-41-128.PMC5409011.pdf
These sites included http://clinicaltrials.gov  and http://www.,Non-OADS,/arxiv_data1/oa_pdf/2c/71/pyw100.PMC5409012.pdf
Available online http://www.fda.gov/ohrms/ dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/71/pyw100.PMC5409012.pdf
Available at: http://cssrs.columbia.,Non-OADS,/arxiv_data1/oa_pdf/86/96/pyw116.PMC5409034.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/fd/ddw416.PMC5409060.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/0e/ddw405.PMC5409085.pdf
"Recent advances in medical research have resulted in large catalogues of mutations causing Mendelian hereditary dis- orders and of susceptibility loci contributing to complex dis- eases, such as those of the Online Mendelian Inheritance in Man (OMIM) database (http://www.omim.org/) ( 1) and the Genome-Wide Association Studies (GWAS) Catalogue (https:// www.ebi.ac.uk/gwas/) ( 2,3).",Non-OADS,/arxiv_data1/oa_pdf/b7/0e/ddw405.PMC5409085.pdf
"For each complex disease trait, an age ofonset was obtained either by considering the mean age of onset reported in the association study with the highest number of in-dividuals and/or the information available in the Medscapedatabase (http://www.medscape.com); for Mendelian genes, theage of onset was retrieved directly from the information pro-vided in the hOMIM dataset ( Supplementary Material, Table S3 ).",OADS,/arxiv_data1/oa_pdf/b7/0e/ddw405.PMC5409085.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/b3/ddw434.PMC5409095.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):309-316 309Korean J Physiol Pharmacol 2017;21(3):309-316 https://doi.org/10.4196/kjpp.2017.21.3.309 Author contributions: Y.N.,Non-OADS,/arxiv_data1/oa_pdf/d4/24/kjpp-21-309.PMC5409111.pdf
310 https://doi.org/10.4196/kjpp.2017.21.3.309 Korean J Physiol Pharmacol 2017;21(3):309-316Nam Y et al (Cinnamomum camphora ) and was the first natural compound  found to activate TRPV3 [4] .,Non-OADS,/arxiv_data1/oa_pdf/d4/24/kjpp-21-309.PMC5409111.pdf
312 https://doi.org/10.4196/kjpp.2017.21.3.309 Korean J Physiol Pharmacol 2017;21(3):309-316Nam Y et al (5) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/24/kjpp-21-309.PMC5409111.pdf
314 https://doi.org/10.4196/kjpp.2017.21.3.309 Korean J Physiol Pharmacol 2017;21(3):309-316Nam Y et al times more than it did at a negative voltage.,Non-OADS,/arxiv_data1/oa_pdf/d4/24/kjpp-21-309.PMC5409111.pdf
"316 https://doi.org/10.4196/kjpp.2017.21.3.309 Korean J Physiol Pharmacol 2017;21(3):309-316Nam Y et al Eisinger B, Liu ML, Huang SM, Caterina MJ, Dempsey P, Michael  LE, Dlugosz AA, Andrews NC, Clapham DE, Xu H. TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier  formation.",Non-OADS,/arxiv_data1/oa_pdf/d4/24/kjpp-21-309.PMC5409111.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):335-343 335Korean J Physiol Pharmacol 2017;21(3):335-343 https://doi.org/10.4196/kjpp.2017.21.3.335 Author contributions: S.J.K.,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/kjpp-21-335.PMC5409112.pdf
"336 https://doi.org/10.4196/kjpp.2017.21.3.335 Korean J Physiol Pharmacol 2017;21(3):335-343Hyung KE et al the four selected strains affect the induction of AD, the symptoms  and immune responses were studied in mice with AD induced by the topical application of house dust mite  Dermatophagoides  farinae  body (Dfb) extract followed by administration of the  strains [9].",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/kjpp-21-335.PMC5409112.pdf
"338 https://doi.org/10.4196/kjpp.2017.21.3.335 Korean J Physiol Pharmacol 2017;21(3):335-343Hyung KE et al dermatitis score, while low doses of CJLP55, such as 105 and 107  CFU/mouse, and heat-killed CJLP55-treated group showed no  effect on the score.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/kjpp-21-335.PMC5409112.pdf
340 https://doi.org/10.4196/kjpp.2017.21.3.335 Korean J Physiol Pharmacol 2017;21(3):335-343Hyung KE et al lymph node.,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/kjpp-21-335.PMC5409112.pdf
"342 https://doi.org/10.4196/kjpp.2017.21.3.335 Korean J Physiol Pharmacol 2017;21(3):335-343Hyung KE et al In conclusion, orally administered viable and heat-killed  CJLP55 suppressed the skin inflammation and AD-like skin  lesions, and altered the immune cell populations and activation.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/kjpp-21-335.PMC5409112.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):287-292 287Korean J Physiol Pharmacol 2017;21(3):287-292 https://doi.org/10.4196/kjpp.2017.21.3.287 Author contributions: P .X., J.C. and C.T.",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/kjpp-21-287.PMC5409113.pdf
288 https://doi.org/10.4196/kjpp.2017.21.3.287 Korean J Physiol Pharmacol 2017;21(3):287-292Xu P et al is involved [6-11] .,Non-OADS,/arxiv_data1/oa_pdf/7c/ed/kjpp-21-287.PMC5409113.pdf
"290 https://doi.org/10.4196/kjpp.2017.21.3.287 Korean J Physiol Pharmacol 2017;21(3):287-292Xu P et al melanogenesis and migration ability, we determined the effects of  pimecrolimus on the protein expression of MITF using Western blotting.",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/kjpp-21-287.PMC5409113.pdf
292 https://doi.org/10.4196/kjpp.2017.21.3.287 Korean J Physiol Pharmacol 2017;21(3):287-292Xu P et al Medicine in Jiangsu Province  (YX1202).,Non-OADS,/arxiv_data1/oa_pdf/7c/ed/kjpp-21-287.PMC5409113.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):279-286 279Korean J Physiol Pharmacol 2017;21(3):279-286 https://doi.org/10.4196/kjpp.2017.21.3.279 Author contributions: Y.L.,Non-OADS,/arxiv_data1/oa_pdf/7f/52/kjpp-21-279.PMC5409114.pdf
280 https://doi.org/10.4196/kjpp.2017.21.3.279 Korean J Physiol Pharmacol 2017;21(3):279-286Li Y et al diabetes.,Non-OADS,/arxiv_data1/oa_pdf/7f/52/kjpp-21-279.PMC5409114.pdf
"282 https://doi.org/10.4196/kjpp.2017.21.3.279 Korean J Physiol Pharmacol 2017;21(3):279-286Li Y et al ethanol under reflux for 1 h. Secondly, the alcoholic extracts were  concentrated, suspended in distilled water and then partitioned successively with 3-fold (v/v) n-butanol saturated with water for three times.",Non-OADS,/arxiv_data1/oa_pdf/7f/52/kjpp-21-279.PMC5409114.pdf
"284 https://doi.org/10.4196/kjpp.2017.21.3.279 Korean J Physiol Pharmacol 2017;21(3):279-286Li Y et al DISCUSSION In the study, it was found that AT12, which was isolated from  Aralia Taibaiensis , was a newly determined AMPK activator.",OADS,/arxiv_data1/oa_pdf/7f/52/kjpp-21-279.PMC5409114.pdf
SUPPLEMENTARY MATERIALS Supplementary data including one figure can be found with  this article online at http://pdf.medrang.co.kr/paper/pdf/Kjpp/Kjpp021-03-01-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7f/52/kjpp-21-279.PMC5409114.pdf
286 https://doi.org/10.4196/kjpp.2017.21.3.279 Korean J Physiol Pharmacol 2017;21(3):279-286Li Y et al 4.,Non-OADS,/arxiv_data1/oa_pdf/7f/52/kjpp-21-279.PMC5409114.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):293-300 293Korean J Physiol Pharmacol 2017;21(3):293-300 https://doi.org/10.4196/kjpp.2017.21.3.293 Author contributions: Z.Y.,Non-OADS,/arxiv_data1/oa_pdf/90/e3/kjpp-21-293.PMC5409115.pdf
294 https://doi.org/10.4196/kjpp.2017.21.3.293 Korean J Physiol Pharmacol 2017;21(3):293-300Zhang Y et al acted as a potent endogenous ligand for the nuclear peroxisome  proliferator-activated receptor gamma (PPAR g) [7].,Non-OADS,/arxiv_data1/oa_pdf/90/e3/kjpp-21-293.PMC5409115.pdf
296 https://doi.org/10.4196/kjpp.2017.21.3.293 Korean J Physiol Pharmacol 2017;21(3):293-300Zhang Y et al Fig.,Non-OADS,/arxiv_data1/oa_pdf/90/e3/kjpp-21-293.PMC5409115.pdf
"298 https://doi.org/10.4196/kjpp.2017.21.3.293 Korean J Physiol Pharmacol 2017;21(3):293-300Zhang Y et al on PGD2-induced atrial ANP secretion (p<0.05 vs. control period,  Fig.",Non-OADS,/arxiv_data1/oa_pdf/90/e3/kjpp-21-293.PMC5409115.pdf
300 https://doi.org/10.4196/kjpp.2017.21.3.293 Korean J Physiol Pharmacol 2017;21(3):293-300Zhang Y et al sion in beating rabbit atria.,Non-OADS,/arxiv_data1/oa_pdf/90/e3/kjpp-21-293.PMC5409115.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):301-308 301Korean J Physiol Pharmacol 2017;21(3):301-308 https://doi.org/10.4196/kjpp.2017.21.3.301 Author contributions: Y.H.S.,Non-OADS,/arxiv_data1/oa_pdf/33/25/kjpp-21-301.PMC5409116.pdf
302 https://doi.org/10.4196/kjpp.2017.21.3.301 Korean J Physiol Pharmacol 2017;21(3):301-308Son Y et al occurring in DC differentiation in response to 27OHCHol to  understand underlying mechanisms leading to increased number of DCs in a milieu rich in cholesterol oxidation products.,Non-OADS,/arxiv_data1/oa_pdf/33/25/kjpp-21-301.PMC5409116.pdf
304 https://doi.org/10.4196/kjpp.2017.21.3.301 Korean J Physiol Pharmacol 2017;21(3):301-308Son Y et al Decreased cell adhesion by treatment with LY294002  and U0126 CD197 (CCR7) is highly expressed on mDCs stage [13] .,Non-OADS,/arxiv_data1/oa_pdf/33/25/kjpp-21-301.PMC5409116.pdf
"306 https://doi.org/10.4196/kjpp.2017.21.3.301 Korean J Physiol Pharmacol 2017;21(3):301-308Son Y et al signaling pathways, including MAPK, ERK and NF- κB [13- 15].",Non-OADS,/arxiv_data1/oa_pdf/33/25/kjpp-21-301.PMC5409116.pdf
SUPPLEMENTARY MATERIALS Supplementary data including three figures can be found with  this article online at http://pdf.medrang.co.kr/paper/pdf/Kjpp/Kjpp021-03-04-s001 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/33/25/kjpp-21-301.PMC5409116.pdf
308 https://doi.org/10.4196/kjpp.2017.21.3.301 Korean J Physiol Pharmacol 2017;21(3):301-308Son Y et al 20.,Non-OADS,/arxiv_data1/oa_pdf/33/25/kjpp-21-301.PMC5409116.pdf
"www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):317-325 317Korean J Physiol Pharmacol 2017;21(3):317-325 https://doi.org/10.4196/kjpp.2017.21.3.317 Author contributions: L.J.P ., J.Y.C., and H.J.H.",Non-OADS,/arxiv_data1/oa_pdf/6e/bb/kjpp-21-317.PMC5409117.pdf
318 https://doi.org/10.4196/kjpp.2017.21.3.317 Korean J Physiol Pharmacol 2017;21(3):317-325Piao L et al responsible for maintenance of intracellular redox homeostasis.,Non-OADS,/arxiv_data1/oa_pdf/6e/bb/kjpp-21-317.PMC5409117.pdf
320 https://doi.org/10.4196/kjpp.2017.21.3.317 Korean J Physiol Pharmacol 2017;21(3):317-325Piao L et al in response to IPGTT was increased in both WT-HF and CKO- HF mice compared to that of WT mice ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/6e/bb/kjpp-21-317.PMC5409117.pdf
"322 https://doi.org/10.4196/kjpp.2017.21.3.317 Korean J Physiol Pharmacol 2017;21(3):317-325Piao L et al biogenesis during short-term HFD feeding, mRNA expression  of mtDNA, Tfam, PGC1 α, COX4-i1, and Nrf1 was measured  by real-time PCR.",OADS,/arxiv_data1/oa_pdf/6e/bb/kjpp-21-317.PMC5409117.pdf
"324 https://doi.org/10.4196/kjpp.2017.21.3.317 Korean J Physiol Pharmacol 2017;21(3):317-325Piao L et al cluding lipid accumulation, insulin resistance, and inflammation,  which can be utilized for screening new therapeutic agents, targeting obesity and obesity related NAFLD.",Non-OADS,/arxiv_data1/oa_pdf/6e/bb/kjpp-21-317.PMC5409117.pdf
SUPPLEMENTARY MATERIALS Supplementary data including three figures can be found with  this article online at http://pdf.medrang.co.kr/paper/pdf/Kjpp/Kjpp021-03-06-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/bb/kjpp-21-317.PMC5409117.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):353-360 353Korean J Physiol Pharmacol 2017;21(3):353-360 https://doi.org/10.4196/kjpp.2017.21.3.353 Author contributions: T.Z.,Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjpp-21-353.PMC5409118.pdf
354 https://doi.org/10.4196/kjpp.2017.21.3.353 Korean J Physiol Pharmacol 2017;21(3):353-360Zhou T et al vascular endothelial cells plays an essential role in regulating  vascular tone and cellular proliferation [10] .,Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjpp-21-353.PMC5409118.pdf
"356 https://doi.org/10.4196/kjpp.2017.21.3.353 Korean J Physiol Pharmacol 2017;21(3):353-360Zhou T et al component analysis on the VIP gene expression indicates that, for  one given subject group in the discovery cohort, the VIP signature significantly differentiates this group from the other two ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjpp-21-353.PMC5409118.pdf
358 https://doi.org/10.4196/kjpp.2017.21.3.353 Korean J Physiol Pharmacol 2017;21(3):353-360Zhou T et al connective tissue disease associated PAH.,Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjpp-21-353.PMC5409118.pdf
SUPPLEMENTARY MATERIALS Supplementary data including three figures and two tables  can be found with this article online at http://pdf.medrang.co.kr/paper/pdf/Kjpp/Kjpp021-03-10-s001.pdf.REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/76/kjpp-21-353.PMC5409118.pdf
"360 https://doi.org/10.4196/kjpp.2017.21.3.353 Korean J Physiol Pharmacol 2017;21(3):353-360Zhou T et al Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP,  Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the  unification of biology.",OADS,/arxiv_data1/oa_pdf/ad/76/kjpp-21-353.PMC5409118.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):345-352 345Korean J Physiol Pharmacol 2017;21(3):345-352 https://doi.org/10.4196/kjpp.2017.21.3.345 Author contributions: Y.S.Y.,Non-OADS,/arxiv_data1/oa_pdf/97/3d/kjpp-21-345.PMC5409119.pdf
"346 https://doi.org/10.4196/kjpp.2017.21.3.345 Korean J Physiol Pharmacol 2017;21(3):345-352Yi YS et al regulated kinases (ERKs), c-Jun N-terminal kinase (JNK), and  p38), resulting in the activation of transcription factors such as nuclear factor-kappa B (NF- κB) and activator protein (AP)-1 [6- 9].",Non-OADS,/arxiv_data1/oa_pdf/97/3d/kjpp-21-345.PMC5409119.pdf
348 https://doi.org/10.4196/kjpp.2017.21.3.345 Korean J Physiol Pharmacol 2017;21(3):345-352Yi YS et al Nuclear lysates of RAW264.7 cells were prepared as described  previously [33] and stored immediately at –80oC until use.,Non-OADS,/arxiv_data1/oa_pdf/97/3d/kjpp-21-345.PMC5409119.pdf
350 https://doi.org/10.4196/kjpp.2017.21.3.345 Korean J Physiol Pharmacol 2017;21(3):345-352Yi YS et al the nuclear translocation of the AP-1 transcription factors c-Jun  and c-Fos in LPS-stimulated RAW264.7 cells by Western blot analysis.,Non-OADS,/arxiv_data1/oa_pdf/97/3d/kjpp-21-345.PMC5409119.pdf
352 https://doi.org/10.4196/kjpp.2017.21.3.345 Korean J Physiol Pharmacol 2017;21(3):345-352Yi YS et al 2015;39:155-161.,Non-OADS,/arxiv_data1/oa_pdf/97/3d/kjpp-21-345.PMC5409119.pdf
www.kjpp.net Korean J Physiol Pharmacol 2017;21(3):327-334 327Korean J Physiol Pharmacol 2017;21(3):327-334 https://doi.org/10.4196/kjpp.2017.21.3.327 Author contributions: D.U.L.,Non-OADS,/arxiv_data1/oa_pdf/f5/61/kjpp-21-327.PMC5409120.pdf
328 https://doi.org/10.4196/kjpp.2017.21.3.327 Korean J Physiol Pharmacol 2017;21(3):327-334Lee DU et al IL-8 [13-16] .,Non-OADS,/arxiv_data1/oa_pdf/f5/61/kjpp-21-327.PMC5409120.pdf
"330 https://doi.org/10.4196/kjpp.2017.21.3.327 Korean J Physiol Pharmacol 2017;21(3):327-334Lee DU et al of respiratory diseases, such as, chronic obstructive pulmonary  disease (COPD) [29] , and therefore, the targeting of ROS  represents a potential therapeutic strategy in such patients.",Non-OADS,/arxiv_data1/oa_pdf/f5/61/kjpp-21-327.PMC5409120.pdf
332 https://doi.org/10.4196/kjpp.2017.21.3.327 Korean J Physiol Pharmacol 2017;21(3):327-334Lee DU et al signals into cells [37] .,Non-OADS,/arxiv_data1/oa_pdf/f5/61/kjpp-21-327.PMC5409120.pdf
"334 https://doi.org/10.4196/kjpp.2017.21.3.327 Korean J Physiol Pharmacol 2017;21(3):327-334Lee DU et al Ichikawa T, Kakizaki S, Takagi H, Izumi T, Mori M. Azelnidipine  is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.",Non-OADS,/arxiv_data1/oa_pdf/f5/61/kjpp-21-327.PMC5409120.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/e6/ddw432.PMC5409121.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/a5/ddw426.PMC5409123.pdf
"Human primary myoblasts were obtained from the University of Massachusetts Medical School Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center for FSHD (http://www.umassmed.edu/wellstone; date last accessed December 30, 2016) in Worcester, MA, USA.",Non-OADS,/arxiv_data1/oa_pdf/14/a5/ddw426.PMC5409123.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/f4/fdv147.PMC5409124.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/85/aew468.PMC5409133.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
Incidence rates were delay-adjusted to account for revisions tothe case counts in future submissions (http://surveillance.cancer.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
"In addition, the CDC has invested resources in uti- lizing NPCR registries for conducting population-basedcomparative effectiveness research ( 100) and in making these data available to researchers through NCHS’s Research DataCenter (http://www.cdc.gov/rdc/index.htm).",OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
Available at http://www.naaccr.org/Certiﬁcation/Criteria.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
"Bethesda, MD: National Cancer Institute; 2015. http://seer.can cer.gov/csr/1975_2012/.",Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
Population estimates used in NCI’s SEER*Stat software.http://seer.cancer.gov/popdata/methods.html.,OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
"https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm.Accessed December 22, 2016.",OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
2015. http://surveillance.cancer.gov/joinpoint/.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
AAPC conﬁdence intervals–Joinpoint Help System 4.3.1.0. https://surveillance.cancer.gov/help/joinpoint/setting- parameters/advanced-tab/aapc-conﬁdence-intervals.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
"Bethesda, MD: National Cancer Institute; 2016. http://seer.cancer.gov/ csr/1975_2013/.",Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
https://www.childrensoncologygroup.org/.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
2015. https://www.bls.gov.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
https://www.whitehouse.gov/can cermoonshot.,Non-OADS,/arxiv_data1/oa_pdf/ef/85/djx030.PMC5409140.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e54869 | Page 1 of 17Video Article A Web Tool for Generating High Quality Machine-readable Biological Pathways Miguel Ramirez-Gaona1, Ana Marcu1, Allison Pon1, Jason Grant1, Anthony Wu1, David S. Wishart1,2 1Department of Computer Science, University of Alberta 2Department of Biological Sciences, University of Alberta Correspondence to: David S. Wishart at dwishart@ualberta.ca URL: https://www.jove.com/video/54869 DOI: doi:10.3791/54869 Keywords: Biochemistry, Issue 120, pathway diagram, web, reaction, illustration, metabolism, interaction, signaling, disease, drug Date Published: 2/8/2017 Citation: Ramirez-Gaona, M., Marcu, A., Pon, A., Grant, J., Wu, A., Wishart, D.S.",Non-OADS,/arxiv_data1/oa_pdf/0e/55/jove-120-54869.PMC5409186.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54869/ Introduction Biological pathway diagrams are like blueprints for life scientists.,Non-OADS,/arxiv_data1/oa_pdf/0e/55/jove-120-54869.PMC5409186.pdf
"PathWhiz was implemented using a Ruby on Rails (http:// rubyonrails.org, version 4.2.0) web framework incorporating a MySQL relational database (https://www.mysql.com, version 5.1.50) to manage all of the pathway data, including entity relationships, external references, descriptions, visualization specifications and chemical structures.",OADS,/arxiv_data1/oa_pdf/0e/55/jove-120-54869.PMC5409186.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e54869 | Page 2 of 17The front-end web client is controlled by Ruby on Rails combined with Backbone.js (http://backbonejs.org, version 1.0.0) as the front-end web framework for the editor.",Non-OADS,/arxiv_data1/oa_pdf/0e/55/jove-120-54869.PMC5409186.pdf
Pathway Generation 1.Go to http://smpdb.ca/pathwhiz using any modern web browser.,OADS,/arxiv_data1/oa_pdf/0e/55/jove-120-54869.PMC5409186.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54885 | Page 1 of 7Video Article Measurement of Particle Size Distribution in Turbid Solutions by Dynamic Light Scattering Microscopy Takashi Hiroi1, Mitsuhiro Shibayama2 1Department of Chemistry, School of Science, University of Tokyo 2Institute for Solid State Physics, University of Tokyo Correspondence to: Takashi Hiroi at hiroi@chem.s.u-tokyo.ac.jp , Mitsuhiro Shibayama at sibayama@issp.u-tokyo.ac.jp URL: https://www.jove.com/video/54885 DOI: doi:10.3791/54885 Keywords: Chemistry, Issue 119, dynamic light scattering, confocal microscopy, polydispersity, colloidal solution, backscattering, heterodyne Date Published: 1/9/2017 Citation: Hiroi, T., Shibayama, M. Measurement of Particle Size Distribution in Turbid Solutions by Dynamic Light Scattering Microscopy.",Non-OADS,/arxiv_data1/oa_pdf/cf/9c/jove-119-54885.PMC5409188.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54885/ Introduction Particle size is one of the most fundamental properties of colloidal and polymer solutions.,Non-OADS,/arxiv_data1/oa_pdf/cf/9c/jove-119-54885.PMC5409188.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 141–148Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  141 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S126073Comparative effectiveness and resource  utilization of nab-paclitaxel plus gemcitabine  vs FOLFIRINOX or gemcitabine for the  first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting Fadi Braiteh1 Manish B Patel2 Monika Parisi2 Quanhong Ni2 Siyeon Park2,3 Claudio Faria2 1Comprehensive Cancer Centers of  Nevada, University of Nevada School  of Medicine, Las Vegas, NV, 2Celgene  Corporation, Summit, NJ, 3The Ohio  State University, Columbus, OH, USAIntroduction: Despite a clinically relevant, statistically significant survival benefit with nab - paclitaxel plus gemcitabine and FOLFIRINOX vs single-agent gemcitabine for metastatic  pancreatic cancer (mPC), little is known regarding their real-world effectiveness.",Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
"These findings support nab -paclitaxel plus gemcitabine as an appropriate first-line treat- ment option for patients with mPC.Key words: metastatic pancreatic cancer, nab -paclitaxel, gemcitabine, FOLFIRINOX, com- parative effectiveness Introduction In the USA, pancreatic cancer (PC) is the fourth leading cause of cancer-related mor - tality, with incidence and mortality rates predicted to increase.1,2 Estimates  suggest  that by 2030, PC will become the second leading cause of cancer-related deaths in the  USA.3 The 5-year relative survival rate for patients with all stages of PC is 7–8%; for Correspondence: Fadi S Braiteh Medical Oncology, Comprehensive Cancer Centers of Nevada, University of Nevada School of Medicine, 3730 S Eastern Avenue, Las Vegas, NV 89169, USATel +1 702 952 3400Fax +1 702 952 3723Email fadi.braiteh@usoncology.comJournal name: Cancer Management and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Braiteh et alRunning head recto: nab-paclitaxel and gemcitabine vs FOLFIRINOX or gemcitabine in PCDOI: http://dx.doi.org/10.2147/CMAR.S126073",Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 148 Braiteh et al Faria, Monika Parisi, Manish B Patel, and Quanhong Ni are  employees of Celgene Corporation.",Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
Available from: https://www.pancan.org/reports/report-the-alarming-rise-of-pancreatic-cancer-deaths-in-the-u-s-2/.,Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
Available from: http://seer.cancer.gov/statfacts/html/pancreas.html.,Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/35/cmar-9-141.PMC5409189.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 133–139Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 133 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S111007 Emerging targeted therapies for plaque psoriasis –  impact of ixekizumab Tiana Kazemi1 Benjamin Farahnik2 John Koo3 Kourosh Beroukhim1 1University of California – Los  Angeles, David Geffen School  of Medicine, Los Angeles, CA,   2University of Vermont College of  Medicine, Burlington, VT, 3University  of California – San Francisco,  Department of Dermatology,  Psoriasis  and Skin Treatment Center,   San Francisco, CA, USABackground: Recent studies into the pathogenesis of psoriasis have identified the importance  of interleukin 17 (IL-17) in disease activity and have thus provided a new target for biologic  therapy.",Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
"2 Due to its characteristic presentation, plaque psoriasis is most often  a clinical diagnosis.Correspondence: Benjamin Farahnik Department of Dermatology, University of California, San Francisco, 515 Spruce St., San Francisco, CA 94118, USATel +1 310 923 3278Fax +1 415 502 4126Email Benjamin.farahnik@med.uvm.eduJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Kazemi et alRunning head recto: Emerging targeted therapies for plaque psoriasisDOI: http://dx.doi.org/10.2147/CCID.S111007",Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm183851.htm.,Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
Available from: http://www.prnewswire.com/news-releases/amgen-to-terminate-participation-in-co-development-and-commercial   ization-of-brodalumab-300088098.html.,Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 139 Emerging targeted therapies for plaque psoriasis 25.,Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
Available from: https://investor.lilly.com/releasedetail.cfm?releaseid=867193.,Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
22 March 2016.Available from:  https://www.fda.gov/News Events/Newsroom/PressAnnouncements/ucm491872.htm.,Non-OADS,/arxiv_data1/oa_pdf/00/46/ccid-10-133.PMC5409192.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2016  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2016 |  118  | e54904 | Page 1 of 9Video Article ACT-PRESTO: Biological Tissue Clearing and Immunolabeling Methods for Volume Imaging Eunsoo Lee1, Woong Sun1 1Department of Anatomy, Korea University College of Medicine Correspondence to: Woong Sun at woongsun@korea.ac.kr URL: https://www.jove.com/video/54904 DOI: doi:10.3791/54904 Keywords: Bioengineering, Issue 118, tissue clearing, immunolabeling, 3D imaging, tissue-hydrogel, tissue engineering, neuroscience, ACT- PRESTO, X-CLARITY Date Published: 12/31/2016 Citation: Lee, E., Sun, W. ACT-PRESTO: Biological Tissue Clearing and Immunolabeling Methods for Volume Imaging.",Non-OADS,/arxiv_data1/oa_pdf/08/8a/jove-118-54904.PMC5409193.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54904/ Introduction One of the challenges in neuroscience is the visualization of neuronal circuit wiring and individual cells within intact brain tissue.,Non-OADS,/arxiv_data1/oa_pdf/08/8a/jove-118-54904.PMC5409193.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54861 | Page 1 of 9Video Article Online Size-exclusion and Ion-exchange Chromatography on a SAXS Beamline Martha E. Brennich1, Adam R. Round2,3, Stephanie Hutin4 1Structural Biology Group, European Synchrotron Radiation Facility 2European Molecular Biology Laboratory 3School of Chemical and Physical Sciences, Keele University 4Groupe de Microscopie Electronique et Méthodes, Institut de Biologie Structurale Correspondence to: Stephanie Hutin at stephanie.hutin@ibs.fr URL: https://www.jove.com/video/54861 DOI: doi:10.3791/54861 Keywords: Biochemistry, Issue 119, Bio-Small Angle X-ray Scattering (BioSAXS), online size-exclusion chromatography (SEC), online ion- exchange chromatography (IEC), background subtraction, D5, vaccinia Date Published: 1/5/2017 Citation: Brennich, M.E., Round, A.R., Hutin, S. Online Size-exclusion and Ion-exchange Chromatography on a SAXS Beamline.",Non-OADS,/arxiv_data1/oa_pdf/7b/55/jove-119-54861.PMC5409194.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54861/ Introduction BioSAXS is a powerful tool to determine the shape of nano-sized objects1-4.,OADS,/arxiv_data1/oa_pdf/7b/55/jove-119-54861.PMC5409194.pdf
"For ESRF, guidelines on available access types and on how to submit an application can be found at:   http://www.esrf.eu/UsersAndScience/UserGuide/Applying.",Non-OADS,/arxiv_data1/oa_pdf/7b/55/jove-119-54861.PMC5409194.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e54983 | Page 1 of 9Video Article Triggering Cell Stress and Death Using Conventional UV Laser Confocal Microscopy Marco Morsch1, Rowan A. W. Radford1, Emily K. Don1, Albert Lee1, Elinor Hortle1, Nicholas J. Cole1, Roger S. Chung1 1Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University Correspondence to: Marco Morsch at marco.morsch@mq.edu.au URL: https://www.jove.com/video/54983 DOI: doi:10.3791/54983 Keywords: Neuroscience, Issue 120, UV laser ablation, cell death, cell stress, zebrafish, microglia, 405 nm, MND, ALS, confocal Date Published: 2/3/2017 Citation: Morsch, M., Radford, R.A., Don, E.K., Lee, A., Hortle, E., Cole, N.J., Chung, R.S.",Non-OADS,/arxiv_data1/oa_pdf/e4/ac/jove-120-54983.PMC5409196.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54983/ Introduction Fluorescence microscopy has long been used to study the effects of transgenes in the zebrafish CNS, particularly their effects on development1.",Non-OADS,/arxiv_data1/oa_pdf/e4/ac/jove-120-54983.PMC5409196.pdf
"1, 1~10, March , 201 7  <Review>   https://doi.org/10.12717/ DR.201 7.21.1.001  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received December 22, 2016, Received in revised form December 28, 2016, Accepted January 2, 2017    † Corresponding Author : Jeong -Soo Park, Ph.D., Department of Biochemistry, College of Medicine, Dankook University , 119, Dandaero, Dongnam -gu,  Cheonan -si, Chungcheongnam -do, 330 -714, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/be/2a/dr-21-1-1.PMC5409204.pdf
"1, 101-110, March , 201 7  <Short communication>   https://doi.org/10.12717/ DR.2017.21.1.",Non-OADS,/arxiv_data1/oa_pdf/f8/d5/dr-21-1-101.PMC5409205.pdf
"1, 11~18, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.2017.21.1.011   ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received December 25, 2016, Received in revised form December 29, 2016, Accepted January 5, 2017    † Corresponding Author : Dr. Seok -Ho Hong , Department of Internal Medicine, School of Medicine, Kangwon National University, Kangwondaehakgil -1,  Chuncheon, Gangwon -do 24341 Republic of Korea .",Non-OADS,/arxiv_data1/oa_pdf/0c/bd/dr-21-1-11.PMC5409206.pdf
"1, 19~33, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.2017.21.1.019   ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received December 28, 2016, Received in revised form Decemb er 31, 2016, Accepted January 8, 2017    † Corresponding Author : In-Seok Park , Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime and Ocean Unive rsity,  Busan 606 -791, Korea .",Non-OADS,/arxiv_data1/oa_pdf/04/68/dr-21-1-19.PMC5409207.pdf
"1, 35~46, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.201 7.21.1.035  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received February 2, 2017, Received in revised form February 8, 2017, Accepted February 14, 2017    † Corresponding Author : Hyunwon Yang , Department of Bioenvironmental Technology, Seoul Women's University,  126 Gongreung -Dong, Nowon -Gu,  Seoul 01797,  Korea .",Non-OADS,/arxiv_data1/oa_pdf/2a/7b/dr-21-1-35.PMC5409208.pdf
"1, 47~54, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.201 7.21.1.047  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received February 12, 2017, Received in revised form February 15, 2017, Accepted February 20, 2017    † Corresponding Author : Seongsoo Hwang, Ph.D. , Animal Biotechnology Division, NIAS , RDA,  1500, Kongjwipatjwi -ro, Wanju, Jeonbuk 55365, R e- public of Korea .",Non-OADS,/arxiv_data1/oa_pdf/b4/4d/dr-21-1-47.PMC5409209.pdf
"1, 55~62, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.2017.21.1.0 55  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received February 15, 2017, Received in revised form February 17, 2017, Accepted February 19, 2017    † Corresponding Author : In-Seok Park, Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime and Ocean University,  Busan 49112 , Korea.",Non-OADS,/arxiv_data1/oa_pdf/95/20/dr-21-1-55.PMC5409210.pdf
"1, 63-69, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.201 7.21.1.063  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received February 18, 2017, Received in revised form February 20, 2017, Accepted March 2, 2017    † Corresponding Author : Jeong  Tae Lee, Gyeongsangnam -do Fisheries Resources Res earch Institute, Tongyeong 50411, Korea.",Non-OADS,/arxiv_data1/oa_pdf/36/12/dr-21-1-63.PMC5409211.pdf
"1, 71~78, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.201 7.21.1.071  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received February 23, 2017, Received in revised form March 2, 2017, Accepted March 4, 2017    † Corresponding Author : Hyunwon Yang, Department of Bioenvironmental Technology, Seoul Women's University, 621 Hwarangro, Nowon -Gu, Seoul  01797 , Korea .",Non-OADS,/arxiv_data1/oa_pdf/43/e8/dr-21-1-71.PMC5409212.pdf
"1, 79~91, March , 201 7  <Original research paper>   https://doi.org/10.12717/ DR.2017.21.1.0 79  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received March 5, 2017, Received in revised form March 8, 2017, Accepted March 10, 2017    † Corresponding Author : In-Seok Park, Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime and Ocean University,  Busan 49112, Korea .",Non-OADS,/arxiv_data1/oa_pdf/0c/e9/dr-21-1-79.PMC5409213.pdf
"1, 93~100, March , 201 7  <Short communication>   https://doi.org/10.12717/ DR.201 7.21.1.093  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received March 8, 2017, Received in revised form March 10, 2017, Accepted March 12, 2017    † Corresponding Author : Se-Jae Kim, Department of Biology , Jeju National University, Jeju Special Self-Governing Province, Korea.",Non-OADS,/arxiv_data1/oa_pdf/db/67/dr-21-1-93.PMC5409214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecom-mons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/15/nlw052.PMC5409217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/80/ddw278.PMC5409218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/6a/ddw287.PMC5409219.pdf
"We analysed the top 1,000 peak se- quences using MEME/TOMTOM (http://meme.nbcr.net/meme/)to identify the consensus binding motifs for each protein ( 37).",OADS,/arxiv_data1/oa_pdf/7b/6a/ddw287.PMC5409219.pdf
PANTHER de- scription (http://pantherdb.org/).,OADS,/arxiv_data1/oa_pdf/7b/6a/ddw287.PMC5409219.pdf
Materials and Methods Protein alignment Protein alignments of all Dux proteins were compared usingEMBOSS Needle (http://www.ebi.ac.uk/Tools/psa/emboss_needle/).,OADS,/arxiv_data1/oa_pdf/7b/6a/ddw287.PMC5409219.pdf
"Signal maps and peak locations were used as input data to ActiveMotif’s (http://www.activemotif.com/) proprietary analysis pro- gram, which created Excel tables containing detailed information on sample comparison, peak metrics, peak locations and geneannotations.",OADS,/arxiv_data1/oa_pdf/7b/6a/ddw287.PMC5409219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/b5/ddw267.PMC5409220.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e55351 | Page 1 of 9Video Article A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time Katrijn R. Six1,2, Rosalie Devloo1, Britt Van Aelst1, Philippe Vandekerckhove2,3,4, Hendrik B. Feys1, Veerle Compernolle1,2,3 1Transfusion Research Center, Belgian Red Cross-Flanders 2Faculty of Medicine and Health Sciences, Ghent University 3Blood Service, Belgian Red Cross-Flanders 4Department of Public Health and Primary Care, KULeuven - University of Leuven Correspondence to: Hendrik B. Feys at hendrik.feys@rodekruis.be URL: https://www.jove.com/video/55351 DOI: doi:10.3791/55351 Keywords: Bioengineering, Issue 120, Platelets, microfluidic flow chamber, coagulation, transfusion, blood reconstitution, fibrin formation Date Published: 2/14/2017 Citation: Six, K.R., Devloo, R., Van Aelst, B., Vandekerckhove, P., Feys, H.B., Compernolle, V. A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time.",Non-OADS,/arxiv_data1/oa_pdf/7c/54/jove-120-55351.PMC5409263.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55351/ Introduction Primary and secondary hemostasis were originally conceptualized as two relatively separable biochemical processes.,Non-OADS,/arxiv_data1/oa_pdf/7c/54/jove-120-55351.PMC5409263.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55360 | Page 1 of 8Video Article A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG) Grant L. Lin1, Michelle Monje2 1Graduate Program in Neuroscience, Department of Neurology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine 2Departments of Neurology, Neurosurgery, Pathology and Pediatrics, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine Correspondence to: Michelle Monje at mmonje@stanford.edu URL: https://www.jove.com/video/55360 DOI: doi:10.3791/55360 Keywords: Cancer Research, Issue 121, DIPG, glioma, patient-derived cell culture, rapid autopsy, brain, tissue dissociation, cancer Date Published: 3/7/2017 Citation: Lin, G.L., Monje, M. A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG).",Non-OADS,/arxiv_data1/oa_pdf/95/65/jove-121-55360.PMC5409295.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55360/ Introduction DIPG is an aggressive central nervous system malignancy that arises in the ventral pons, typically during mid-childhood1,2.",Non-OADS,/arxiv_data1/oa_pdf/95/65/jove-121-55360.PMC5409295.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55425 | Page 1 of 9Video Article A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC) Katharina Grosser1,2, Nicole M. van Dam1,2 1German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig 2Institute of Ecology, Friedrich Schiller University Jena Correspondence to: Nicole M. van Dam at nicole.vandam@idiv.de URL: https://www.jove.com/video/55425 DOI: doi:10.3791/55425 Keywords: Chemistry, Issue 121, Arabidopsis , Brassica , cabbage, European community official method, mustard, high-pressure liquid chromatography-photodiode array (HPLC-PDA), indole glucosinolates, oilseed rape, response factors Date Published: 3/15/2017 Citation: Grosser, K., van Dam, N.M. A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC).",Non-OADS,/arxiv_data1/oa_pdf/9e/d9/jove-121-55425.PMC5409297.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55425/ Introduction It is estimated that plants produce over 200,000 different types of chemical compounds1.",Non-OADS,/arxiv_data1/oa_pdf/9e/d9/jove-121-55425.PMC5409297.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55262 | Page 1 of 8Video Article Differential Scanning Calorimetry — A Method for Assessing the Thermal Stability and Conformation of Protein Antigen Ibrahim B. Durowoju1, Kamaljit S. Bhandal1, Jian Hu1, Bruce Carpick1, Marina Kirkitadze1 1Analytical Research & Development, Sanofi Pasteur Limited Correspondence to: Marina Kirkitadze at Marina.Kirkitadze@sanofi.com URL: https://www.jove.com/video/55262 DOI: doi:10.3791/55262 Keywords: Biochemistry, Issue 121, Differential Scanning Calorimetry, Thermal Stability, Tertiary Structure, Protein Unfolding, Thermal Transition Temperature, Enthalpy, Protein Stability Date Published: 3/4/2017 Citation: Durowoju, I.B., Bhandal, K.S., Hu, J., Carpick, B., Kirkitadze, M. Differential Scanning Calorimetry — A Method for Assessing the Thermal Stability and Conformation of Protein Antigen.",Non-OADS,/arxiv_data1/oa_pdf/8a/30/jove-121-55262.PMC5409303.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55262/ Introduction Differential scanning calorimetry (DSC) is an experimental method that directly measures the difference in heat energy uptake taking place in a sample relative to a reference during a regulated temperature change 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12.",Non-OADS,/arxiv_data1/oa_pdf/8a/30/jove-121-55262.PMC5409303.pdf
"Availability and Implementation: The program source code for FSWM including a documentation, as well as the software that we used to generate artiﬁcial genome sequences are freely available athttp://fswm.gobics.de/ Contact: chris.leimeister@stud.uni-goettingen.de Supplementary information: Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/56/d2/btw776.PMC5409309.pdf
OMBlast can be downloaded from https://github.com/aldenleung/OMBlast and run directly on machines equipped with a Java virtual machine.,OADS,/arxiv_data1/oa_pdf/4b/c2/btw620.PMC5409310.pdf
"311 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/c2/btw620.PMC5409310.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2017 |  120  | e55143 | Page 1 of 8Video Article Detection of Copy Number Alterations Using Single Cell Sequencing Kristin A. Knouse1,2,3, Jie Wu4, Austin Hendricks5 1Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology 2Howard Hughes Medical Institute 3Division of Health Sciences and Technology, Harvard Medical School 4The Barbara K. Ostrom (1978) Bioinformatics and Computing Facility in the Swanson Biotechnology Center, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology 5BioMicro Center, Department of Biology, Massachusetts Institute of Technology Correspondence to: Kristin A. Knouse at kknouse@mit.edu URL: https://www.jove.com/video/55143 DOI: doi:10.3791/55143 Keywords: Genetics, Issue 120, copy number alteration, aneuploidy, genomic heterogeneity, single cell, whole genome amplification, whole genome sequencing Date Published: 2/17/2017 Citation: Knouse, K.A., Wu, J., Hendricks, A.",Non-OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55143/ Introduction Alterations in DNA copy number can range in size from several base pairs (copy number variants) (CNVs) to entire chromosomes (aneuploidy).,Non-OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
All scripts can be found at https://sourceforge.net/projects/singlecellseqcnv/ .,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://www.illumina.com/products/nextera_xt_dna_library_prep_kit.html> (2016).,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://aati-us.com/product/fragment-analyzer> (2016).,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://hannonlab.cshl.edu/fastx_toolkit/> (2016).,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://bio-bwa.sourceforge.net/> (2016).,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://samtools.sourceforge.net/> (2016).,Non-OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://compbio.bccrc.ca/software/hmmcopy/> (2016).,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <https://bioconductor.org/packages/release/bioc/html/DNAcopy.html> (2016).,OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://broadinstitute.github.io/picard/> (2016).,Non-OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
at <http://bedtools.readthedocs.io/en/latest/> (2016).,Non-OADS,/arxiv_data1/oa_pdf/df/52/jove-120-55143.PMC5409325.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Journal of Visualized Experiments February 2017 |  120  | e55146 | Page 1 of 6Video Article Legionella pneumophila  Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages Anna Lena Jung1, Kerstin Hoffmann1, Christina E. Herkt1, Christine Schulz1, Wilhelm Bertrams1, Bernd Schmeck1,2,3 1Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg 2German Center for Lung Research 3Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg Correspondence to: Bernd Schmeck at bernd.schmeck@uni-marburg.de URL: https://www.jove.com/video/55146 DOI: doi:10.3791/55146 Keywords: Infection, Issue 120, Legionella pneumophila , outer membrane vesicles, macrophage, purification, differential ultracentrifugation, pro- inflammatory response, bacterial replication Date Published: 2/22/2017 Citation: Jung, A.L., Hoffmann, K., Herkt, C.E., Schulz, C., Bertrams, W., Schmeck, B. Legionella pneumophila  Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages.",Non-OADS,/arxiv_data1/oa_pdf/03/a2/jove-120-55146.PMC5409326.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55146/ Introduction Bacteria can secrete virulence factors via different mechanisms1.,Non-OADS,/arxiv_data1/oa_pdf/03/a2/jove-120-55146.PMC5409326.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Journal of Visualized Experiments February 2017 |  120  | e55146 | Page 6 of 601X1304E; http://www.bmbf.de/), Deutsche Forschungsgemeinschaft (SFB/TR-84; http://www.sfb-tr84.de/), and Hessisches Ministerium für Wissenschaft und Kunst (LOEWE Medical RNomics - FKZ 519/03/00.001-(0003); http://www.proloewe.de/medicalrnomics), all to BS.",Non-OADS,/arxiv_data1/oa_pdf/03/a2/jove-120-55146.PMC5409326.pdf
33.https://www.novartis.com/news/media-releases/novartis-bexsero%C2%AE-vaccine-approved-fda-prevention-meningitis-b-leading-cause.,Non-OADS,/arxiv_data1/oa_pdf/03/a2/jove-120-55146.PMC5409326.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2017 |  121  | e55354 | Page 1 of 5Video Article Magnetic Stirrer Method for the Detection of Trichinella Larvae in Muscle Samples Anne Mayer-Scholl1, Edoardo Pozio2, Jennifer Gayda1, Nora Thaben1, Peter Bahn1, Karsten Nöckler1 1Federal Institute for Risk Assessment 2Istituto Superiore di Sanità Correspondence to: Anne Mayer-Scholl at anne.mayer-scholl@bfr.bund.de URL: https://www.jove.com/video/55354 DOI: doi:10.3791/55354 Keywords: Infection, Issue 121, Trichinella larvae, food borne disease, trichinellosis, pork, game meat, magnetic stirrer method, digestion method, digestion, sedimentation, filtration Date Published: 3/3/2017 Citation: Mayer-Scholl, A., Pozio, E., Gayda, J., Thaben, N., Bahn, P., Nöckler, K. Magnetic Stirrer Method for the Detection of Trichinella Larvae in Muscle Samples.",Non-OADS,/arxiv_data1/oa_pdf/23/48/jove-121-55354.PMC5409328.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55354/ Introduction Nematodes of the genus Trichinella can be detected in striated muscles of carnivore and omnivore mammals, birds, and reptiles worldwide.",Non-OADS,/arxiv_data1/oa_pdf/23/48/jove-121-55354.PMC5409328.pdf
1-16 http://wahis2-devt.oie.int/fileadmin/Home/fr/Health_standards/tahm/1.01.05_VALIDATION.pdf (2013).,Non-OADS,/arxiv_data1/oa_pdf/23/48/jove-121-55354.PMC5409328.pdf
"L 212 , 7-34 http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32015R1375  (2015).",Non-OADS,/arxiv_data1/oa_pdf/23/48/jove-121-55354.PMC5409328.pdf
https://www.gpo.gov/fdsys/pkg/CFR-2016-title9-vol2/pdf/CFR-2016- title9-vol2-sec318-10.pdf  (2012).,Non-OADS,/arxiv_data1/oa_pdf/23/48/jove-121-55354.PMC5409328.pdf
http://www.iso.org/ (2015).,Non-OADS,/arxiv_data1/oa_pdf/23/48/jove-121-55354.PMC5409328.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55101 | Page 1 of 10Video Article Image-guided, Laser-based Fabrication of Vascular-derived Microfluidic Networks Keely A. Heintz1, David Mayerich2, John H. Slater1,3 1Department of Biomedical Engineering, University of Delaware 2Department of Electrical and Computer Engineering, University of Houston 3Delaware Biotechnology Institute Correspondence to: John H. Slater at jhslater@udel.edu URL: https://www.jove.com/video/55101 DOI: doi:10.3791/55101 Keywords: Bioengineering, Issue 119, biomimetic, tissue engineering, vasculature, biomaterials, microenvironment, microfabrication, biotransport, lymphatic, hydrogel Date Published: 1/3/2017 Citation: Heintz, K.A., Mayerich, D., Slater, J.H.",Non-OADS,/arxiv_data1/oa_pdf/62/f1/jove-119-55101.PMC5409340.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55101/ Introduction The vascular system, consisting of both lymphatic and cardiovasculature, forms highly dense networks that are essential for the transport of nutrients and oxygen and for the removal of metabolic waste.",Non-OADS,/arxiv_data1/oa_pdf/62/f1/jove-119-55101.PMC5409340.pdf
"[9] The complexity of the lesions was  recorded as Syntax score based on the coronary dominance  using the Syntax score calculator, Version 2.11 (available at:  http://www.syntax-score.com).",OADS,/arxiv_data1/oa_pdf/c8/6d/jgc-14-02-087.PMC5409349.pdf
DOI:  https://doi.org/10.1093/eurheartj/ehw381.,Non-OADS,/arxiv_data1/oa_pdf/98/fd/jgc-14-02-108.PMC5409352.pdf
" Journal of Geriatric Cardiology (201 7) 14: 153154   ©2017 JGC All rights  reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Correspondence   Open Access     Recurrent acute myocardial infarction and atrial fibrillation     Levent Cerit   Department of Cardiology, Near East University, Nicosia, Cyprus .",Non-OADS,/arxiv_data1/oa_pdf/14/ea/jgc-14-02-153.PMC5409357.pdf
"Recurrent acute myocardial infarction and atrial fibrillation     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  nosis , we unfortunately did not have data  about the heart  rhythm of the patients.",Non-OADS,/arxiv_data1/oa_pdf/14/ea/jgc-14-02-153.PMC5409357.pdf
Available	 from:	http://www.cbi.,Non-OADS,/arxiv_data1/oa_pdf/ee/f8/AJNS-12-180.PMC5409362.pdf
Available	 from:	http://edition.cnn.com/2016/12/14/health/david‑nott‑ war‑surgery‑training‑syria/.,Non-OADS,/arxiv_data1/oa_pdf/61/d0/AJNS-12-342.PMC5409410.pdf
We compared the crystal structure of EV71 2C 116 –329 with all structures in the PDB using the Dali server (http://ekhidna.bio center.helsinki.fi/dali_server/).,OADS,/arxiv_data1/oa_pdf/ba/45/1602573.PMC5409451.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602573/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/ba/45/1602573.PMC5409451.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602747/DC1Procedures for characterizing the catalysts fig.,Non-OADS,/arxiv_data1/oa_pdf/10/00/1602747.PMC5409452.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1603224/DC1SupplementaryTextSupplementary Materials and Methodssection S1.,Non-OADS,/arxiv_data1/oa_pdf/45/fd/1603224.PMC5409453.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602813/DC1 Characterization of the WS 2triangles PL spectroscopy at low temperatureDensity functional calculations of gas adsorption and WS 3vacancy fig.,Non-OADS,/arxiv_data1/oa_pdf/dd/10/1602813.PMC5409454.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602570/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/b2/d1/1602570.PMC5409494.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602326/DC1Supplementary Text fig.,Non-OADS,/arxiv_data1/oa_pdf/7d/e7/1602326.PMC5409495.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602506/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/19/e4/1602506.PMC5409496.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/4/e1602743/DC1 Characterization of the TVPSPhoton counting and experimental detailsExperimental violation of the bilocal inequalitiesExperimental violation of the CHSH inequalityOur bilocal inequalities violations are not device-independent certifications of A-Centanglement: Counterexample table S1.,Non-OADS,/arxiv_data1/oa_pdf/3a/2c/1602743.PMC5409499.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/61/main.PMC5409500.pdf
http://dx.doi.org/10.1016/j.eucr.2016.05.009Urology Case Reports 13 (2017) 85 e86,Non-OADS,/arxiv_data1/oa_pdf/73/61/main.PMC5409500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/1c/main.PMC5409654.pdf
http://dx.doi.org/10.1016/j.eucr.2016.08.009Urology Case Reports 13 (2017) 79 e81,Non-OADS,/arxiv_data1/oa_pdf/78/1c/main.PMC5409654.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/73/main.PMC5409851.pdf
"Her  physical  examination  was normal;  however,  her  levels  of  tumor  markers  were  as  follows: CA19-9,  370  U/mL  (normal,  <37.0  U/mL);  carcinoembryonic  anti- gen,  1.6  ng/mL  (normal,  <5.5  ng/mL);  alfa-fetoprotein,  2.2  ng/mL http://dx.doi.org/10.1016/j.ijscr.2017.04.012 2210-2612/© 2017  The  Authors.",OADS,/arxiv_data1/oa_pdf/39/73/main.PMC5409851.pdf
"(2017),  http://dx.doi.org/10.1007/s00268-017- 3909-7 .",Non-OADS,/arxiv_data1/oa_pdf/39/73/main.PMC5409851.pdf
"ContentsWorld Journal of Transplantation Volume 7  Number 2  April 24, 2017 EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li      Responsible Science Editor:  Fang-Fang Ji  Responsible Electronic Editor: Huan-Liang Wu      Proofing Editorial Office Director:  Xiu-Xia Song Proofing Editor-in-Chief:  Lian-Sheng Ma World Journal of  Transplantation Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE April 24 , 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/8f/53/WJT-7-103.PMC5409910.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION 	 http://www.f6publishing.com II WJT|www.wjgnet.comABOUT COVER AIM AND SCOPE AIM AND SCOPE FLYLEAF April 24, 2017 |Volume 7 |Issue 2|NAME	OF	JOURNAL 	 World Journal of  Transplantation ISSN ISSN 2220-3230 (online) LAUNCH	DATE December 24, 2011 FREQUENCY Bimonthly EDITOR-IN-CHIEF Maurizio Salvadori, MD, Professor,  Renal Unit, Care - ggi University Hospital, Florence 50139, Italy EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/2220-3230/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Direct orEditorial	Board	Member	of	World	Journal	of	Transplantation ,	Frieder	Keller,	MD,	 Doctor,	Nephrology 	Division,	Medical	Department 	Innere	1,	University 	Hospital,	 D-89070	Ulm,	Germany World Journal of  Transplantation (World J Transplant , WJT, online ISSN 2220-3230, DOI:  10.5500) is a peer-reviewed open access academic journal that aims to guide clinical  practice and improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/8f/53/WJT-7-103.PMC5409910.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Walter W Chan, MD, MPH,  Division  of Gastroenterology, Hepatology and Endoscopy, Brigham and  Women’s Hospital, 75 Francis Street, Boston, MA 02115,  United States.",Non-OADS,/arxiv_data1/oa_pdf/8f/53/WJT-7-103.PMC5409910.pdf
"This paper reviews the mechanisms of GERD-induced REVIEW 103 April 24, 2017 |Volume 7 |Issue 2| WJT|www.wjgnet.comRole of gastroesophageal reflux disease in lung  transplantationWorld J Transplant   2017 April 24; 7(2): 103-116 ISSN 2220-3230 (online)Submit a Manuscript: http://www.f6publishing.com DOI: 10.5500/wjt.v7.i2.103World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/8f/53/WJT-7-103.PMC5409910.pdf
wjgnet.com/2220-3230/full/v7/i2/103.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8f/53/WJT-7-103.PMC5409910.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.f6publishing.com",Non-OADS,/arxiv_data1/oa_pdf/8f/53/WJT-7-103.PMC5409910.pdf
"ContentsWorld Journal of Transplantation Volume 7  Number 2  April 24, 2017 EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li      Responsible Science Editor:  Fang-Fang Ji  Responsible Electronic Editor: Huan-Liang Wu      Proofing Editorial Office Director:  Xiu-Xia Song Proofing Editor-in-Chief:  Lian-Sheng Ma World Journal of  Transplantation Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE April 24 , 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/96/5a/WJT-7-117.PMC5409911.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION 	 http://www.f6publishing.com II WJT|www.wjgnet.comABOUT COVER AIM AND SCOPE AIM AND SCOPE FLYLEAF April 24, 2017 |Volume 7 |Issue 2|NAME	OF	JOURNAL 	 World Journal of  Transplantation ISSN ISSN 2220-3230 (online) LAUNCH	DATE December 24, 2011 FREQUENCY Bimonthly EDITOR-IN-CHIEF Maurizio Salvadori, MD, Professor,  Renal Unit, Care - ggi University Hospital, Florence 50139, Italy EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/2220-3230/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Direct orEditorial	Board	Member	of	World	Journal	of	Transplantation ,	Frieder	Keller,	MD,	 Doctor,	Nephrology 	Division,	Medical	Department 	Innere	1,	University 	Hospital,	 D-89070	Ulm,	Germany World Journal of  Transplantation (World J Transplant , WJT, online ISSN 2220-3230, DOI:  10.5500) is a peer-reviewed open access academic journal that aims to guide clinical  practice and improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/96/5a/WJT-7-117.PMC5409911.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Appakalai N Balamurugan, PhD,  Clinical Islet Cell Laboratory, Center for Cellular Transplantation,  Cardiovascular Innovation Institute, Department of Surgery,  University of Louisville, 302 E Muhammad Ali Blvd., Louisville,  KY 40202, United States.",Non-OADS,/arxiv_data1/oa_pdf/96/5a/WJT-7-117.PMC5409911.pdf
"REVIEW 117 April 24, 2017 |Volume 7 |Issue 2| WJT|www.wjgnet.comIntra-islet endothelial cell and β-cell crosstalk: Implication  for islet cell transplantationWorld J Transplant   2017 April 24; 7(2): 117-128 ISSN 2220-3230 (online)Submit a Manuscript: http://www.f6publishing.com DOI: 10.5500/wjt.v7.i2.117World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/96/5a/WJT-7-117.PMC5409911.pdf
wjgnet.com/2220-3230/full/v7/i2/117.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/96/5a/WJT-7-117.PMC5409911.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.f6publishing.com",Non-OADS,/arxiv_data1/oa_pdf/96/5a/WJT-7-117.PMC5409911.pdf
"ContentsWorld Journal of Transplantation Volume 7  Number 2  April 24, 2017 EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li      Responsible Science Editor:  Fang-Fang Ji  Responsible Electronic Editor: Huan-Liang Wu      Proofing Editorial Office Director:  Xiu-Xia Song Proofing Editor-in-Chief:  Lian-Sheng Ma World Journal of  Transplantation Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE April 24 , 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/WJT-7-129.PMC5409912.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION 	 http://www.f6publishing.com II WJT|www.wjgnet.comABOUT COVER AIM AND SCOPE AIM AND SCOPE FLYLEAF April 24, 2017 |Volume 7 |Issue 2|NAME	OF	JOURNAL 	 World Journal of  Transplantation ISSN ISSN 2220-3230 (online) LAUNCH	DATE December 24, 2011 FREQUENCY Bimonthly EDITOR-IN-CHIEF Maurizio Salvadori, MD, Professor,  Renal Unit, Care - ggi University Hospital, Florence 50139, Italy EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/2220-3230/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Direct orEditorial	Board	Member	of	World	Journal	of	Transplantation ,	Frieder	Keller,	MD,	 Doctor,	Nephrology 	Division,	Medical	Department 	Innere	1,	University 	Hospital,	 D-89070	Ulm,	Germany World Journal of  Transplantation (World J Transplant , WJT, online ISSN 2220-3230, DOI:  10.5500) is a peer-reviewed open access academic journal that aims to guide clinical  practice and improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/WJT-7-129.PMC5409912.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to:  Dr. Ahmed Halawa, Consultant  Transplant Surgeon,  Sheffield Teaching Hospital, University of  Sheffield, Herries Road, Sheffield S5 7AU,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/WJT-7-129.PMC5409912.pdf
"Core tip:  There are several studies addressing the effect MINIREVIEWS 129 April 24, 2017 |Volume 7 |Issue 2| WJT|www.wjgnet.comSmoking in Renal Transplantation; Facts Beyond MythWorld J Transplant   2017 April 24; 7(2): 129-133 ISSN 2220-3230 (online)Submit a Manuscript: http://www.f6publishing.com DOI: 10.5500/wjt.v7.i2.129World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/WJT-7-129.PMC5409912.pdf
"World J Transplant  2017; 7(2): 129-133   Available from: URL: http://www.wjgnet.com/2220-3230/full/ v7/i2/129.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v7.i2.129 INTRODUCTION Smoking is a challenging  health care problem; it has a  well-established correlation with many serious medical  conditions like cardiovascular diseases, pulmonary  diseases, malignancy and death[1].",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/WJT-7-129.PMC5409912.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.f6publishing.com",Non-OADS,/arxiv_data1/oa_pdf/f5/4e/WJT-7-129.PMC5409912.pdf
"ContentsWorld Journal of Transplantation Volume 7  Number 2  April 24, 2017 EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li      Responsible Science Editor:  Fang-Fang Ji  Responsible Electronic Editor: Huan-Liang Wu      Proofing Editorial Office Director:  Xiu-Xia Song Proofing Editor-in-Chief:  Lian-Sheng Ma World Journal of  Transplantation Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE April 24 , 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/43/59/WJT-7-134.PMC5409913.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION 	 http://www.f6publishing.com II WJT|www.wjgnet.comABOUT COVER AIM AND SCOPE AIM AND SCOPE FLYLEAF April 24, 2017 |Volume 7 |Issue 2|NAME	OF	JOURNAL 	 World Journal of  Transplantation ISSN ISSN 2220-3230 (online) LAUNCH	DATE December 24, 2011 FREQUENCY Bimonthly EDITOR-IN-CHIEF Maurizio Salvadori, MD, Professor,  Renal Unit, Care - ggi University Hospital, Florence 50139, Italy EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/2220-3230/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Direct orEditorial	Board	Member	of	World	Journal	of	Transplantation ,	Frieder	Keller,	MD,	 Doctor,	Nephrology 	Division,	Medical	Department 	Innere	1,	University 	Hospital,	 D-89070	Ulm,	Germany World Journal of  Transplantation (World J Transplant , WJT, online ISSN 2220-3230, DOI:  10.5500) is a peer-reviewed open access academic journal that aims to guide clinical  practice and improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/43/59/WJT-7-134.PMC5409913.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Vivek B Kute, MBBS, MD, FCPS,  DM Nephrology (Gold Medalist), FASN, Associate Professor,  Department of Nephrology and Clinical Transplantation, Institute  of Kidney Diseases and Research Centre, Dr HL Trivedi Institute of Transplantation Sciences, B ­130, Triveni, Ph ­1, Ahmedabad  380016, India.",Non-OADS,/arxiv_data1/oa_pdf/43/59/WJT-7-134.PMC5409913.pdf
"MINIREVIEWS 134 April 24, 2017 |Volume 7 |Issue 2 | WJT|www.wjgnet.comPast, present and future of kidney paired donation  transplantation in IndiaWorld J Transplant   2017 April 24; 7(2): 134-143 ISSN 2220-3230 (online)Submit a Manuscript: http://www.f6publishing.com DOI: 10.5500/wjt.v7.i2.134World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/43/59/WJT-7-134.PMC5409913.pdf
"World J Transplant  2017; 7(2): 1 34­143  Available from: URL:  http://www.wjgnet.com/2220 ­3230/full/v7/i2/134.htm   DOI:  http://dx.doi.org/ 10.5500 /wjt.v7.i2.134 INTRODUCTION Low insurance coverage, poor public health system leading  to out of pocket health expenditure and unavailability of  adequate trained doctors and staff are problems of renal  replacement therapies in developing country.",Non-OADS,/arxiv_data1/oa_pdf/43/59/WJT-7-134.PMC5409913.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.f6publishing.com",Non-OADS,/arxiv_data1/oa_pdf/43/59/WJT-7-134.PMC5409913.pdf
"ContentsWorld Journal of Transplantation Volume 7  Number 2  April 24, 2017 EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li      Responsible Science Editor:  Fang-Fang Ji  Responsible Electronic Editor: Huan-Liang Wu      Proofing Editorial Office Director:  Xiu-Xia Song Proofing Editor-in-Chief:  Lian-Sheng Ma World Journal of  Transplantation Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE April 24 , 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/d1/57/WJT-7-144.PMC5409914.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION 	 http://www.f6publishing.com II WJT|www.wjgnet.comABOUT COVER AIM AND SCOPE AIM AND SCOPE FLYLEAF April 24, 2017 |Volume 7 |Issue 2|NAME	OF	JOURNAL 	 World Journal of  Transplantation ISSN ISSN 2220-3230 (online) LAUNCH	DATE December 24, 2011 FREQUENCY Bimonthly EDITOR-IN-CHIEF Maurizio Salvadori, MD, Professor,  Renal Unit, Care - ggi University Hospital, Florence 50139, Italy EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/2220-3230/editorialboard.htm EDITORIAL 	OFFICE Xiu-Xia Song, Direct orEditorial	Board	Member	of	World	Journal	of	Transplantation ,	Frieder	Keller,	MD,	 Doctor,	Nephrology 	Division,	Medical	Department 	Innere	1,	University 	Hospital,	 D-89070	Ulm,	Germany World Journal of  Transplantation (World J Transplant , WJT, online ISSN 2220-3230, DOI:  10.5500) is a peer-reviewed open access academic journal that aims to guide clinical  practice and improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/d1/57/WJT-7-144.PMC5409914.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Jayant Kumar, MD, MS, Department of  Cancer and Surgery, Imperial College, Du Cane Ro ad, London W120HS, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/d1/57/WJT-7-144.PMC5409914.pdf
"CONCLUSION The evidence reviewed in this meta-analysis suggests META-ANALYSIS 144 April 24, 2017 |Volume 7 |Issue 2| WJT|www.wjgnet.comSystemic meta-analysis assessing the short term  applicability of early conversion to mammalian target of  rapamycin inhibitors in kidney transplantWorld J Transplant   2017 April 24; 7(2): 144-151 ISSN 2220-3230 (online)Submit a Manuscript: http://www.f6publishing.com DOI: 10.5500/wjt.v7.i2.144World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/d1/57/WJT-7-144.PMC5409914.pdf
World J Transplant  2017; 7(2): 144-151   Available from: URL: http://www.wjgnet.com/2220-3230/full/ v7/i2/144.htm   DOI: http://dx.doi.org/ 10.5500 /wjt.v7.i2.144 INTRODUCTION Inventions in medical science enhance life which has  been realized in the concept of kidney transplantation  and add significant amount of productive years  to the patients of chronic kidney disease[1].,Non-OADS,/arxiv_data1/oa_pdf/d1/57/WJT-7-144.PMC5409914.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.f6publishing.com",Non-OADS,/arxiv_data1/oa_pdf/d1/57/WJT-7-144.PMC5409914.pdf
"ContentsWorld Journal of Transplantation Volume 7  Number 2  April 24, 2017 EDITORS FOR  THIS ISSUEResponsible Assistant Editor:  Xiang Li      Responsible Science Editor:  Fang-Fang Ji  Responsible Electronic Editor: Huan-Liang Wu      Proofing Editorial Office Director:  Xiu-Xia Song Proofing Editor-in-Chief:  Lian-Sheng Ma World Journal of  Transplantation Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: editorialoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLISHER Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501,  Pleasanton, CA 94588, USA Telephone: +1-925-2238242 Fax: +1-925-2238243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www .f6publishing.com/helpdesk http://www.wjgnet.com PUBLICATION 	DATE April 24 , 2017COPYRIGHT © 2017 Baishideng Publishing Group Inc.",Non-OADS,/arxiv_data1/oa_pdf/9c/49/WJT-7-152.PMC5409915.pdf
"INSTRUCTIONS 	TO	AUTHORS http://www.wjgnet.com/bpg/gerinfo/204 ONLINE	SUBMISSION 	 http://www.f6publishing.com II WJT|www.wjgnet.comABOUT COVER AIM AND SCOPE AIM AND SCOPE FLYLEAF April 24, 2017 |Volume 7 |Issue 2|NAME	OF	JOURNAL	 World Journal of  Transplantation ISSN ISSN 2220-3230 (online) LAUNCH	DATE December 24, 2011 FREQUENCY Bimonthly EDITOR-IN-CHIEF Maurizio Salvadori, MD, Professor,  Renal Unit, Care - ggi University Hospital, Florence 50139, Italy EDITORIAL	BOARD	MEMBERS All editorial board members resources online at http:// www .wjgnet.com/2220-3230/editorialboard.htm EDITORIAL	OFFICE Xiu-Xia Song, Direct orEditorial	Board	Member	of	World	Journal	of	Transplantation ,	Frieder	Keller,	MD,	 Doctor,	Nephrology	Division,	Medical	Department	Innere	1,	University	Hospital,	 D-89070	Ulm,	Germany World Journal of  Transplantation (World J Transplant , WJT, online ISSN 2220-3230, DOI:  10.5500) is a peer-reviewed open access academic journal that aims to guide clinical  practice and improve diagnostic and therapeutic skills of  clinicians.",Non-OADS,/arxiv_data1/oa_pdf/9c/49/WJT-7-152.PMC5409915.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Nasser Simforoosh, Professor, Depart - ment of Urology, Shahid Labbafi Nejad Hospital, Urology and  Nephrology Research Center, Shahid Beheshti University of  Medical Sciences, 9th Boostan Avenue, Pasdaran Avenue, Tehran  198396-3113, Iran.",Non-OADS,/arxiv_data1/oa_pdf/9c/49/WJT-7-152.PMC5409915.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.META-ANALYSIS 152 April 24, 2017 |Volume 7 |Issue 2| WJT|www.wjgnet.comLiving related and living unrelated kidney transplantations:  A systematic review and meta -analysisWorld J Transplant   2017 April 24; 7(2): 152-160 ISSN 2220-3230 (online)Submit a Manuscript: http://www.f6publishing.com DOI: 10.5500/wjt.v7.i2.152World Journal of  Transplantation WJT",Non-OADS,/arxiv_data1/oa_pdf/9c/49/WJT-7-152.PMC5409915.pdf
wjgnet.com/2220-3230/full/v7/i2/152.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/49/WJT-7-152.PMC5409915.pdf
"© 2017 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.f6publishing.com",Non-OADS,/arxiv_data1/oa_pdf/9c/49/WJT-7-152.PMC5409915.pdf
"He received nerve root injections and a foot splint for a ‘‘foot drop.’’ Nine months later, at the age of 81 years, he had a right L5 decompression by a different orthopedic surgeonFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/a7/49/tre-07-455-7522-1.PMC5409931.pdf
Alien Leg in Corticobasal Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/a7/49/tre-07-455-7522-1.PMC5409931.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/a7/49/tre-07-455-7522-1.PMC5409931.pdf
Alien Leg in Corticobasal Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/a7/49/tre-07-455-7522-1.PMC5409931.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/a7/49/tre-07-455-7522-1.PMC5409931.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0042; April 2017 DOI: 10.1530/EDM-17-0042Gonadotrophin abnormalities  in Lowe syndromeB E Warner and others Gonadotrophin abnormalities in an infant with  Lowe syndrome Bronwen E Warner1, Carol D Inward2 and Christine P Burren1,3 Departments of 1Paediatric Endocrinology and Diabetes, and 2Paediatric Nephrology, Bristol Royal Hospital for  Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK,and 3NIHR Biomedical Research Unit in  Nutrition, Diet & Lifestyle, University Hospitals Bristol NHS Foundation Trust, Education Centre, Bristol, UK Summary This case, presenting with bilateral impalpable testes, illustrates the relevance of a broad differential disorders of sex  development case management.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/edmcr-2017-170042.PMC5409933.pdf
B E Warner and others Gonadotrophin abnormalities  in Lowe syndromeID: 17-0042; April 2017 DOI: 10.1530/EDM-17-0042 http://www.edmcasereports.com  2mid­adulthood.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/edmcr-2017-170042.PMC5409933.pdf
B E Warner and othersID: 17-0042; April 2017 DOI: 10.1530/EDM-17-0042 Gonadotrophin abnormalities  in Lowe syndrome http://www.edmcasereports.com  3elevated protein:creatinine ratio 589 mg/mmol (normal  <30) and generalised aminoaciduria.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/edmcr-2017-170042.PMC5409933.pdf
"B E Warner and others Gonadotrophin abnormalities  in Lowe syndromeID: 17-0042; April 2017 DOI: 10.1530/EDM-17-0042 http://www.edmcasereports.com  4LH elevation can indicate a testosterone biosynthetic  defect, but testosterone baseline levels and increase on  HCG stimulation were normal.",OADS,/arxiv_data1/oa_pdf/68/bf/edmcr-2017-170042.PMC5409933.pdf
"B E Warner and othersID: 17-0042; April 2017 DOI: 10.1530/EDM-17-0042 Gonadotrophin abnormalities  in Lowe syndrome http://www.edmcasereports.com  5 7 Brook C, Clayton P & Brown R 2009 Brook’s Clinical Pediatric  Endocrinology , 6th ed.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/edmcr-2017-170042.PMC5409933.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0141; April 2017 DOI: 10.1530/EDM-16-0141Mid-life extra-haematopoetic  features of DBAC Muir and others Mid-life extra-haematopoetic manifestations  of Diamond–Blackfan anaemia Christopher Muir1, Anthony Dodds2 and Katherine Samaras1,3 Departments of 1Endocrinology, 2Haematology and Bone Marrow Transplantation, St Vincent’s Hospital,  Sydney, Australia, and 3Garvan Institute of Medical Research, Sydney, Australia Summary Diamond–Blackfan anaemia (DBA) is a rare cause of bone marrow failure.",Non-OADS,/arxiv_data1/oa_pdf/f7/07/edmcr-2017-160141.PMC5409934.pdf
"C Muir and others Mid-life extra-haematopoetic  features of DBAID: 16-0141; April 2017 DOI: 10.1530/EDM-16-0141 http://www.edmcasereports.com  2We report the case of a 45-year-old woman with DBA  who developed osteoporosis and avascular necrosis (AVN),  as well as invasive rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/f7/07/edmcr-2017-160141.PMC5409934.pdf
C Muir and othersID: 16-0141; April 2017 DOI: 10.1530/EDM-16-0141 Mid-life extra-haematopoetic  features of DBA http://www.edmcasereports.com  3Discussion DBA is an established ribosomopathy resulting in  hypoplastic anaemia and bone marrow failure.,Non-OADS,/arxiv_data1/oa_pdf/f7/07/edmcr-2017-160141.PMC5409934.pdf
C Muir and others Mid-life extra-haematopoetic  features of DBAID: 16-0141; April 2017 DOI: 10.1530/EDM-16-0141 http://www.edmcasereports.com  4glucocorticoid-induced bone loss.,Non-OADS,/arxiv_data1/oa_pdf/f7/07/edmcr-2017-160141.PMC5409934.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0157; April 2017 DOI: 10.1530/EDM-16-0157Macroprolactinoma   and hydrocephalusO D Bruno and others Macroprolactinoma appearing after resolution  of hydrocephalus Oscar D Bruno1,2, Ricardo Fernández Pisani3, Gabriel Isaac1 and Armando Basso3 1Division of Endocrinology, 2Fundacion de Endocrinologia, and 3Division of Neurosurgery,  Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina Summary The role of mechanical forces influencing the growth of a pituitary adenoma is poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/10/b8/edmcr-2017-160157.PMC5409935.pdf
"O D Bruno and others Macroprolactinoma   and hydrocephalusID: 16-0157; April 2017 DOI: 10.1530/EDM-16-0157 http://www.edmcasereports.com  2Treatment After two unsuccessful attempts to place shunting  devices (a medium pressure valve and a flow-dependent  valve respectively), a ventricular-peritoneal shunt using  a mean-pressure valve was performed.",Non-OADS,/arxiv_data1/oa_pdf/10/b8/edmcr-2017-160157.PMC5409935.pdf
O D Bruno and othersID: 16-0157; April 2017 DOI: 10.1530/EDM-16-0157 Macroprolactinoma   and hydrocephalus http://www.edmcasereports.com  3the ventricular system ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/10/b8/edmcr-2017-160157.PMC5409935.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018Anorexia–cachexia syndrome,  craniopharyngiomaL Balcázar-Hernández   and others Anorexia–cachexia syndrome-like  hypothalamic neuroendocrine dysfunction in a  patient with a papillary craniopharyngioma Lourdes Balcázar-Hernández1, Guadalupe Vargas-Ortega1, Yelitza Valverde-García2,  Victoria Mendoza-Zubieta1 and Baldomero González-Virla1 1Endocrinology Department, and 2Anatomic Pathology Department, Hospital de Especialidades, Centro  Médico Nacional Siglo XXI, Colonia Doctores, Mexico City, Mexico Summary The craniopharyngiomas are solid cystic suprasellar tumors that can present extension to adjacent structures,  conditioning pituitary and hypothalamic dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"L Balcázar-Hernández   and othersAnorexia–cachexia syndrome,  craniopharyngiomaID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018 http://www.edmcasereports.com  2craniopharyngiomas.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"L Balcázar-Hernández   and othersID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018 Anorexia–cachexia syndrome,  craniopharyngioma http://www.edmcasereports.com  3At 6 months, patient was again admitted for stupor in the  health center.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"L Balcázar-Hernández   and othersAnorexia–cachexia syndrome,  craniopharyngiomaID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018 http://www.edmcasereports.com  4lining epithelium.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"L Balcázar-Hernández   and othersID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018 Anorexia–cachexia syndrome,  craniopharyngioma http://www.edmcasereports.com  5Anorexia–cachexia syndrome (ACS) is a complex  metabolic process experienced by patients in advanced  stages of chronic illness.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"L Balcázar-Hernández   and othersAnorexia–cachexia syndrome,  craniopharyngiomaID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018 http://www.edmcasereports.com  6of POMC neurons.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"L Balcázar-Hernández   and othersID: 17-0018; April 2017 DOI: 10.1530/EDM-17-0018 Anorexia–cachexia syndrome,  craniopharyngioma http://www.edmcasereports.com  7and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/9a/84/edmcr-2017-170018.PMC5409936.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0106; April 2017 DOI: 10.1530/EDM-16-0106Periodontal profile in a  patient with ADOD da Silva Barbirato and  others Periodontal profile and radiographic  characterization of the jaws in a patient  with autosomal dominant osteopetrosis Davi da Silva Barbirato1, Mariana Fampa Fogacci1, Mariana Arruda2,  Monique Oliveira Rodrigues3,4 and Leonardo Vieira Neto2 1Wolfgang C. Pfeiffer Laboratory of Environmental Biogeochemistry, Federal University of Rondônia  (UNIR), Rio de Janeiro, Brazil, 2Department of Internal Medicine and Endocrine Section, Medical School and  Hospital Universitário Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,  3Division of Graduate Periodontics, Department of Dental Clinic, Federal University of Rio de Janeiro,   Rio de Janeiro, Brazil and 4Faculdades São José, Rio de Janeiro, Brazil Summary Osteopetrosis (OP) comprehends a rare group of conditions, presenting on radiographs increased bone density,  deriving from irregularities in osteoclast differentiation or function.",Non-OADS,/arxiv_data1/oa_pdf/d8/0d/edmcr-2017-160106.PMC5409937.pdf
"D da Silva Barbirato and  othersPeriodontal profile in a  patient with ADOID: 16-0106; April 2017 DOI: 10.1530/EDM-16-0106 http://www.edmcasereports.com  2Background Osteopetrosis (OP) comprehends a group of conditions,  clinically and genetically heterogeneous, presenting  on radiographs increased bone density, deriving from  irregularities in osteoclast differentiation or function  (1).",Non-OADS,/arxiv_data1/oa_pdf/d8/0d/edmcr-2017-160106.PMC5409937.pdf
D da Silva Barbirato and  othersID: 16-0106; April 2017 DOI: 10.1530/EDM-16-0106 Periodontal profile in a  patient with ADO http://www.edmcasereports.com  3the left femoral neck.,Non-OADS,/arxiv_data1/oa_pdf/d8/0d/edmcr-2017-160106.PMC5409937.pdf
D da Silva Barbirato and  othersPeriodontal profile in a  patient with ADOID: 16-0106; April 2017 DOI: 10.1530/EDM-16-0106 http://www.edmcasereports.com  4Treatment Outcome and follow-up The patient is being folowed up at the Endocrinology  and Orthopedic units.,Non-OADS,/arxiv_data1/oa_pdf/d8/0d/edmcr-2017-160106.PMC5409937.pdf
"D da Silva Barbirato and  othersID: 16-0106; April 2017 DOI: 10.1530/EDM-16-0106 Periodontal profile in a  patient with ADO http://www.edmcasereports.com  5stated a direct correlation between facial trauma and tooth  extractions and the subsequent osteomyelitis incident,  pointing the complexity of managing OP patients as the  importance of preventive oral health care and dental/ periodontal assistance.",Non-OADS,/arxiv_data1/oa_pdf/d8/0d/edmcr-2017-160106.PMC5409937.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0013; April 2017 DOI: 10.1530/EDM-17-0013PHOA masquerading as  acromegalyR Mangupli and others Primary hypertrophic osteoarthropathy due   to a novel SLCO2A1  mutation masquerading   as acromegaly Ruth Mangupli1, Adrian F Daly2, Elvia Cuauro1, Paul Camperos1, Jaime Krivoy1   and Albert Beckers2 1Department of Neurosurgery, Section of Neuroendocrinology, Hospital Universitario de Caracas,  Caracas, Venezuela and 2Department of Endocrinology, Centre Hospitalier Universitaire de Liège,  University of Liège, Liège, Belgium Summary A 20-year-old man with an 8-year history of progressive enlargement of his hands and feet, coarsening facial features,  painful joints and thickened, oily skin was referred for investigation of acromegaly.",Non-OADS,/arxiv_data1/oa_pdf/98/7b/edmcr-2017-170013.PMC5409938.pdf
R Mangupli and others PHOA masquerading as  acromegalyID: 17-0013; April 2017 DOI: 10.1530/EDM-17-0013 http://www.edmcasereports.com  2Background The current case illustrates well the potential for PHOA to  present as a queried case of acromegaly.,Non-OADS,/arxiv_data1/oa_pdf/98/7b/edmcr-2017-170013.PMC5409938.pdf
R Mangupli and othersID: 17-0013; April 2017 DOI: 10.1530/EDM-17-0013 PHOA masquerading as  acromegaly http://www.edmcasereports.com  3(HPGD) and solute carrier organic anion transporter  family member 2A1 ( SLCO2A1 ) genes.,OADS,/arxiv_data1/oa_pdf/98/7b/edmcr-2017-170013.PMC5409938.pdf
R Mangupli and others PHOA masquerading as  acromegalyID: 17-0013; April 2017 DOI: 10.1530/EDM-17-0013 http://www.edmcasereports.com  4Outcome and follow-up Pain and joint swelling improved substantially after the  initiation of non-steroidal anti-inflammatory therapy and  bisphosphonate treatment.,Non-OADS,/arxiv_data1/oa_pdf/98/7b/edmcr-2017-170013.PMC5409938.pdf
R Mangupli and othersID: 17-0013; April 2017 DOI: 10.1530/EDM-17-0013 PHOA masquerading as  acromegaly http://www.edmcasereports.com  5 3 Friedreich N 1868 Hyperostose des gessamten Skelletes.,Non-OADS,/arxiv_data1/oa_pdf/98/7b/edmcr-2017-170013.PMC5409938.pdf
"PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0148; April 2017 DOI: 10.1530/EDM-16-0148IgG4-related hypophysitis T Anno and others Clinical course of pituitary function and image  in IgG4-related hypophysitis Takatoshi Anno1, Fumiko Kawasaki1, Maiko Takai1, Ryo Shigemoto1, Yuki Kan1,  Hideaki Kaneto2, Tomoatsu Mune2, Kohei Kaku1 and Niro Okimoto1 1Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan and 2Department of  Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Kurashiki, Japan Summary A 76-year-old man had a hypopituitarism including adrenal insufficiency, hypogonadism and hypothyroidism.",Non-OADS,/arxiv_data1/oa_pdf/13/27/edmcr-2017-160148.PMC5409939.pdf
PROOF ONLY T Anno and others IgG4-related hypophysitisID: 16-0148; April 2017 DOI: 10.1530/EDM-16-0148 http://www.edmcasereports.com  2Case presentation A 76-year-old man was hospitalized due to persistent  general fatigue and appetite loss since approximately  2  months before.,Non-OADS,/arxiv_data1/oa_pdf/13/27/edmcr-2017-160148.PMC5409939.pdf
"PROOF ONLY T Anno and othersID: 16-0148; April 2017 DOI: 10.1530/EDM-16-0148 IgG4-related hypophysitis http://www.edmcasereports.com  39.9 IU/mL, anti-thyroglobulin antibodies <10.0 IU/ mL, SS-A/Ro antibodies <1.0 U/mL, SS-B/La antibodies   <1.0 U/mL and serum pituitary cell antibody negative).",Non-OADS,/arxiv_data1/oa_pdf/13/27/edmcr-2017-160148.PMC5409939.pdf
PROOF ONLY T Anno and others IgG4-related hypophysitisID: 16-0148; April 2017 DOI: 10.1530/EDM-16-0148 http://www.edmcasereports.com  4related hypophysitis are spontaneously reduced without  steroid therapy.,Non-OADS,/arxiv_data1/oa_pdf/13/27/edmcr-2017-160148.PMC5409939.pdf
PROOF ONLY T Anno and othersID: 16-0148; April 2017 DOI: 10.1530/EDM-16-0148 IgG4-related hypophysitis http://www.edmcasereports.com  5or evaluation for a longer period would be necessary to  conclude our hypothesis.,Non-OADS,/arxiv_data1/oa_pdf/13/27/edmcr-2017-160148.PMC5409939.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0005; April 2017 DOI: 10.1530/EDM-17-0005Effective localization in TIO S Kawai and others Effective localization in tumor-induced  osteomalacia using 68Ga-DOTATOC-PET/CT,  venous sampling and 3T-MRI Shintaro Kawai1, Hiroyuki Ariyasu1, Yasushi Furukawa1, Reika Yamamoto1,  Shinsuke Uraki1, Ken Takeshima1, Kenji Warigaya2, Yuji Nakamoto3 and  Takashi Akamizu1 1The First Department of Medicine, 2Department of Human Pathology, Wakayama Medical University,  Wakayama, Japan, and 3Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University  Graduate School of Medicine, Kyoto, Japan Summary Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by renal phosphate wasting leading  to hypophosphatemia due to excessive actions of fibroblast growth factor 23 (FGF23) produced by the tumors.",Non-OADS,/arxiv_data1/oa_pdf/ed/9c/edmcr-2017-170005.PMC5409940.pdf
S Kawai and others Effective localization in TIOID: 17-0005; April 2017 DOI: 10.1530/EDM-17-0005 http://www.edmcasereports.com  2is not well known ( 3).,OADS,/arxiv_data1/oa_pdf/ed/9c/edmcr-2017-170005.PMC5409940.pdf
"S Kawai and othersID: 17-0005; April 2017 DOI: 10.1530/EDM-17-0005 Effective localization in TIO http://www.edmcasereports.com  3a final diagnosis was reached by using 68Ga-DOTATOC  positron emission tomography/computed tomography  (68Ga-DOTATOC-PET/CT), systemic venous sampling  (SVS) and 3T-magnetic resonance imaging (MRI).",OADS,/arxiv_data1/oa_pdf/ed/9c/edmcr-2017-170005.PMC5409940.pdf
"S Kawai and others Effective localization in TIOID: 17-0005; April 2017 DOI: 10.1530/EDM-17-0005 http://www.edmcasereports.com  4Whole body 18F-fluorodeoxyglucose PET/CT (18F FDG- PET/CT) scan showed intense uptake in the rib, hip and  heel bones where bone scintigraphy was identified, but  no tumor lesions were detected (data not shown).",OADS,/arxiv_data1/oa_pdf/ed/9c/edmcr-2017-170005.PMC5409940.pdf
"S Kawai and othersID: 17-0005; April 2017 DOI: 10.1530/EDM-17-0005 Effective localization in TIO http://www.edmcasereports.com  5conjugated peptide including DOTATOC, DOTATATE and  DOTANOC is becoming available.",OADS,/arxiv_data1/oa_pdf/ed/9c/edmcr-2017-170005.PMC5409940.pdf
S Kawai and others Effective localization in TIOID: 17-0005; April 2017 DOI: 10.1530/EDM-17-0005 http://www.edmcasereports.com  6histopathologic entity: an analysis of 32 cases and a comprehensive  review of the literature.,OADS,/arxiv_data1/oa_pdf/ed/9c/edmcr-2017-170005.PMC5409940.pdf
"PROOF ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0035; April 2017 DOI: 10.1530/EDM-17-0035Pituitary adenoma–gangliocytoma  causing acromegalyM H Lee and others An intrasellar pituitary adenoma– gangliocytoma presenting as acromegaly Melissa H Lee1, Penelope McKelvie2, Balasubramanian Krishnamurthy1,  Yi Yuen Wang3 and Carmela Caputo1 Departments of 1Endocrinology and Diabetes, 2Anatomical Pathology, St Vincent’s Hospital Melbourne,  Victoria, Australia, and 3Department of Neurosurgery and Surgery, The University of Melbourne,  St Vincent’s Hospital Melbourne, Victoria, Australia Summary Most cases of acromegaly are due to growth hormone (GH)-secreting pituitary adenomas arising from somatotroph cells.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/edmcr-2017-170035.PMC5409941.pdf
PROOF ONLY M H Lee and others Pituitary adenoma–gangliocytoma  causing acromegalyID: 17-0035; April 2017 DOI: 10.1530/EDM-17-0035 http://www.edmcasereports.com  2a rare case of acromegaly secondary to a mixed pituitary  adenoma–gangliocytoma and review the literature about  this uncommon condition and its proposed pathogenesis.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/edmcr-2017-170035.PMC5409941.pdf
PROOF ONLY M H Lee and othersID: 17-0035; April 2017 DOI: 10.1530/EDM-17-0035 Pituitary adenoma–gangliocytoma  causing acromegaly http://www.edmcasereports.com  3of 44  nmol/L.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/edmcr-2017-170035.PMC5409941.pdf
PROOF ONLY M H Lee and others Pituitary adenoma–gangliocytoma  causing acromegalyID: 17-0035; April 2017 DOI: 10.1530/EDM-17-0035 http://www.edmcasereports.com  4The management of pituitary adenoma– gangliocytomas is similar to that of other pituitary lesions.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/edmcr-2017-170035.PMC5409941.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/cc/ofx059.PMC5410113.pdf
Available at: http://hdl.handle.net/10138/153180.,Non-OADS,/arxiv_data1/oa_pdf/9c/cc/ofx059.PMC5410113.pdf
Available at: https://www.r-pro-ject.org .,Non-OADS,/arxiv_data1/oa_pdf/9c/cc/ofx059.PMC5410113.pdf
"Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> Received 15 November 2016 | Accepted 26 April 2017 | Published 28 April 2017© 2017 Molecular Vision 296Identification of seven novel ZNF469  mutations in keratoconus  patients in a Han Chinese population Xiaoning Yu, Binbin Chen, Xin Zhang, Xingchao Shentu Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China Purpose:  To test for the potential presence of novel mutations in the zinc finger protein  (ZNF469 ) gene in patients with  sporadic keratoconus (KC) from a Han Chinese population.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
"Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  297reported that mutations in ZNF469  could confer increased risk  of KC [ 18-20], while recent sequencing analysis of ZNF469   in patients with KC and high myopia showed no significant  variants [ 4].",Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
"Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  298°C 2 min; 35 cycles x (96 °C10 s, 68 °C1 min); 4 °C for ever.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  299from the 220 Han Chinese individuals without ocular abnor - malities.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
"Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  300races, and the present results indicated that the gene may have  an important pathogenic role in the Han Chinese population.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  301of 20 (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  302Table  3.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
"Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  303To date, the exact etiology of KC is still unclear.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
Available at: http://hdl.handle.net/2328/ 25860 .,Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  30418.,Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
"Molecular Vision  2017; 23:296-305 <http://www.molvis.org/molvis/v 23/296> © 2017 Molecular Vision  305Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/f7/20/mv-v23-296.PMC5410165.pdf
"In a clinical context, this  extremely high sensitivity may be undesired because nonvi - able bacteria and bacterial flora on the ocular surface do Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> Received 13 August 2016 | Accepted 26 April 2017 | Published 28 April 2017© 2017 Molecular Vision 306A dot hybridization assay for the diagnosis of bacterial keratitis Po-Chiung Fang,1 Chun-Chih Chien,2 Hun-Ju Yu,1 Ren-Wen Ho,1 Shin-Ling Tseng,1 Yu-Hsuan Lai,1 Ming-Tse  Kuo1 (The first two authors contributed equally to this study.)",Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  307not cause infectious keratitis [ 36].,Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  308marker and spotted on the membrane to form a cross (0.6 cm  × 0.4 cm).,Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  309bacterial and fungal polymicrobial keratitis.,Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  310 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
"Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  311In a comparison of the standardized signal intensities  among the patients with non-BK, the patients with non- Pseudomonas  BK, and the patients with Pseudomonas  BK,  the mean signal intensities for the Psu probe were statistically  significantly different (Figure 3A).",OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  312 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  313worksheet (Microsoft Excel) to report standardized intensi - ties and final diagnoses.,OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
"Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  314Table  2. p aTienTs wiTh posi Tive resul Ts for bac Teria as DeTermine D by microscopy , cul Ture, pcr , anD/or The bac Terial  DoT assay .",Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  315      Cases with true negatives by the probe BP3 but false negatives by the probes BP1 or BP2       31       20       M       −       Acanthamoeba  spp.,Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
"Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  316(CMRPG8C0762), the Ministry of Science and Tech - nology (Grant No.",Non-OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
"Molecular Vision  2017; 23:306-317 <http://www.molvis.org/molvis/v 23/306> © 2017 Molecular Vision  317Takeuchi M, Mochizuki M. Use of a comprehensive poly - merase chain reaction system for diagnosis of ocular infec - tious diseases.",OADS,/arxiv_data1/oa_pdf/c7/98/mv-v23-306.PMC5410166.pdf
Developmental Cognitive Neuroscience  25  (2017)  272–280 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Cognitive  components underpinning the  development  of model-based  learning Tracey  C.S.,Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"To  make  goal-directed  decisions,  individuals  must  be  able  to anticipate  likely  events,  consider  the  consequences  of  their  poten- tial  actions,  and  evaluate  the  most  efﬁcient  means  to  obtain  a https://doi.org/10.1016/j.dcn.2016.10.005 1878-9293/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"54, 664–673, http://dx.doi.org/10.1002/dev.20587 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Human  and  rodent  homologies  in  action control: corticostriatal  determinants  of  goal-directed  and  habitual  action.Neuropsychopharmacology  35,  48–69,  http://dx.doi.org/10.1038/npp.2009.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Neuroimage 14, 1136–1149,  http://dx.doi.org/ 10.1006/nimg.2001.0922 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"13,  1–22, http://dx.doi.org/10.3758/s13415-012- 0125-7 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"12,  55–66,  http://dx.doi.org/10.1111/j.1467-7687.2008.00743.x .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"7,  415–423,  http://dx.doi.org/10.1016/ S1364-6613(03)00197-9 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Neuron  69, 1204–1215,  http://dx.doi.org/10.1016/j.neuron.2011.02.027 .",OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"15,  310–320,  http://dx.doi.org/10.3758/s13415-014-0332-5 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Sci.,  http://dx.doi.org/10.1177/ 0956797616639301 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"11,  189–228, http://dx.doi.org/10.1214/ss/1032280214 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"45,  9–18, http://dx.doi.org/10.1016/j.neubiorev.2014.04.011 .",OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"3,  46–51,  http://dx.doi.org/10.3389/neuro.01.003.2009 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"99,  15822–15826,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Neuron  66,  585–595,  http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Gen.  137,  39–51,  http://dx.doi.org/10.1037/0096-3445.137.1.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"38,  115–142,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"24,  751–761,  http://dx.doi.org/10.1177/ 0956797612463080 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Hippocampus  14,  148–152,  http://dx.doi.org/10.1002/hipo.20009 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"3,  501–506, http://dx.doi.org/10.1016/B978-0-12-397025-1.00276-1 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"26, 1736–1747,  http://dx.doi.org/10.1162/jocn  a  00578 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"28, 3586–3594, http://dx.doi.org/10.1523/JNEUROSCI.5309-07.2008 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"25,  1611–1623,  http://dx.doi.org/10.1162/jocn  a  00434 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Gen.  134, 552–564, http://dx.doi.org/10.1037/0096- 3445.134.4.552 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"16,  433–445,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"11,  37–63,  http://dx.doi.org/10.1016/S0885- 2014(96)90027-1 .",Non-OADS,/arxiv_data1/oa_pdf/60/a6/main.PMC5410189.pdf
"Developmental Cognitive  Neuroscience  25  (2017)  29–44 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Sensitive periods of  substance  abuse:  Early  risk  for  the  transition  to dependence Chloe J.  Jordan∗,  Susan  L.  Andersen Department  of  Psychiatry,  Mclean  Hospital/Harvard  Medical  School,  Belmont,  MA  02478,  United  States a  r  t  i  c  l  e  i  n  f  o Article  history: Received  28 September  2016 Accepted 10  October  2016 Available  online  29  October  2016 Keywords:AbuseAdolescenceAddictionSubstance dependence Sensitive  periods Vulnerabilitya  b  s  t  r  a  c  t Early  adolescent  substance  use  dramatically  increases  the  risk  of  lifelong  substance  use  disorder  (SUD).",Non-OADS,/arxiv_data1/oa_pdf/4e/c3/main.PMC5410194.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c3/main.PMC5410194.pdf
https://doi.org/10.1016/j.dcn.2016.10.004 1878-9293/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/c3/main.PMC5410194.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/4e/c3/main.PMC5410194.pdf
https://www.drugabuse.gov/publications/principles-adolescent- substance-use-disorder-treatment-research-based-guide/introduction .,Non-OADS,/arxiv_data1/oa_pdf/4e/c3/main.PMC5410194.pdf
https://www.drugabuse.gov/related-topics/trends- statistics .,Non-OADS,/arxiv_data1/oa_pdf/4e/c3/main.PMC5410194.pdf
Keywords Phagocytes; Nanoparticles; Cellular uptake; Exposure conditions; Inhalation exposure This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/3f/emss-72517.PMC5410379.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/BY-NC-ND/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/26/nihms860697.PMC5410383.pdf
"Images were iteratively smoothed until the smoothness of any  image had a full-width half maximum of approximately 6 mm ( Friedman et al., 2006 ;  Scheinost et al., 2014 ) using AFNI’s 3dBlurToFWHM ( http://afni.nimh.nih.gov/afni/ ).",Non-OADS,/arxiv_data1/oa_pdf/0f/26/nihms860697.PMC5410383.pdf
"http://apallergy.orgDietary primary prevention of allergic diseases in  children: the Philippine guidelines Marysia Stella T. Recto1, Maria Lourdes G. Genuino2, Mary Anne R. Castor1,*, Roxanne J. Casis-Hao1, Diana R.  Tamondong-Lachica3, Maria Imelda V. Sales4, Marilou G. Tan5, Karen S. Mondonedo6, and Regina C.  Dionisio-Capulong7, for the PSAAI and the PSPGHAN 1Section of Allergy and Immunology, Department of Pediatrics, College of Medicine, University of the Philippines, Manila 1000, the Philippines 2Department of Physiology, College of Medicine, University of the Philippines, Manila  1000, the Philippines 3Section of Adult Medicine, Department of Medicine, College of Medicine, University of the Philippines, Manila  1000, the Philippines 4Makati Medical Center, Makati 1229, the Philippines 5Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Philippine Children’s Medical Center, Quezon City 1101, the Philippines 6Dagupan Doctors Villaflor Memorial Hospital, Dagupan City 2400 , the Philippines 7Manila Doctors Hospital, Manila 1000, the Philippines Allergic diseases, such as asthma, allergic rhinitis, eczema, and food allergy, are preventable diseases.",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
Educational & Teaching Material Review Article  https://doi.org/10.5415/apallergy.2017.7.2.102 Asia Pac Allergy 2017;7:102-114 INTRODUCTION The incidence of allergic diseases among children has been  increasing worldwide.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Philippine primary prevention of allergies103 apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.102 been proposed at different stages of early life such as in  antenatal period, early postnatal period (infancy), and early  childhood (2 years and above).",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Recto MS, et al.Asia Pacific allergy104 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.102have been prepared by the Philippine Society of Allergy, Asthma  and Immunology (PSAAI) and the Philippine Society for Pediatric  Gastroenterology, Hepatology and Nutrition (PSPGHAN).",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
Philippine primary prevention of allergies105   apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.102made.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Recto MS, et al.Asia Pacific allergy106 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.102noted not to have high levels of anti-inflammatory effects  compared to omega-3 PUFA contained in oily fish.",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
Philippine primary prevention of allergies107   apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.102There are no RCTs evaluating any specific type of maternal diet  during lactation to prevent allergic diseases in the child.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Recto MS, et al.Asia Pacific allergy108 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.102atopic dermatitis, rhinitis, infant cow milk allergy, childhood soy  protein allergy, and urticaria [56].",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Philippine primary prevention of allergies109   apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.102A RCT involving 530 infants with severe eczema, egg allergy, or  both that were given peanuts at 4–1 1 months had significantly  decreased risk for peanut allergy among children at high risk for  this allergy [67].",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Recto MS, et al.Asia Pacific allergy110 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.102the risk of developing atopy (odds ratio [OR], 1.66) and allergic  rhinitis (OR, 1.46) than those who received it irregularly or none at  all [75].",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
Philippine primary prevention of allergies111   apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.1024.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
J Aller Ther  2013;S3:005. https://doi.org/10.4172/2155-6121  .,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
https://doi.org/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Recto MS, et al.Asia Pacific allergy112 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.10227.",OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
Philippine primary prevention of allergies113   apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.10253.,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
Available from:  https://www.allergy.org.au/images/pcc/ASCIA_Guidelines_infant_ feeding_and_allergy_prevention.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"Recto MS, et al.Asia Pacific allergy114 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.102Wickman M. Early-life supplementation of vitamins A and D, in  water-soluble form or in peanut oil, and allergic diseases during  childhood.",Non-OADS,/arxiv_data1/oa_pdf/0b/93/apa-7-102.PMC5410409.pdf
"http://apallergy.org Anaphylaxis following intralesional triamcinolone  acetonide (Kenacort) injection  Wannada Laisuan1,*, Chamard Wongsa1, Nizchapha Dchapaphapeaktak1, Malinee Tongdee1,  Jidapa Chatmapanrangsee2, and Ticha Rerkpattanapipat1 1Division of Allergy, Immunology and Rheumatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand  2Department of Pharmacy, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand  Intralesional triamcinolone acetonide injection is indicated for multiple skin conditions such as keloid scars, alopecia areata, and  hypertrophic lichen planus.",Non-OADS,/arxiv_data1/oa_pdf/21/5e/apa-7-115.PMC5410410.pdf
Case Report https://doi.org/10.5415/apallergy.2017.7.2.115 Asia Pac Allergy 2017;7:115-118,Non-OADS,/arxiv_data1/oa_pdf/21/5e/apa-7-115.PMC5410410.pdf
"Laisuan W, et al.Asia Pacific allergy116 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.115chest tightness, and hypotension 2 minutes after injection.",Non-OADS,/arxiv_data1/oa_pdf/21/5e/apa-7-115.PMC5410410.pdf
"Anaphylaxis following intralesional corticosteroid injection117   apallergy.org https://doi.org/10.5415/apallergy.2017.7.2.115However, hypersensitivity reactions can occur.",Non-OADS,/arxiv_data1/oa_pdf/21/5e/apa-7-115.PMC5410410.pdf
"Laisuan W, et al.Asia Pacific allergy118 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.115triamcinolone acetonide was the causative agent in 5 out of 8  patients.",Non-OADS,/arxiv_data1/oa_pdf/21/5e/apa-7-115.PMC5410410.pdf
"http://apallergy.org Thunderstorm asthma: potential danger but a  unique opportunity Francis Thien*  Respiratory Medicine Eastern Health and Monash University, Box Hill, Victoria 3128, Australia *Correspondence:  Francis Thien  Respiratory Medicine, Eastern Health, Box Hill Hospital &  Monash University, Level 2, 5 Arnold Street, Box Hill, Victoria  3128, Australia Tel: +61-3-9095 2415 Fax: +61-3-9899 6810 E-mail: frank.thien@monash.edu Received:  April 23, 2017 Accepted:  April 23, 2017This is an Open Access article distributed under the terms of the Creative  Commons Attribution.",Non-OADS,/arxiv_data1/oa_pdf/ee/a6/apa-7-55.PMC5410411.pdf
Editorial  https://doi.org/10.5415/apallergy.2017.7.2.55 Asia Pac Allergy 2017;7:55-56 Thunderstorm asthma refers to an observed increase in  acute bronchospasm cases following the occurrence of  thunderstorms in the local vicinity.,Non-OADS,/arxiv_data1/oa_pdf/ee/a6/apa-7-55.PMC5410411.pdf
" Thien F Asia Pacific allergy56 apallergy.org  https://doi.org/10.5415/apallergy.2017.7.2.55(43%), is far in excess of that expected in the resident population,  and has not been previously described.",OADS,/arxiv_data1/oa_pdf/ee/a6/apa-7-55.PMC5410411.pdf
Available from: http://www.igem.vic.gov.au/home/ reports+and+publications/reports/review+of+response+to+the+t hunderstorm+asthma+event+of++november+2016+preliminary+ report .,Non-OADS,/arxiv_data1/oa_pdf/ee/a6/apa-7-55.PMC5410411.pdf
